[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_byId_093c1903-f357-4856-b101-e87a1be158cd":3,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:093c1903-f357-4856-b101-e87a1be158cd,\"}":117},{"code":4,"data":5,"meta":24},"SUCCESS",{"id":6,"createTime":7,"updateTime":8,"relativeEntities":9,"slug":10,"properties":11,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":26,"manageAffiliations":39,"indexDatabases":54,"url":90,"thumbnailPath":24,"statistic":91,"gsStatistic":24,"type":24,"analyzePriority":24},"093c1903-f357-4856-b101-e87a1be158cd","2023-05-29T11:08:56.331+00:00","2025-11-21T09:56:17.015+00:00",[],"Progress-in-Retinal-and-Eye-Research",{"country":12,"eissn":14,"issn":16,"title":18,"introduce":20},{"VOID":13},"GB",{"VOID":15},"18731635",{"VOID":17},"13509462",{"EN":19},"Progress in Retinal and Eye Research",{"EN":21},"By invitation leading experts write on basic and clinical aspects of the eye in a style appealing to molecular biologists, neuroscientists and physiologists, as well as to vision researchers and ophthalmologists. The journal covers all aspects of eye research, including topics pertaining to the retina and pigment pithelial layer, cornea, tears, lacrimal glands, aqueous humour, iris, ciliary body, trabeculum, lens, vitreous humour and diseases such as dry-eye, inflammation, keratoconus, corneal dystrophy, glaucoma and cataract.","PUBLISHER","PENDING",null,5,[27,33],{"id":28,"createTime":24,"updateTime":24,"relativeEntities":29,"label":30,"description":32,"parentId":24,"standard":24,"scholarHubFieldId":24},"0ac89b60-9474-4215-aa05-1a74737cce1f",[],{"EN":31},"Sensory Systems",{},{"id":34,"createTime":24,"updateTime":24,"relativeEntities":35,"label":36,"description":38,"parentId":24,"standard":24,"scholarHubFieldId":24},"2bba103c-f8d9-400d-a8f7-25c4b4d620dd",[],{"EN":37},"Ophthalmology",{},[40,47],{"id":41,"createTime":24,"updateTime":24,"relativeEntities":42,"slug":24,"properties":43,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":46,"statistic":24},"4255270c-c84d-4cec-8432-a117a0ce9d06",[],{"title":44},{"EN":45},"PERGAMON-ELSEVIER SCIENCE LTD",[],{"id":48,"createTime":24,"updateTime":24,"relativeEntities":49,"slug":24,"properties":50,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":53,"statistic":24},"cbc888ff-f0a8-49ab-90e6-8acb752d4f88",[],{"title":51},{"EN":52},"Elsevier Ltd.",[],[55,73],{"id":56,"indexDatabase":57,"url":67,"indexYears":68,"academicFieldIds":69,"indexDatabaseRanking":72},"006a10ab-97bb-4cda-9bb0-5f07a6f70043",{"id":58,"createTime":24,"updateTime":24,"relativeEntities":59,"label":60,"description":62,"key":64,"publicationTags":65,"standard":24},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9",[],{"EN":61,"VI":61},"Scopus - Elsevier",{"EN":61,"VI":63},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[66],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F15090","1994-2025",[70,71],"0192af6d-bf1a-453f-a70f-03b005c180ce","a21c376f-b412-49d2-9f93-88cd3fda9810","SCOPUS__Q1",{"id":74,"indexDatabase":75,"url":87,"indexYears":24,"academicFieldIds":88,"indexDatabaseRanking":24},"778449ef-3cb0-4fbe-b988-43c15f0b1595",{"id":76,"createTime":24,"updateTime":24,"relativeEntities":77,"label":78,"description":80,"key":83,"publicationTags":84,"standard":24},"a4921856-b128-4d9f-8f1f-e80813d3bbd4",[],{"EN":79,"VI":79},"ISI\u002FSCIE - Science Citation Index Expanded",{"EN":81,"VI":82},"SCIE database","Cơ sở dữ liệu SCIE","scie",[85,86],"SCIE","ISI","https:\u002F\u002Fmjl.clarivate.com\u002Fsearch-results?issn=1350-9462",[89],"8489dfd2-544a-4115-98eb-4c0135274297","https:\u002F\u002Fwww.journals.elsevier.com\u002Fprogress-in-retinal-and-eye-research",{"impactFactor":92,"impactFactorByYear":93,"i10Index":92,"i10IndexLast5Year":92,"totalPublication":94,"totalPublicationByYear":95,"totalCitation":92,"totalCitationByYear":115,"totalCitationPerPublication":92,"totalCitationPerPublicationByYear":116,"hindexLast5Year":92,"hindex":92},0,{},512,{"1994":96,"1995":97,"1996":98,"1997":99,"1998":100,"1999":101,"2000":102,"2001":103,"2002":104,"2003":102,"2004":100,"2005":103,"2006":105,"2007":106,"2008":98,"2009":106,"2010":97,"2011":105,"2012":104,"2013":107,"2014":105,"2015":108,"2016":108,"2017":109,"2018":110,"2019":111,"2020":112,"2021":113,"2022":114,"2023":111},12,21,9,7,8,13,15,18,16,14,10,19,22,23,29,27,20,31,24,{},{},{"meta":118,"data":120},{"total":119},"491",[121,838,983,1455,1567,1820,1927,2016,2128,2200],{"id":122,"createTime":123,"updateTime":124,"relativeEntities":125,"slug":126,"properties":127,"entityType":134,"verifyStatus":135,"verifyTime":136,"verifyNote":137,"languages":24,"translateLanguages":24,"viewCount":92,"primaryUrl":138,"fullTextUrl":24,"authors":139,"publicationType":156,"publisherRelationship":157,"citationCount":92,"citationInfo":210,"publishDate":213,"publishYear":211,"citationAnalyzeStatus":214,"lastCitationAnalyze":215,"indexDatabases":216,"openAccess":24,"references":217,"isForceReanalyzing":837},"3e4c36ae-5e55-4e2f-8054-90f6b7b5251e","2024-02-07T15:44:16.923+00:00","2026-07-20T00:19:07.945+00:00",[],"Ocular-vascular-occlusive-disorders-Natural-history-of-visual-outcome",{"title":128,"gsPaper":130,"doi":132},{"EN":129},"Ocular vascular occlusive disorders: Natural history of visual outcome",{"VOID":131},"[\"5914846740099959665\"]",{"VOID":133},"10.1016\u002Fj.preteyeres.2014.04.001","PUBLICATION","VERIFIED","2024-05-01T13:00:14.114+00:00","Auto Verify","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1350946214000251",[140],{"id":141,"sortIndex":92,"researcher":24,"roles":142,"affiliations":144,"properties":153,"displayName":155,"givenName":24,"familyName":24},"9312f632-63e7-48df-8bdf-95279e5a43d6",[143],"AUTHOR",[145],{"id":146,"sortIndex":92,"affiliation":147,"properties":24},"2cdfd223-13d5-4e66-94dd-c01a54bd4351",{"id":146,"createTime":24,"updateTime":24,"relativeEntities":148,"slug":24,"properties":149,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":152,"statistic":24},[],{"title":150},{"VI":151},"Department of Ophthalmology and Visual Sciences, College of Medicine, University of Iowa, Iowa City, IA, USA",[],{"title":154},{"VI":155},"Sohan Singh Hayreh","ARTICLE",{"url":138,"publisher":158,"properties":205},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":159,"slug":10,"properties":160,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":165,"manageAffiliations":174,"indexDatabases":185,"url":90,"thumbnailPath":24,"statistic":200,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":161,"eissn":162,"issn":163,"title":164},{"VOID":13},{"VOID":15},{"VOID":17},{"EN":19},[166,170],{"id":28,"createTime":24,"updateTime":24,"relativeEntities":167,"label":168,"description":169,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":31},{},{"id":34,"createTime":24,"updateTime":24,"relativeEntities":171,"label":172,"description":173,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":37},{},[175,180],{"id":41,"createTime":24,"updateTime":24,"relativeEntities":176,"slug":24,"properties":177,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":179,"statistic":24},[],{"title":178},{"EN":45},[],{"id":48,"createTime":24,"updateTime":24,"relativeEntities":181,"slug":24,"properties":182,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":184,"statistic":24},[],{"title":183},{"EN":52},[],[186,193],{"id":56,"indexDatabase":187,"url":67,"indexYears":68,"academicFieldIds":192,"indexDatabaseRanking":72},{"id":58,"createTime":24,"updateTime":24,"relativeEntities":188,"label":189,"description":190,"key":64,"publicationTags":191,"standard":24},[],{"EN":61,"VI":61},{"EN":61,"VI":63},[66],[70,71],{"id":74,"indexDatabase":194,"url":87,"indexYears":24,"academicFieldIds":199,"indexDatabaseRanking":24},{"id":76,"createTime":24,"updateTime":24,"relativeEntities":195,"label":196,"description":197,"key":83,"publicationTags":198,"standard":24},[],{"EN":79,"VI":79},{"EN":81,"VI":82},[85,86],[89],{"impactFactor":92,"impactFactorByYear":201,"i10Index":92,"i10IndexLast5Year":92,"totalPublication":94,"totalPublicationByYear":202,"totalCitation":92,"totalCitationByYear":203,"totalCitationPerPublication":92,"totalCitationPerPublicationByYear":204,"hindexLast5Year":92,"hindex":92},{},{"1994":96,"1995":97,"1996":98,"1997":99,"1998":100,"1999":101,"2000":102,"2001":103,"2002":104,"2003":102,"2004":100,"2005":103,"2006":105,"2007":106,"2008":98,"2009":106,"2010":97,"2011":105,"2012":104,"2013":107,"2014":105,"2015":108,"2016":108,"2017":109,"2018":110,"2019":111,"2020":112,"2021":113,"2022":114,"2023":111},{},{},{"pages":206,"volume":208},{"VOID":207},"1-25",{"VOID":209},"41",{"total":92,"publishYear":211,"statisticByYear":212},2014,{},"2014-07-01","DONE_ANALYZE_CITATION","2026-07-20T00:19:07.944+00:00",[85,72],[218,226,234,240,246,249,257,265,268,276,284,292,296,304,313,322,328,332,340,343,346,350,359,368,377,383,392,395,399,407,415,421,426,434,442,450,453,457,463,467,476,481,485,493,499,505,509,517,525,529,535,541,547,553,557,561,566,575,581,585,589,597,601,607,611,615,619,623,631,635,643,649,653,660,666,670,678,681,686,694,697,703,706,709,713,716,724,732,740,748,756,762,768,777,785,789,793,799,803,812,818,823,826,834],{"id":24,"text":219,"url":220,"identifiers":221},"Arnold, 1994, Natural history of nonarteritic anterior ischemic optic neuropathy, J. Neuroophthalmol., 14, 66, 10.1097\u002F00041327-199406000-00002","https:\u002F\u002Fdoi.org\u002F10.1097\u002F00041327-199406000-00002",{"mag":222,"openalex":223,"pm":224,"doi":225},"2024560332","W2024560332","7951929","10.1097\u002F00041327-199406000-00002",{"id":24,"text":227,"url":228,"identifiers":229},"Brown, 1982, Central retinal artery obstruction and visual acuity, Ophthalmology, 89, 14, 10.1016\u002FS0161-6420(82)34853-8","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0161-6420(82)34853-8",{"mag":230,"openalex":231,"pm":232,"doi":233},"2015490452","W2015490452","7070767","10.1016\u002Fs0161-6420(82)34853-8",{"id":24,"text":235,"url":236,"identifiers":237},"Brown, 1983, Cilioretinal artery obstruction, Retina, 3, 182, 10.1097\u002F00006982-198300330-00007","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fb978-0-323-75772-0.00035-3",{"openalex":238,"doi":239},"W4205117634","10.1016\u002Fb978-0-323-75772-0.00035-3",{"id":241,"text":242,"url":243,"identifiers":244},"4c68646b-0035-4279-8000-0006b275d4fa","Chen, 1995, Natural course of perfused central retinal vein occlusion, Can. J. Ophthalmol., 30, 21","https:\u002F\u002Flink.springer.com\u002F10.1007\u002Fs10440-022-00541-7",{"doi":245},"10.1007\u002Fs10440-022-00541-7",{"id":241,"text":247,"url":243,"identifiers":248},"Chopdar, 1982, Hemi-central retinal vein occlusion. Pathogenesis, clinical features, natural history and incidence of dual trunk central retinal vein, Trans. Ophthalmol. Soc. U. K., 102, 241",{"doi":245},{"id":24,"text":250,"url":251,"identifiers":252},"Chopdar, 1984, Dual trunk central retinal vein incidence in clinical practice, Arch. Ophthalmol., 102, 85, 10.1001\u002Farchopht.1984.01040030069038","https:\u002F\u002Fdoi.org\u002F10.1001\u002Farchopht.1984.01040030069038",{"mag":253,"openalex":254,"pm":255,"doi":256},"1972900537","W1972900537","6703973","10.1001\u002Farchopht.1984.01040030069038",{"id":24,"text":258,"url":259,"identifiers":260},"Chopdar, 1986, Hemispheric retinal vein occlusion or hemicentral retinal vein occlusion, Arch. Ophthalmol., 104, 1128, 10.1001\u002Farchopht.1986.01050200034028","https:\u002F\u002Fdoi.org\u002F10.1001\u002Farchopht.1986.01050200034028",{"mag":261,"openalex":262,"pm":263,"doi":264},"2074226890","W2074226890","3741234","10.1001\u002Farchopht.1986.01050200034028",{"id":241,"text":266,"url":243,"identifiers":267},"Clemett, 1973, The visual prognosis in retinal branch vein occlusion, Trans. Ophthalmol. Soc. U. K., 93, 523",{"doi":245},{"id":24,"text":269,"url":270,"identifiers":271},"David, 1967, Fluorescein angiography in central retinal artery occlusion, Arch. Ophthalmol., 77, 619, 10.1001\u002Farchopht.1967.00980020621010","https:\u002F\u002Fdoi.org\u002F10.1001\u002Farchopht.1967.00980020621010",{"mag":272,"openalex":273,"pm":274,"doi":275},"2060423738","W2060423738","6022731","10.1001\u002Farchopht.1967.00980020621010",{"id":24,"text":277,"url":278,"identifiers":279},"Fineman, 1996, Branch retinal artery occlusion as the initial sign of giant cell arteritis, Am. J. Ophthalmol., 122, 428, 10.1016\u002FS0002-9394(14)72073-2","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0002-9394(14)72073-2",{"mag":280,"openalex":281,"pm":282,"doi":283},"2046179216","W2046179216","8794719","10.1016\u002Fs0002-9394(14)72073-2",{"id":24,"text":285,"url":286,"identifiers":287},"Finkelstein, 1992, Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion, Arch. Ophthalmol., 110, 1427, 10.1001\u002Farchopht.1992.01080220089028","https:\u002F\u002Fdoi.org\u002F10.1001\u002Farchopht.1992.01080220089028",{"mag":288,"openalex":289,"pm":290,"doi":291},"2053662423","W2053662423","1417544","10.1001\u002Farchopht.1992.01080220089028",{"id":24,"text":293,"url":24,"identifiers":294},"Fong, 1992, Central retinal vein occlusion in young adults (papillophlebitis), Retina, 12, 3, 10.1097\u002F00006982-199212010-00002",{"doi":295},"10.1097\u002F00006982-199212010-00002",{"id":24,"text":297,"url":298,"identifiers":299},"Garcia-Arumi, 2003, Chorioretinal anastomosis after radial optic neurotomy for central retinal vein occlusion, Arch. Ophthalmol., 121, 1385, 10.1001\u002Farchopht.121.10.1385","https:\u002F\u002Fdoi.org\u002F10.1001\u002Farchopht.121.10.1385",{"mag":300,"openalex":301,"pm":302,"doi":303},"2123167267","W2123167267","14557173","10.1001\u002Farchopht.121.10.1385",{"id":24,"text":305,"url":306,"identifiers":307},"Garcia-Arumi, 2006, Surgical embolus removal in retinal artery occlusion, Br. J. Ophthalmol., 90, 1252, 10.1136\u002Fbjo.2006.097642","https:\u002F\u002Fdoi.org\u002F10.1136\u002Fbjo.2006.097642",{"mag":308,"pmc":309,"openalex":310,"pm":311,"doi":312},"2123804918","1857432","W2123804918","16854826","10.1136\u002Fbjo.2006.097642",{"id":24,"text":314,"url":315,"identifiers":316},"Giuffré, 1993, Optociliary veins and central retinal vein occlusion, Br. J. Ophthalmol., 77, 774, 10.1136\u002Fbjo.77.12.774","https:\u002F\u002Fdoi.org\u002F10.1136\u002Fbjo.77.12.774",{"mag":317,"pmc":318,"openalex":319,"pm":320,"doi":321},"2091309853","504653","W2091309853","8110670","10.1136\u002Fbjo.77.12.774",{"id":323,"text":324,"url":325,"identifiers":326},"f21743d1-5cab-48db-ad2e-f29a2adade9f","Giuffré, 1992, Central retinal vein occlusion in young people, Doc. Ophthalmol., 80, 127, 10.1007\u002FBF00161238","https:\u002F\u002Flink.springer.com\u002Farticle\u002F10.1007\u002FBF00161238",{"doi":327},"10.1007\u002FBF00161238",{"id":24,"text":329,"url":24,"identifiers":330},"Glacet-Bernard, 1996, Prognostic factors for retinal vein occlusion: prospective study of 175 cases, Ophthalmology, 103, 551, 10.1016\u002FS0161-6420(96)30653-2",{"doi":331},"10.1016\u002FS0161-6420(96)30653-2",{"id":24,"text":333,"url":334,"identifiers":335},"Gómez-Ulla de Irazazabal, 1986, Hemispheric retinal branch vein occlusions, Ophthalmologica, 193, 14, 10.1159\u002F000309673","https:\u002F\u002Fdoi.org\u002F10.1159\u002F000309673",{"mag":336,"openalex":337,"pm":338,"doi":339},"2067294531","W2067294531","3822392","10.1159\u002F000309673",{"id":24,"text":341,"url":24,"identifiers":342},"Green, 1981, Central vein occlusion: a prospective histological study of 29 eyes in 28 cases, Trans. Am. Ophthalmol. Soc., 79, 371",{},{"id":24,"text":344,"url":24,"identifiers":345},"Hayreh, 1958",{},{"id":24,"text":347,"url":24,"identifiers":348},"Hayreh, 1963, The cilio-retinal arteries, Br. J. Ophthalmol., 47, 71, 10.1136\u002Fbjo.47.2.71",{"doi":349},"10.1136\u002Fbjo.47.2.71",{"id":24,"text":351,"url":352,"identifiers":353},"Hayreh, 1965, Occlusion of the central retinal vessels, Br. J. Ophthalmol., 49, 626, 10.1136\u002Fbjo.49.12.626","https:\u002F\u002Fdoi.org\u002F10.1136\u002Fbjo.49.12.626",{"mag":354,"pmc":355,"openalex":356,"pm":357,"doi":358},"2112404146","506176","W2112404146","4954984","10.1136\u002Fbjo.49.12.626",{"id":24,"text":360,"url":361,"identifiers":362},"Hayreh, 1969, Blood supply of the optic nerve head and its role in optic atrophy, glaucoma and oedema of the optic disc, Br. J. Ophthalmol., 53, 72l, 10.1136\u002Fbjo.53.11.721","https:\u002F\u002Fdoi.org\u002F10.1136\u002Fbjo.53.11.721",{"mag":363,"pmc":364,"openalex":365,"pm":366,"doi":367},"1965464815","506749","W1965464815","4982590","10.1136\u002Fbjo.53.11.721",{"id":24,"text":369,"url":370,"identifiers":371},"Hayreh, 1970, Pathogenesis of visual field defects – role of the ciliary circulation, Br. J. Ophthalmol., 54, 289, 10.1136\u002Fbjo.54.5.289","https:\u002F\u002Fdoi.org\u002F10.1136\u002Fbjo.54.5.289",{"mag":372,"pmc":373,"openalex":374,"pm":375,"doi":376},"2068700054","1207817","W2068700054","4987892","10.1136\u002Fbjo.54.5.289",{"id":378,"text":379,"url":380,"identifiers":381},"d175b2c2-4a19-435a-9d7b-e30441514e0f","Hayreh, 1971, Pathogenesis of occlusion of the central retinal vessels, Am. J. Ophthalmol., 72, 998, 10.1016\u002F0002-9394(71)91706-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F0002939471917065",{"doi":382},"10.1016\u002F0002-9394(71)91706-5",{"id":24,"text":384,"url":385,"identifiers":386},"Hayreh, 1974, Anterior ischaemic optic neuropathy II. Fundus on ophthalmoscopy and fluorescein angiography, Br. J. Ophthalmol., 58, 964, 10.1136\u002Fbjo.58.12.964","https:\u002F\u002Fdoi.org\u002F10.1136\u002Fbjo.58.12.964",{"mag":387,"pmc":388,"openalex":389,"pm":390,"doi":391},"2067438085","1215076","W2067438085","4376416","10.1136\u002Fbjo.58.12.964",{"id":24,"text":393,"url":24,"identifiers":394},"Hayreh, 1974, Central retinal vascular occlusion: morphology and pathogenesis, 15",{},{"id":24,"text":396,"url":24,"identifiers":397},"Hayreh, 1976, So-called “central retinal vein occlusion”: 1. Pathogenesis, terminology, clinical features, Ophthalmologica, 172, 1, 10.1159\u002F000307579",{"doi":398},"10.1159\u002F000307579",{"id":24,"text":400,"url":401,"identifiers":402},"Hayreh, 1981, Anterior ischemic optic neuropathy, Arch Neurol., 38, 675, 10.1001\u002Farchneur.1981.00510110035002","https:\u002F\u002Fpubmed.ncbi.nlm.nih.gov\u002F7305693",{"mag":403,"openalex":404,"pm":405,"doi":406},"2091397664","W2091397664","7305693","10.1001\u002Farchneur.1981.00510110035002",{"id":24,"text":408,"url":409,"identifiers":410},"Hayreh, 1983, Classification of central retinal vein occlusion, Ophthalmology, 90, 458, 10.1016\u002FS0161-6420(83)34530-9","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0161-6420(83)34530-9",{"mag":411,"openalex":412,"pm":413,"doi":414},"2133150079","W2133150079","6877778","10.1016\u002Fs0161-6420(83)34530-9",{"id":416,"text":417,"url":418,"identifiers":419},"d900d7f2-e94d-44d7-a46e-8214ac531d33","Hayreh, 1990, Anterior ischaemic optic neuropathy: differentiation of arteritic from non-arteritic type and its management, Eye, 4, 25, 10.1038\u002Feye.1990.4","https:\u002F\u002Fwww.nature.com\u002Farticles\u002Feye19904",{"doi":420},"10.1038\u002Feye.1990.4",{"id":24,"text":422,"url":423,"identifiers":424},"Hayreh, 1998, Central retinal vein occlusion, Ophthalmol. Clin. North Am., 11, 559, 10.1016\u002FS0896-1549(05)70079-1","http:\u002F\u002Fdx.doi.org\u002F10.5005\u002Fjp\u002Fbooks\u002F11238_16",{"doi":425},"10.5005\u002Fjp\u002Fbooks\u002F11238_16",{"id":24,"text":427,"url":428,"identifiers":429},"Hayreh, 1999, Retinal arterial occlusion with LIF using rTPA, Ophthalmology, 106, 1236, 10.1016\u002FS0161-6420(99)10101-5","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0161-6420(99)10101-5",{"mag":430,"openalex":431,"pm":432,"doi":433},"1500558262","W1500558262","10406599","10.1016\u002Fs0161-6420(99)10101-5",{"id":24,"text":435,"url":436,"identifiers":437},"Hayreh, 2004, Posterior ischaemic optic neuropathy: clinical features, pathogenesis and management, Eye, 18, 1188, 10.1038\u002Fsj.eye.6701562","https:\u002F\u002Fdoi.org\u002F10.1038\u002Fsj.eye.6701562",{"mag":438,"openalex":439,"pm":440,"doi":441},"2017443832","W2017443832","15534605","10.1038\u002Fsj.eye.6701562",{"id":24,"text":443,"url":444,"identifiers":445},"Hayreh, 2005, Prevalent misconceptions about acute retinal vascular occlusive disorders, Prog. Retin. Eye Res., 24, 493, 10.1016\u002Fj.preteyeres.2004.12.001","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.preteyeres.2004.12.001",{"mag":446,"openalex":447,"pm":448,"doi":449},"2071206465","W2071206465","15845346","10.1016\u002Fj.preteyeres.2004.12.001",{"id":241,"text":451,"url":243,"identifiers":452},"Hayreh, 2007, Surgical embolus removal in retinal artery occlusion, Br. J. Ophthalmol., 91, 1096",{"doi":245},{"id":24,"text":454,"url":24,"identifiers":455},"Hayreh, 2008, Restoration of retinal blood flow via translumenal Nd:YAG embolysis\u002Fembolectomy (TYL\u002FE) for central and branch retinal artery occlusion, Retina, 28, 1369, 10.1097\u002FIAE.0b013e3181846640",{"doi":456},"10.1097\u002FIAE.0b013e3181846640",{"id":458,"text":459,"url":460,"identifiers":461},"7c2974fd-de89-43cf-b179-ec4a05dedd7e","Hayreh, 2009, Ischemic optic neuropathy, Prog Retin Eye Res., 28, 34, 10.1016\u002Fj.preteyeres.2008.11.002","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1350946208000761",{"doi":462},"10.1016\u002Fj.preteyeres.2008.11.002",{"id":24,"text":464,"url":24,"identifiers":465},"Hayreh, 2012, Treatment of acute visual loss in giant cell arteritis: should we prescribe high-dose intravenous steroids or just oral steroids?, J. Neuroophthamol., 32, 278, 10.1097\u002FWNO.0b013e3182688218",{"doi":466},"10.1097\u002FWNO.0b013e3182688218",{"id":24,"text":468,"url":469,"identifiers":470},"Hayreh, 1972, Occlusion of the posterior ciliary artery II. Chorio-retinal lesions, Br. J. Ophthalmol., 56, 736, 10.1136\u002Fbjo.56.10.736","https:\u002F\u002Fdoi.org\u002F10.1136\u002Fbjo.56.10.736",{"mag":471,"pmc":472,"openalex":473,"pm":474,"doi":475},"1982684195","1214711","W1982684195","4679697","10.1136\u002Fbjo.56.10.736",{"id":24,"text":477,"url":478,"identifiers":479},"Hayreh, 1972, Occlusion of the posterior ciliary artery III. Effects on the optic nerve head, Br. J. Ophthalmol., 56, 754, 10.1136\u002Fbjo.56.10.754","http:\u002F\u002Fdx.doi.org\u002F10.1136\u002Fbjo.56.10.754",{"doi":480},"10.1136\u002Fbjo.56.10.754",{"id":24,"text":482,"url":24,"identifiers":483},"Hayreh, 1982, Occlusion of the posterior ciliary artery V. Protective influence of simultaneous vortex vein occlusion, Arch. Ophthalmol., 100, 1481, 10.1001\u002Farchopht.1982.01030040459019",{"doi":484},"10.1001\u002Farchopht.1982.01030040459019",{"id":24,"text":486,"url":487,"identifiers":488},"Hayreh, 2008, Central retinal vein occlusion associated with cilioretinal artery occlusion, Retina, 28, 581, 10.1097\u002FIAE.0b013e31815ec29b","https:\u002F\u002Fdoi.org\u002F10.1097\u002Fiae.0b013e31815ec29b",{"mag":489,"openalex":490,"pm":491,"doi":492},"1965781272","W1965781272","18398361","10.1097\u002Fiae.0b013e31815ec29b",{"id":494,"text":495,"url":496,"identifiers":497},"ca3782bf-50ce-4e20-9307-b87677490b25","Hayreh, 1980, Hemi-central retinal vein occlusion. Pathogenesis, clinical features, and natural history, Arch. Ophthalmol., 98, 1600, 10.1001\u002Farchopht.1980.01020040452011","http:\u002F\u002Farchopht.jamanetwork.com\u002Farticle.aspx?doi=10.1001\u002Farchopht.1980.01020040452011",{"doi":498},"10.1001\u002Farchopht.1980.01020040452011",{"id":500,"text":501,"url":502,"identifiers":503},"661c2529-c8ff-41a7-87f4-2173834483f5","Hayreh, 2000, Optic disk and retinal nerve fiber layer damage after transient central retinal artery occlusion: an experimental study in rhesus monkeys, Am. J. Ophthalmol., 129, 786, 10.1016\u002FS0002-9394(00)00384-6","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0002939400003846",{"doi":504},"10.1016\u002Fs0002-9394(00)00384-6",{"id":24,"text":506,"url":24,"identifiers":507},"Hayreh, 1994, Systemic diseases associated with non-arteritic anterior ischemic optic neuropathy, Am. J. Ophthalmol., 118, 766, 10.1016\u002FS0002-9394(14)72557-7",{"doi":508},"10.1016\u002FS0002-9394(14)72557-7",{"id":24,"text":510,"url":511,"identifiers":512},"Hayreh, 1990, Differentiation of ischemic from non-ischemic central retinal vein occlusion during the early acute phase, Graefes Arch. Clin. Exp. Ophthalmol., 228, 201, 10.1007\u002FBF00920022","https:\u002F\u002Fdoi.org\u002F10.1007\u002Fbf00920022",{"mag":513,"openalex":514,"pm":515,"doi":516},"1974030864","W1974030864","2361592","10.1007\u002Fbf00920022",{"id":24,"text":518,"url":519,"identifiers":520},"Hayreh, 1980, Central retinal artery occlusion and retinal tolerance time, Ophthalmology, 87, 75, 10.1016\u002FS0161-6420(80)35283-4","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0161-6420(80)35283-4",{"mag":521,"openalex":522,"pm":523,"doi":524},"2068836232","W2068836232","6769079","10.1016\u002Fs0161-6420(80)35283-4",{"id":24,"text":526,"url":24,"identifiers":527},"Hayreh, 1982, Ocular neovascularization with retinal vascular occlusion II. Occurrence in central and branch retinal artery occlusion, Arch. Ophthalmol., 100, 1585, 10.1001\u002Farchopht.1982.01030040563002",{"doi":528},"10.1001\u002Farchopht.1982.01030040563002",{"id":530,"text":531,"url":532,"identifiers":533},"25f1c492-de26-46f9-ab01-3193969b5076","Hayreh, 1998, Ocular manifestations of giant cell arteritis, Am. J. Ophthalmol., 125, 509, 10.1016\u002FS0002-9394(99)80192-5","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0002939499801925",{"doi":534},"10.1016\u002Fs0002-9394(99)80192-5",{"id":536,"text":537,"url":538,"identifiers":539},"b5078506-c6c9-4740-909f-d150c282d0bc","Hayreh, 2009, Branch retinal artery occlusion: natural history of visual outcome, Ophthalmology, 116, 1188, 10.1016\u002Fj.ophtha.2009.01.015","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0161642009000426",{"doi":540},"10.1016\u002Fj.ophtha.2009.01.015",{"id":542,"text":543,"url":544,"identifiers":545},"3994908d-fe78-422d-a674-963bb9b181bb","Hayreh, 2011, Natural history of visual outcome in central retinal vein occlusion, Ophthalmology, 118, 119, 10.1016\u002Fj.ophtha.2010.04.019","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0161642010004471",{"doi":546},"10.1016\u002Fj.ophtha.2010.04.019",{"id":548,"text":549,"url":550,"identifiers":551},"4451a005-5bcb-4864-98d2-dabb1b127267","Hayreh, 2011, Central and hemi-central retinal vein occlusion: role of anti-platelet aggregation agents and anticoagulant, Ophthalmology, 118, 1603, 10.1016\u002Fj.ophtha.2011.04.036","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0161642011004234",{"doi":552},"10.1016\u002Fj.ophtha.2011.04.036",{"id":24,"text":554,"url":24,"identifiers":555},"Hayreh, 1983, Ocular neovascularization with retinal vascular occlusion III. Incidence of ocular neovascularization with retinal vein occlusion, Ophthalmology, 90, 488, 10.1016\u002FS0161-6420(83)34542-5",{"doi":556},"10.1016\u002FS0161-6420(83)34542-5",{"id":24,"text":558,"url":24,"identifiers":559},"Hayreh, 1978, Experimental retinal vascular occlusion I. Pathogenesis of central retinal vein occlusion, Arch. Ophthalmol., 96, 311, 10.1001\u002Farchopht.1978.03910050179015",{"doi":560},"10.1001\u002Farchopht.1978.03910050179015",{"id":24,"text":562,"url":563,"identifiers":564},"Hayreh, 1980, Experimental occlusion of the central artery of the retina l. Ophthalmoscopic and fluorescein fundus angiographic studies, Br. J. Ophthalmol., 64, 896, 10.1136\u002Fbjo.64.12.896","http:\u002F\u002Fdx.doi.org\u002F10.1136\u002Fbjo.64.12.896",{"doi":565},"10.1136\u002Fbjo.64.12.896",{"id":24,"text":567,"url":568,"identifiers":569},"Hayreh, 1980, Experimental occlusion of the central artery of the retina IV. Retinal tolerance time to acute ischaemia, Br. J. Ophthalmol., 64, 818, 10.1136\u002Fbjo.64.11.818","https:\u002F\u002Fdoi.org\u002F10.1136\u002Fbjo.64.11.818",{"mag":570,"pmc":571,"openalex":572,"pm":573,"doi":574},"2039799564","1043826","W2039799564","7426553","10.1136\u002Fbjo.64.11.818",{"id":576,"text":577,"url":578,"identifiers":579},"9b9ee1e5-8980-4285-bdc9-9f7570fe017e","Hayreh, 2003, Visual deterioration in giant cell arteritis patients while on high doses of corticosteroid therapy, Ophthalmology, 110, 1204, 10.1016\u002FS0161-6420(03)00228-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0161642003002288",{"doi":580},"10.1016\u002Fs0161-6420(03)00228-8",{"id":24,"text":582,"url":24,"identifiers":583},"Hayreh, 2003, Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies, Ophthalmologica, 217, 239, 10.1159\u002F000070631",{"doi":584},"10.1159\u002F000070631",{"id":24,"text":586,"url":24,"identifiers":587},"Hayreh, 2005, Visual field abnormalities in nonarteritic anterior ischemic optic neuropathy: their pattern and prevalence at initial presentation, Arch. Ophthalmol., 123, 1554, 10.1001\u002Farchopht.123.11.1554",{"doi":588},"10.1001\u002Farchopht.123.11.1554",{"id":24,"text":590,"url":591,"identifiers":592},"Hayreh, 2005, Central retinal artery occlusion: visual outcome, Am. J. Ophthalmol., 140, 376, 10.1016\u002Fj.ajo.2005.03.038","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.ajo.2005.03.038",{"mag":593,"openalex":594,"pm":595,"doi":596},"1971502700","W1971502700","16138997","10.1016\u002Fj.ajo.2005.03.038",{"id":24,"text":598,"url":24,"identifiers":599},"Hayreh, 2007, Fundus changes in central retinal artery occlusion, Retina, 27, 276, 10.1097\u002F01.iae.0000238095.97104.9b",{"doi":600},"10.1097\u002F01.iae.0000238095.97104.9b",{"id":602,"text":603,"url":604,"identifiers":605},"fc9fc514-7bf9-4753-95a7-4bbf897bde9b","Hayreh, 2008, Non-arteritic anterior ischemic optic neuropathy: natural history of visual outcome, Ophthalmology, 115, 298, 10.1016\u002Fj.ophtha.2007.05.027","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0161642007005799",{"doi":606},"10.1016\u002Fj.ophtha.2007.05.027",{"id":24,"text":608,"url":24,"identifiers":609},"Hayreh, 2012, Hemi-central retinal vein occlusion: natural history of visual outcome, Retina, 32, 68, 10.1097\u002FIAE.0b013e31821801f5",{"doi":610},"10.1097\u002FIAE.0b013e31821801f5",{"id":24,"text":612,"url":24,"identifiers":613},"Hayreh, 2012, Ocular neovascularization associated with central and hemi-central retinal vein occlusion, Retina, 32, 1553, 10.1097\u002FIAE.0b013e318246912c",{"doi":614},"10.1097\u002FIAE.0b013e318246912c",{"id":24,"text":616,"url":24,"identifiers":617},"Hayreh, 2014, Branch retinal vein occlusion: natural history of visual outcome, JAMA Ophthalmol., 132, 3, 10.1001\u002Fjamaophthalmol.2013.5515",{"doi":618},"10.1001\u002Fjamaophthalmol.2013.5515",{"id":24,"text":620,"url":24,"identifiers":621},"Hayreh, 2014, Amaurosis fugax in ocular vascular occlusive disorders: prevalence and pathogeneses, Retina, 34, 115, 10.1097\u002FIAE.0b013e31829234b5",{"doi":622},"10.1097\u002FIAE.0b013e31829234b5",{"id":24,"text":624,"url":625,"identifiers":626},"Hayreh, 2002, Visual improvement with corticosteroid therapy in giant cell arteritis: report of a large study and review of literature, Acta Ophthalmol. Scand., 80, 355, 10.1034\u002Fj.1600-0420.2002.800403.x","https:\u002F\u002Fdoi.org\u002F10.1034\u002Fj.1600-0420.2002.800403.x",{"mag":627,"openalex":628,"pm":629,"doi":630},"2061202079","W2061202079","12190776","10.1034\u002Fj.1600-0420.2002.800403.x",{"id":24,"text":632,"url":24,"identifiers":633},"Hayreh, 2004, Central retinal artery occlusion. Retinal survival time, Exp. Eye Res., 78, 723, 10.1016\u002FS0014-4835(03)00214-8",{"doi":634},"10.1016\u002FS0014-4835(03)00214-8",{"id":24,"text":636,"url":637,"identifiers":638},"Hayreh, 1994, Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics, Am. J. Ophthalmol., 117, 429, 10.1016\u002FS0002-9394(14)70001-7","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0002-9394(14)70001-7",{"mag":639,"openalex":640,"pm":641,"doi":642},"2038247586","W2038247586","8154523","10.1016\u002Fs0002-9394(14)70001-7",{"id":644,"text":645,"url":646,"identifiers":647},"a3c5bf86-6add-4e93-98fe-e3c6df255d22","Heier, 2014, Intravitreal Aflibercept injection for macular edema due to Central retinal vein occlusion: two-year results from the COPERNICUS study, Ophthalmology, 10.1016\u002Fj.ophtha.2014.01.027","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0161642014000712",{"doi":648},"10.1016\u002Fj.ophtha.2014.01.027",{"id":24,"text":650,"url":24,"identifiers":651},"Ischemic Optic Neuropathy Decompression Trial Research Group, 2000, Ischemic optic neuropathy decompression trial: twenty-four-month update, Arch. Ophthalmol., 118, 793, 10.1001\u002Farchopht.118.6.793",{"doi":652},"10.1001\u002Farchopht.118.6.793",{"id":24,"text":654,"url":655,"identifiers":656},"Ischemic Optic Neuropathy Decompression Trial Research Group, 1995, Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful, J. Am. Med. Assoc., 273, 625, 10.1001\u002Fjama.1995.03520320035038","https:\u002F\u002Fdoi.org\u002F10.1001\u002Fjama.1995.03520320035038",{"mag":657,"openalex":658,"doi":659},"2132661211","W2132661211","10.1001\u002Fjama.1995.03520320035038",{"id":661,"text":662,"url":663,"identifiers":664},"f4bbafc6-3f9d-4728-b910-b4dcea41b919","Juarez, 1986, Experimental retinal vascular occlusion II. A clinico-pathologic correlative study of simultaneous occlusion of central retinal vein and artery, Int. Ophthalmol., 9, 77, 10.1007\u002FBF00159836","https:\u002F\u002Flink.springer.com\u002Farticle\u002F10.1007\u002FBF00159836",{"doi":665},"10.1007\u002FBF00159836",{"id":24,"text":667,"url":24,"identifiers":668},"Juarez, 1986, Experimental retinal vascular occlusion III. An ultrastructural study of simultaneous occlusion of central retinal vein and artery, Int. Ophthalmol., 9, 89, 10.1007\u002FBF00159837",{"doi":669},"10.1007\u002FBF00159837",{"id":24,"text":671,"url":672,"identifiers":673},"Kwon, 2005, Vitreous and retinal amino acid concentrations in experimental central retinal artery occlusion in the primate, Eye, 9, 455, 10.1038\u002Fsj.eye.6701546","https:\u002F\u002Fdoi.org\u002F10.1038\u002Fsj.eye.6701546",{"mag":674,"openalex":675,"pm":676,"doi":677},"2002251243","W2002251243","15184939","10.1038\u002Fsj.eye.6701546",{"id":24,"text":679,"url":24,"identifiers":680},"Mann, 1969, 228",{},{"id":24,"text":682,"url":683,"identifiers":684},"Mason, 2007, Trans-luminal nd: YAG laser embolysis for branch retinal artery occlusion, Retina, 27, 573, 10.1097\u002FIAE.0b013e3180546c4d","http:\u002F\u002Fdx.doi.org\u002F10.1097\u002Fmd.0000000000027984",{"doi":685},"10.1097\u002Fmd.0000000000027984",{"id":24,"text":687,"url":688,"identifiers":689},"Mason, 2008, Branch retinal artery occlusion: visual prognosis, Am. J. Ophthalmol., 46, 455, 10.1016\u002Fj.ajo.2008.05.009","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.ajo.2008.05.009",{"mag":690,"openalex":691,"pm":692,"doi":693},"2075511895","W2075511895","18599018","10.1016\u002Fj.ajo.2008.05.009",{"id":24,"text":695,"url":24,"identifiers":696},"Michel, 1878, Ueber die anatomischen Ursachen von Veranderungen des Augenhintergrundes bei einigen Allgemeinerkrankungen, Dtsch. Arch. Klin. Med., 22, 339",{},{"id":698,"text":699,"url":700,"identifiers":701},"532230cd-def0-40df-8c04-189a6c85a780","Mizener, 1997, Ocular ischemic syndrome, Ophthalmology, 104, 859, 10.1016\u002FS0161-6420(97)30221-8","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0161642097302218",{"doi":702},"10.1016\u002FS0161-6420(97)30221-8",{"id":241,"text":704,"url":243,"identifiers":705},"Moore, 1924, Retinal venous thrombosis. A clinical study of sixty-two cases followed over many years, Br. J. Ophthalmol., 2, 4",{"doi":245},{"id":24,"text":707,"url":24,"identifiers":708},"Oeller, 1896",{},{"id":24,"text":710,"url":24,"identifiers":711},"Opremcak, 2008, Restoration of retinal blood flow via traslumenal Nd:YAG embolysis\u002Fembolectomy (TYL\u002FE) for central and branch retinal artery occlusion, Retina, 28, 226, 10.1097\u002FIAE.0b013e31814b1d6e",{"doi":712},"10.1097\u002FIAE.0",{"id":241,"text":714,"url":243,"identifiers":715},"Parodi, 1992, Hemicentral and hemispheric retinal vein occlusions, Metab. Pediatr. Syst. Ophthalmol., 15, 64",{"doi":245},{"id":24,"text":717,"url":718,"identifiers":719},"Petrig, 1999, Laser Doppler flowmetry and optic nerve head blood flow, Am. J. Ophthalmol., 127, 413, 10.1016\u002FS0002-9394(98)00437-1","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0002-9394(98)00437-1",{"mag":720,"openalex":721,"pm":722,"doi":723},"1987723673","W1987723673","10218694","10.1016\u002Fs0002-9394(98)00437-1",{"id":24,"text":725,"url":726,"identifiers":727},"Priluck, 1980, Long-term follow-up of occlusion of the central retinal vein in young adults, Am. J. Ophthalmol., 90, 190, 10.1016\u002FS0002-9394(14)74853-6","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0002-9394(14)74853-6",{"mag":728,"openalex":729,"pm":730,"doi":731},"2063641742","W2063641742","6158866","10.1016\u002Fs0002-9394(14)74853-6",{"id":24,"text":733,"url":734,"identifiers":735},"Quinlan, 1990, The natural course of central retinal vein occlusion, Am. J. Ophthalmol., 110, 118, 10.1016\u002FS0002-9394(14)76979-X","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0002-9394(14)76979-x",{"mag":736,"openalex":737,"pm":738,"doi":739},"2014434030","W2014434030","2378375","10.1016\u002Fs0002-9394(14)76979-x",{"id":24,"text":741,"url":742,"identifiers":743},"Repka, 1983, Clinical profile and long-term implications of anterior ischemic optic neuropathy, Am. J. Ophthalmol., 96, 478, 10.1016\u002FS0002-9394(14)77911-5","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0002-9394(14)77911-5",{"mag":744,"openalex":745,"pm":746,"doi":747},"2058631417","W2058631417","6624829","10.1016\u002Fs0002-9394(14)77911-5",{"id":24,"text":749,"url":750,"identifiers":751},"Richard, 1999, Treatment of retinal arterial occlusion with local fibrinolysis using recombinant tissue plasminogen activator, Ophthalmology, 106, 768, 10.1016\u002FS0161-6420(99)90165-3","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fs0161-6420(99)90165-3",{"mag":752,"openalex":753,"pm":754,"doi":755},"2000393406","W2000393406","10201601","10.1016\u002Fs0161-6420(99)90165-3",{"id":24,"text":757,"url":758,"identifiers":759},"Rogers, 2010, Natural history of branch retinal vein occlusion: an evidence-based systematic review, Ophthalmology, 117, 1094, 10.1016\u002Fj.ophtha.2010.01.058","https:\u002F\u002Fdoi.org\u002F10.1016\u002Fj.ophtha.2010.01.058",{"openalex":760,"doi":761},"W4243694564","10.1016\u002Fj.ophtha.2010.01.058",{"id":763,"text":764,"url":765,"identifiers":766},"1cba40bf-1eff-4117-9ee9-10a9dd85a42d","Sanborn, 1984, Characteristics of the hemispheric retinal vein occlusion, Ophthalmology, 91, 1616, 10.1016\u002FS0161-6420(84)34111-2","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0161642084341112",{"doi":767},"10.1016\u002Fs0161-6420(84)34111-2",{"id":24,"text":769,"url":770,"identifiers":771},"Sawle, 1990, The natural history of non-arteritic anterior ischaemic optic neuropathy, J. Neurol. Neurosurg. Psychiatry, 53, 830, 10.1136\u002Fjnnp.53.10.830","https:\u002F\u002Fdoi.org\u002F10.1136\u002Fjnnp.53.10.830",{"mag":772,"pmc":773,"openalex":774,"pm":775,"doi":776},"2040177289","488241","W2040177289","2266361","10.1136\u002Fjnnp.53.10.830",{"id":24,"text":778,"url":779,"identifiers":780},"Sergott, 1989, Optic nerve decompression may improve the progressive form of nonarteritic ischemic optic neuropathy, Arch. Ophthalmol., 107, 1743, 10.1001\u002Farchopht.1989.01070020825022","https:\u002F\u002Fdoi.org\u002F10.1001\u002Farchopht.1989.01070020825022",{"mag":781,"openalex":782,"pm":783,"doi":784},"1982425033","W1982425033","2597065","10.1001\u002Farchopht.1989.01070020825022",{"id":24,"text":786,"url":24,"identifiers":787},"Singh, 1960, The central artery of the retina I. Origin and course, Br. J. Ophthalmol., 44, 193, 10.1136\u002Fbjo.44.4.193",{"doi":788},"10.1136\u002Fbjo.44.4.193",{"id":24,"text":790,"url":24,"identifiers":791},"Singh, 1960, The central artery of the retina II. Distribution and anastomoses, Br. J. Ophthalmol., 44, 280, 10.1136\u002Fbjo.44.5.280",{"doi":792},"10.1136\u002Fbjo.44.5.280",{"id":794,"text":795,"url":796,"identifiers":797},"fc3e3b1f-e232-422f-9d30-c8057284db31","The Branch Vein Occlusion Study Group, 1984, Argon laser photocoagulation for macular edema in branch retinal vein occlusion, Am. J. Ophthalmol., 98, 271, 10.1016\u002F0002-9394(84)90316-7","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002F0002939484903167",{"doi":798},"10.1016\u002F0002-9394(84)90316-7",{"id":24,"text":800,"url":24,"identifiers":801},"The Central Vein Occlusion Study Group, 1997, Natural history and clinical management of central retinal vein occlusion, Arch. Ophthalmol., 115, 486, 10.1001\u002Farchopht.1997.01100150488006",{"doi":802},"10.1001\u002Farchopht.1997.01100150488006",{"id":24,"text":804,"url":805,"identifiers":806},"The SCORE Study Research Group, 2009, A randomized trial comparing the efficacy and safety of intravitreal triamcinolone with observation to treat vision loss associated with macular edema secondary to central retinal vein occlusion, Arch. Ophthalmol., 127, 1101, 10.1001\u002Farchophthalmol.2009.234","https:\u002F\u002Fdoi.org\u002F10.1001\u002Farchophthalmol.2009.234",{"mag":807,"pmc":808,"openalex":809,"pm":810,"doi":811},"1565832645","2872173","W1565832645","19752420","10.1001\u002Farchophthalmol.2009.234",{"id":813,"text":814,"url":815,"identifiers":816},"ce41213d-ca87-4705-8763-59abc9a17113","Varma, 2012, Improved vision-related function after ranibizumab for macular edema after retinal vein occlusion: results from the BRAVO and CRUISE trials, Ophthalmology, 119, 2108, 10.1016\u002Fj.ophtha.2012.05.017","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS0161642012004435",{"doi":817},"10.1016\u002Fj.ophtha.2012.05.017",{"id":24,"text":819,"url":820,"identifiers":821},"Von Graefe, 1859, Über Embolie der Arteria centralis retinae als Ursache plötzlicher Erblindung, Graefes Arch. Ophthalmol., 5, 136, 10.1007\u002FBF02720764","http:\u002F\u002Fdx.doi.org\u002F10.1007\u002Fbf02720764",{"doi":822},"10.1007\u002Fbf02720764",{"id":241,"text":824,"url":243,"identifiers":825},"Watson, 1969, The treatment of acute retinal arterial occlusion, 234",{"doi":245},{"id":24,"text":827,"url":828,"identifiers":829},"Yuzurihara, 2004, Visual outcome in central retinal and branch retinal artery occlusion, Jpn. J. Ophthalmol., 48, 490, 10.1007\u002Fs10384-004-0102-y","https:\u002F\u002Fdoi.org\u002F10.1007\u002Fs10384-004-0102-y",{"mag":830,"openalex":831,"pm":832,"doi":833},"2094402989","W2094402989","15486774","10.1007\u002Fs10384-004-0102-y",{"id":24,"text":835,"url":734,"identifiers":836},"Zegarra, 1979, The natural course of central retinal vein occlusion, Ophthalmology, 86, 1931, 10.1016\u002FS0161-6420(79)35327-1",{"mag":736,"openalex":737,"pm":738,"doi":739},false,{"id":839,"createTime":840,"updateTime":841,"relativeEntities":842,"slug":843,"properties":844,"entityType":134,"verifyStatus":135,"verifyTime":853,"verifyNote":137,"languages":24,"translateLanguages":24,"viewCount":92,"primaryUrl":854,"fullTextUrl":24,"authors":855,"publicationType":156,"publisherRelationship":926,"citationCount":24,"citationInfo":24,"publishDate":979,"publishYear":980,"citationAnalyzeStatus":23,"lastCitationAnalyze":981,"indexDatabases":982,"openAccess":24,"references":24,"isForceReanalyzing":837},"2fffd0a3-f5a0-435c-810e-a2bce30617af","2023-12-25T06:08:43.145+00:00","2026-05-02T08:24:48.942+00:00",[],"Uveal-melanoma-Towards-a-molecular-understanding",{"title":845,"gsPaper":847,"references":849,"doi":851},{"EN":846},"Uveal melanoma: Towards a molecular understanding",{"VOID":848},"[\"14080460445023133074\"]",{"VOID":850},"Alsafadi, 2016, Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage, Nat. Commun., 7, 10615, 10.1038\u002Fncomms10615\nAngi, 2016, In-depth proteomic profiling of the uveal melanoma secretome, Oncotarget, 7, 49623, 10.18632\u002Foncotarget.10418\nArtzner, 2019, Chemosaturation with percutaneous hepatic perfusion of melphalan for liver-dominant metastatic uveal melanoma: a single center experience, Cancer Image, 19, 31, 10.1186\u002Fs40644-019-0218-4\nAugsburger, 2009, Effectiveness of treatments for metastatic uveal melanoma, Am. J. Ophthalmol., 148, 119, 10.1016\u002Fj.ajo.2009.01.023\nBailey, 2016, Genomic analyses identify molecular subtypes of pancreatic cancer, Nature, 531, 47, 10.1038\u002Fnature16965\nBeasley, 2018, Clinical application of circulating tumor cells and circulating tumor DNA in uveal melanoma, JCO Precis. Oncol., 1\nBidard, 2014, Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma, Int. J. Cancer, 134, 1207, 10.1002\u002Fijc.28436\nBol, 2016, Adjuvant dendritic cell vaccination in high-risk uveal melanoma, Ophthalmology, 123, 2265, 10.1016\u002Fj.ophtha.2016.06.027\nBommi, 2010, The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors, Cell Cycle, 9, 2663, 10.4161\u002Fcc.9.13.12147\nBononi, 2017, BAP1 regulates IP3R3-mediated Ca(2+) flux to mitochondria suppressing cell transformation, Nature, 546, 549, 10.1038\u002Fnature22798\nBronkhorst, 2011, Detection of M2-macrophages in uveal melanoma and relation with survival, Investig. Ophthalmol. Vis. Sci., 52, 643, 10.1167\u002Fiovs.10-5979\nBronkhorst, 2012, Different subsets of tumor-infiltrating lymphocytes correlate with macrophage influx and monosomy 3 in uveal melanoma, Investig. Ophthalmol. Vis. Sci., 53, 5370, 10.1167\u002Fiovs.11-9280\nBrouwer, 2019, Tumour angiogenesis in uveal melanoma is related to genetic evolution, Cancers, vol 11\nCancer Genome Atlas Research Network Electronic address, w.b.e., Cancer Genome Atlas Research, N., 2017, Comprehensive and integrative genomic characterization of hepatocellular carcinoma, Cell, 169, 1327, 10.1016\u002Fj.cell.2017.05.046\nCarvajal, 2018, Selumetinib in combination with dacarbazine in patients with metastatic uveal melanoma: a phase III, multicenter, randomized trial (SUMIT), J. Clin. Oncol., 36, 1232, 10.1200\u002FJCO.2017.74.1090\nCarvajal, 2014, Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial, J. Am. Med. Assoc., 311, 2397, 10.1001\u002Fjama.2014.6096\nCarvajal, 2014, A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma, Eur. J. Cancer, 50, 2099, 10.1016\u002Fj.ejca.2014.03.289\nCassoux, 2014, Genome-wide profiling is a clinically relevant and affordable prognostic test in posterior uveal melanoma, Br. J. Ophthalmol., 98, 769, 10.1136\u002Fbjophthalmol-2013-303867\nChattopadhyay, 2016, Uveal melanoma: from diagnosis to treatment and the science in between, Cancer, 122, 2299, 10.1002\u002Fcncr.29727\nChen, 2017, RasGRP3 mediates MAPK pathway activation in GNAQ mutant uveal melanoma, Cancer Cell, 31, 685, 10.1016\u002Fj.ccell.2017.04.002\nChittock, 2017, Molecular architecture of polycomb repressive complexes, Biochem. Soc. Trans., 45, 193, 10.1042\u002FBST20160173\nCiriello, 2015, Comprehensive molecular portraits of invasive lobular breast cancer, Cell, 163, 506, 10.1016\u002Fj.cell.2015.09.033\nCoupland, 1996, Metastatic choroidal melanoma to the contralateral orbit 40 years after enucleation, Arch. Ophthalmol., 114, 751, 10.1001\u002Farchopht.1996.01100130743022\nDamato, 2018, Ocular treatment of choroidal melanoma in relation to the prevention of metastatic death - a personal view, Prog. Retin. Eye Res., 66, 187, 10.1016\u002Fj.preteyeres.2018.03.004\nDamato, 2011, Estimating prognosis for survival after treatment of choroidal melanoma, Prog. Retin. Eye Res., 30, 285, 10.1016\u002Fj.preteyeres.2011.05.003\nDamato, 2019, Tebentafusp: T cell redirection for the treatment of metastatic uveal melanoma, Cancers, 11, 10.3390\u002Fcancers11070971\nDarman, 2015, Cancer-associated SF3B1 hotspot mutations induce cryptic 3' splice site selection through use of a different branch point, Cell Rep., 13, 1033, 10.1016\u002Fj.celrep.2015.09.053\nde Lange, 2015, Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma, Oncotarget, 6, 37824, 10.18632\u002Foncotarget.5637\nDey, 2012, Loss of the tumor suppressor BAP1 causes myeloid transformation, Science, 337, 1541, 10.1126\u002Fscience.1221711\nDogrusoz, 2017, The prognostic value of AJCC staging in uveal melanoma is enhanced by adding chromosome 3 and 8q status, Investig. Ophthalmol. Vis. Sci., 58, 833, 10.1167\u002Fiovs.16-20212\nDono, 2014, Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma, Br. J. Canc., 110, 1058, 10.1038\u002Fbjc.2013.804\nDrabarek, 2019, Multi-modality analysis improves survival prediction in enucleated uveal melanoma patients, Investig. Ophthalmol. Vis. Sci., 60, 3595, 10.1167\u002Fiovs.18-24818\nEleuteri, 2012, Enhancing survival prognostication in patients with choroidal melanoma by integrating pathologic clinical and genetic predictors of metastases, Int. J. Biomed. Eng. Technol., 18, 10.1504\u002FIJBET.2012.045355\nEskelin, 2000, Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment, Ophthalmology, 107, 1443, 10.1016\u002FS0161-6420(00)00182-2\nEskens, 2013, Phase I pharmacokinetic and pharmacodynamic study of the first-in-class spliceosome inhibitor E7107 in patients with advanced solid tumors, Clin. Cancer Res., 19, 6296, 10.1158\u002F1078-0432.CCR-13-0485\nEwens, 2014, Chromosome 3 status combined with BAP1 and EIF1AX mutation profiles are associated with metastasis in uveal melanoma, Investig. Ophthalmol. Vis. Sci., 55, 5160, 10.1167\u002Fiovs.14-14550\nFan, 2011, Sudemycins, novel small molecule analogues of FR901464, induce alternative gene splicing, ACS Chem. Biol., 6, 582, 10.1021\u002Fcb100356k\nFarquhar, 2018, Patterns of BAP1 protein expression provide insights into prognostic significance and the biology of uveal melanoma, J. Pathol. Clin. Res., 4, 26, 10.1002\u002Fcjp2.86\nFeng, 2014, Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry, Cancer Cell, 25, 831, 10.1016\u002Fj.ccr.2014.04.016\nField, 2018, Punctuated evolution of canonical genomic aberrations in uveal melanoma, Nat. Commun., 9, 116, 10.1038\u002Fs41467-017-02428-w\nField, 2016, Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas, Oncotarget, 7, 59209, 10.18632\u002Foncotarget.10962\nFuchs, 1882, Das Sarkom des Uvealtractus, Graefe's Arch. Ophthalmol., 233\nFurney, 2013, SF3B1 mutations are associated with alternative splicing in uveal melanoma, Cancer Discov., 3, 1122, 10.1158\u002F2159-8290.CD-13-0330\nGezgin, 2017, Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment, Cancer Immunol. Immunother., 66, 903, 10.1007\u002Fs00262-017-1991-1\nGriewank, 2014, Genetic and clinico-pathologic analysis of metastatic uveal melanoma, Mod. Pathol., 27, 175, 10.1038\u002Fmodpathol.2013.138\nGriner, 2007, Protein kinase C and other diacylglycerol effectors in cancer, Nat. Rev. Cancer, 7, 281, 10.1038\u002Fnrc2110\nGrossmann, 2013, The small GTPase ARF6 stimulates beta-catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis, Sci Signal, 6, ra14, 10.1126\u002Fscisignal.2003398\nHalkidou, 2004, Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer, The Prostate, 59, 177, 10.1002\u002Fpros.20022\nHarbour, 2010, Frequent mutation of BAP1 in metastasizing uveal melanomas, Science, 330, 1410, 10.1126\u002Fscience.1194472\nHarbour, 2013, Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma, Nat. Genet., 45, 133, 10.1038\u002Fng.2523\nHong, 2014, A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors, Investig. New Drugs, 32, 436, 10.1007\u002Fs10637-013-0046-5\nHoshino, 2015, Tumour exosome integrins determine organotropic metastasis, Nature, 527, 329, 10.1038\u002Fnature15756\nHsu, 2015, The spliceosome is a therapeutic vulnerability in MYC-driven cancer, Nature, 525, 384, 10.1038\u002Fnature14985\nJager, 2018, The cancer genome Atlas project: an integrated molecular view of uveal melanoma, Ophthalmology, 125, 1139, 10.1016\u002Fj.ophtha.2018.03.011\nJager, 2011, Macrophages in uveal melanoma and in experimental ocular tumor models: friends or foes?, Prog. Retin. Eye Res., 30, 129, 10.1016\u002Fj.preteyeres.2010.11.004\nJi, 2014, The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex, Nucleic Acids Res., 42, 6232, 10.1093\u002Fnar\u002Fgku274\nJohansson, 2016, Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4, Oncotarget, 7, 4624, 10.18632\u002Foncotarget.6614\nJohansson, 2019, Prolonged stable disease in a uveal melanoma patient with germline MBD4 nonsense mutation treated with pembrolizumab and ipilimumab, Immunogenetics, 71, 433, 10.1007\u002Fs00251-019-01108-x\nKaida, 2007, Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA, Nat. Chem. Biol., 3, 576, 10.1038\u002Fnchembio.2007.18\nKalirai, 2014, Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing, Br. J. Canc., 111, 1373, 10.1038\u002Fbjc.2014.417\nKilic, 2005, Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients, Investig. Ophthalmol. Vis. Sci., 46, 2253, 10.1167\u002Fiovs.04-1460\nKirchberger, 2018, Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients, Oncotarget, 9, 28903, 10.18632\u002Foncotarget.25627\nKomatsubara, 2017, Immunotherapy for the treatment of uveal melanoma: current status and emerging therapies, Curr. Oncol. Rep., 19, 45, 10.1007\u002Fs11912-017-0606-5\nKoopmans, 2014, Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma, Mod. Pathol., 27, 1321, 10.1038\u002Fmodpathol.2014.43\nKotake, 2007, Splicing factor SF3b as a target of the antitumor natural product pladienolide, Nat. Chem. Biol., 3, 570, 10.1038\u002Fnchembio.2007.16\nLambert, 2017, Emerging biological principles of metastasis, Cell, 168, 670, 10.1016\u002Fj.cell.2016.11.037\nLandreville, 2012, Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma, Clin. Cancer Res., 18, 408, 10.1158\u002F1078-0432.CCR-11-0946\nLee, 2016, Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins, Nat. Med., 22, 672, 10.1038\u002Fnm.4097\nLi, 2010, Highly compacted chromatin formed in vitro reflects the dynamics of transcription activation in vivo, Mol. Cell, 38, 41, 10.1016\u002Fj.molcel.2010.01.042\nLiu, 2016, Organotropic metastasis: role of tumor exosomes, Cell Res., 26, 149, 10.1038\u002Fcr.2015.153\nLy, 2010, In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages, J. Immunol., 185, 3481, 10.4049\u002Fjimmunol.0903479\nMaat, 2008, Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma, Investig. Ophthalmol. Vis. Sci., 49, 505, 10.1167\u002Fiovs.07-0786\nMachida, 2009, The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1, J. Biol. Chem., 284, 34179, 10.1074\u002Fjbc.M109.046755\nMani, 2008, The epithelial-mesenchymal transition generates cells with properties of stem cells, Cell, 133, 704, 10.1016\u002Fj.cell.2008.03.027\nMartin-Marcos, 2017, eIF1A residues implicated in cancer stabilize translation preinitiation complexes and favor suboptimal initiation sites in yeast, Elife, 6, 10.7554\u002FeLife.31250\nMartin, 2013, Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3, Nat. Genet., 45, 933, 10.1038\u002Fng.2674\nMashtalir, 2014, Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O, Mol. Cell, 54, 392, 10.1016\u002Fj.molcel.2014.03.002\nMatatall, 2013, BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma, BMC Canc., 13, 371, 10.1186\u002F1471-2407-13-371\nMcCarthy, 2016, Insights into genetic alterations of liver metastases from uveal melanoma, Pigment Cell Melanoma Res., 29, 60, 10.1111\u002Fpcmr.12433\nMcClorey, 2015, An overview of the clinical application of antisense oligonucleotides for RNA-targeting therapies, Curr. Opin. Pharmacol., 24, 52, 10.1016\u002Fj.coph.2015.07.005\nMcLean, 1982, Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis, Hum. Pathol., 13, 123, 10.1016\u002FS0046-8177(82)80116-0\nMeijer, 2019, Safety of percutaneous hepatic perfusion with melphalan in patients with unresectable liver metastases from ocular melanoma using the delcath systems' second-generation hemofiltration system: a prospective non-randomized phase II trial, Cardiovasc. Interv. Radiol., 42, 841, 10.1007\u002Fs00270-019-02177-x\nMetz, 2013, Ultradeep sequencing detects GNAQ and GNA11 mutations in cell‐free DNA from plasma of patients with uveal melanoma, Canc. Med., 2, 208, 10.1002\u002Fcam4.61\nMoore, 2016, Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma, Nat. Genet., 48, 675, 10.1038\u002Fng.3549\nMoore, 2018, GNA11 Q209L mouse model reveals RasGRP3 as an essential signaling node in uveal melanoma, Cell Rep., 22, 2455, 10.1016\u002Fj.celrep.2018.01.081\nMouti, 2016, Minimal contribution of ERK1\u002F2-MAPK signalling towards the maintenance of oncogenic GNAQQ209P-driven uveal melanomas in zebrafish, Oncotarget, 7, 39654, 10.18632\u002Foncotarget.9207\nNazarian, 2010, Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation, Nature, 468, 973, 10.1038\u002Fnature09626\nNiederkorn, 2009, Immune escape mechanisms of intraocular tumors, Prog. Retin. Eye Res., 28, 329, 10.1016\u002Fj.preteyeres.2009.06.002\nO'Hayre, 2013, The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer, Nat. Rev. Cancer, 13, 412, 10.1038\u002Fnrc3521\nOlofsson, 2014, Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial, Trials, 15, 317, 10.1186\u002F1745-6215-15-317\nOnken, 2004, Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death, Cancer Res., 64, 7205, 10.1158\u002F0008-5472.CAN-04-1750\nPaget, 1889, The distribution of secondary growths in cancer of the breast, The Lancet, 133, 571, 10.1016\u002FS0140-6736(00)49915-0\nPaolella, 2017, Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability, Elife, 6, 10.7554\u002FeLife.23268\nPeng, 2018, Familial and somatic BAP1 mutations inactivate ASXL1\u002F2-mediated allosteric regulation of BAP1 deubiquitinase by targeting multiple independent domains, Cancer Res., 78, 1200, 10.1158\u002F0008-5472.CAN-17-2876\nPerez, 2018, Uveal melanoma driver mutations in GNAQ\u002F11 yield numerous changes in melanocyte biology, Pigment Cell Melanoma Res., 31, 604, 10.1111\u002Fpcmr.12700\nPrescher, 1996, Prognostic implications of monosomy 3 in uveal melanoma, Lancet, 347, 1222, 10.1016\u002FS0140-6736(96)90736-9\nRantala, 2019, Overall survival after treatment for metastatic uveal melanoma: a systematic review and meta-analysis, Melanoma Res., 10.1097\u002FCMR.0000000000000575\nRimoldi, 2003, Lack of BRAF mutations in uveal melanoma, Cancer Res., 63, 5712\nRobertson, 2017, Integrative analysis identifies four molecular and clinical subsets in uveal melanoma, Cancer Cell, 32, 204, 10.1016\u002Fj.ccell.2017.07.003\nRodrigues, 2019, Evolutionary routes in metastatic uveal melanomas depend on MBD4 alterations, Clin. Cancer Res., 10.1158\u002F1078-0432.CCR-19-1215\nRodrigues, 2018, Outlier response to anti-PD1 in uveal melanoma reveals germline MBD4 mutations in hypermutated tumors, Nat. Commun., 9, 1866, 10.1038\u002Fs41467-018-04322-5\nScheuermann, 2010, Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB, Nature, 465, 243, 10.1038\u002Fnature08966\nSeiler, 2018, Somatic mutational landscape of splicing factor genes and their functional consequences across 33 cancer types, Cell Rep., 23, 282, 10.1016\u002Fj.celrep.2018.01.088\nSeiler, 2018, H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers, Nat. Med., 24, 497, 10.1038\u002Fnm.4493\nShah, 2013, BAP1 protein loss by immunohistochemistry: a potentially useful tool for prognostic prediction in patients with uveal melanoma, Pathology, 45, 651, 10.1097\u002FPAT.0000000000000002\nShain, 2019, The genetic evolution of metastatic uveal melanoma, Nat. Genet., 51, 1123, 10.1038\u002Fs41588-019-0440-9\nShields, 2009, Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes, Arch. Ophthalmol., 127, 989, 10.1001\u002Farchophthalmol.2009.208\nShoushtari, 2016, A randomized phase 2 study of trametinib with or without GSK2141795 in patients with advanced uveal melanoma, J. Clin. Oncol., 34, 10.1200\u002FJCO.2016.34.15_suppl.9511\nSingh, 2004, The Zimmerman-McLean-Foster hypothesis: 25 years later, Br. J. Ophthalmol., 88, 962, 10.1136\u002Fbjo.2003.029058\nSingh, 2011, Uveal melanoma: trends in incidence, treatment, and survival, Ophthalmology, 118, 1881, 10.1016\u002Fj.ophtha.2011.01.040\nSmit, 2018, Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma, Mod. Pathol., 31, 763, 10.1038\u002Fmodpathol.2017.187\nSong, 2005, Increased expression of histone deacetylase 2 is found in human gastric cancer, APMIS, 113, 264, 10.1111\u002Fj.1600-0463.2005.apm_04.x\nSowa, 2009, Defining the human deubiquitinating enzyme interaction landscape, Cell, 138, 389, 10.1016\u002Fj.cell.2009.04.042\nStalhammar, 2019, Digital image analysis of BAP-1 accurately predicts uveal melanoma metastasis, Transl. Vis. Sci. Technol., 8, 11, 10.1167\u002Ftvst.8.3.11\nStalhammar, 2019, Expression of immune checkpoint receptors Indoleamine 2,3-dioxygenase and T cell Ig and ITIM domain in metastatic versus nonmetastatic choroidal melanoma, Canc. Med., 8, 2784, 10.1002\u002Fcam4.2167\nSzalai, 2018, Uveal melanoma nuclear BRCA1-associated protein-1 immunoreactivity is an indicator of metastasis, Ophthalmology, 125, 203, 10.1016\u002Fj.ophtha.2017.07.018\nTate, 2019, COSMIC: the catalogue of somatic mutations in cancer, Nucleic Acids Res., 47, D941, 10.1093\u002Fnar\u002Fgky1015\nTschentscher, 2003, Tumor classification based on gene expression profiling shows that uveal melanomas with and without monosomy 3 represent two distinct entities, Cancer Res., 63, 2578\nVader, 2017, GNAQ and GNA11 mutations and downstream YAP activation in choroidal nevi, Br. J. Canc., 117, 884, 10.1038\u002Fbjc.2017.259\nvan den Bosch, 2012, Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis, Investig. Ophthalmol. Vis. Sci., 53, 2668, 10.1167\u002Fiovs.11-8697\nvan der Kooij, 2017, Anti-PD1 treatment in metastatic uveal melanoma in The Netherlands, Acta Oncol., 56, 101, 10.1080\u002F0284186X.2016.1260773\nvan Essen, 2014, Prognostic parameters in uveal melanoma and their association with BAP1 expression, Br. J. Ophthalmol., 98, 1738, 10.1136\u002Fbjophthalmol-2014-305047\nvan Gils, 2008, Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis, Investig. Ophthalmol. Vis. Sci., 49, 4254, 10.1167\u002Fiovs.08-2033\nvan Leeuwen, 2005, Histone modifications: from genome-wide maps to functional insights, Genome Biol., 6, 113, 10.1186\u002Fgb-2005-6-6-113\nvan Poppelen, 2019, SRSF2 mutations in uveal melanoma: a preference for in-frame deletions?, Cancers, 11, 10.3390\u002Fcancers11081200\nvan Poppelen, 2018, Genetic background of Iris melanomas and Iris melanocytic tumors of uncertain malignant potential, Ophthalmology, 125, 904, 10.1016\u002Fj.ophtha.2017.12.022\nVan Raamsdonk, 2009, Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi, Nature, 457, 599, 10.1038\u002Fnature07586\nVan Raamsdonk, 2010, Mutations in GNA11 in uveal melanoma, N. Engl. J. Med., 363, 2191, 10.1056\u002FNEJMoa1000584\nVaquero-Garcia, 2017, PRiMeUM: a model for predicting risk of metastasis in uveal melanoma, Investig. Ophthalmol. Vis. Sci., 58, 4096, 10.1167\u002Fiovs.17-22255\nVersluis, 2015, Digital PCR validates 8q dosage as prognostic tool in uveal melanoma, PLoS One, 10, 10.1371\u002Fjournal.pone.0116371\nVogel, 2017, Chemosaturation percutaneous hepatic perfusion: a systematic review, Adv. Ther., 33, 2122, 10.1007\u002Fs12325-016-0424-4\nWalpole, 2018, Comprehensive study of the clinical phenotype of germline BAP1 variant-carrying families worldwide, J. Natl. Cancer Inst., 110, 1328, 10.1093\u002Fjnci\u002Fdjy171\nWang, 2011, SF3B1 and other novel cancer genes in chronic lymphocytic leukemia, N. Engl. J. Med., 365, 2497, 10.1056\u002FNEJMoa1109016\nWierenga, 2019, Immune checkpoint inhibitors in uveal and conjunctival melanoma, Int. Ophthalmol. Clin., 59, 53, 10.1097\u002FIIO.0000000000000263\nYavuzyigitoglu, 2017, Correlation of gene mutation status with copy number profile in uveal melanoma, Ophthalmology, 124, 573, 10.1016\u002Fj.ophtha.2016.10.039\nYavuzyigitoglu, 2016, Lipomatous change in uveal melanoma: histopathological, immunohistochemical and cytogenetic analysis, Ocul. Oncol. Pathol., 2, 133, 10.1159\u002F000440981\nYavuzyigitoglu, 2016, Uveal melanomas with SF3B1 mutations: a distinct subclass Associated with late-onset metastases, Ophthalmology, 123, 1118, 10.1016\u002Fj.ophtha.2016.01.023\nYokoi, 2011, Biological validation that SF3b is a target of the antitumor macrolide pladienolide, FEBS J., 278, 4870, 10.1111\u002Fj.1742-4658.2011.08387.x\nYoo, 2016, ARF6 is an actionable node that orchestrates oncogenic GNAQ signaling in uveal melanoma, Cancer Cell, 29, 889, 10.1016\u002Fj.ccell.2016.04.015\nYu, 2014, Mutant Gq\u002F11 promote uveal melanoma tumorigenesis by activating YAP, Cancer Cell, 25, 822, 10.1016\u002Fj.ccr.2014.04.017\nYu, 2014, YAP as oncotarget in uveal melanoma, Oncoscience, 1, 480, 10.18632\u002Foncoscience.57\nYu, 2010, The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression, Mol. Cell. Biol., 30, 5071, 10.1128\u002FMCB.00396-10\nYu, 2014, Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair, Proc. Natl. Acad. Sci. U. S. A., 111, 285, 10.1073\u002Fpnas.1309085110\nZhang, 2005, Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast*, Breast Canc. Res. Treat., 94, 11, 10.1007\u002Fs10549-005-6001-1\nZhu, 2007, A histone H2A deubiquitinase complex coordinating histone acetylation and H1 dissociation in transcriptional regulation, Mol. Cell, 27, 609, 10.1016\u002Fj.molcel.2007.07.024\nZimmer, 2015, Phase II DeCOG-study of ipilimumab in pretreated and treatment-naive patients with metastatic uveal melanoma, PLoS One, 10, 10.1371\u002Fjournal.pone.0118564\nZimmerman, 1978, Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells, Br. J. Ophthalmol., 62, 420, 10.1136\u002Fbjo.62.6.420\nZoroquiain, 2018, Programmed cell death ligand-1 expression in tumor and immune cells is associated with better patient outcome and decreased tumor-infiltrating lymphocytes in uveal melanoma, Mod. Pathol., 31, 1201, 10.1038\u002Fs41379-018-0043-5\nZuidervaart, 2003, Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development, Br. J. Canc., 89, 1914, 10.1038\u002Fsj.bjc.6601374",{"VOID":852},"10.1016\u002Fj.preteyeres.2019.100800","2024-06-24T15:47:31.619+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1350946219300874",[856,881,898,912],{"id":857,"sortIndex":92,"researcher":24,"roles":858,"affiliations":859,"properties":878,"displayName":880,"givenName":24,"familyName":24},"69333a4f-7aa7-4cf6-bf55-74a47e156ba6",[143],[860,868],{"id":861,"sortIndex":92,"affiliation":862,"properties":24},"c0a8e86c-99e7-4042-8a4e-ca713308982a",{"id":861,"createTime":24,"updateTime":24,"relativeEntities":863,"slug":24,"properties":864,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":867,"statistic":24},[],{"title":865},{"VI":866},"Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands",[],{"id":869,"sortIndex":870,"affiliation":871,"properties":877},"147079af-1fb2-44d0-a1b0-f063f278dc6e",1,{"id":869,"createTime":24,"updateTime":24,"relativeEntities":872,"slug":24,"properties":873,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":876,"statistic":24},[],{"title":874},{"VI":875},"Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands",[],{},{"title":879},{"VI":880},"Kyra N. Smit",{"id":882,"sortIndex":870,"researcher":24,"roles":883,"affiliations":884,"properties":893,"displayName":895,"givenName":24,"familyName":24},"bfba1d7b-ea50-433d-90bc-ba844b5c57ba",[143],[885],{"id":886,"sortIndex":92,"affiliation":887,"properties":24},"1827dfa4-81a2-4919-a4ff-9ced2a2fa7ca",{"id":886,"createTime":24,"updateTime":24,"relativeEntities":888,"slug":24,"properties":889,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":892,"statistic":24},[],{"title":890},{"EN":891},"Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands",[],{"title":894,"gsAuthor":896},{"VI":895},"Martine J. Jager",{"VOID":897},"[\"TkyFD6kAAAAJ\"]",{"id":899,"sortIndex":900,"researcher":24,"roles":901,"affiliations":902,"properties":909,"displayName":911,"givenName":24,"familyName":24},"c1dd3bc5-5c89-41fb-8860-3499f5b9a9e3",2,[143],[903],{"id":869,"sortIndex":92,"affiliation":904,"properties":24},{"id":869,"createTime":24,"updateTime":24,"relativeEntities":905,"slug":24,"properties":906,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":908,"statistic":24},[],{"title":907},{"VI":875},[],{"title":910},{"VI":911},"Annelies de Klein",{"id":913,"sortIndex":914,"researcher":24,"roles":915,"affiliations":916,"properties":923,"displayName":925,"givenName":24,"familyName":24},"0aebc9bb-c504-4680-b35f-4d71418e4891",3,[143],[917],{"id":861,"sortIndex":92,"affiliation":918,"properties":24},{"id":861,"createTime":24,"updateTime":24,"relativeEntities":919,"slug":24,"properties":920,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":922,"statistic":24},[],{"title":921},{"VI":866},[],{"title":924},{"VI":925},"Emine Kiliҫ",{"url":854,"publisher":927,"properties":974},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":928,"slug":10,"properties":929,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":934,"manageAffiliations":943,"indexDatabases":954,"url":90,"thumbnailPath":24,"statistic":969,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":930,"eissn":931,"issn":932,"title":933},{"VOID":13},{"VOID":15},{"VOID":17},{"EN":19},[935,939],{"id":28,"createTime":24,"updateTime":24,"relativeEntities":936,"label":937,"description":938,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":31},{},{"id":34,"createTime":24,"updateTime":24,"relativeEntities":940,"label":941,"description":942,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":37},{},[944,949],{"id":41,"createTime":24,"updateTime":24,"relativeEntities":945,"slug":24,"properties":946,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":948,"statistic":24},[],{"title":947},{"EN":45},[],{"id":48,"createTime":24,"updateTime":24,"relativeEntities":950,"slug":24,"properties":951,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":953,"statistic":24},[],{"title":952},{"EN":52},[],[955,962],{"id":56,"indexDatabase":956,"url":67,"indexYears":68,"academicFieldIds":961,"indexDatabaseRanking":72},{"id":58,"createTime":24,"updateTime":24,"relativeEntities":957,"label":958,"description":959,"key":64,"publicationTags":960,"standard":24},[],{"EN":61,"VI":61},{"EN":61,"VI":63},[66],[70,71],{"id":74,"indexDatabase":963,"url":87,"indexYears":24,"academicFieldIds":968,"indexDatabaseRanking":24},{"id":76,"createTime":24,"updateTime":24,"relativeEntities":964,"label":965,"description":966,"key":83,"publicationTags":967,"standard":24},[],{"EN":79,"VI":79},{"EN":81,"VI":82},[85,86],[89],{"impactFactor":92,"impactFactorByYear":970,"i10Index":92,"i10IndexLast5Year":92,"totalPublication":94,"totalPublicationByYear":971,"totalCitation":92,"totalCitationByYear":972,"totalCitationPerPublication":92,"totalCitationPerPublicationByYear":973,"hindexLast5Year":92,"hindex":92},{},{"1994":96,"1995":97,"1996":98,"1997":99,"1998":100,"1999":101,"2000":102,"2001":103,"2002":104,"2003":102,"2004":100,"2005":103,"2006":105,"2007":106,"2008":98,"2009":106,"2010":97,"2011":105,"2012":104,"2013":107,"2014":105,"2015":108,"2016":108,"2017":109,"2018":110,"2019":111,"2020":112,"2021":113,"2022":114,"2023":111},{},{},{"pages":975,"volume":977},{"VOID":976},"100800",{"VOID":978},"75","2020-03-01",2020,"2026-05-02T08:24:48.941+00:00",[85,72],{"id":984,"createTime":985,"updateTime":986,"relativeEntities":987,"slug":988,"properties":989,"entityType":134,"verifyStatus":135,"verifyTime":985,"verifyNote":137,"languages":1004,"translateLanguages":24,"viewCount":92,"primaryUrl":1006,"fullTextUrl":24,"authors":1007,"publicationType":156,"publisherRelationship":1134,"citationCount":1187,"citationInfo":1188,"publishDate":1201,"publishYear":1189,"citationAnalyzeStatus":1202,"lastCitationAnalyze":1203,"indexDatabases":1204,"openAccess":24,"references":1205,"isForceReanalyzing":837},"17d98602-24a1-4e53-80da-09b07a7922cc","2024-10-09T05:40:10.311+00:00","2026-03-03T07:07:42.113+00:00",[],"Glaucomatous-damage-of-the-macula",{"mag":990,"gsPaper":992,"pmc":994,"openalex":996,"title":998,"pm":1000,"doi":1002},{"VOID":991},"2032872662",{"VOID":993},"[]",{"VOID":995},"3529818",{"VOID":997},"W2032872662",{"EN":999},"Glaucomatous damage of the macula",{"VOID":1001},"22995953",{"VOID":1003},"10.1016\u002Fj.preteyeres.2012.08.003",[1005],"EN","https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS1350946212000584",[1008,1035,1060,1085,1108],{"id":1009,"sortIndex":92,"researcher":24,"roles":1010,"affiliations":1011,"properties":1028,"displayName":1032,"givenName":24,"familyName":24},"1007bd70-4c0c-460c-88e9-699b99fa3fb1",[],[1012,1020],{"id":1013,"sortIndex":92,"affiliation":1014,"properties":24},"0b1c54f8-0b57-45bf-8d63-328287bfc777",{"id":1013,"createTime":24,"updateTime":24,"relativeEntities":1015,"slug":24,"properties":1016,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1019,"statistic":24},[],{"title":1017},{"EN":1018},"Department of Ophthalmology, Columbia University, New York, NY 10027-7004, USA",[],{"id":1021,"sortIndex":870,"affiliation":1022,"properties":24},"9927d7f8-9062-486a-921b-2933611db771",{"id":1021,"createTime":24,"updateTime":24,"relativeEntities":1023,"slug":24,"properties":1024,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1027,"statistic":24},[],{"title":1025},{"EN":1026},"Department of Psychology, Columbia University, New York, NY 10027-7004, USA",[],{"orcid":1029,"title":1031,"openalex":1033},{"VOID":1030},"https:\u002F\u002Forcid.org\u002F0000-0003-2440-9559",{"EN":1032},"Donald C. Hood",{"VOID":1034},"A5102912394",{"id":1036,"sortIndex":870,"researcher":24,"roles":1037,"affiliations":1038,"properties":1053,"displayName":1057,"givenName":24,"familyName":24},"c8f8c795-d9fe-4432-abad-b08d1156030a",[],[1039,1047],{"id":1040,"sortIndex":92,"affiliation":1041,"properties":24},"f8dfeef5-5b8a-4239-a012-52258edc377f",{"id":1040,"createTime":24,"updateTime":24,"relativeEntities":1042,"slug":24,"properties":1043,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1046,"statistic":24},[],{"title":1044},{"EN":1045},"Department of Neurobiology and Behavior, Columbia University, New York, NY, USA",[],{"id":1021,"sortIndex":870,"affiliation":1048,"properties":24},{"id":1021,"createTime":24,"updateTime":24,"relativeEntities":1049,"slug":24,"properties":1050,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1052,"statistic":24},[],{"title":1051},{"EN":1026},[],{"orcid":1054,"title":1056,"openalex":1058},{"VOID":1055},"https:\u002F\u002Forcid.org\u002F0000-0002-5719-821X",{"EN":1057},"Ali S. Raza",{"VOID":1059},"A5019943988",{"id":1061,"sortIndex":900,"researcher":24,"roles":1062,"affiliations":1063,"properties":1080,"displayName":1082,"givenName":24,"familyName":24},"8ad453de-b558-4eb2-880e-5bf148d3c9b9",[],[1064,1072],{"id":1065,"sortIndex":92,"affiliation":1066,"properties":24},"e10fb945-779b-4e94-9d05-b0c590425bbe",{"id":1065,"createTime":24,"updateTime":24,"relativeEntities":1067,"slug":24,"properties":1068,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1071,"statistic":24},[],{"title":1069},{"VI":1070},"Department of Ophthalmology, New York University, New York, NY, USA",[],{"id":1073,"sortIndex":870,"affiliation":1074,"properties":24},"e4c91b5f-9e56-4bc2-b685-38887fcfe3f4",{"id":1073,"createTime":24,"updateTime":24,"relativeEntities":1075,"slug":24,"properties":1076,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1079,"statistic":24},[],{"title":1077},{"VI":1078},"Einhorn Clinical Research Center, New York Eye and Ear, Infirmary, New York, NY, USA",[],{"title":1081,"openalex":1083},{"EN":1082},"Carlos Gustavo V. De Moraes",{"VOID":1084},"A5066362956",{"id":1086,"sortIndex":914,"researcher":24,"roles":1087,"affiliations":1088,"properties":1101,"displayName":1105,"givenName":24,"familyName":24},"f7268bbe-b2a5-4ba0-aa5e-5a0383b897b0",[],[1089,1095],{"id":1065,"sortIndex":92,"affiliation":1090,"properties":24},{"id":1065,"createTime":24,"updateTime":24,"relativeEntities":1091,"slug":24,"properties":1092,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1094,"statistic":24},[],{"title":1093},{"VI":1070},[],{"id":1073,"sortIndex":870,"affiliation":1096,"properties":24},{"id":1073,"createTime":24,"updateTime":24,"relativeEntities":1097,"slug":24,"properties":1098,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1100,"statistic":24},[],{"title":1099},{"VI":1078},[],{"orcid":1102,"title":1104,"openalex":1106},{"VOID":1103},"https:\u002F\u002Forcid.org\u002F0000-0002-5663-0533",{"EN":1105},"Jeffrey M. Liebmann",{"VOID":1107},"A5082809595",{"id":1109,"sortIndex":1110,"researcher":24,"roles":1111,"affiliations":1112,"properties":1127,"displayName":1131,"givenName":24,"familyName":24},"11ab998c-4cc4-492e-bffe-dd57da8015e3",4,[],[1113,1121],{"id":1114,"sortIndex":92,"affiliation":1115,"properties":24},"f3614035-ef40-4015-8688-c2f30a9b8403",{"id":1114,"createTime":24,"updateTime":24,"relativeEntities":1116,"slug":24,"properties":1117,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1120,"statistic":24},[],{"title":1118},{"EN":1119},"Department of Ophthalmology and Visual Science, New York Medical College, Valhalla, NY, USA",[],{"id":1073,"sortIndex":870,"affiliation":1122,"properties":24},{"id":1073,"createTime":24,"updateTime":24,"relativeEntities":1123,"slug":24,"properties":1124,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1126,"statistic":24},[],{"title":1125},{"VI":1078},[],{"orcid":1128,"title":1130,"openalex":1132},{"VOID":1129},"https:\u002F\u002Forcid.org\u002F0000-0002-9484-3572",{"EN":1131},"Robert Ritch",{"VOID":1133},"A5102793713",{"url":24,"publisher":1135,"properties":1182},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1136,"slug":10,"properties":1137,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":1142,"manageAffiliations":1151,"indexDatabases":1162,"url":90,"thumbnailPath":24,"statistic":1177,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":1138,"eissn":1139,"issn":1140,"title":1141},{"VOID":13},{"VOID":15},{"VOID":17},{"EN":19},[1143,1147],{"id":28,"createTime":24,"updateTime":24,"relativeEntities":1144,"label":1145,"description":1146,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":31},{},{"id":34,"createTime":24,"updateTime":24,"relativeEntities":1148,"label":1149,"description":1150,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":37},{},[1152,1157],{"id":41,"createTime":24,"updateTime":24,"relativeEntities":1153,"slug":24,"properties":1154,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1156,"statistic":24},[],{"title":1155},{"EN":45},[],{"id":48,"createTime":24,"updateTime":24,"relativeEntities":1158,"slug":24,"properties":1159,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1161,"statistic":24},[],{"title":1160},{"EN":52},[],[1163,1170],{"id":56,"indexDatabase":1164,"url":67,"indexYears":68,"academicFieldIds":1169,"indexDatabaseRanking":72},{"id":58,"createTime":24,"updateTime":24,"relativeEntities":1165,"label":1166,"description":1167,"key":64,"publicationTags":1168,"standard":24},[],{"EN":61,"VI":61},{"EN":61,"VI":63},[66],[70,71],{"id":74,"indexDatabase":1171,"url":87,"indexYears":24,"academicFieldIds":1176,"indexDatabaseRanking":24},{"id":76,"createTime":24,"updateTime":24,"relativeEntities":1172,"label":1173,"description":1174,"key":83,"publicationTags":1175,"standard":24},[],{"EN":79,"VI":79},{"EN":81,"VI":82},[85,86],[89],{"impactFactor":92,"impactFactorByYear":1178,"i10Index":92,"i10IndexLast5Year":92,"totalPublication":94,"totalPublicationByYear":1179,"totalCitation":92,"totalCitationByYear":1180,"totalCitationPerPublication":92,"totalCitationPerPublicationByYear":1181,"hindexLast5Year":92,"hindex":92},{},{"1994":96,"1995":97,"1996":98,"1997":99,"1998":100,"1999":101,"2000":102,"2001":103,"2002":104,"2003":102,"2004":100,"2005":103,"2006":105,"2007":106,"2008":98,"2009":106,"2010":97,"2011":105,"2012":104,"2013":107,"2014":105,"2015":108,"2016":108,"2017":109,"2018":110,"2019":111,"2020":112,"2021":113,"2022":114,"2023":111},{},{},{"pages":1183,"volume":1185},{"VOID":1184},"1-21",{"VOID":1186},"32",754,{"total":1187,"publishYear":1189,"statisticByYear":1190},2013,{"2013":104,"2014":1191,"2015":1192,"2016":1192,"2017":1193,"2018":1194,"2019":1195,"2020":1196,"2021":1197,"2022":1198,"2023":1199,"2024":1200},45,49,57,81,70,86,99,82,78,42,"2013-01-01","ERROR_IN_GET_PLATFORM_ID","2026-03-03T07:07:42.112+00:00",[85,72],[1206,1210,1214,1218,1221,1224,1228,1232,1236,1239,1243,1247,1250,1254,1258,1262,1266,1269,1272,1276,1279,1283,1287,1291,1295,1299,1302,1306,1310,1313,1317,1321,1325,1328,1332,1336,1340,1344,1348,1351,1354,1358,1362,1366,1370,1374,1378,1382,1386,1390,1394,1398,1402,1406,1410,1413,1416,1420,1424,1428,1431,1435,1439,1443,1447,1451],{"id":24,"text":1207,"url":24,"identifiers":1208},"Airaksinen, 1983, Visual field and retinal nerve fibre layer in early glaucoma after optic disc haemorrhage, Acta Ophthalmol. (Copenh.), 61, 186, 10.1111\u002Fj.1755-3768.1983.tb01412.x",{"doi":1209},"10.1111\u002Fj.1755-3768.1983.tb01412.x",{"id":24,"text":1211,"url":24,"identifiers":1212},"Anctil, 1984, Early foveal involvement and generalized depression of the visual field in glaucoma, Arch. Ophthalmol., 102, 363, 10.1001\u002Farchopht.1984.01040030281019",{"doi":1213},"10.1001\u002Farchopht.1984.01040030281019",{"id":24,"text":1215,"url":24,"identifiers":1216},"Araie, 1995, Pattern of visual field defects in normal-tension and high-tension glaucoma, Curr. Opin. Ophthalmol., 6, 36, 10.1097\u002F00055735-199504000-00007",{"doi":1217},"10.1097\u002F00055735-199504000-00007",{"id":24,"text":1219,"url":24,"identifiers":1220},"Aulhorn, 1967, Early visual field defects in glaucoma, 151",{},{"id":24,"text":1222,"url":24,"identifiers":1223},"Aulhorn, 1977, Frequency distribution in early glaucomatous visual field defects, Doc. Ophthalmol. Proc. Ser., 14, 75",{},{"id":24,"text":1225,"url":24,"identifiers":1226},"Bixenman, 1982, Apparent foveal displacement in normal subjects and in cyclotropia, Ophthalmology, 89, 58, 10.1016\u002FS0161-6420(82)34862-9",{"doi":1227},"10.1016\u002FS0161-6420(82)34862-9",{"id":24,"text":1229,"url":24,"identifiers":1230},"Budenz, 2007, Determinants of normal retinal nerve fiber layer thickness measured by Stratus OCT, Ophthalmology, 114, 1046, 10.1016\u002Fj.ophtha.2006.08.046",{"doi":1231},"10.1016\u002Fj.ophtha.2006.08.046",{"id":24,"text":1233,"url":24,"identifiers":1234},"Curcio, 1990, Topography of ganglion cells in human retina, J. Comp. Neurol., 300, 5, 10.1002\u002Fcne.903000103",{"doi":1235},"10.1002\u002Fcne.903000103",{"id":24,"text":1237,"url":24,"identifiers":1238},"Curcio, 2011, Human choroidal layer thicknesses measured in macula-wide, high-resolution histologic sections, Retina, 52, 3943",{},{"id":24,"text":1240,"url":24,"identifiers":1241},"Dandona, 1990, Quantitative regional structure of the normal human lamina cribrosa. A racial comparison, Arch. Ophthalmol., 108, 393, 10.1001\u002Farchopht.1990.01070050091039",{"doi":1242},"10.1001\u002Farchopht.1990.01070050091039",{"id":24,"text":1244,"url":24,"identifiers":1245},"de A Moura, 2012, Retinal ganglion cell and inner plexiform layer thickness in regions of severe visual field sensitivity loss in patients with glaucoma, Eye, 26, 1188, 10.1038\u002Feye.2012.110",{"doi":1246},"10.1038\u002Feye.2012.110",{"id":24,"text":1248,"url":24,"identifiers":1249},"Drance, 1969, Some studies of the relationships of hemodynamics and ocular pressure in open-angle glaucoma, Trans. Ophthalmol. Soc. U. K., 88, 633",{},{"id":24,"text":1251,"url":24,"identifiers":1252},"Drance, 1977, The visual field of low tension glaucoma and shock induced optic neuropathy, Arch. Ophthalmol., 95, 1359, 10.1001\u002Farchopht.1977.04450080069004",{"doi":1253},"10.1001\u002Farchopht.1977.04450080069004",{"id":24,"text":1255,"url":24,"identifiers":1256},"Drasdo, 2007, The length of Henle fibers in the human retina and a model of ganglion receptive field density in the visual field, Vis. Res., 47, 2901, 10.1016\u002Fj.visres.2007.01.007",{"doi":1257},"10.1016\u002Fj.visres.2007.01.007",{"id":24,"text":1259,"url":24,"identifiers":1260},"Gabriele, 2010, Three dimensional optical coherence tomography imaging: advantages and advances, Prog. Retin. Eye Res., 29, 556, 10.1016\u002Fj.preteyeres.2010.05.005",{"doi":1261},"10.1016\u002Fj.preteyeres.2010.05.005",{"id":24,"text":1263,"url":24,"identifiers":1264},"Garway-Heath, 2000, Mapping the visual field to the optic disc in normal tension glaucoma eyes, Ophthalmology, 107, 1809, 10.1016\u002FS0161-6420(00)00284-0",{"doi":1265},"10.1016\u002FS0161-6420(00)00284-0",{"id":24,"text":1267,"url":24,"identifiers":1268},"Garway-Heath, 2000, Scaling the hill of vision: the physiological relationship between light sensitivity and ganglion cell numbers, Invest. Ophthalmol. Vis. Sci., 41, 1774",{},{"id":24,"text":1270,"url":24,"identifiers":1271},"Harrington, 1990",{},{"id":24,"text":1273,"url":24,"identifiers":1274},"Heijl, 1984, The frequency distribution of earliest glaucomatous visual field defects documented by automated perimetry, Acta Ophthalmol., 62, 657, 10.1111\u002Fj.1755-3768.1984.tb03979.x",{"doi":1275},"10.1111\u002Fj.1755-3768.1984.tb03979.x",{"id":24,"text":1277,"url":24,"identifiers":1278},"Henson, 1999, Diffuse loss of sensitivity in early glaucoma, Invest. Ophthalmol. Vis. Sci., 40, 3147",{},{"id":24,"text":1280,"url":24,"identifiers":1281},"Hood, 2007, A framework for comparing structural and functional measures of glaucomatous damage, Prog. Retin. Eye Res., 26, 688, 10.1016\u002Fj.preteyeres.2007.08.001",{"doi":1282},"10.1016\u002Fj.preteyeres.2007.08.001",{"id":24,"text":1284,"url":24,"identifiers":1285},"Hood, 2011, Method for comparing visual field defects to local RNFL and RGC damage seen on frequency domain OCT in patients with glaucoma, Biomed. Opt. Exp., 2, 1097, 10.1364\u002FBOE.2.001097",{"doi":1286},"10.1364\u002FBOE.2.001097",{"id":24,"text":1288,"url":24,"identifiers":1289},"Hood, 2007, Structure versus function in glaucoma: an application of a linear model, Invest. Ophthalmol. Vis. Sci., 48, 3662, 10.1167\u002Fiovs.06-1401",{"doi":1290},"10.1167\u002Fiovs.06-1401",{"id":24,"text":1292,"url":24,"identifiers":1293},"Hood, 2008, Retinal nerve fiber structure versus visual field function in patients with ischemic optic neuropathy: a test of a linear model, Ophthalmology, 115, 90, 10.1016\u002Fj.ophtha.2007.06.001",{"doi":1294},"10.1016\u002Fj.ophtha.2007.06.001",{"id":24,"text":1296,"url":24,"identifiers":1297},"Hood, 2008, Blood vessel contributions to retinal nerve fiber layer thickness profiles measured with optical coherence tomography, J. Glaucoma, 17, 519, 10.1097\u002FIJG.0b013e3181629a02",{"doi":1298},"10.1097\u002FIJG.0b013e3181629a02",{"id":24,"text":1300,"url":24,"identifiers":1301},"Hood, 2009, A test of a linear model of glaucomatous structure–function loss reveals sources of variability in retinal nerve fiber and visual field measurements, Invest. Ophthalmol. Vis. Sci., 127, 875",{},{"id":24,"text":1303,"url":24,"identifiers":1304},"Hood, 2011, Reliability of a computer-aided manual procedure for segmenting optical coherence tomography scans, Optom. Vis. Sci., 88, 113, 10.1097\u002FOPX.0b013e3181fc3625",{"doi":1305},"10.1097\u002FOPX.0b013e3181fc3625",{"id":24,"text":1307,"url":24,"identifiers":1308},"Hood, 2011, Initial arcuate defects within the central 10 degrees in glaucoma, Invest. Ophthalmol. Vis. Sci., 52, 940, 10.1167\u002Ftvst.1.1.3",{"doi":1309},"10.1167\u002Ftvst.1.1.3",{"id":24,"text":1311,"url":24,"identifiers":1312},"Hood, 2012, The nature of macular damage in glaucoma as revealed by averaging optical coherence tomography data, Trans. Vis. Sci. Tech., 1, 1, 10.1167\u002Ftvst.1.1.3",{"doi":1309},{"id":24,"text":1314,"url":24,"identifiers":1315},"Jansonius, 2009, A mathematical description of nerve fiber bundle trajectories and their variability in the human retina, Vis. Res., 49, 2157, 10.1016\u002Fj.visres.2009.04.029",{"doi":1316},"10.1016\u002Fj.visres.2009.04.029",{"id":24,"text":1318,"url":24,"identifiers":1319},"Keltner, 2003, Classification of visual field abnormalities in the ocular hypertension treatment study, Arch. Ophthalmol., 121, 643, 10.1001\u002Farchopht.121.5.643",{"doi":1320},"10.1001\u002Farchopht.121.5.643",{"id":24,"text":1322,"url":24,"identifiers":1323},"Lan, 2008, Characteristics of disc hemorrhage in primary angle-closure glaucoma, Ophthalmology, 115, 1328, 10.1016\u002Fj.ophtha.2007.10.041",{"doi":1324},"10.1016\u002Fj.ophtha.2007.10.041",{"id":24,"text":1326,"url":24,"identifiers":1327},"Langerhorst, 1997, Measurements for description of very early glaucomatous field defects, 67",{},{"id":24,"text":1329,"url":24,"identifiers":1330},"Lefèvre, 2007, Study of the optic nerve head-fovea angle with retinophotography in healthy patients, J. Fr. Ophthalmol., 30, 598, 10.1016\u002FS0181-5512(07)89664-1",{"doi":1331},"10.1016\u002FS0181-5512(07)89664-1",{"id":24,"text":1333,"url":24,"identifiers":1334},"Leite, 2012, Structure–function relationships using the Cirrus spectral domain optical coherence tomograph and standard automated perimetry, J. Glaucoma, 21, 49, 10.1097\u002FIJG.0b013e31822af27a",{"doi":1335},"10.1097\u002FIJG.0b013e31822af27a",{"id":24,"text":1337,"url":24,"identifiers":1338},"Lewis, 1984, A comparison of visual field loss in primary open-angle glaucoma and the secondary glaucomas, Ophthalmologica, 189, 41, 10.1159\u002F000309383",{"doi":1339},"10.1159\u002F000309383",{"id":24,"text":1341,"url":24,"identifiers":1342},"Morgan, 2002, Retinal ganglion cell shrinkage in glaucoma, J. Glaucoma, 11, 365, 10.1097\u002F00061198-200208000-00015",{"doi":1343},"10.1097\u002F00061198-200208000-00015",{"id":24,"text":1345,"url":24,"identifiers":1346},"Mwanza, 2011, Cirrus OCT Normative Database Study Group. Profile and predictors of normal ganglion cell-inner plexiform layer thickness measured with frequency-domain optical coherence tomography, Invest. Ophthalmol. Vis. Sci., 52, 7872, 10.1167\u002Fiovs.11-7896",{"doi":1347},"10.1167\u002Fiovs.11-7896",{"id":24,"text":1349,"url":24,"identifiers":1350},"Nguyen, 2012",{},{"id":24,"text":1352,"url":24,"identifiers":1353},"Nicholas, 1980, Location of early glaucomatous visual field defects, Can. J. Ophthalmol., 15, 131",{},{"id":24,"text":1355,"url":24,"identifiers":1356},"Ooto, 2011, Effects of age, sex, and axial length on the three-dimensional profile of normal macular layer structures, Invest. Ophthalmol. Vis. Sci., 52, 8769, 10.1167\u002Fiovs.11-8388",{"doi":1357},"10.1167\u002Fiovs.11-8388",{"id":24,"text":1359,"url":24,"identifiers":1360},"Parikh, 2007, Normal age-related decay of retinal nerve fiber layer thickness, Ophthalmology, 114, 921, 10.1016\u002Fj.ophtha.2007.01.023",{"doi":1361},"10.1016\u002Fj.ophtha.2007.01.023",{"id":24,"text":1363,"url":24,"identifiers":1364},"Park, 2011, Initial parafoveal versus peripheral scotomas in glaucoma: risk factors and visual field characteristics, Ophthalmology, 118, 1782, 10.1016\u002Fj.ophtha.2011.02.013",{"doi":1365},"10.1016\u002Fj.ophtha.2011.02.013",{"id":24,"text":1367,"url":24,"identifiers":1368},"Patel, 2012, Agreement between retinal nerve fiber layer measures from Spectralis and Cirrus spectral domain OCT, Optom. Vis. Sci., 89, 652, 10.1097\u002FOPX.0b013e318238c34e",{"doi":1369},"10.1097\u002FOPX.0b013e318238c34e",{"id":24,"text":1371,"url":24,"identifiers":1372},"Plant, 1990, The anatomical basis of the caecocentral scotoma: new observations and a review, Brain, 113, 1441, 10.1093\u002Fbrain\u002F113.5.1441",{"doi":1373},"10.1093\u002Fbrain\u002F113.5.1441",{"id":24,"text":1375,"url":24,"identifiers":1376},"Poinoosawmy, 1997, Variation of nerve fibre layer thickness measurements with age and ethnicity by scanning laser polarimetry, Br. J. Ophthalmol., 81, 350, 10.1136\u002Fbjo.81.5.350",{"doi":1377},"10.1136\u002Fbjo.81.5.350",{"id":24,"text":1379,"url":24,"identifiers":1380},"Quigley, 1981, Regional differences in the structure of the lamina cribrosa and their relation to glaucomatous optic nerve damage, Arch. Ophthalmol., 99, 137, 10.1001\u002Farchopht.1981.03930010139020",{"doi":1381},"10.1001\u002Farchopht.1981.03930010139020",{"id":24,"text":1383,"url":24,"identifiers":1384},"Rao, 2012, Retinal nerve fiber layer and macular inner retina measurements by spectral domain optical coherence tomograph in Indian eyes with early glaucoma, Eye, 26, 133, 10.1038\u002Feye.2011.277",{"doi":1385},"10.1038\u002Feye.2011.277",{"id":24,"text":1387,"url":24,"identifiers":1388},"Raza, 2011, Retinal ganglion cell layer thickness and local visual field sensitivity in glaucoma, Arch. Ophthalmol., 129, 1529, 10.1001\u002Farchophthalmol.2011.352",{"doi":1389},"10.1001\u002Farchophthalmol.2011.352",{"id":24,"text":1391,"url":24,"identifiers":1392},"Reis, 2012, Optic disc margin anatomy in patients with glaucoma and normal controls with spectral domain optical coherence tomography, Ophthalmology, 119, 738, 10.1016\u002Fj.ophtha.2011.09.054",{"doi":1393},"10.1016\u002Fj.ophtha.2011.09.054",{"id":24,"text":1395,"url":24,"identifiers":1396},"Rohrschneider, 2004, Determination of the location of the fovea on the fundus, Invest. Ophthalmol. Vis. Sci., 45, 3257, 10.1167\u002Fiovs.03-1157",{"doi":1397},"10.1167\u002Fiovs.03-1157",{"id":24,"text":1399,"url":24,"identifiers":1400},"Schiefer, 2003, Increased detection rate of glaucomatous visual field damage with locally condensed grids: a comparison between fundus-oriented perimetry and conventional visual field examination, Arch. Ophthalmol., 121, 458, 10.1001\u002Farchopht.121.4.458",{"doi":1401},"10.1001\u002Farchopht.121.4.458",{"id":24,"text":1403,"url":24,"identifiers":1404},"Schiefer, 2010, Spatial pattern of glaucomatous visual field loss obtained with regionally condensed stimulus arrangements, Invest. Ophthalmol. Vis. Sci., 51, 5685, 10.1167\u002Fiovs.09-5067",{"doi":1405},"10.1167\u002Fiovs.09-5067",{"id":24,"text":1407,"url":24,"identifiers":1408},"Schuman, 1996, Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography, Ophthalmology, 103, 1889, 10.1016\u002FS0161-6420(96)30410-7",{"doi":1409},"10.1016\u002FS0161-6420(96)30410-7",{"id":24,"text":1411,"url":24,"identifiers":1412},"Stamper, 1984, The effect of glaucoma on central visual function, Trans. Am. Ophthalmol. Soc., 82, 792",{},{"id":24,"text":1414,"url":24,"identifiers":1415},"Su, D., Park, S.C., Simonson, J.L., Liebmann, J.M., Ritch, R. Progression pattern of initial parafoveal scotomas in glaucoma. Ophthalmology, in press.",{},{"id":24,"text":1417,"url":24,"identifiers":1418},"Swanson, 2004, Perimetric defects and ganglion cell damage: interpreting linear relations using a two-stage neural model, Invest. Ophthalmol. Vis. Sci., 45, 466, 10.1167\u002Fiovs.03-0374",{"doi":1419},"10.1167\u002Fiovs.03-0374",{"id":24,"text":1421,"url":24,"identifiers":1422},"Tan, 2009, Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography, Ophthalmology, 116, 2305, 10.1016\u002Fj.ophtha.2009.05.025",{"doi":1423},"10.1016\u002Fj.ophtha.2009.05.025",{"id":24,"text":1425,"url":24,"identifiers":1426},"Timberlake, 2005, Retinal location of the preferred retinal locus relative to the fovea in scanning laser ophthalmoscope images, Optom. Vis. Sci., 82, 177, 10.1097\u002F01.OPX.0000156311.49058.C8",{"doi":1427},"10.1097\u002F01.OPX.0000156311.49058.C8",{"id":24,"text":1429,"url":24,"identifiers":1430},"Traynis, 2012",{},{"id":24,"text":1432,"url":24,"identifiers":1433},"Wall, 2009, Use of a continuous probability scale to display visual field damage, Arch. Ophthalmol., 127, 749, 10.1001\u002Farchophthalmol.2009.111",{"doi":1434},"10.1001\u002Farchophthalmol.2009.111",{"id":24,"text":1436,"url":24,"identifiers":1437},"Wang, 2009, Measurement of local retinal ganglion cell layer thickness in patients with glaucoma using frequency-domain optical coherence tomography, Arch. Ophthalmol., 127, 875, 10.1001\u002Farchophthalmol.2009.145",{"doi":1438},"10.1001\u002Farchophthalmol.2009.145",{"id":24,"text":1440,"url":24,"identifiers":1441},"Weber, 1989, The visual field in advanced glaucoma, Int. Ophthalmol., 13, 47, 10.1007\u002FBF02028637",{"doi":1442},"10.1007\u002FBF02028637",{"id":24,"text":1444,"url":24,"identifiers":1445},"Xin, 2011, Hypodense regions (“holes”) in the retinal nerve fiber layer in frequency-domain OCT scans of glaucoma patients and suspects, Invest. Ophthalmol. Vis. Sci., 52, 7180, 10.1167\u002Fiovs.11-7716",{"doi":1446},"10.1167\u002Fiovs.11-7716",{"id":24,"text":1448,"url":24,"identifiers":1449},"Yang, 2010, Automated layer segmentation of macular OCT images using dual-scale gradient information, Opt. Exp., 18, 21293, 10.1364\u002FOE.18.021293",{"doi":1450},"10.1364\u002FOE.18.021293",{"id":24,"text":1452,"url":24,"identifiers":1453},"Zhang, 2011, Deriving visual field loss based upon OCT of inner retinal thicknesses of the macula, Biomed. Opt. Exp., 2, 1734, 10.1364\u002FBOE.2.001734",{"doi":1454},"10.1364\u002FBOE.2.001734",{"id":1456,"createTime":1457,"updateTime":1458,"relativeEntities":1459,"slug":1460,"properties":1461,"entityType":134,"verifyStatus":135,"verifyTime":1470,"verifyNote":137,"languages":24,"translateLanguages":24,"viewCount":92,"primaryUrl":1471,"fullTextUrl":24,"authors":1472,"publicationType":156,"publisherRelationship":1510,"citationCount":24,"citationInfo":24,"publishDate":1563,"publishYear":1564,"citationAnalyzeStatus":1565,"lastCitationAnalyze":24,"indexDatabases":1566,"openAccess":24,"references":24,"isForceReanalyzing":837},"93579d7c-84e7-433b-80b8-4b45db6c8488","2023-12-19T18:16:53.479+00:00","2026-01-20T09:27:20.664+00:00",[],"Fixation-strategies-for-retinal-immunohistochemistry",{"title":1462,"gsPaper":1464,"references":1466,"doi":1468},{"EN":1463},"Fixation strategies for retinal immunohistochemistry",{"VOID":1465},"[\"6790238970845161556\"]",{"VOID":1467},"Adams, 1974, Rod and cone densities in the Rhesus, Investig. Ophthalmol., 13, 885\nAmes, 1965, Effects of osmotic changes on water and electrolytes in nervous tissue, J. Physiol., 177, 246, 10.1113\u002Fjphysiol.1965.sp007590\nAmmermüller, 1988, Physiological and morphological characterization of OFF-center amacrine cells in the turtle retina, J. Comp. Neurol., 273, 137, 10.1002\u002Fcne.902730202\nAnderson, 1967, Purification and quantitation of glutaraldehyde and its effect on several enzyme activities in skeletal muscle, J. Histochem. Cytochem., 15, 652, 10.1177\u002F15.11.652\nAndrews, 1982, Factors that improve the preservation of nephron morphology during cold-storage, Lab. Investig., 46, 100\nAvrameas, 1969, The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents, Immunochemistry, 6, 53, 10.1016\u002F0019-2791(69)90178-5\nBadea, 2009, New mouse lines for the analysis of neuronal morphology using CreER(T)\u002FloxP-directed sparse labeling, PLoS One, 4, e7859, 10.1371\u002Fjournal.pone.0007859\nBalaton, 1995, An EDTA-pressure cooker protocol. A high performance immunohistochemistry technique, Ann. Pathol., 15, 295\nBankfalvi, 1996, Significance of wet autoclave pretreatment in immunohistochemistry, Pathol. Oncol. Res., 2, 71, 10.1007\u002FBF02893955\nBarnett, 1966, A controlled-heat method of fixation, J. Anat., 100, 937\nBarnstable, 1984, Thy-1 antigen: a ganglion cell specific marker in rodent retina, Neuroscience, 11, 847, 10.1016\u002F0306-4522(84)90195-7\nBarsony, 1990, Immunocytology on microwave-fixed cells reveals rapid and agonist-specific changes in subcellular accumulation patterns for cAMP or cGMP, Proc. Natl. Acad. Sci. U. S. A., 87, 1188, 10.1073\u002Fpnas.87.3.1188\nBattifora, 1986, The influence of protease digestion and duration of fixation on the immunostaining of keratins – a comparison of formalin and ethanol fixation, J. Histochem. Cytochem., 34, 1095, 10.1177\u002F34.8.2426335\nBee, 1982, Glycoconjugates of the avian eye: the development and maturation of the neural retina as visualized by lectin binding, Differentiation, 23, 128, 10.1111\u002Fj.1432-0436.1982.tb01275.x\nBeisker, 1987, An improved immunocytochemical procedure for high-sensitivity detection of incorporated bromodeoxyuridine, Cytometry, 8, 235, 10.1002\u002Fcyto.990080218\nBernstein, 2006, Analysis of optic nerve stroke by retinal Bex expression, Mol. Vis., 12, 147\nBerod, 1981, Importance of fixation in immunohistochemistry – use of formaldehyde solutions at variable pH for the localization of tyrosine-hydroxylase, J. Histochem. Cytochem., 29, 844, 10.1177\u002F29.7.6167611\nBlankenship, 2007, Structural specializations emerging late in mouse lens fiber cell differentiation, Investig. Ophthalmol. Vis. Sci., 48, 3269, 10.1167\u002Fiovs.07-0109\nBloem, 1968, Thin layer chromatography of aldehydes, J. Chromatogr., 35, 108, 10.1016\u002FS0021-9673(01)82359-1\nBlom, 2012, Characterization of nitric oxide signaling pathways in the mouse retina, J. Comp. Neurol., 520, 4204, 10.1002\u002Fcne.23148\nBlute, 1998, Functional localization of soluble guanylate cyclase in turtle retina: modulation of cGMP by nitric oxide donors, Vis. Neurosci., 15, 485, 10.1017\u002FS0952523898153075\nBoiko, 2003, Functional specialization of the axon initial segment by isoform-specific sodium channel targeting, J. Neurosci., 23, 2306, 10.1523\u002FJNEUROSCI.23-06-02306.2003\nBonin, 2005, DNA and RNA obtained from Bouin's fixed tissues, J. Clin. Pathol., 58, 313, 10.1136\u002Fjcp.2004.016477\nBoon, 2008, Theory and practice of combining coagulant fixation and microwave histoprocessing, Biotech. Histochem., 83, 261, 10.1080\u002F10520290802553476\nBorovikov, 1984, The effect of glutaraldehyde and phalloidin on the conformation of F-actin, Gen. Physiol. Biophys., 3, 513\nBowes, 1965, Crosslinking of collagen, J. Appl. Chem., 15, 296, 10.1002\u002Fjctb.5010150702\nBrandon, 1985, Improved immunocytochemical staining through the use of Fab fragments of primary antibody, Fab-specific 2nd antibody, and Fab horseradish-peroxidase, J. Histochem. Cytochem., 33, 715, 10.1177\u002F33.7.2409131\nBrandon, 1985, Retinal GABA neurons: localization in vertebrate species using an antiserum to rabbit brain glutamate decarboxylase, Brain Res., 344, 286, 10.1016\u002F0006-8993(85)90806-6\nBrandon, 1987, Cholinergic neurons in the rabbit retina: immunocytochemical localization, and relationship to GABAergic and cholinesterase-containing neurons, Brain Res., 401, 385, 10.1016\u002F0006-8993(87)91426-0\nBrandstätter, 2004, The postsynaptic scaffold proteins ProSAP1\u002FShank2 and Homer1 are associated with glutamate receptor complexes at rat retinal synapses, J. Comp. Neurol., 475, 551, 10.1002\u002Fcne.20194\nBrandstätter, 1999, Differential expression of the presynaptic cytomatrix protein bassoon among ribbon synapses in the mammalian retina, Eur. J. Neurosci., 11, 3683, 10.1046\u002Fj.1460-9568.1999.00793.x\nBrecha, 1988, Cholinergic amacrine cells of the rabbit retina contain glutamate-decarboxylase and gamma-aminobutyrate immunoreactivity, Proc. Natl. Acad. Sci. U. S. A., 85, 6187, 10.1073\u002Fpnas.85.16.6187\nBrecha, 1979, Enkephalin-containing amacrine cells in the avian retina: immunohistochemical localization, Proc. Natl. Acad. Sci. U. S. A., 76, 3010, 10.1073\u002Fpnas.76.6.3010\nBubenik, 1974, Immunohistological localization of N-acetylindolealkylamines in pineal gland, retina and cerebellum, Brain Res., 81, 233, 10.1016\u002F0006-8993(74)90938-X\nBumsted, 1999, Distribution and development of short-wavelength cones differ between Macaca monkey and human fovea, J. Comp. Neurol., 403, 502, 10.1002\u002F(SICI)1096-9861(19990125)403:4\u003C502::AID-CNE6>3.0.CO;2-N\nCasini, 1992, Postnatal development of tyrosine hydroxylase immunoreactive amacrine cells in the rabbit retina: I. Morphological characterization, J. Comp. Neurol., 326, 283, 10.1002\u002Fcne.903260210\nCastellarin, 1998, In vitro transplantation of fetal human retinal pigment epithelial cells onto human cadaver Bruch's membrane, Exp. Eye Res., 66, 49, 10.1006\u002Fexer.1997.0404\nChaw, 1980, Isolation and identification of cross-links from formaldehyde-treated nucleic-acids, Biochemistry, 19, 5525, 10.1021\u002Fbi00565a010\nChen, 2009, The transmembrane protein CBP plays a role in transiently anchoring small clusters of Thy-1, a GPI-anchored protein, to the cytoskeleton, J. Cell Sci., 122, 3966, 10.1242\u002Fjcs.049346\nChidlow, 2011, Localization of a wide-ranging panel of antigens in the rat retina by immunohistochemistry: comparison of Davidson's solution and formalin as fixatives, J. Histochem. Cytochem., 59, 884, 10.1369\u002F0022155411418115\nChirita, 1971, Investigations of reaction of aldehydes with functional groups of some amino acids of collagen structure, J. Am. Leather Chem. Assoc., 66, 369\nClancy, 1998, Reduction of background autofluorescence in brain sections following immersion in sodium borohydride, J. Neurosci. Methods, 83, 97, 10.1016\u002FS0165-0270(98)00066-1\nCleary, 1980, Ultrastructure of traction retinal detachment in rhesus monkey eyes after a posterior penetrating ocular injury, Am. J. Ophthalmol., 90, 829, 10.1016\u002FS0002-9394(14)75198-0\nContini, 2003, GABAergic synapses made by a retinal dopaminergic neuron, Proc. Natl. Acad. Sci. U. S. A., 100, 1358, 10.1073\u002Fpnas.0337681100\nCoombs, 2006, Morphological properties of mouse retinal ganglion cells, Neuroscience, 140, 123, 10.1016\u002Fj.neuroscience.2006.02.079\nCoupland, 1966, The mechanism of the differential staining reaction for adrenaline-and noradrenaline-storing granules in tissues fixed in glutaraldehyde, J. Anat., 100, 227\nCristofanilli, 2006, Calcium channel and glutamate receptor activities regulate actin organization in salamander retinal neurons, J. Physiol., 575, 543, 10.1113\u002Fjphysiol.2006.114108\nCuenca, 2008\nCuenca, 2014, Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases, Prog. Retin. Eye Res., 43, 17, 10.1016\u002Fj.preteyeres.2014.07.001\nda Silva Filho, 2013, A new low cost wide-field illumination method for photooxidation of intracellular fluorescent markers, PLoS One, 8, e56512, 10.1371\u002Fjournal.pone.0056512\nDacey, 1990, The dopaminergic amacrine cell, J. Comp. Neurol., 301, 461, 10.1002\u002Fcne.903010310\nDacey, 2003, Fireworks in the primate retina: In vitro photodynamics reveals diverse LGN-projecting ganglion cell types, Neuron, 37, 15, 10.1016\u002FS0896-6273(02)01143-1\nDaniele, 2007, Novel distribution of junctional adhesion molecule-C in the neural retina and retinal pigment epithelium, J. Comp. Neurol., 505, 166, 10.1002\u002Fcne.21489\nDe Marzo, 2002, Inadequate formalin fixation decreases reliability of p27 immunohistochemical staining: probing optimal fixation time using high-density tissue microarrays, Hum. Pathol., 33, 756, 10.1053\u002Fhupa.2002.126187\nde Vente, 1987, A new approach to immunocytochemistry of 3′,5′-cyclic guanosine monophosphate: preparation, specificity, and initial application of a new antiserum against formaldehyde-fixed 3′,5′-cyclic guanosine monophosphate, Neuroscience, 22, 361, 10.1016\u002F0306-4522(87)90226-0\nDeerinck, 2006\nDeVries, 2000, Bipolar cells use kainate and AMPA receptors to filter visual information into separate channels, Neuron, 28, 847, 10.1016\u002FS0896-6273(00)00158-6\nDoughty, 1997, Shrinkage and distortion of the rabbit corneal endothelial cell mosaic caused by a high osmolality glutaraldehyde-formaldehyde fixative compared to glutaraldehyde, Tissue Cell, 29, 533, 10.1016\u002FS0040-8166(97)80054-7\nDowling, 1975, Synaptic organization of the amine-containing interplexiform cells of the goldfish and Cebus monkey retinas, Science, 188, 270, 10.1126\u002Fscience.804181\nDuong, 2013, A multispectral LED array for the reduction of background autofluorescence in brain tissue, J. Neurosci. Methods, 220, 46, 10.1016\u002Fj.jneumeth.2013.08.018\nEldred, 1983, Comparison of fixation and penetration enhancement techniques for use in ultrastructural immunocytochemistry, J. Histochem. Cytochem., 31, 285, 10.1177\u002F31.2.6339606\nElias, 2004, Temporal kinetics of the light\u002Fdark translocation and compartmentation of arrestin and alpha-transducin in mouse photoreceptor cells, Mol. Vis., 10, 672\nEltoum, 2001, Introduction to the theory and practice of fixation of tissues, J. Histotechnol., 24, 173, 10.1179\u002Fhis.2001.24.3.173\nEranko, 1955, Distribution of fluorescing islets, adrenaline and noradrenaline in the adrenal medulla of the cat, Acta Endocrinol., 18, 180, 10.1530\u002Facta.0.0180180\nEranko, 1955, Distribution of fluorescing islets, adrenaline and noradrenaline in the adrenal medulla of the hamster, Acta Endocrinol., 18, 174, 10.1530\u002Facta.0.0180174\nErickson, 1987, Glial fibrillary acidic protein increases in Muller cells after retinal detachment, Exp. Eye Res., 44, 37, 10.1016\u002FS0014-4835(87)80023-4\nEspina, 2009, Tissue is alive: new technologies are needed to address the problems of protein biomarker pre-analytical variability, Proteomics Clin. Appl., 3, 874, 10.1002\u002Fprca.200800001\nEvers, 1994, Microwave-stimulated antigen retrieval is pH and temperature dependent, J. Histochem. Cytochem., 42, 1555, 10.1177\u002F42.12.7983356\nEzaki, 2000, Antigen retrieval on formaldehyde-fixed paraffin sections: Its potential drawbacks and optimization for double immunostaining, Micron, 31, 639, 10.1016\u002FS0968-4328(99)00064-5\nFahimi, 1968, Purification of glutaraldehyde – its significance for preservation of acid phosphatase activity, J. Histochem. Cytochem., 16, 199, 10.1177\u002F16.3.199\nFalck, 1962, Fluorescence of catechol amines and related compounds condensed with formaldehyde, J. Histochem. Cytochem., 10, 348, 10.1177\u002F10.3.348\nFalck, 1961, A fluorescence method for histochemical demonstration of noradrenalin in the adrenal medulla, Med. Exp., 5, 428\nFamiglietti, 1985, Starburst amacrine cells – morphological constancy and systematic variation in the anisotropic field of rabbit retinal neurons, J. Neurosci., 5, 562, 10.1523\u002FJNEUROSCI.05-02-00562.1985\nFamiglietti, 1987, Immunocytochemical staining of cholinergic amacrine cells in rabbit retina, Brain Res., 413, 398, 10.1016\u002F0006-8993(87)91037-7\nFarber, 1981, Cyclic nucleotides of cone-dominant retinas. Reduction of cyclic AMP levels by light and by cone degeneration, Investig. Ophthalmol. Vis. Sci., 20, 24\nFeder, 1958, Methods and principles of fixation by freeze-substitution, J. Biophys. Biochem. Cytol., 4, 593, 10.1083\u002Fjcb.4.5.593\nFischer, 2008\nFisher, 2013\nFox, 1985, Formaldehyde fixation, J. Histochem. Cytochem., 33, 845, 10.1177\u002F33.8.3894502\nFraenkel-Conrat, 1948, The reaction of formaldehyde with proteins; cross-linking between amino and primary amide or guanidyl groups, J. Am. Chem. Soc., 70, 2673, 10.1021\u002Fja01188a018\nFree, 2007, D1 and D2 dopamine receptor expression is regulated by direct interaction with the chaperone protein calnexin, J. Biol. Chem., 282, 21285, 10.1074\u002Fjbc.M701555200\nFrench, 2008, Retinal folding in the term rabbit fetus-Developmental abnormality or fixation artifact?, Reprod. Toxicol., 26, 262, 10.1016\u002Fj.reprotox.2008.08.008\nFujiwara, 1995, Monoclonal antibody against the glutaraldehyde-conjugated polyamine, spermine, Histochem. Cell Biol., 104, 309, 10.1007\u002FBF01464327\nGabriel, 2004, AII amacrine neurons of the rat retina show diurnal and circadian rhythms of parvalbumin immunoreactivity, Cell Tissue Res., 315, 181, 10.1007\u002Fs00441-003-0785-2\nGabriel, 2001, Diurnal and circadian variation of protein kinase C immunoreactivity in the rat retina, J. Comp. Neurol., 439, 140, 10.1002\u002Fcne.1338\nGage, 2012, Whole animal perfusion fixation for rodents, J. Vis. Exp., 30, 3564\nGalbinur, 2009, Effect of para-aminobenzoic acid on the course of retinal degeneration in the rd10 mouse, J. Ocul. Pharmacol. Ther., 25, 475, 10.1089\u002Fjop.2009.0020\nGallegos Ruiz, 2007, Epidermal growth factor receptor (EGFR) gene copy number detection in non-small-cell lung cancer; a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization, Histopathology, 51, 631, 10.1111\u002Fj.1365-2559.2007.02854.x\nGarcia-Caballero, 2010, Determination of HER2 amplification in primary breast cancer using dual-colour chromogenic in situ hybridization is comparable to fluorescence in situ hybridization: a European multicentre study involving 168 specimens, Histopathology, 56, 472, 10.1111\u002Fj.1365-2559.2010.03503.x\nGastinger, 1999, Histamine immunoreactive axons in the macaque retina, Investig. Ophthalmol. Vis. Sci., 40, 487\nGoodyear, 2010, Spatial and temporal dissociation of AQP4 and Kir4.1 expression during induction of refractive errors, Mol. Vis., 16, 1610\nGown, 2002, Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3, J. Histochem. Cytochem., 50, 449, 10.1177\u002F002215540205000401\nGraham, 1966, Glomerular permeability – ultrastructural cytochemical studies using peroxidases as protein tracers, J. Exp. Med., 124, 1123, 10.1084\u002Fjem.124.6.1123\nGreenberg, 2011, Differential targeting of optical neuromodulators to ganglion cell soma and dendrites allows dynamic control of center-surround antagonism, Neuron, 69, 713, 10.1016\u002Fj.neuron.2011.01.024\nGreenwood, 2007, Dendritic and mitochondrial changes during glutamate excitotoxicity, Neuropharmacology, 53, 891, 10.1016\u002Fj.neuropharm.2007.10.003\nGrillo, 1971, Effects of histological and electron microscopical fixatives on the insulin content of the rat pancreas, J. Endocrinol., 51, 645, 10.1677\u002Fjoe.0.0510645\nGrunert, 1993, Immunocytochemical localization of glycine receptors in the mammalian retina, J. Comp. Neurol., 335, 523, 10.1002\u002Fcne.903350405\nGuo, 2010, Guinea pig horizontal cells express GABA, the GABA-synthesizing enzyme GAD 65, and the GABA vesicular transporter, J. Comp. Neurol., 518, 1647, 10.1002\u002Fcne.22294\nHaase, 1990, Immunological characterization and localization of the Na+\u002FCa2(+)-exchanger in bovine retina, J. Neurosci., 10, 1486, 10.1523\u002FJNEUROSCI.10-05-01486.1990\nHack, 2001, Heterogeneous distribution of AMPA glutamate receptor subunits at the photoreceptor synapses of rodent retina, Eur. J. Neurosci., 13, 15\nHageman, 1991, Structure, composition and function of the retinal interphotoreceptor matrix, Prog. Ret. Res., 10, 207, 10.1016\u002F0278-4327(91)90014-S\nHäggendal, 1965, Identification and cellular localization of the catecholamines in the retina and the choroid of the rabbit, Acta Physiol. Scand., 64, 58, 10.1111\u002Fj.1748-1716.1965.tb04153.x\nHamazaki, 1993, The effect of formalin fixation on restriction-endonuclease digestion of DNA and Pcr amplification, Pathol. Res. Pract., 189, 553, 10.1016\u002FS0344-0338(11)80365-1\nHarahush, 2012, Optimal preservation of the shark retina for ultrastructural analysis: an assessment of chemical, microwave, and high-pressure freezing fixation techniques, Microsc. Res. Tech., 75, 1218, 10.1002\u002Fjemt.22052\nHardy, 1976, Formation of quaternary pyridinium compounds by action of glutaraldehyde on proteins, J. Chem. Soc. Chem. Commun., 157, 10.1039\u002Fc39760000157\nHardy, 1969, Nature of glutaraldehyde in aqueous solution, J. Chem. Soc. Chem. Commun., 565, 10.1039\u002Fc29690000565\nHarrach, 1990, Polyclonal antibodies against formaldehyde-modified apolipoprotein A-I. An approach to circumventing fixation-induced loss of antigenicity in immunocytochemistry, Arteriosclerosis, 10, 564, 10.1161\u002F01.ATV.10.4.564\nHarries, 1908, Concerning the breakdown of cyclopentenes into semi aldehydes of glutaric acid or to glutaric dialdehyde, Ber. Dtsch. Chem. Ges., 41, 1701, 10.1002\u002Fcber.19080410230\nHattar, 2002, Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity, Science, 295, 1065, 10.1126\u002Fscience.1069609\nHaverkamp, 2000, The cone pedicle, a complex synapse in the retina, Neuron, 27, 85, 10.1016\u002FS0896-6273(00)00011-8\nHaverkamp, 2000, Immunocytochemical analysis of the mouse retina, J. Comp. Neurol., 424, 1, 10.1002\u002F1096-9861(20000814)424:1\u003C1::AID-CNE1>3.0.CO;2-V\nHaverkamp, 2005, The primordial, blue-cone color system of the mouse retina, J. Neurosci., 25, 5438, 10.1523\u002FJNEUROSCI.1117-05.2005\nHayashida, 2009, Inhibition of adult rat retinal ganglion cells by D-1-type dopamine receptor activation, J. Neurosci., 29, 15001, 10.1523\u002FJNEUROSCI.3827-09.2009\nHelander, 1994, Kinetic studies of formaldehyde binding in tissue, Biotech. Histochem., 69, 177, 10.3109\u002F10520299409106282\nHendrickson, 1985, Colocalization of [3H]muscimol and antisera to GABA and glutamic acid decarboxylase within the same neurons in monkey retina, Brain Res., 348, 391, 10.1016\u002F0006-8993(85)90464-0\nHeneberg, 2006, Topography of plasma membrane microdomains and its consequences for mast cell signaling, Eur. J. Immunol., 36, 2795, 10.1002\u002Feji.200636159\nHermanson, 2013\nHighberger, 1939, The combination of formaldehyde with collagen, J. Am. Leather Chem. Assoc., 34, 131\nHoffman, 2010, Fixative composition alters distributions of immunoreactivity for glutaminase and two markers of nociceptive neurons, Nav1.8 and TRPV1, in the rat dorsal root ganglion, J. Histochem. Cytochem., 58, 329, 10.1369\u002Fjhc.2009.954008\nHopwood, 1967, The effect of formaldehyde fixation and dehydration on ox adrenal medulla with respect to the chromaffin reaction and post-chroming, Histochem. Histochem. Histochim., 10, 98\nHopwood, 1967, Some aspects of fixation with glutaraldehyde – a biochemical and histochemical comparison of effects of formaldehyde and glutaraldehyde fixation on various enzymes and glycogen with a note on penetration of glutaraldehyde into liver, J. Anat., 101, 83\nHopwood, 1968, The effect of pH and various fixatives on isolated ox chromaffin granules with respect to the chromaffin reaction, J. Anat., 102, 415\nHopwood, 1969, Fixatives and fixation: a review, Histochem. J., 1, 323, 10.1007\u002FBF01003278\nHopwood, 1970, The reactions between formaldehyde, glutaraldehyde and osmium tetroxide, and their fixation effects o bovine serum albumin and on tissue blocks, Histochem. Histochem. Histochim., 24, 50, 10.1007\u002FBF00310003\nHopwood, 1972, Theoretical and practical aspects of glutaraldehyde fixation, Histochem. J., 4, 267, 10.1007\u002FBF01005005\nHopwood, 1985, Cell and tissue fixation, 1972–1982, Histochem. J., 17, 389, 10.1007\u002FBF01003203\nHornstein, 2004, Electrical coupling between red and green cones in primate retina, Nat. Neurosci., 7, 745, 10.1038\u002Fnn1274\nHoshi, 2009, ON inputs to the OFF layer: bipolar cells that break the stratification rules of the retina, J. Neurosci., 29, 8875, 10.1523\u002FJNEUROSCI.0912-09.2009\nHu, 2004, Characterization of R9AP, a membrane anchor for the photoreceptor GTPase-accelerating protein, RGS9-1, Methods Enzymol., 390, 178, 10.1016\u002FS0076-6879(04)90012-2\nHua, 1985, Selective destruction by formaldehyde fixation of an H-2Kb serological determinant involving lysine 89 without loss of T-cell reactivity, Immunogenetics, 21, 227, 10.1007\u002FBF00375375\nHuang, 2006, CED: a conformational epitope database, BMC Immunol., 7, 7, 10.1186\u002F1471-2172-7-7\nHuang, 1992, Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus, Proc. Natl. Acad. Sci. U. S. A., 89, 11988, 10.1073\u002Fpnas.89.24.11988\nHuang, 1976, Application of immunofluorescent staining on paraffin sections improved by trypsin digestion, Lab. Investig., 35, 383\nHuebner, 2004, Antibody-antigen Interactions and Measurements of Immunologic Reactions, 10.1128\u002F9781555816148.ch9\nHuh, 2000, Functional requirement for class I MHC in CNS development and plasticity, Science, 290, 2155, 10.1126\u002Fscience.290.5499.2155\nHuxlin, 1997, Retinal ganglion cells in the albino rat: revised morphological classification, J. Comp. Neurol., 385, 309, 10.1002\u002F(SICI)1096-9861(19970825)385:2\u003C309::AID-CNE9>3.0.CO;2-5\nIto, 1968, Formaldehyde-glutaraldehyde fixatives containing trinitro compounds, J. Cell Biol., 39, A168\nIvanova, 2013, Optimized protocol for retinal wholemount preparation for imaging and immunohistochemistry, J. Vis. Exp., e51018\nIzumi, 2000, Comparison of rat retinal fixation techniques: chemical fixation and microwave irradiation, Exp. Eye Res., 70, 191, 10.1006\u002Fexer.1999.0779\nJakobs, 2008, The spatial distribution of glutamatergic inputs to dendrites of retinal ganglion cells, J. Comp. Neurol., 510, 221, 10.1002\u002Fcne.21795\nJan, 1974, Ultrastructural localization of rhodopsin in the vertebrate retina, J. Cell Biol., 62, 257, 10.1083\u002Fjcb.62.2.257\nJanssen-Bienhold, 1998, Distribution of connexin43 immunoreactivity in the retinas of different vertebrates, J. Comp. Neurol., 396, 310, 10.1002\u002F(SICI)1096-9861(19980706)396:3\u003C310::AID-CNE3>3.0.CO;2-5\nJasani, 1997, Significance of metallothionein overexpression in human tumours, Histopathology, 31, 211, 10.1046\u002Fj.1365-2559.1997.2140848.x\nJob, 1998, Calcium and protein kinase C regulate the actin cytoskeleton in the synaptic terminal of retinal bipolar cells, J. Cell Biol., 143, 1661, 10.1083\u002Fjcb.143.6.1661\nJones, 1974, Electron microscopy of frog photoreceptor outer segments after fixation with aldehydes, J. Cell Sci., 16, 199, 10.1242\u002Fjcs.16.1.199\nJuhl, 1984, The effect of Tween 20 on indirect immunoperoxidase staining of blood group antigen A in human urothelium, J. Histochem. Cytochem., 32, 935, 10.1177\u002F32.9.6205049\nKageyama, 1989, Glutamate-immunoreactivity in the retina and optic tectum of goldfish, Brain Res., 503, 118, 10.1016\u002F0006-8993(89)91711-3\nKamphuis, 2005, Circadian expression of clock genes and clock-controlled genes in the rat retina, Biochem. Biophys. Res. Commun., 330, 18, 10.1016\u002Fj.bbrc.2005.02.118\nKarma, 2007, Primary intraocular lymphoma: improving the diagnostic procedure, Ophthalmology, 114, 1372, 10.1016\u002Fj.ophtha.2006.11.009\nKarnovsky, 1965, A formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy, J. Cell Biol., 27, 137\nKasukurthi, 2009, Transcardial perfusion versus immersion fixation for assessment of peripheral nerve regeneration, J. Neurosci. Methods, 184, 303, 10.1016\u002Fj.jneumeth.2009.08.019\nKeeley, 2010, Role of afferents in the differentiation of bipolar cells in the mouse retina, J. Neurosci., 30, 1677, 10.1523\u002FJNEUROSCI.5153-09.2010\nKeyser, 1988, Cholinoceptive neurons in the retina of the chick: an immunohistochemical study of the nicotinic acetylcholine receptors, Vis. Neurosci., 1, 349, 10.1017\u002FS0952523800004120\nKiernan, 2000, Formaldehyde, formalin, paraformaldehyde and glutaraldehyde: what they are and what they do, Microsc. Today, 00, 8, 10.1017\u002FS1551929500057060\nKiernan, 2009, A system for quantitative evaluation of fixatives for light microscopy using paraffin sections of kidney and brain, Biotech. Histochem., 84, 1, 10.1080\u002F10520290802646619\nKim, 2008, Molecular identification of a retinal cell type that responds to upward motion, Nature, 452, 478, 10.1038\u002Fnature06739\nKino, 2009, Retinal topography of ganglion cells in immature ocean sunfish, Mola mola, Environ. Biol. Fish., 85, 33, 10.1007\u002Fs10641-009-9453-z\nKlumpp, 1995, The Shaker-like potassium channels of the mouse rod bipolar cell and their contributions to the membrane current, J. Neurosci., 15, 5004, 10.1523\u002FJNEUROSCI.15-07-05004.1995\nKoizumi, 2007, Organotypic culture of physiologically functional adult mammalian retina, PLoS One, 2, e221, 10.1371\u002Fjournal.pone.0000221\nKolb, 1987, Distribution and morphology of dopaminergic amacrine cells in the retina of the turtle (Pseudemys scripta elegans), J. Neurocytol., 16, 577, 10.1007\u002FBF01637651\nKoopal, 1998, Low-temperature heating overnight in tris-HCl buffer pH 9 is a good alternative for antigen retrieval in formalin-fixed paraffin-embedded tissue, Appl. Immunohistochem., 6, 228, 10.1097\u002F00022744-199812000-00010\nKoulen, 1998, Immunocytochemical localization of the postsynaptic density protein PSD-95 in the mammalian retina, J. Neurosci., 18, 10136, 10.1523\u002FJNEUROSCI.18-23-10136.1998\nKouyama, 1992, Bipolar cells specific for blue cones in the macaque retina, J. Neurosci., 12, 1233, 10.1523\u002FJNEUROSCI.12-04-01233.1992\nKrauss, 1990, New technique to demonstrate the network of blood capillaries of the human retina in their three-dimensional arrangement, Albr. Graefes Arch. Klin Exp. Ophthalmol., 228, 187, 10.1007\u002FBF02764316\nKrizaj, 1998, Compartmentalization of calcium extrusion mechanisms in the outer and inner segments of photoreceptors, Neuron, 21, 249, 10.1016\u002FS0896-6273(00)80531-0\nKuby, 1994\nKwong, 2003, Hyperthermic pre-conditioning protects retinal neurons from N-methyl-D-aspartate (NMDA)-induced apoptosis in rat, Brain Res., 970, 119, 10.1016\u002FS0006-8993(03)02298-4\nLamberts, 1986, Fixation, fine structure, and immunostaining for neuropeptides: perfusion versus immersion of the neuroendocrine hypothalamus, J. Histochem. Cytochem., 34, 389, 10.1177\u002F34.3.2419392\nLatendresse, 2002, Fixation of testes and eyes using a modified Davidson's fluid: comparison with Bouin's fluid and conventional Davidson's fluid, Toxicol. Pathol., 30, 524, 10.1080\u002F01926230290105721\nLaties, 1966, Photoreceptor morphology in freeze-dried retina, Cryobiology, 2, 314, 10.1016\u002FS0011-2240(66)80107-4\nLee, 2014, Synapse elimination and learning rules co-regulated by MHC class I H2-Db, Nature, 509, 195, 10.1038\u002Fnature13154\nLehrer, 1972, The crosslinking of actin and of tropomyosin by glutaraldehyde, Biochem. Biophys. Res. Commun., 48, 967, 10.1016\u002F0006-291X(72)90703-6\nLi, 1986, Colocalization of immunoreactive substance P and neurotensin in amacrine cells of the goldfish retina, Brain Res., 366, 307, 10.1016\u002F0006-8993(86)91308-9\nLi, 2004, Separate blue and green cone networks in the mammalian retina, Nat. Neurosci., 7, 751, 10.1038\u002Fnn1275\nLiang, 2004, Structural and elemental evidence for edema in the retina, retinal pigment epithelium, and choroid during recovery from experimentally induced myopia, Investig. Ophthalmol. Vis. Sci., 45, 2463, 10.1167\u002Fiovs.03-1009\nLight, 2012, Organizational motifs for ground squirrel cone bipolar cells, J. Comp. Neurol., 520, 2864, 10.1002\u002Fcne.23068\nLin, 2005, Synaptic contacts between an identified type of ON cone bipolar cell and ganglion cells in the mouse retina, Eur. J. Neurosci., 21, 1257, 10.1111\u002Fj.1460-9568.2005.03967.x\nLin, 2006, Populations of wide-field amacrine cells in the mouse retina, J. Comp. Neurol., 499, 797, 10.1002\u002Fcne.21126\nLindstrom, 2009, Distribution and structure of efferent synapses in the chicken retina, Vis. Neurosci., 26, 215, 10.1017\u002FS0952523809090063\nLiu, 2009, A novel protocol of whole mount electro-immunofluorescence staining, Mol. Vis., 15, 505\nLorincz, 2008, Specificity of immunoreactions: the importance of testing specificity in each method, J. Neurosci., 28, 9083, 10.1523\u002FJNEUROSCI.2494-08.2008\nLuedtke, 1999, Immunoblot and immunohistochemical comparison of murine monoclonal antibodies specific for the rat D1a and D1b dopamine receptor subtypes, J. Neuroimmunol., 101, 170, 10.1016\u002FS0165-5728(99)00142-3\nLuftig, 1981, The importance of adequate fixation in preservation of membrane ultrastructure, Int. Rev. Cytol. Suppl., 12, 309\nMacri, 2000, Distribution of the alpha1 subunit of the GABA(A) receptor on midget and parasol ganglion cells in the retina of the common marmoset Callithrix jacchus, Vis. Neurosci., 17, 437, 10.1017\u002FS0952523800173109\nMajumdar, 2008, Mirror-symmetrical populations of wide-field amacrine cells of the macaque monkey retina, J. Comp. Neurol., 508, 13, 10.1002\u002Fcne.21666\nMan, 1996, A simple epitope retrieval method without the use of microwave oven or enzyme digestion, Appl. Immunohistochem., 4, 139\nMani, 2000, Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice, Science, 287, 1053, 10.1126\u002Fscience.287.5455.1053\nManoonkitiwongsa, 2002, Proper nomenclature of formaldehyde and paraformaldehyde fixatives for histochemistry, Histochem. J., 34, 365, 10.1023\u002FA:1023342929105\nMarc, 1999, Mapping glutamatergic drive in the vertebrate retina with a channel-permeant organic cation, J. Comp. Neurol., 407, 47, 10.1002\u002F(SICI)1096-9861(19990428)407:1\u003C47::AID-CNE4>3.0.CO;2-0\nMarc, 2008, 1565\nMarc, 2014\nMarc, 2002, Molecular phenotyping of retinal ganglion cells, J. Neurosci., 22, 413, 10.1523\u002FJNEUROSCI.22-02-00413.2002\nMarc, 2013, Retinal connectomics: towards complete, accurate networks, Prog. Retin. Eye Res., 37, 141, 10.1016\u002Fj.preteyeres.2013.08.002\nMarc, 1985, (3H) glycine-accumulating neurons of the human retina, J. Comp. Neurol., 232, 241, 10.1002\u002Fcne.902320209\nMargo, 1995, Fixation of whole eyes: the role of fixative osmolarity in the production of tissue artifact, Albr. Graefes Arch. Klin Exp. Ophthalmol., 233, 366, 10.1007\u002FBF00200486\nMarx, 2013, Finding the right antibody for the job, Nat. Methods, 10, 703, 10.1038\u002Fnmeth.2570\nMasland, 2001, Neuronal diversity in the retina, Curr. Opin. Neurobiol., 11, 431, 10.1016\u002FS0959-4388(00)00230-0\nMasland, 1979, Autoradiographic identification of acetylcholine in the rabbit retina, J. Cell Biol., 83, 159, 10.1083\u002Fjcb.83.1.159\nMassey, 1996, A calbindin-immunoreactive cone bipolar cell type in the rabbit retina, J. Comp. Neurol., 366, 15, 10.1002\u002F(SICI)1096-9861(19960226)366:1\u003C15::AID-CNE2>3.0.CO;2-N\nMassey, 1999, Antibody to calretinin stains AII amacrine cells in the rabbit retina: double-label and confocal analyses, J. Comp. Neurol., 411, 3, 10.1002\u002F(SICI)1096-9861(19990816)411:1\u003C3::AID-CNE2>3.0.CO;2-1\nMcMenamin, 2000, Optimal methods for preparation and immunostaining of iris, ciliary body, and choroidal wholemounts, Investig. Ophthalmol. Vis. Sci., 41, 3043\nMcKay, 2009, An antibody panel for immunohistochemical analysis of the retina in Davidson's-fixed, paraffin-embedded eyes of rats, Exp. Toxicol. Pathol., 61, 91, 10.1016\u002Fj.etp.2008.06.005\nMeissner, 1990, Improved cryoprotection and freeze-substitution of embryonic quail retina: a TEM study on ultrastructural preservation, J. Electr. Microsc. Tech., 14, 348, 10.1002\u002Fjemt.1060140410\nMigneault, 2004, Glutaraldehyde: behavior in aqueous solution, reaction with proteins, and application to enzyme crosslinking, Biotechniques, 37, 798\nMills, 1994, Distribution and coverage of A- and B-type horizontal cells stained with neurobiotin in the rabbit retina, Vis. Neurosci., 11, 549, 10.1017\u002FS0952523800002455\nMills, 2014, Stratification of the inner plexiform layer in the mammalian retina\nMills, 2001, Rod pathways in the mammalian retina use connexin 36, J. Comp. Neurol., 436, 336, 10.1002\u002Fcne.1071\nMobius, 2010, Electron microscopy of the mouse central nervous system, Methods Cell Biol., 96, 475, 10.1016\u002FS0091-679X(10)96020-2\nMolday, 1991, The cGMP-gated channel of the rod photoreceptor cell characterization and orientation of the amino terminus, J. Biol. Chem., 266, 21917, 10.1016\u002FS0021-9258(18)54724-4\nMollenhauer, 1971, Studies on seeds. I. Fixation of seeds, J. Cell Biol., 48, 387, 10.1083\u002Fjcb.48.2.387\nMonsan, 1975, Mechanism of glutaraldehyde-protein bond formation, Biochimie, 57, 1281, 10.1016\u002FS0300-9084(76)80540-8\nMoran, 1991, Similar properties of taurine release induced by potassium and hyposmolarity in the rat retina, Exp. Eye Res., 53, 347, 10.1016\u002F0014-4835(91)90240-F\nMorgan, 2006, Axons and dendrites originate from neuroepithelial-like processes of retinal bipolar cells, Nat. Neurosci., 9, 85, 10.1038\u002Fnn1615\nMorgans, 2001, Localization of the alpha(1F) calcium channel subunit in the rat retina, Investig. Ophthalmol. Vis. Sci., 42, 2414\nMorgans, 1998, Calcium extrusion from mammalian photoreceptor terminals, J. Neurosci., 18, 2467, 10.1523\u002FJNEUROSCI.18-07-02467.1998\nMosiman, 1997, Reducing cellular autofluorescence in flow cytometry: an in situ method, Cytometry, 30, 151, 10.1002\u002F(SICI)1097-0320(19970615)30:3\u003C151::AID-CYTO6>3.0.CO;2-O\nMüller, 2003, HCN channels are expressed differentially in retinal bipolar cells and concentrated at synaptic terminals, Eur. J. Neurosci., 17, 2084, 10.1046\u002Fj.1460-9568.2003.02634.x\nNadal-Nicolás, 2009, Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas, Investig. Ophthalmol. Vis. Sci., 50, 3860, 10.1167\u002Fiovs.08-3267\nNagle, 1986, The teleost cone cytoskeleton. Localization of actin, microtubules, and intermediate filaments, Investig. Ophthalmol. Vis. Sci., 27, 689\nNakagawa, 1989, Development of effective cross-linking method for bioactive substance – enzyme immobilization using glutaraldehyde oligomers, Chem. Pharm. Bull., 37, 2463, 10.1248\u002Fcpb.37.2463\nNakane, 1966, Enzyme-labeled antibodies: preparation and application for the localization of antigens, J. Histochem. Cytochem., 14, 929, 10.1177\u002F14.12.929\nNegishi, 1979, Histochemical studies on catecholaminergic cells in the carp retina, Neurochem. Res., 4, 473, 10.1007\u002FBF00964642\nNelson, 1978, Intracellular staining reveals different levels of stratification for on- and off-center ganglion cells in cat retina, J. Neurophysiol., 41, 472, 10.1152\u002Fjn.1978.41.2.472\nNeumann, 2002, Simple method for reduction of autofluorescence in fluorescence microscopy, J. Histochem. Cytochem., 50, 437, 10.1177\u002F002215540205000315\nNIOSH, 2011\nNIOSH, 2014\nNir, 1974, The ultrastructure of lipid-depleted rod photoreceptor membranes, J. Cell Biol., 63, 587, 10.1083\u002Fjcb.63.2.587\nNovikoff, 1972, Diffusion artifacts in 3,3′-diaminobenzidine cytochemistry, J. Histochem. Cytochem., 20, 745, 10.1177\u002F20.9.745\nO'Brien, 2002, Intrinsic physiological properties of cat retinal ganglion cells, J. Physiol., 538, 787, 10.1113\u002Fjphysiol.2001.013009\nO'Brien, 2012, Photoreceptor coupling mediated by connexin36 in the primate retina, J. Neurosci., 32, 4675, 10.1523\u002FJNEUROSCI.4749-11.2012\nO'Brien, 2006, Coupling between A-type horizontal cells is mediated by connexin 50 gap junctions in the rabbit retina, J. Neurosci., 26, 11624, 10.1523\u002FJNEUROSCI.2296-06.2006\nOgata, 2012, Dopamine and full-field illumination activate D1 and D2-D5-type receptors in adult rat retinal ganglion cells, J. Comp. Neurol., 520, 4032, 10.1002\u002Fcne.23159\nOrr, 1976, Distribution of 3′:5′-cyclic AMP and 3′:5′-cyclic GMP in rabbit retina in vivo: selective effects of dark and light adaptation and ischemia, Proc. Natl. Acad. Sci. U. S. A., 73, 4442, 10.1073\u002Fpnas.73.12.4442\nOrtez, 1980, Residual cyclic nucleotide associated with tissues after exposure to aqueous buffer analogous to that used in immunocytochemistry, J. Cycl. Nucl. Res., 6, 93\nOrtez, 1980, Immunohistochemical localization of cyclic GMP in goldfish retina, J. Histochem. Cytochem., 28, 263, 10.1177\u002F28.3.6243683\nOttesen, 1971, Modification of papain by treatment with glutaraldehyde under reducing and non-reducing conditions, C. R. Trav. Lab. Carlsb., 38, 171\nPartida, 2004, DARPP-32-like immunoreactivity in AII amacrine cells of rat retina, J. Comp. Neurol., 480, 251, 10.1002\u002Fcne.20330\nPartida, 2012, Thy1 associates with the cation channel subunit HCN4 in adult rat retina, Investig. Ophthalmol. Vis. Sci., 53, 1696, 10.1167\u002Fiovs.11-9307\nPeichl, 1989, Alpha and delta ganglion cells in the rat retina, J. Comp. Neurol., 286, 120, 10.1002\u002Fcne.902860108\nPetrides, 2008, Differential output of the high-sensitivity rod photoreceptor: AII amacrine pathway, J. Comp. Neurol., 507, 1653, 10.1002\u002Fcne.21617\nPfeffer, 2009, Preservation of structure and immunoreactivity at the vitreoretinal interface of the rabbit eye, Albr. Graefes Arch. Klin. Exp. Ophthalmol., 247, 193, 10.1007\u002Fs00417-008-0991-4\nPhilp, 1987, Light-stimulated protein movement in rod photoreceptor cells of the rat retina, FEBS Lett., 225, 127, 10.1016\u002F0014-5793(87)81144-4\nPiccolino, 1984, Decrease of gap junction permeability induced by dopamine and cyclic adenosine 3':5'-monophosphate in horizontal cells of turtle retina, J. Neurosci., 4, 2477, 10.1523\u002FJNEUROSCI.04-10-02477.1984\nPileri, 1997, Antigen retrieval techniques in immunohistochemistry: comparison of different methods, J. Pathol., 183, 116, 10.1002\u002F(SICI)1096-9896(199709)183:1\u003C116::AID-PATH1087>3.0.CO;2-2\nPinheiro, 1963, Standardized heat fixation for blood smears, Stain Technol., 38, 227, 10.3109\u002F10520296309061183\nPolyak, 1941\nPow, 1997, Immunocytochemical detection of amino acid neurotransmitters in paraformaldehyde-fixed tissues, Methods Mol. Biol., 72, 103\nPow, 1995, The immunocytochemical detection of amino-acid neurotransmitters in paraformaldehyde-fixed tissues, J. Neurosci. Methods, 56, 115, 10.1016\u002F0165-0270(94)00113-U\nProchniewicz-Nakayama, 1982, The effect of crosslinking of thin filament with glutaraldehyde on the contractility of muscle fiber, J. Biochem., 92, 1269, 10.1093\u002Foxfordjournals.jbchem.a134045\nQuiocho, 1966, Enzymic behavior of carboxypeptidase-A in solid state, Biochemistry, 5, 4062, 10.1021\u002Fbi00876a041\nRamón y Cajal, 1893, La rétine des vertébrés, La Cellule, 9, 119\nRasband, 1999, K+ channel distribution and clustering in developing and hypomyelinated axons of the optic nerve, J. Neurocytol., 28, 319, 10.1023\u002FA:1007057512576\nRasmussen, 1974, Fixation in aldehydes. A study on the influence of the fixative, buffer, and osmolarity upon the fixation of the rat retina, J. Ultrastruct. Res., 46, 87, 10.1016\u002FS0022-5320(74)80024-9\nReale, 1970, Fixation with aldehydes. Their usefulness for histological and histochemical studies in light and electron microscopy, Histochem. Histochem. Histochim., 23, 144\nReyes, 2000, Immunolocalization of the arachidonic acid and mechanosensitive baseline traak potassium channel in the nervous system, Neuroscience, 95, 893, 10.1016\u002FS0306-4522(99)00484-4\nRhodes, 2006, Antibodies as valuable neuroscience research tools versus reagents of mass distraction, J. Neurosci., 26, 8017, 10.1523\u002FJNEUROSCI.2728-06.2006\nRichards, 1968, Glutaraldehyde as a protein cross-linkage reagent, J. Mol. Biol., 37, 231, 10.1016\u002F0022-2836(68)90086-7\nRiepe, 1977, Muller cell localization of glutamine-synthetase in rat retina, Nature, 268, 654, 10.1038\u002F268654a0\nRiggs, 1958, Isothiocyanate compounds as fluorescent labeling agents for immune serum, Am. J. Pathol., 34, 1081\nRobertson, 1970, The impurities in commercial glutaraldehyde and their effect on the fixation of brain, J. Ultrastruct. Res., 30, 275, 10.1016\u002FS0022-5320(70)80063-6\nRockhill, 2002, The diversity of ganglion cells in a mammalian retina, J. Neurosci., 22, 3831, 10.1523\u002FJNEUROSCI.22-09-03831.2002\nRodger, 2005, Eph\u002Fephrin expression in the adult rat visual system following localized retinal lesions: localized and transneuronal up-regulation in the retina and superior colliculus, Eur. J. Neurosci., 22, 1840, 10.1111\u002Fj.1460-9568.2005.04381.x\nRodriguez, 2014, The RNA binding protein RBPMS is a selective marker of ganglion cells in the mammalian retina, J. Comp. Neurol., 522, 1411, 10.1002\u002Fcne.23521\nRöhlich, 1994, Two different visual pigments in one retinal cone cell, Neuron, 13, 1159, 10.1016\u002F0896-6273(94)90053-1\nRohrenbeck, 1989, Horizontal cells in the monkey retina: Immunocytochemical staining with antibodies against calcium binding proteins, Eur. J. Neurosci., 1, 407, 10.1111\u002Fj.1460-9568.1989.tb00349.x\nRosillo, 2013, Olfacto-retinalis pathway in Austrolebias charrua fishes: a neuronal tracer study, Neuroscience, 253, 304, 10.1016\u002Fj.neuroscience.2013.08.047\nRost, 1971, New methods for the histochemical demonstration of catecholamines, tryptamines, histamine and other arylethylamines by acid- and aldehyde-induced fluorescence, Histochem. J., 3, 207, 10.1007\u002FBF01002565\nRuppelt, 2007, Inhibition of T cell activation by cyclic adenosine 5'-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin, J. Immunol., 179, 5159, 10.4049\u002Fjimmunol.179.8.5159\nRyskamp, 2011, The polymodal ion channel transient receptor potential vanilloid 4 modulates calcium flux, spiking rate, and apoptosis of mouse retinal ganglion cells, J. Neurosci., 31, 7089, 10.1523\u002FJNEUROSCI.0359-11.2011\nSabatini, 1963, Cytochemistry and electron microscopy. The preservation of cellular ultrastructure and enzymatic activity by aldehyde fixation, J. Cell Biol., 17, 19, 10.1083\u002Fjcb.17.1.19\nSaenz-de-Viteri, 2014, Oxidative stress and histological changes in a model of retinal phototoxicity in rabbits, Oxid. Med. Cell. Longev., 2014, 637137, 10.1155\u002F2014\u002F637137\nSaez, 2006, HER-2 gene amplification by chromogenic in situ hybridisation (CISH) compared with fluorescence in situ hybridisation (FISH) in breast cancer-A study of two hundred cases, Breast, 15, 519, 10.1016\u002Fj.breast.2005.09.008\nSaper, 2009, A guide to the perplexed on the specificity of antibodies, J. Histochem. Cytochem., 57, 1, 10.1369\u002Fjhc.2008.952770\nSaper, 2003, Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry, J. Comp. Neurol., 465, 161, 10.1002\u002Fcne.10858\nSassoe-Pognetto, 1995, Colocalization of gephyrin and GABAA-receptor subunits in the rat retina, J. Comp. Neurol., 357, 1, 10.1002\u002Fcne.903570102\nSchmidt, 1971, Cyclic adenosine monophosphate in brain areas: microwave irradiation as a means of tissue fixation, Science, 173, 1142, 10.1126\u002Fscience.173.4002.1142\nSchnitzer, 1985, Distribution and immunoreactivity of glia in the retina of the rabbit, J. Comp. Neurol., 240, 128, 10.1002\u002Fcne.902400203\nSeydewitz, 2004, Expression of CNTF receptor-alpha in chick violet-sensitive cones with unique morphologic properties, Investig. Ophthalmol. Vis. Sci., 45, 655, 10.1167\u002Fiovs.03-0182\nShehab, 1990, Preferential histochemical staining of protoplasmic and fibrous astrocytes in rat CNS with GFAP antibodies using different fixatives, Brain Res., 518, 347, 10.1016\u002F0006-8993(90)90996-O\nShi, 1994, Antigen retrieval using pH 3.5 glycine-HCl buffer or urea solution for immunohistochemical localization of Ki-67, Biotech. Histochem., 69, 213, 10.3109\u002F10520299409106289\nShi, 1999, Calcium-induced modification of protein conformation demonstrated by immunohistochemistry: what is the signal?, J. Histochem. Cytochem., 47, 463, 10.1177\u002F002215549904700404\nShi, 1991, Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections, J. Histochem. Cytochem., 39, 741, 10.1177\u002F39.6.1709656\nSiegert, 2009, Genetic address book for retinal cell types, Nat. Neurosci., 12, 1197, 10.1038\u002Fnn.2370\nSmith, 1983, J. Histochem. Cytochem., 31, 1183, 10.1177\u002F31.10.6411804\nSokolov, 2002, Massive light-driven translocation of transducin between the two major compartments of rod cells: a novel mechanism of light adaptation, Neuron, 34, 95, 10.1016\u002FS0896-6273(02)00636-0\nSompuram, 2006, Antibodies immunoreactive with formalin-fixed tissue antigens recognize linear protein epitopes, Am. J. Clin. Pathol., 125, 82, 10.1309\u002F6H0ARQF7K3Y608EH\nSompuram, 2004, A molecular mechanism of formalin fixation and antigen retrieval, Am. J. Clin. Pathol., 121, 190, 10.1309\u002FBRN7CTX1E84NWWPL\nStahl, 1984, Immunocytochemical localization of Na+, K+ adenosine-triphosphatase in the rat retina, J. Histochem. Cytochem., 32, 248, 10.1177\u002F32.2.6319483\nStefanini, 1967, Fixation of ejaculated spermatozoa for electron microscopy, Nature, 216, 173, 10.1038\u002F216173a0\nSteinberg, 1973, The distribution of rods and cones in the retina of the cat (Felis domesticus), J. Comp. Neurol., 148, 229, 10.1002\u002Fcne.901480209\nStell, 1972, The morphological organization of the vertebrate retina, 111, 10.1007\u002F978-3-642-65340-7_4\nStell, 1975, Color-specific interconnections of cones and horizontal cells in the retina of the goldfish, J. Comp. Neurol., 159, 473, 10.1002\u002Fcne.901590404\nSternberger, 1979, The unlabeled antibody method. Hormone receptor, golgi-like and dual color immunocytochemistry, J. Histochem. Cytochem., 27, 1658, 10.1177\u002F27.12.230258\nStewart, 2007, Changes in fluorescence intensity of selected leukocyte surface markers following fixation, Cytom. Part A, 71A, 379, 10.1002\u002Fcyto.a.20392\nStradleigh, 2015, Moniliform deformation of retinal ganglion cells by formaldehyde-based fixatives, J. Comp. Neurol., 523, 545, 10.1002\u002Fcne.23689\nStradleigh, 2011, Colocalization of hyperpolarization-activated, cyclic nucleotide-gated channel subunits in rat retinal ganglion cells, J. Comp. Neurol., 519, 2546, 10.1002\u002Fcne.22638\nSullivan, 1984, Asymmetric distribution of the chemotactic peptide receptor on polymorphonuclear leukocytes, J. Cell Biol., 99, 1461, 10.1083\u002Fjcb.99.4.1461\nSutherland, 2008, Utility of formaldehyde cross-linking and mass spectrometry in the study of protein-protein interactions, J. Mass Spectrom., 43, 699, 10.1002\u002Fjms.1415\nTakahashi, 1993, Proliferating cell nuclear antigen (Pcna) immunohistochemistry – influence of tissue fixation, processing and effects of antigen retrieval, Micron, 24, 385, 10.1016\u002F0968-4328(93)90004-K\nTanito, 2002, Change of redox status and modulation by thiol replenishment in retinal photooxidative damage, Investig. Ophthalmol. Vis. Sci., 43, 2392\nTauchi, 1984, The shape and arrangement of the cholinergic neurons in the rabbit retina, Proc. R. Soc. Lond., 223B, 101, 10.1098\u002Frspb.1984.0085\nTaylor, 1998, Localization and properties of voltage-gated calcium channels in cone photoreceptors of Tupaia belangeri, Vis. Neurosci., 15, 541, 10.1017\u002FS0952523898153142\nTerada, 2006, Immunohistochemical detection of phosphorylated rhodopsin in light-exposed retina of living mouse with in vivo cryotechnique, J. Histochem. Cytochem., 54, 479, 10.1369\u002Fjhc.5A6844.2006\nTerada, 2009, Immunoreactivity of glutamate in mouse retina inner segment of photoreceptors with in vivo cryotechnique, J. Histochem. Cytochem., 57, 883, 10.1369\u002Fjhc.2009.953851\nTezel, 2003, Immunohistochemical assessment of the glial mitogen-activated protein kinase activation in glaucoma, Investig. Ophthalmol. Vis. Sci., 44, 3025, 10.1167\u002Fiovs.02-1136\nTezel, 2004, Hypoxia-inducible factor 1alpha in the glaucomatous retina and optic nerve head, Arch. Ophthalmol., 122, 1348, 10.1001\u002Farchopht.122.9.1348\nThermo, 2015\nThiessen, 1970, The diffusin of 59Fe-labelled hemoglobin, an artefact of the fixation with glutaraldehyde, Histochem. Histochem. Histochim., 23, 171\nTkatchenko, 2006, Whole-mount BrdU staining of proliferating cells by DNase treatment: application to postnatal mammalian retina, Biotechniques, 40, 29, 10.2144\u002F000112094\nTomimatsu, 1971, Physical chemical observations on alpha-chymotrypsin glutaraldehyde system during formation of an insoluble derivative, J. Colloid Interf. Sci., 36, 51, 10.1016\u002F0021-9797(71)90239-6\nTrexler, 2001, Coupling from AII amacrine cells to ON cone bipolar cells is bidirectional, J. Comp. Neurol., 437, 408, 10.1002\u002Fcne.1292\nUsukura, 1993, Rapid freezing and subsequent preparation methods in retinal cell biology, 37, 10.1016\u002FB978-0-12-185279-5.50008-X\nVan Hook, 2012, Dopaminergic modulation of ganglion-cell photoreceptors in rat, Eur. J. Neurosci., 35, 507, 10.1111\u002Fj.1460-9568.2011.07975.x\nVan Wart, 2007, Polarized distribution of ion channels within microdomains of the axon initial segment, J. Comp. Neurol., 500, 339, 10.1002\u002Fcne.21173\nVaney, 1991, Many diverse types of retinal neurons show tracer coupling when injected with biocytin or Neurobiotin, Neurosci. Lett., 125, 187, 10.1016\u002F0304-3940(91)90024-N\nVanha-Perttula, 1970, Loss of proteins and other macromolecules during preparation of cell cultures for high resolution autoradiography. Quantitation by a micromethod, J. Histochem. Cytochem., 18, 565, 10.1177\u002F18.8.565\nVani, 2006, A high throughput combinatorial library technique for identifying formalin-sensitive epitopes, J. Immunol. Methods, 317, 80, 10.1016\u002Fj.jim.2006.09.009\nVaquero, 2001, A dopamine- and protein kinase A-dependent mechanism for network adaptation in retinal ganglion cells, J. Neurosci., 21, 8624, 10.1523\u002FJNEUROSCI.21-21-08624.2001\nVaquero, 1996, Protein kinase C localization in the synaptic terminal of rod bipolar cells, Neuroreport, 7, 2176, 10.1097\u002F00001756-199609020-00024\nVaughan, 1990, Glial fibrillary acidic protein (GFAP) immunoreactivity in rabbit retina – effect of fixation, Exp. Eye Res., 50, 385, 10.1016\u002F0014-4835(90)90139-L\nVaughan, 1990, Distribution of F-actin in bipolar and horizontal cells of bass retinas, Am. J. Physiol., 259, C205, 10.1152\u002Fajpcell.1990.259.2.C205\nVerhoeff, 1931, The condition of the ocular structures immediately after removal of the lens in capsule, as determined by microscopic examination, Trans. Am. Ophthalmol. Soc., 29, 184\nVillalobos, 2013, A wide-field suprachoroidal retinal prosthesis is stable and well tolerated following chronic implantation, Investig. Ophthalmol. Vis. Sci., 54, 3751, 10.1167\u002Fiovs.12-10843\nVillegas, 1964, Ultrastructure of the human retina, J. Anat., 98, 501\nVoigt, 1987, Dopaminergic innervation of A II amacrine cells in mammalian retina, J. Neurosci., 7, 4115, 10.1523\u002FJNEUROSCI.07-12-04115.1987\nVolgyi, 2005, Morphology and tracer coupling pattern of alpha ganglion cells in the mouse retina, J. Comp. Neurol., 492, 66, 10.1002\u002Fcne.20700\nVolgyi, 2009, Tracer coupling patterns of the ganglion cell subtypes in the mouse retina, J. Comp. Neurol., 512, 664, 10.1002\u002Fcne.21912\nWagner, 1993, Localization of D2 dopamine receptors in vertebrate retinae with anti-peptide antibodies, J. Comp. Neurol., 331, 469, 10.1002\u002Fcne.903310404\nWalls, 1963\nWalt, 1994, The chemistry of enzyme and protein immobilization with glutaraldehyde, TrAC – Trend Anal. Chem., 13, 425, 10.1016\u002F0165-9936(94)85023-2\nWan, 1993, A rapid and simple microfluorometric phagocytosis assay, J. Immunol. Methods, 162, 1, 10.1016\u002F0022-1759(93)90400-2\nWang, 1969, Modification of glycogen phosphorylase b by glutaraldehyde. Preparation and isolation of enzyme derivatives with enhanced stability, Biochemistry, 8, 4403, 10.1021\u002Fbi00839a027\nWässle, 2004, Parallel processing in the mammalian retina, Nat. Rev. Neurosci., 5, 747, 10.1038\u002Fnrn1497\nWässle, 2000, The mosaic of horizontal cells in the macaque monkey retina: with a comment on biplexiform ganglion cells, Vis. Neurosci., 17, 591, 10.1017\u002FS0952523800174097\nWässle, 1993, Immunocytochemical staining of AII-amacrine cells in the rat retina with antibodies against parvalbumin, J. Comp. Neurol., 332, 407, 10.1002\u002Fcne.903320403\nWässle, 2009, Cone contacts, mosaics, and territories of bipolar cells in the mouse retina, J. Neurosci., 29, 106, 10.1523\u002FJNEUROSCI.4442-08.2009\nWebster, 1969, A quantitative morphological study of osmotically induced swelling and shrinkage in nervous tissue, Tissue Cell, 1, 201, 10.1016\u002FS0040-8166(69)80022-4\nWendt, 2004, Comparison of conventional and microwave-assisted processing of mouse retinas for transmission electron microscopy, J. Microsc., 214, 80, 10.1111\u002Fj.0022-2720.2004.01310.x\nWenk, 2006, Fixatives: coagulative vs non-coagulative or is it additive vs non-additive?, Histologic, 39, 4\nWerner, 2000, Effect of formalin tissue fixation and processing on immunohistochemistry, Am. J. Surg. Pathol., 24, 1016, 10.1097\u002F00000478-200007000-00014\nWiemelt, 1997, Immunochemical visualization and quantitation of cyclic AMP in single cells, J. Biol. Chem., 272, 31489, 10.1074\u002Fjbc.272.50.31489\nWikler, 1990, Distribution of photoreceptor subtypes in the retina of diurnal and nocturnal primates, J. Neurosci., 10, 3390, 10.1523\u002FJNEUROSCI.10-10-03390.1990\nWitkovsky, 2007, Cellular localization and function of DARPP-32 in the rodent retina, Eur. J. Neurosci., 25, 3233, 10.1111\u002Fj.1460-9568.2007.05571.x\nWitkovsky, 2004, Activity-dependent phosphorylation of tyrosine hydroxylase in dopaminergic neurons of the rat retina, J. Neurosci., 24, 4242, 10.1523\u002FJNEUROSCI.5436-03.2004\nWollner, 1986, Localization of sodium channels in axon hillocks and initial segments of retinal ganglion cells, Proc. Natl. Acad. Sci. U. S. A., 83, 8424, 10.1073\u002Fpnas.83.21.8424\nWu, 2013, rAAV-mediated subcellular targeting of optogenetic tools in retinal ganglion cells in vivo, PLoS One, 8, e66332, 10.1371\u002Fjournal.pone.0066332\nXu, 2008, Different types of ganglion cell share a synaptic pattern, J. Comp. Neurol., 507, 1871, 10.1002\u002Fcne.21644\nYamada, 1980, Somatostatin-like immunoreactivity in the retina, Proc. Natl. Acad. Sci. U. S. A., 77, 1691, 10.1073\u002Fpnas.77.3.1691\nYamashita, 2005, Mechanisms of heat-induced antigen retrieval: analyses in vitro employing SDS-PAGE and immunohistochemistry, J. Histochem. Cytochem., 53, 13, 10.1177\u002F002215540505300103\nYanez, 1994, Are the dopaminergic cells of the lamprey retina interplexiform cells? A dopamine, tyrosine hydroxylase and dopamine beta-hydroxylase immunocytochemical study, Neurosci. Lett., 165, 63, 10.1016\u002F0304-3940(94)90710-2\nYoshiki, 1993, The mouse chimera during intrauterine stages: immunohistochemical analysis with the C3H strain-specific antibody, J. Histochem. Cytochem., 41, 1583, 10.1177\u002F41.10.8245417\nYoung, 1991, Rod-signal interneurons in the rabbit retina: 1. Rod bipolar cells, J. Comp. Neurol., 310, 139, 10.1002\u002Fcne.903100202\nZafra, 1995, Glycine transporters are differentially expressed among CNS cells, J. Neurosci., 15, 3952, 10.1523\u002FJNEUROSCI.15-05-03952.1995\nZhang, 2005, Stratification of alpha ganglion cells and ON\u002FOFF directionally selective ganglion cells in the rabbit retina, Vis. Neurosci., 22, 535, 10.1017\u002FS0952523805224148\nZhu, 2002, Mouse cone arrestin expression pattern: light induced translocation in cone photoreceptors, Mol. Vis., 8, 462\nZucker, 1998, Localization of gephyrin and glycine receptor subunit immunoreactivity in the rabbit retina, Vis. Neurosci., 15, 389, 10.1017\u002FS0952523898152173",{"VOID":1469},"10.1016\u002Fj.preteyeres.2015.04.001","2024-05-14T05:45:11.362+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS135094621500018X",[1473,1488],{"id":1474,"sortIndex":92,"researcher":24,"roles":1475,"affiliations":1476,"properties":1485,"displayName":1487,"givenName":24,"familyName":24},"790a0d7b-7c70-4e39-a414-45a3f382b733",[143],[1477],{"id":1478,"sortIndex":92,"affiliation":1479,"properties":24},"a10d3176-cbdc-4fdd-8219-6511a6644277",{"id":1478,"createTime":24,"updateTime":24,"relativeEntities":1480,"slug":24,"properties":1481,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1484,"statistic":24},[],{"title":1482},{"VI":1483},"Department of Neurobiology, Physiology and Behavior, University of California, Davis, CA 95616, USA",[],{"title":1486},{"VI":1487},"Tyler W. Stradleigh",{"id":1489,"sortIndex":870,"researcher":24,"roles":1490,"affiliations":1491,"properties":1507,"displayName":1509,"givenName":24,"familyName":24},"1c7b4310-a014-4fad-ad49-ee469091d798",[143],[1492,1498],{"id":1478,"sortIndex":92,"affiliation":1493,"properties":24},{"id":1478,"createTime":24,"updateTime":24,"relativeEntities":1494,"slug":24,"properties":1495,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1497,"statistic":24},[],{"title":1496},{"VI":1483},[],{"id":1499,"sortIndex":870,"affiliation":1500,"properties":1506},"46ae8c78-9282-4603-b0b0-0cf16fef5de6",{"id":1499,"createTime":24,"updateTime":24,"relativeEntities":1501,"slug":24,"properties":1502,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1505,"statistic":24},[],{"title":1503},{"VI":1504},"Department of Ophthalmology and Vision Science, University of California, Sacramento, CA 95817, USA",[],{},{"title":1508},{"VI":1509},"Andrew T. Ishida",{"url":1471,"publisher":1511,"properties":1558},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1512,"slug":10,"properties":1513,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":1518,"manageAffiliations":1527,"indexDatabases":1538,"url":90,"thumbnailPath":24,"statistic":1553,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":1514,"eissn":1515,"issn":1516,"title":1517},{"VOID":13},{"VOID":15},{"VOID":17},{"EN":19},[1519,1523],{"id":28,"createTime":24,"updateTime":24,"relativeEntities":1520,"label":1521,"description":1522,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":31},{},{"id":34,"createTime":24,"updateTime":24,"relativeEntities":1524,"label":1525,"description":1526,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":37},{},[1528,1533],{"id":41,"createTime":24,"updateTime":24,"relativeEntities":1529,"slug":24,"properties":1530,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1532,"statistic":24},[],{"title":1531},{"EN":45},[],{"id":48,"createTime":24,"updateTime":24,"relativeEntities":1534,"slug":24,"properties":1535,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1537,"statistic":24},[],{"title":1536},{"EN":52},[],[1539,1546],{"id":56,"indexDatabase":1540,"url":67,"indexYears":68,"academicFieldIds":1545,"indexDatabaseRanking":72},{"id":58,"createTime":24,"updateTime":24,"relativeEntities":1541,"label":1542,"description":1543,"key":64,"publicationTags":1544,"standard":24},[],{"EN":61,"VI":61},{"EN":61,"VI":63},[66],[70,71],{"id":74,"indexDatabase":1547,"url":87,"indexYears":24,"academicFieldIds":1552,"indexDatabaseRanking":24},{"id":76,"createTime":24,"updateTime":24,"relativeEntities":1548,"label":1549,"description":1550,"key":83,"publicationTags":1551,"standard":24},[],{"EN":79,"VI":79},{"EN":81,"VI":82},[85,86],[89],{"impactFactor":92,"impactFactorByYear":1554,"i10Index":92,"i10IndexLast5Year":92,"totalPublication":94,"totalPublicationByYear":1555,"totalCitation":92,"totalCitationByYear":1556,"totalCitationPerPublication":92,"totalCitationPerPublicationByYear":1557,"hindexLast5Year":92,"hindex":92},{},{"1994":96,"1995":97,"1996":98,"1997":99,"1998":100,"1999":101,"2000":102,"2001":103,"2002":104,"2003":102,"2004":100,"2005":103,"2006":105,"2007":106,"2008":98,"2009":106,"2010":97,"2011":105,"2012":104,"2013":107,"2014":105,"2015":108,"2016":108,"2017":109,"2018":110,"2019":111,"2020":112,"2021":113,"2022":114,"2023":111},{},{},{"pages":1559,"volume":1561},{"VOID":1560},"181-202",{"VOID":1562},"48","2015-09-01",2015,"DONE_GET_PLATFORM_ID",[85,72],{"id":1568,"createTime":1569,"updateTime":1570,"relativeEntities":1571,"slug":1572,"properties":1573,"entityType":134,"verifyStatus":135,"verifyTime":1581,"verifyNote":137,"languages":24,"translateLanguages":24,"viewCount":92,"primaryUrl":1582,"fullTextUrl":24,"authors":1583,"publicationType":156,"publisherRelationship":1763,"citationCount":24,"citationInfo":24,"publishDate":1816,"publishYear":1817,"citationAnalyzeStatus":1202,"lastCitationAnalyze":1818,"indexDatabases":1819,"openAccess":24,"references":24,"isForceReanalyzing":837},"8b575c0a-2bba-4224-80aa-942e0acdfa6f","2024-01-10T03:22:35.824+00:00","2026-01-15T06:37:02.000+00:00",[],"Endpoints-for-clinical-trials-in-ophthalmology",{"title":1574,"gsPaper":1576,"references":1577,"doi":1579},{"EN":1575},"Endpoints for clinical trials in ophthalmology",{"VOID":993},{"VOID":1578},"Abdelfattah, 2016, Drusen volume as a predictor of disease progression in patients with late age-related macular degeneration in the fellow eye, Investig. Ophthalmol. Vis. Sci., 57, 1839, 10.1167\u002Fiovs.15-18572\nAbe, 2015, Frequency doubling technology perimetry and changes in quality of life of glaucoma patients: a longitudinal study, Am. J. Ophthalmol., 160, 114, 10.1016\u002Fj.ajo.2015.04.007\nAbe, 2016, The impact of location of progressive visual field loss on longitudinal changes in quality of life of patients with glaucoma, Ophthalmology, 123, 552, 10.1016\u002Fj.ophtha.2015.10.046\nAbe, 2016, The relative odds of progressing by structural and functional tests in glaucoma, Investig. Ophthalmol. Vis. Sci., 57, OCT421, 10.1167\u002Fiovs.15-18940\nAbe, 2018, Predicting vision-related disability in glaucoma, Ophthalmology, 125, 22, 10.1016\u002Fj.ophtha.2017.08.034\n2009, 1\nAgemy, 2015, Retinal vascular perfusion density mapping using optical coherence tomography angiography in normals and diabetic retinopathy patients, Retina, 35, 2353, 10.1097\u002FIAE.0000000000000862\nAhlers, 2010, Imaging of the retinal pigment epithelium in age-related macular degeneration using polarization-sensitive optical coherence tomography, Investig. Ophthalmol. Vis. Sci., 51, 2149, 10.1167\u002Fiovs.09-3817\nAiello, 1997, Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies, Investig. Ophthalmol. Vis. Sci., 38, 1647\nAl-Sheikh, 2016, Swept-source OCT angiography imaging of the foveal avascular zone and macular capillary network density in diabetic retinopathy, Investig. Ophthalmol. Vis. Sci., 57, 3907, 10.1167\u002Fiovs.16-19570\nAl-Sheikh, 2018, Biomarkers of neovascular activity in age-related macular degeneration using optical coherence tomography angiography, Retina, 38, 220, 10.1097\u002FIAE.0000000000001628\nAlagorie, 2019, Quantitative assessment of choriocapillaris flow deficits in eyes with advanced age-related macular degeneration versus healthy eyes, Am. J. Ophthalmol., 205, 132, 10.1016\u002Fj.ajo.2019.04.037\nAlagorie, 2020, Relationship between proximity of choriocapillaris flow deficits and enlargement rate of geographic atrophy, Graefe's Arch. Clin. Exper. Ophthalmol., 258, 995, 10.1007\u002Fs00417-020-04615-w\nAlagorie, 2020, Association of intravitreal aflibercept with optical coherence tomography angiography vessel density in patients with proliferative diabetic retinopathy: a secondary analysis of a randomized clinical trial, JAMA Ophthalmology, 138, 851, 10.1001\u002Fjamaophthalmol.2020.2130\nAlagorie, 2021, Effect of aflibercept on diabetic retinopathy severity and visual function in the RECOVERY study for proliferative diabetic retinopathy, Ophthalmol. Ret., 5, 409, 10.1016\u002Fj.oret.2020.08.018\nAlahmadi, 2018, Contrast sensitivity deficits in patients with mutation-proven inherited retinal degenerations, BMC Ophthalmol., 18, 1, 10.1186\u002Fs12886-018-0982-0\nAlasil, 2010, Relationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edema, Ophthalmology, 117, 2379, 10.1016\u002Fj.ophtha.2010.03.051\nAlibhai, 2020, Quantification of retinal capillary nonperfusion in diabetics using wide-field optical coherence tomography angiography, Retina, 40, 10.1097\u002FIAE.0000000000002403\nAnderson, 1992\nAref, 2019, Relating glaucomatous visual field loss to retinal oxygen delivery and metabolism, Acta Ophthalmol., 97, e968, 10.1111\u002Faos.14120\nAronson, 2017, Biomarkers—a general review, Curr. Protoc. Pharmacol., 76, 10.1002\u002Fcpph.19\nAsahi, 2020, Multifocal ERG and microperimetry changes in response to ranibizumab treatment of neovascular AMD: randomized phase 2 open-label study, Clin. Ophthalmol., 14, 3599, 10.2147\u002FOPTH.S270243\nAslam, 2016, Development and testing of an automated computer tablet-based method for self-testing of high and low contrast near visual acuity in ophthalmic patients, Graefe's Arch. Clin. Exper. Ophthalmol., 254, 891, 10.1007\u002Fs00417-016-3293-2\nAzimipour, 2019, Functional retinal imaging using adaptive optics swept-source OCT at 1.6 MHz, Optica, 6, 300, 10.1364\u002FOPTICA.6.000300\nAzimipour, 2020, Optoretinogram: optical measurement of human cone and rod photoreceptor responses to light, Opt. Lett., 45, 4658, 10.1364\u002FOL.398868\nBabiuch, 2019, Association of disorganization of retinal inner layers with visual acuity response to anti–vascular endothelial growth factor therapy for macular edema secondary to retinal vein occlusion, JAMA Ophthalmology, 137, 38, 10.1001\u002Fjamaophthalmol.2018.4484\nBach, 1996, The freiburg visual acuity test--automatic measurement of visual acuity, Optom. Vis. Sci.: Off. Publ. Am. Acad. Optom., 73 1, 49, 10.1097\u002F00006324-199601000-00008\nBach, 2013, ISCEV standard for clinical pattern electroretinography (PERG): 2012 update, Doc. Ophthalmol., 126, 1, 10.1007\u002Fs10633-012-9353-y\nBagdonaite-Bejarano, 2019, 334\nBainbridge, 2008, Effect of gene therapy on visual function in Leber's congenital amaurosis, N. Engl. J. Med., 358, 2231, 10.1056\u002FNEJMoa0802268\nBalaratnasingam, 2016, Visual acuity is correlated with the area of the foveal avascular zone in diabetic retinopathy and retinal vein occlusion, Ophthalmology, 123, 2352, 10.1016\u002Fj.ophtha.2016.07.008\nBalcer, 2012, Low-contrast acuity measures visual improvement in phase 3 trial of natalizumab in relapsing MS, J. Neurol. Sci., 318, 119, 10.1016\u002Fj.jns.2012.03.009\nBalcer, 2017, Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis, Multiple Scleros. J., 23, 734, 10.1177\u002F1352458517690822\nBarkana, 2021, Visual field endpoints based on subgroups of points may be useful in glaucoma clinical trials: a study with the humphrey field analyzer and compass perimeter, J. Glaucoma, 30, 10.1097\u002FIJG.0000000000001856\nBarkana, 2021, Improved sensitivity of microperimetric outcomes for clinical studies in age-related macular degeneration, Sci. Rep., 11, 4764, 10.1038\u002Fs41598-021-83716-w\nBata, 2019, Age-related decline of retinal oxygen extraction in healthy subjects, Investig. Ophthalmol. Vis. Sci., 60, 3162, 10.1167\u002Fiovs.18-26234\nBeck, 2007, Visual acuity as an outcome measure in clinical trials of retinal diseases, Ophthalmology, 114, 1804, 10.1016\u002Fj.ophtha.2007.06.047\nBecker, 2019, First data of a prospective study comparing the impact of retinitis pigmentosa linked to usher syndrome 1B caused by MYO7A mutations and non-syndromic on daily living one year apart, Investig. Ophthalmol. Vis. Sci., 60\nBeykin, 2021, Discovery and clinical translation of novel glaucoma biomarkers, Prog. Retin. Eye Res., 80, 10.1016\u002Fj.preteyeres.2020.100875\nBirch, 2013, Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa, JAMA Ophthalmology, 131, 1143, 10.1001\u002Fjamaophthalmol.2013.4160\nBirch, 2015, Rates of decline in regions of the visual field defined by frequency-domain optical coherence tomography in patients with RPGR-mediated X-linked retinitis pigmentosa, Ophthalmology, 122, 833, 10.1016\u002Fj.ophtha.2014.11.005\nBird, 1995, An international classification and grading system for age-related maculopathy and age-related macular degeneration, Surv. Ophthalmol., 39, 367, 10.1016\u002FS0039-6257(05)80092-X\nBlack, 2011, Inferior field loss increases rate of falls in older adults with glaucoma, Optom. Vis. Sci., 88, 1275, 10.1097\u002FOPX.0b013e31822f4d6a\nDe Boer, 2017, Polarization sensitive optical coherence tomography–a review, Biomed. Opt Express, 8, 1838, 10.1364\u002FBOE.8.001838\nBoland, 2007, Risk factors and open-angle glaucoma: classification and application, J. Glaucoma, 16, 406, 10.1097\u002FIJG.0b013e31806540a1\nBowl, 2015, Fundus-controlled two-color dark adaptometry with the microperimeter MP1, Graefe's Arch. Clin. Exper. Ophthalmol., 253, 965, 10.1007\u002Fs00417-015-3010-6\nBowl, 2019, Fundus-controlled dark adaptometry in young children without and with spontaneously regressed retinopathy of prematurity, Transl. Vis. Sci. Technol., 8, 10.1167\u002Ftvst.8.3.62\nBoyle, 2020, Mechanisms of light-induced deformations in photoreceptors, Biophys. J., 119, 1481, 10.1016\u002Fj.bpj.2020.09.005\nBraithwaite, 2019, The use of patient-reported outcome research in modern ophthalmology: impact on clinical trials and routine clinical practice, Patient Relat. Outcome Meas., 10, 9, 10.2147\u002FPROM.S162802\nBressler, 2001, Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2, Arch. Ophthalmol., 119, 198\nBressler, 2012, Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab, Arch. Ophthalmol., 130, 1153, 10.1001\u002Farchophthalmol.2012.1107\nBroman, 2008, Estimating the rate of progressive visual field damage in those with open-angle glaucoma, from cross-sectional data, Investig. Ophthalmol. Vis. Sci., 49, 66, 10.1167\u002Fiovs.07-0866\nBrown, 2001, Spatial scale and cellular substrate of contrast adaptation by retinal ganglion cells, Nat. Neurosci., 4, 44, 10.1038\u002F82888\nBrown, 2021, Evaluation of intravitreal aflibercept for the treatment of severe nonproliferative diabetic retinopathy: results from the PANORAMA randomized clinical trial, JAMA Ophthalmology, 139, 946, 10.1001\u002Fjamaophthalmol.2021.2809\nBrown, 2022, KESTREL and KITE: 52-week results from two phase III pivotal trials of brolucizumab for diabetic macular edema, Am. J. Ophthalmol., 238, 157, 10.1016\u002Fj.ajo.2022.01.004\nBrowning, 2005, Regional patterns of sight-threatening diabetic macular edema, Am. J. Ophthalmol., 140, 117, 10.1016\u002Fj.ajo.2005.02.032\nBrowning, 2008, Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema, Ophthalmology, 115, 1366, 10.1016\u002Fj.ophtha.2007.12.004\nBunce, 2015, Considerations for randomizing 1 eye or 2 eyes, JAMA Ophthalmology, 133, 10.1001\u002Fjamaophthalmol.2015.2757\nBurns, 2019, Adaptive optics imaging of the human retina, Prog. Retin. Eye Res., 68, 1, 10.1016\u002Fj.preteyeres.2018.08.002\nByeon, 2012, New insights into the pathoanatomy of diabetic macular edema: angiographic patterns and optical coherence tomography, Retina, 32, 1087, 10.1097\u002FIAE.0b013e3182349686\nByon, 2021, Topographic assessment of choriocapillaris flow deficits in the intermediate age-related macular degeneration eyes with hyporeflective cores inside drusen, Retina, 41, 393, 10.1097\u002FIAE.0000000000002906\nCalzetti, 2018, Efficacy outcome measures for clinical trials of USH2A caused by the common c. 2299delG mutation, Am. J. Ophthalmol., 193, 114, 10.1016\u002Fj.ajo.2018.06.017\nCalzetti, 2022, Measuring optic nerve head perfusion to monitor glaucoma: a study on structure–function relationships using laser speckle flowgraphy, Acta Ophthalmol., 100, e181, 10.1111\u002Faos.14862\nCarnevali, 2017, Optical coherence tomography angiography analysis of retinal vascular plexuses and choriocapillaris in patients with type 1 diabetes without diabetic retinopathy, Acta Diabetol., 54, 695, 10.1007\u002Fs00592-017-0996-8\nCaspi, 2015, Assessing the utility of visual acuity measures in visual prostheses, Vis. Res., 108, 77, 10.1016\u002Fj.visres.2015.01.006\nCense, 2004, In vivo birefringence and thickness measurements of the human retinal nerve fiber layer using polarization-sensitive optical coherence tomography, J. Biomed. Opt., 9, 121, 10.1117\u002F1.1627774\nCharbel Issa, 2013, Macular telangiectasia type 2, Prog. Retin. Eye Res., 34, 49, 10.1016\u002Fj.preteyeres.2012.11.002\nChen, 2021, A critical review: psychophysical assessments of diabetic retinopathy, Surv. Ophthalmol., 66, 213, 10.1016\u002Fj.survophthal.2020.08.003\nChen, 2015, Adaptive optics imaging of healthy and abnormal regions of retinal nerve fiber bundles of patients with glaucoma, Investig. Ophthalmol. Vis. Sci., 56, 674, 10.1167\u002Fiovs.14-15936\nCheong, 2020, Deshadowgan: a deep learning approach to remove shadows from optical coherence tomography images, Transl. Vis. Sci. Technol., 9, 10.1167\u002Ftvst.9.2.23\nChew, 2013, Long-term effects of vitamins C and E, beta-carotene, and zinc on age-related macular egeneration: AREDS report no. 35, Ophthalmology, 120, 1604, 10.1016\u002Fj.ophtha.2013.01.021\nChew, 2014, Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report No. 36, JAMA Ophthalmology, 132, 272, 10.1001\u002Fjamaophthalmol.2013.6636\nChew, 2019, Effect of ciliary neurotrophic factor on retinal neurodegeneration in patients with macular telangiectasia type 2: a randomized clinical trial, Ophthalmology, 126, 540, 10.1016\u002Fj.ophtha.2018.09.041\nChiang, 2013, Vision impairment and major causes of vision loss impacts on vision-specific functioning independent of socioeconomic factors, Ophthalmology, 120, 415, 10.1016\u002Fj.ophtha.2012.07.077\nChong, 2016, Assessing the GOANNA visual field algorithm using artificial scotoma generation on human observers, Transl. Vis. Sci. Technol., 5, 10.1167\u002Ftvst.5.5.1\nChristenbury, 2013, Progression of intermediate age-related macular degeneration with proliferation and inner retinal migration of hyperreflective foci, Ophthalmology, 120, 1038, 10.1016\u002Fj.ophtha.2012.10.018\nChua, 2019, Future clinical applicability of optical coherence tomography angiography, Clin. Exp. Optom., 102, 260, 10.1111\u002Fcxo.12854\nChua, 2020, Optical coherence tomography angiography in diabetes and diabetic retinopathy, J. Clin. Med., 9, 1723, 10.3390\u002Fjcm9061723\nChung, 2017, Correlation of multi-luminance mobility testing with visual function tests in a phase 3 trial of voretigene neparvovec for biallelic RPE65-mediated inherited retinal disease, Investig. Ophthalmol. Vis. Sci., 58\nChung, 2018, Novel mobility test to assess functional vision in patients with inherited retinal dystrophies, Clin. Exp. Ophthalmol., 46, 247, 10.1111\u002Fceo.13022\nCiulla, 2020, Voretigene neparvovec-rzyl for treatment of RPE65-mediated inherited retinal diseases: a model for ocular gene therapy development, Expet Opin. Biol. Ther., 20, 565, 10.1080\u002F14712598.2020.1740676\nDe Civita, 2005, Evaluating health-related quality-of-life studies in paediatric populations, Pharmacoeconomics, 23, 659, 10.2165\u002F00019053-200523070-00003\nCleland, 2021, Quantification of geographic atrophy using spectral domain OCT in age-related macular degeneration, Ophthalmol. Ret., 5, 41, 10.1016\u002Fj.oret.2020.07.006\nColburn, 2000, Optimizing the use of biomarkers, surrogate endpoints, and clinical endpoints for more efficient drug development, J. Clin. Pharmacol., 40, 1419, 10.1177\u002F009127000004001212\nCooper, 2020, Optoretinography of individual human cone photoreceptors, Opt Express, 28, 39326, 10.1364\u002FOE.409193\nCorazza, 2021, Predicting wet age-related macular degeneration (AMD) using DARC (detecting apoptosing retinal cells) AI (artificial intelligence) technology, Expert Rev. Mol. Diagn., 21, 109, 10.1080\u002F14737159.2020.1865806\nCordeiro, 2017, Real-time imaging of single neuronal cell apoptosis in patients with glaucoma, Brain, 140, 1757, 10.1093\u002Fbrain\u002Fawx088\nCordeiro, 2021, Detecting retinal cell stress and apoptosis with DARC: progression from lab to clinic, Prog. Retin. Eye Res.\nCorradetti, 2021, Natural history of incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration, Can. J. Ophthalmol., 56, 325, 10.1016\u002Fj.jcjo.2021.01.005\nCorradetti, 2021, Scotopic microperimetric sensitivity and inner choroid flow deficits as predictors of progression to nascent geographic atrophy, Br. J. Ophthalmol., 105, 1584, 10.1136\u002Fbjophthalmol-2020-316893\nCorvi, 2017, Choroidal structure in eyes with drusen and reticular pseudodrusen determined by binarisation of optical coherence tomographic images, Br. J. Ophthalmol., 101, 348\nCorvi, 2017, Pilot evaluation of short-term changes in macular pigment and retinal sensitivity in different phenotypes of early age-related macular degeneration after carotenoid supplementation, Br. J. Ophthalmol., 101, 770, 10.1136\u002Fbjophthalmol-2016-309115\nCorvi, 2018, Reproducibility of vessel density, fractal dimension, and foveal avascular zone using 7 different optical coherence tomography angiography devices, Am. J. Ophthalmol., 186, 25, 10.1016\u002Fj.ajo.2017.11.011\nCorvi, 2020, Comparison between several optical coherence tomography angiography devices and indocyanine green angiography of choroidal neovascularization, Retina, 40, 873, 10.1097\u002FIAE.0000000000002471\nCorvi, 2021, Comparison of spectralis and cirrus optical cohence tomography for the detection of incomplete and complete retinal pigment epithelium and outer retinal atrophy, Retina, 41, 1851, 10.1097\u002FIAE.0000000000003158\nCorvi, 2021, Topography of choriocapillaris flow deficit predicts development of neovascularization or atrophy in age-related macular degeneration, Graefe's Arch. Clin. Exper. Ophthalmol., 259, 2887, 10.1007\u002Fs00417-021-05167-3\nCorvi, 2021, Quantitative assessment of choriocapillaris flow deficits in eyes with macular neovascularization, Graefe's Arch. Clin. Exper. Ophthalmol., 259, 1811, 10.1007\u002Fs00417-020-05056-1\nCorvi, 2021, Optical coherence tomography angiography for detection of macular neovascularization associated with atrophy in age-related macular degeneration, Graefe's Arch. Clin. Exper. Ophthalmol., 259, 291, 10.1007\u002Fs00417-020-04821-6\nCorvi, 2021, Choriocapillaris flow deficits as a risk factor for progression of age-related macular degeneration, Retina, 41, 686, 10.1097\u002FIAE.0000000000002990\nCrabb, 2012, Intervals between visual field tests when monitoring the glaucomatous patient: wait-and-see approach, Investig. Ophthalmol. Vis. Sci., 53, 2770, 10.1167\u002Fiovs.12-9476\nCsaky, 2008, Report from the NEI\u002FFDA ophthalmic clinical trial design and endpoints symposium, Investig. Ophthalmol. Vis. Sci., 49, 479, 10.1167\u002Fiovs.07-1132\nCsaky, 2017, Report from the NEI\u002FFDA endpoints workshop on age-related macular degeneration and inherited retinal diseases, Investig. Ophthalmol. Vis. Sci., 58, 3456, 10.1167\u002Fiovs.17-22339\nCurcio, 1996, Photoreceptor loss in age-related macular degeneration, Investig. Ophthalmol. Vis. Sci., 37, 1236\nDaruich, 2018, Mechanisms of macular edema: beyond the surface, Prog. Retin. Eye Res., 63, 20, 10.1016\u002Fj.preteyeres.2017.10.006\nDavis, 2005, The age-related eye disease study severity scale for age-related macular degeneration: AREDS report no. 17, Arch. Ophthalmol., 123, 1484, 10.1001\u002Farchopht.123.11.1484\nDelaunay, 2020, Glial cells of the human fovea, Mol. Vis., 26, 235\nDenniston, 2014, An introduction to patient-reported outcome measures in ophthalmic research, Eye, 28, 637, 10.1038\u002Feye.2014.41\nDesai, 2006, Blood pressure as an example of a biomarker that functions as a surrogate, AAPS J., 8, E146, 10.1208\u002Faapsj080117\nDeshpande, 2011, Patient-reported outcomes: a new era in clinical research, Perspect. Clin. Res., 2, 137, 10.4103\u002F2229-3485.86879\nDesissaire, 2020, Analysis of retinal nerve fiber layer birefringence in patients with glaucoma and diabetic retinopathy by polarization sensitive OCT, Biomed. Opt Express, 11, 5488, 10.1364\u002FBOE.402475\nDevalla, 2018, A deep learning approach to digitally stain optical coherence tomography images of the optic nerve head, Investig. Ophthalmol. Vis. Sci., 59, 63, 10.1167\u002Fiovs.17-22617\nDevalla, 2019, A deep learning approach to denoise optical coherence tomography images of the optic nerve head, Sci. Rep., 9, 1, 10.1038\u002Fs41598-019-51062-7\nDevalla, 2020, Towards label-free 3D segmentation of optical coherence tomography images of the optic nerve head using deep learning, Biomed. Opt Express, 11, 6356, 10.1364\u002FBOE.395934\nDhoot, 2018, Baseline factors affecting changes in diabetic retinopathy severity scale score after intravitreal aflibercept or laser for diabetic macular edema: post hoc analyses from VISTA and VIVID, Ophthalmology, 125, 51, 10.1016\u002Fj.ophtha.2017.06.029\nDimitrova, 2017, Quantitative retinal optical coherence tomography angiography in patients with diabetes without diabetic retinopathy, Investig. Ophthalmol. Vis. Sci., 58, 190, 10.1167\u002Fiovs.16-20531\nDimopoulos, 2018, Two-year results after AAV2-mediated gene therapy for choroideremia: the Alberta experience, Am. J. Ophthalmol., 193, 130, 10.1016\u002Fj.ajo.2018.06.011\nDoblhoff-Dier, 2014, Measurement of the total retinal blood flow using dual beam Fourier-domain Doppler optical coherence tomography with orthogonal detection planes, Biomed. Opt Express, 5, 630, 10.1364\u002FBOE.5.000630\nDong, 2017, Adaptive optics optical coherence tomography in glaucoma, Prog. Retin. Eye Res., 57, 76, 10.1016\u002Fj.preteyeres.2016.11.001\nDowning, 2001, Biomarkers and surrogate endpoints: preferred definitions and conceptual framework, Clin. Pharmacol. Therapeut., 69, 89, 10.1067\u002Fmcp.2001.113989\nDrance, 1999, The collaborative normal-tension glaucoma study and some of its lessons, Can. J. Ophthalmol., 34, 1\nDugel, 2020, HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration, Ophthalmology, 127, 72, 10.1016\u002Fj.ophtha.2019.04.017\nDuh, 2017, Diabetic retinopathy: current understanding, mechanisms, and treatment strategies, JCI Insight, 2, 10.1172\u002Fjci.insight.93751\nEichler, 2020, Are novel, nonrandomized analytic methods fit for decision making? The need for prospective, controlled, and transparent validation, Clin. Pharmacol. Therapeut., 107, 773, 10.1002\u002Fcpt.1638\nEichler, 2021, Randomized controlled trials versus real world evidence: neither magic nor myth, Clin. Pharmacol. Therapeut., 109, 1212, 10.1002\u002Fcpt.2083\nElSheikh, 2022, Current and novel therapeutic approaches for treatment of neovascular age-related macular degeneration, Biomolecules, 12, 1629, 10.3390\u002Fbiom12111629\nEng, 2020, Complete RPE and outer retinal atrophy in patients receiving anti-VEGF treatment for neovascular age-related macular degeneration, PLoS One, 15, 10.1371\u002Fjournal.pone.0232353\nFalavarjani, 2017, Optical coherence tomography angiography analysis of the foveal avascular zone and macular vessel density after anti-VEGF therapy in eyes with diabetic macular edema and retinal vein occlusion, Investig. Ophthalmol. Vis. Sci., 58, 30, 10.1167\u002Fiovs.16-20579\nFaryan, 2015, Retinal blood flow and retinal blood oxygen saturation in mild to moderate diabetic retinopathy, Investig. Ophthalmol. Vis. Sci., 56, 6796, 10.1167\u002Fiovs.15-17481\nDe Fauw, 2018, Clinically applicable deep learning for diagnosis and referral in retinal disease, Nat. Med., 24, 1342, 10.1038\u002Fs41591-018-0107-6\nFayers, 2013\nFelder, 2015, Inner retinal oxygen extraction fraction in response to light flicker stimulation in humans, Investig. Ophthalmol. Vis. Sci., 56, 6633, 10.1167\u002Fiovs.15-17321\nFercher, 2010, Optical coherence tomography – development, principles, applications, Z. Med. Phys., 20, 251, 10.1016\u002Fj.zemedi.2009.11.002\nFernández-Vigo, 2020, Normative database of peripapillary vessel density measured by optical coherence tomography angiography and correlation study, Curr. Eye Res., 45, 1430, 10.1080\u002F02713683.2020.1744164\nFernández‐Vigo, 2020, Normative database and determinants of macular vessel density measured by optical coherence tomography angiography, Clin. Exp. Ophthalmol., 48, 44, 10.1111\u002Fceo.13648\nFerrara, 2006, Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration, Retina, 26, 859, 10.1097\u002F01.iae.0000242842.14624.e7\nFerris, 2005, A simplified severity scale for age-related macular degeneration: AREDS Report No. 18, Arch. Ophthalmol., 123, 1570, 10.1001\u002Farchopht.123.11.1570\nFinger, 2008, Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools, Qual. Life Res., 17, 559, 10.1007\u002Fs11136-008-9327-4\nFinger, 2016, Reticular pseudodrusen and their association with age-related macular degeneration: the Melbourne collaborative cohort study, Ophthalmology, 123, 599, 10.1016\u002Fj.ophtha.2015.10.029\nFlammer, 1985, Quantification of glaucomatous visual field defects with automated perimetry, Investig. Ophthalmol. Vis. Sci., 26, 176\nFleckenstein, 2008, High-resolution spectral domain-OCT imaging in geographic atrophy associated with age-related macular degeneration, Investig. Ophthalmol. Vis. Sci., 49, 4137, 10.1167\u002Fiovs.08-1967\nFleckenstein, 2014, The “diffuse-trickling” fundus autofluorescence phenotype in geographic atrophy, Investig. Ophthalmol. Vis. Sci., 55, 2911, 10.1167\u002Fiovs.13-13409\nFleckenstein, 2018, The progression of geographic atrophy secondary to age-related macular degeneration, Ophthalmology, 125, 369, 10.1016\u002Fj.ophtha.2017.08.038\nFleckenstein, 2021, Age-related macular degeneration, Nat. Rev. Dis. Prim., 7, 31, 10.1038\u002Fs41572-021-00265-2\nFleming, 1996, Surrogate end points in clinical trials: are we being misled?, Ann. Intern. Med., 125, 605, 10.7326\u002F0003-4819-125-7-199610010-00011\nFleming, 2012, Biomarkers and surrogate endpoints in clinical trials, Stat. Med., 31, 2973, 10.1002\u002Fsim.5403\nFondi, 2017, Retinal oxygen extraction in individuals with type 1 diabetes with no or mild diabetic retinopathy, Diabetologia, 60, 1534, 10.1007\u002Fs00125-017-4309-0\nForte, 2013, Multimodal evaluation of foveal sparing in patients with geographicatrophy due to age-related macular degeneration, Retina, 33, 482, 10.1097\u002FIAE.0b013e318276e11e\nFrancis, 2011, Population and high-risk group screening for glaucoma: the Los Angeles Latino eye study, Investig. Ophthalmol. Vis. Sci., 52, 6257, 10.1167\u002Fiovs.09-5126\nFraser, 2016, Assessment of retinotopic rod photoreceptor function using a dark-adapted chromatic perimeter in intermediate age-related macular degeneration, Investig. Ophthalmol. Vis. Sci., 57, 5436, 10.1167\u002Fiovs.16-19295\nFreemantle, 2003, Composite outcomes in randomized trials: greater precision but with greater uncertainty?, JAMA, 289, 2554, 10.1001\u002Fjama.289.19.2554\nFry, 2018, The coma in glaucoma: retinal ganglion cell dysfunction and recovery, Prog. Retin. Eye Res., 65, 77, 10.1016\u002Fj.preteyeres.2018.04.001\nFujimoto, 2016, The development, commercialization, and impact of optical coherence tomography, Investig. Ophthalmol. Vis. Sci., 57, OCT1, 10.1167\u002Fiovs.16-19963\nFujinami, 2013, A longitudinal study of stargardt disease: clinical and electrophysiologic assessment, progression, and genotype correlations, Am. J. Ophthalmol., 155, 1075, 10.1016\u002Fj.ajo.2013.01.018\nFujiwara, 2021, En face image-based classification of diabetic macular edema using swept source optical coherence tomography, Sci. Rep., 11, 1, 10.1038\u002Fs41598-021-87440-3\nGarafalo, 2020, Progress in treating inherited retinal diseases: early subretinal gene therapy clinical trials and candidates for future initiatives, Prog. Retin. Eye Res., 77, 10.1016\u002Fj.preteyeres.2019.100827\nGardiner, 2018, Differences in the relation between perimetric sensitivity and variability between locations across the visual field, Investig. Ophthalmol. Vis. Sci., 59, 3667, 10.1167\u002Fiovs.18-24303\nGardiner, 2016, The effect of limiting the range of perimetric sensitivities on pointwise assessment of visual field progression in glaucoma, Investig. Ophthalmol. Vis. Sci., 57, 288, 10.1167\u002Fiovs.15-18000\nGarway-Heath, 2013, The United Kingdom Glaucoma Treatment Study: a multicenter, randomized, placebo-controlled clinical trial: design and methodology, Ophthalmology, 120, 68, 10.1016\u002Fj.ophtha.2012.07.028\nGarway-Heath, 2018, Combining optical coherence tomography with visual field data to rapidly detect disease progression in glaucoma: a diagnostic accuracy study, Health Technol. Assess., 22, 1, 10.3310\u002Fhta22040\nGaudric, 2006, Optical coherence tomography in group 2A idiopathic juxtafoveolar retinal telangiectasis, Arch. Ophthalmol., 124, 1410, 10.1001\u002Farchopht.124.10.1410\nGaudric, 2015, Outer retina capillart invasion and ellipsoid zone loss in macular telangiectasia type 2 imaged by optical coherence tomography angiography, Retina, 35, 2300, 10.1097\u002FIAE.0000000000000799\nGeorgiou, 2020, Intraobserver repeatability and interobserver reproducibility of foveal cone density measurements in CNGA3-and CNGB3-associated achromatopsia, Transl. Vis. Sci. Technol., 9, 10.1167\u002Ftvst.9.7.37\nGherghel, 2022, Barriers to IOP-independent treatments in glaucoma clinical trials, Eye\nGiarratano, 2020, Automated segmentation of optical coherence tomography angiography images: benchmark data and clinically relevant metrics, Transl. Vis. Sci. Technol., 9, 10.1167\u002Ftvst.9.13.5\nGirard, 2020, Artificial intelligence and deep learning in glaucoma: current state and future prospects, Prog. Brain Res., 257, 37, 10.1016\u002Fbs.pbr.2020.07.002\nGlaucoma Laser Trial Research, 1995, The glaucoma laser trial (GLT) and glaucoma laser trial follow-up study: 7. results, Am. J. Ophthalmol., 120, 718, 10.1016\u002FS0002-9394(14)72725-4\nGoldberg, 2022\nGomez, 2016, Strategies for improving patient comfort during intravitreal injections: results from a survey-based study, Ophthalmol. Ther., 5, 183, 10.1007\u002Fs40123-016-0058-2\nGonzález-Herrero, 2018, Supplementation with a highly concentrated docosahexaenoic acid plus xanthophyll carotenoid multivitamin in nonproliferative diabetic retinopathy: prospective controlled study of macular function by fundus microperimetry, Clin. Ophthalmol., 12, 1011, 10.2147\u002FOPTH.S157635\nGordon, 2002, The ocular hypertension treatment study: baseline factors that predict the onset of primary open-angle glaucoma, Arch. Ophthalmol., 120, 714, 10.1001\u002Farchopht.120.6.714\n2018\n2018\n2018\n2019\n2020\n2020\n2021\n2021\nGracitelli, 2015, Association between progressive retinal nerve fiber layer loss and longitudinal change in quality of life in glaucoma, JAMA Ophthalmology, 133, 384, 10.1001\u002Fjamaophthalmol.2014.5319\nGross, 2015, Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial, JAMA, 314, 2137, 10.1001\u002Fjama.2015.15217\n1981, Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of diabetic retinopathy study (DRS) findings, DRS report number 8, Ophthalmology, 88, 583, 10.1016\u002FS0161-6420(81)34978-1\n1991, Early photocoagulation for diabetic retinopathy: ETDRS report number 9, Ophthalmology, 98, 766, 10.1016\u002FS0161-6420(13)38011-7\n1991, Fundus photographic risk factors for progression of diabetic retinopathy: ETDRS report number 12, Ophthalmology, 98, 823, 10.1016\u002FS0161-6420(13)38014-2\n2007, Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study, Ophthalmology, 114, 3, 10.1016\u002Fj.ophtha.2006.05.075\n2016\nGündüz, 1988, Color vision defects in ocular hypertension and glaucoma: quantification with a computer-driven color television system, Arch. Ophthalmol., 106, 929, 10.1001\u002Farchopht.1988.01060140075028\nGune, 2020, Spectral-domain OCT–based prevalence and progression of macular atrophy in the HARBOR study for neovascular age-related macular degeneration, Ophthalmology, 127, 523, 10.1016\u002Fj.ophtha.2019.09.030\nGuymer, 2020, Incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration: classification of atrophy meeting report 4, Ophthalmology, 127, 394, 10.1016\u002Fj.ophtha.2019.09.035\nHaindl, 2016, Total retinal blood flow measurement by three beam Doppler optical coherence tomography, Biomed. Opt Express, 7, 287, 10.1364\u002FBOE.7.000287\nHaraldstad, 2019, A systematic review of quality of life research in medicine and health sciences, Qual. Life Res., 28, 2641, 10.1007\u002Fs11136-019-02214-9\nHarrer, 2019, Artificial intelligence for clinical trial design, Trends Pharmacol. Sci., 40, 577, 10.1016\u002Fj.tips.2019.05.005\nHathibelagal, 2015, Measuring infant visual acuity with gaze tracker monitored visual fixation, Optom. Vis. Sci., 92, 823, 10.1097\u002FOPX.0000000000000613\nHeijl, 2002, Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial, Arch. Ophthalmol., 120, 1268, 10.1001\u002Farchopht.120.10.1268\nHeijl, 2011, The effect of different criteria on the number of patients blind from open-angle glaucoma, BMC Ophthalmol., 11, 31, 10.1186\u002F1471-2415-11-31\nHillmann, 2016, In vivo optical imaging of physiological responses to photostimulation in human photoreceptors, Proc. Natl. Acad. Sci. USA, 113, 13138, 10.1073\u002Fpnas.1606428113\nHirano, 2019, Quantifying vascular density and morphology using different swept-source optical coherence tomography angiographic scan patterns in diabetic retinopathy, Br. J. Ophthalmol., 103, 216, 10.1136\u002Fbjophthalmol-2018-311942\nHo, 2011, Documentation of intraretinal retinal pigment epithelium migration via high-speed ultrahigh-resolution optical coherence tomography, Ophthalmology, 118, 687, 10.1016\u002Fj.ophtha.2010.08.010\nHo, 2015, Quantitative characteristics of spectral-domain optical coherence tomography (SDOCT) in corresponding areas of decreased autofluorescence in patients with Stargardt disease, Investig. Ophthalmol. Vis. Sci., 56\nHoffmann, 2021, ISCEV standard for clinical multifocal electroretinography (mfERG) (2021 update), Doc. Ophthalmol., 142, 5, 10.1007\u002Fs10633-020-09812-w\nHolz, 2001, Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration, Investig. Ophthalmol. Vis. Sci., 42, 1051\nHolz, 2007, Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration, Am. J. Ophthalmol., 143, 463, 10.1016\u002Fj.ajo.2006.11.041\nHolz, 2014, Geographic atrophy: clinical features and potential therapeutic approaches, Ophthalmology, 121, 1079, 10.1016\u002Fj.ophtha.2013.11.023\nHolz, 2017, Imaging protocols in clinical studies in advanced age-related macular degeneration: recommendations from classification of atrophy consensus meetings, Ophthalmology, 124, 464, 10.1016\u002Fj.ophtha.2016.12.002\nHolz, 2018, Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and spectri phase 3 randomized clinical trials, JAMA Ophthalmology, 136, 666, 10.1001\u002Fjamaophthalmol.2018.1544\nHood, 2003, The multifocal electroretinogram, J. Neuro Ophthalmol., 23, 225, 10.1097\u002F00041327-200309000-00008\nHood, 2011, The transition zone between healthy and diseased retina in patients with retinitis pigmentosa, Investig. Ophthalmol. Vis. Sci., 52, 101, 10.1167\u002Fiovs.10-5799\nHou, 2016, Evaluating the performance of the quick CSF method in detecting contrast sensitivity function changes, J. Vis., 16, 10.1167\u002F16.6.18\nHsieh, 2019, OCT angiography biomarkers for predicting visual outcomes after ranibizumab treatment for diabetic macular edema, Ophthalmol. Ret., 3, 826, 10.1016\u002Fj.oret.2019.04.027\nHurko, 2009, The uses of biomarkers in drug development, Ann. N. Y. Acad. Sci., 1180, 1, 10.1111\u002Fj.1749-6632.2009.04946.x\nHussain, 2007, Measurement of greatest linear diameter for choroidal neovascular membrane using optical coherence tomography, Am. J. Ophthalmol., 143, 1038, 10.1016\u002Fj.ajo.2007.01.039\nIafe, 2016, Optical coherence tomography angiography of type 1 neovascularization in age-related macular degeneration, OCT Angiogr. Ret. Macular Dis., 56, 45, 10.1159\u002F000442776\nIftikhar, 2018, Progression of retinitis pigmentosa as measured on microperimetry: the PREP-1 Study, Ophthalmol. Ret., 2, 502, 10.1016\u002Fj.oret.2017.09.008\nInoue, 2016, A comparison between optical coherence tomography angiography and fluorescein angiography for the imaging of type 1 neovascularization, Investig. Ophthalmol. Vis. Sci., 57, OCT314, 10.1167\u002Fiovs.15-18900\nInvestigators, 2000, The advanced glaucoma intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration, Am. J. Ophthalmol., 130, 429, 10.1016\u002FS0002-9394(00)00538-9\nItoh, 2016, Volumetric ellipsoid zone mapping for enhanced visualisation of outer retinal integrity with optical coherence tomography, Br. J. Ophthalmol., 100, 295, 10.1136\u002Fbjophthalmol-2015-307105\nJackson, 2014, Diagnostic sensitivity and specificity of dark adaptometry for detection of age-related macular degeneration, Investig. Ophthalmol. Vis. Sci., 55, 1427, 10.1167\u002Fiovs.13-13745\nJacobson, 1986, Automated light-and dark-adapted perimetry for evaluating retinitis pigmentosa, Ophthalmology, 93, 1604, 10.1016\u002FS0161-6420(86)33522-X\nJacobson, 2011, Human retinal disease from AIPL1 gene mutations: foveal cone loss with minimal macular photoreceptors and rod function remaining, Investig. Ophthalmol. Vis. Sci., 52, 70, 10.1167\u002Fiovs.10-6127\nJacobson, 2017, Outcome measures for clinical trials of Leber congenital amaurosis caused by the intronic mutation in the CEP290 gene, Investig. Ophthalmol. Vis. Sci., 58, 2609, 10.1167\u002Fiovs.17-21560\nJaffe, 2021, Imaging features associated with progression to geographic atrophy in age-related macular degeneration: classification of atrophy Meeting Report 5, Ophthalmol. Ret., 5, 855, 10.1016\u002Fj.oret.2020.12.009\nJammal, 2022, Blood pressure and glaucomatous progression in a large clinical population, Ophthalmology, 129, 161, 10.1016\u002Fj.ophtha.2021.08.021\nJammal, 2019, What is the amount of visual field loss associated with disability in glaucoma?, Am. J. Ophthalmol., 197, 45, 10.1016\u002Fj.ajo.2018.09.002\nJampel, 2001, Glaucoma patients' assessment of their visual function and quality of life, Trans. Am. Ophthalmol. Soc., 99, 301\nJoao, 2019, Retinal contrast gain control and temporal modulation sensitivity across the visual field in glaucoma at photopic and mesopic light conditions, Investig. Ophthalmol. Vis. Sci., 60, 4270, 10.1167\u002Fiovs.19-27123\nJohnson, 1995, Effects of luminance, contrast, and blur on visual acuity, Optom. Vis. Sci., 72, 864, 10.1097\u002F00006324-199512000-00004\nJolly, 2020, Validation of electronic visual acuity (EVA) measurement against standardised ETDRS charts in patients with visual field loss from inherited retinal degenerations, Br. J. Ophthalmol., 104, 924, 10.1136\u002Fbjophthalmol-2019-315124\nJones, 2019, Are patient self-reported outcome measures sensitive enough to be used as end points in clinical trials?: evidence from the United Kingdom glaucoma treatment study, Ophthalmology, 126, 682, 10.1016\u002Fj.ophtha.2018.09.034\nJonnal, 2017, The properties of outer retinal band three investigated with adaptive-optics optical coherence tomography, Investig. Ophthalmol. Vis. Sci., 58, 4559, 10.1167\u002Fiovs.16-21138\nKadziauskiene, 2020, Association between structure-function characteristics and visual field outcomes in glaucoma subjects with intraocular pressure reduction after trabeculectomy, J. Glaucoma, 29, 648, 10.1097\u002FIJG.0000000000001550\nKallab, 2022\nKang, 2004, The correlation between fluorescein angiographic and optical coherence tomographic features in clinically significant diabetic macular edema, Am. J. Ophthalmol., 137, 313, 10.1016\u002Fj.ajo.2003.09.016\nKardon, 2011, Chromatic pupillometry in patients with retinitis pigmentosa, Ophthalmology, 118, 376, 10.1016\u002Fj.ophtha.2010.06.033\nKarimi, 2016, Health, health-related quality of life, and quality of life: what is the difference?, Pharmacoeconomics, 34, 645, 10.1007\u002Fs40273-016-0389-9\nKashani, 2017, Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications, Prog. Retin. Eye Res., 60, 66, 10.1016\u002Fj.preteyeres.2017.07.002\nKass, 2002, The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma, Arch. Ophthalmol., 120, 701, 10.1001\u002Farchopht.120.6.701\nKatz, 2010, Mesopic foveal contrast sensitivity is impaired in diabetic patients without retinopathy, Graefe's Arch. Clin. Exper. Ophthalmol., 248, 1699, 10.1007\u002Fs00417-010-1413-y\nKeenan, 2018, Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16, Ophthalmology, 125, 1913, 10.1016\u002Fj.ophtha.2018.05.028\nKelbsch, 2019, Objective measurement of local rod and cone function using gaze-controlled chromatic pupil campimetry in healthy subjects, Transl. Vis. Sci. Technol., 8, 10.1167\u002Ftvst.8.6.19\nKelly, 1996, Foveal color and luminance sensitivity losses in glaucoma, Pohthal. Surg. Laser. Imag. Ret., 27, 179, 10.3928\u002F1542-8877-19960301-05\nKhadka, 2013, Quality assessment of ophthalmic questionnaires: review and recommendations, Optom. Vis. Sci., 90, 720, 10.1097\u002FOPX.0000000000000001\nKiire, 2015, Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema, Clin. Ophthalmol., 9, 2305, 10.2147\u002FOPTH.S90322\nKim, 2009, Retinal nerve fibre layer thickness measurement reproducibility improved with spectral domain optical coherence tomography, Br. J. Ophthalmol., 93, 1057, 10.1136\u002Fbjo.2009.157875\nKim, 2016, Quantifying microvascular density and morphology in diabetic retinopathy using spectral-domain optical coherence tomography angiography, Investig. Ophthalmol. Vis. Sci., 57, OCT362, 10.1167\u002Fiovs.15-18904\nKim, 2017, A normative data set for the clinical assessment of achromatic and chromatic contrast sensitivity using a qCSF approach, Investig. Ophthalmol. Vis. Sci., 58, 3628, 10.1167\u002Fiovs.17-21645\nKim, 2019, Progressive retinal neurodegeneration and microvascular change in diabetic retinopathy: longitudinal study using OCT angiography, Acta Diabetol., 56, 1275, 10.1007\u002Fs00592-019-01395-6\nKim, 2020, Electroretinography and retinal microvascular changes in type 2 diabetes, Acta Ophthalmol., 98, e807, 10.1111\u002Faos.14421\nKlein, 2009, Psychophysical assessment of low visual function in patients with retinal degenerative diseases (RDDs) with the Diagnosys full-field stimulus threshold (D-FST), Doc. Ophthalmol., 119, 217, 10.1007\u002Fs10633-009-9204-7\nKlein, 2001, How many steps of progression of diabetic retinopathy are meaningful?: the Wisconsin Epidemiologic Study of Diabetic Retinopathy, Arch. Ophthalmol., 119, 547, 10.1001\u002Farchopht.119.4.547\nKorobelnik, 2014, Intravitreal aflibercept for diabetic macular edema, Ophthalmology, 121, 2247, 10.1016\u002Fj.ophtha.2014.05.006\nKrumholz, 2008, Redefining quality — implications of recent clinical trials, N. Engl. J. Med., 358, 2537, 10.1056\u002FNEJMp0803740\nKrupin, 2011, A randomized trial of brimonidine versus timolol in preserving visual function: results from the low-pressure glaucoma treatment study, Am. J. Ophthalmol., 151, 671, 10.1016\u002Fj.ajo.2010.09.026\nKubota, 2014, Phase 1, dose-ranging study of emixustat hydrochloride (ACU-4429), a novel visual cycle modulator, in healthy volunteers, Retina, 34, 603, 10.1097\u002F01.iae.0000434565.80060.f8\nKuehlewein, 2016, Comparison of manual and semiautomated fundus autofluorescence analysis of macular atrophy in Stargardt disease phenotype, Retina, 36, 1216, 10.1097\u002FIAE.0000000000000870\nKugelman, 2020, Retinal boundary segmentation in stargardt disease optical coherence tomography images using automated deep learning, Transl. Vis. Sci. Technol., 9, 10.1167\u002Ftvst.9.11.12\nKvanta, 2017, Optical coherence tomography angigraphy of the foveal microvasculature in geographic atrophy, Retina, 37, 936, 10.1097\u002FIAE.0000000000001248\nLahav, 2011, Reduced mesopic and photopic foveal contrast sensitivity in glaucoma, Arch. Ophthalmol., 129, 16, 10.1001\u002Farchophthalmol.2010.332\nLamoureux, 2006, The impact of vision impairment questionnaire: an evaluation of its measurement properties using Rasch analysis, Investig. Ophthalmol. Vis. Sci., 47, 4732, 10.1167\u002Fiovs.06-0220\nLamoureux, 2007, The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and Rasch analysis, Investig. Ophthalmol. Vis. Sci., 48, 1001, 10.1167\u002Fiovs.06-0361\nLange, 2009, Resolving the clinical acuity categories “hand motion” and “counting fingers” using the Freiburg Visual Acuity Test (FrACT), Graefe's Arch. Clin. Exper. Ophthalmol., 247, 137, 10.1007\u002Fs00417-008-0926-0\nLaw, 2009, Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies, BMJ, 338, b1665, 10.1136\u002Fbmj.b1665\nLazaridis, 2022, Predicting visual fields from optical coherence tomography via an ensemble of deep representation learners, Am. J. Ophthalmol., 238, 52, 10.1016\u002Fj.ajo.2021.12.020\nLee, 2000, Health-related quality of life in patients with cataract and glaucoma, J. Glaucoma, 9, 87, 10.1097\u002F00061198-200002000-00015\nLei, 2017, Proposal of a simple optical coherence tomography-based scoring system for progression of age-related macular degeneration, Graefe's Arch. Clin. Exper. Ophthalmol., 255, 1551, 10.1007\u002Fs00417-017-3693-y\nLeisser, 2020, Reproducibility of microperimeter 3 (MP-3) microperimetry in open-angle glaucoma patients, Ophthalmic Res., 63, 302, 10.1159\u002F000501693\nLeitgeb, 2014, Doppler optical coherence tomography, Prog. Retin. Eye Res., 41, 26, 10.1016\u002Fj.preteyeres.2014.03.004\nLeske, 2007, Predictors of long-term progression in the early manifest glaucoma trial, Ophthalmology, 114, 1965, 10.1016\u002Fj.ophtha.2007.03.016\nLesko, 2001, Use of biomarkers and surrogate endpoints in drug development and regulatory decision making: criteria, validation, strategies, Annu. Rev. Pharmacol. Toxicol., 41, 347, 10.1146\u002Fannurev.pharmtox.41.1.347\nLesmes, 2010, Bayesian adaptive estimation of the contrast sensitivity function: the quick CSF method, J. Vis., 10, 10.1167\u002F10.3.17\nLi, 2021, Digital technology, tele-medicine and artificial intelligence in ophthalmology: a global perspective, Prog. Retin. Eye Res., 82, 10.1016\u002Fj.preteyeres.2020.100900\nLiang, 1997, Supernormal vision and high-resolution retinal imaging through adaptive optics, J. Opt. Soc. Am. A, 14, 2884, 10.1364\u002FJOSAA.14.002884\nLiang, 2020, Dynamic-range compression and contrast enhancement in swept-source optical coherence tomography systems with a frequency gain compensation amplifier, J. Biomed. Opt., 25, 10.1117\u002F1.JBO.25.11.110502\nLing, 2020, High-speed interferometric imaging reveals dynamics of neuronal deformation during the action potential, Proc. Natl. Acad. Sci. USA, 117, 10278, 10.1073\u002Fpnas.1920039117\nLisboa, 2014, Association between rate of binocular visual field change and vision-related quality of life, JAMA Ophthalmology, 132, 785, 10.1001\u002Fjamaophthalmol.2014.2005\nLisowska, 2017, Development of a chromatic pupillography protocol for the first gene therapy trial in patients with CNGA3-linked achromatopsia, Investig. Ophthalmol. Vis. Sci., 58, 1274, 10.1167\u002Fiovs.16-20505\nLiu, 2017, Imaging and quantifying ganglion cells and other transparent neurons in the living human retina, Proc. Natl. Acad. Sci. USA, 114, 12803, 10.1073\u002Fpnas.1711734114\nLu, 2017, Photoreceptor layer thickness changes during dark adaptation observed with ultrahigh-resolution optical coherence tomography, Investig. Ophthalmol. Vis. Sci., 58, 4632, 10.1167\u002Fiovs.17-22171\nLupidi, 2018, Optical coherence tomography angiography in age-related macular degeneration: the game changer, Eur. J. Ophthalmol., 28, 349, 10.1177\u002F1120672118766807\nMa, 2013, Reliability and validity of an automated computerized visual acuity and stereoacuity test in children using an interactive video game, Am. J. Ophthalmol., 156, 195, 10.1016\u002Fj.ajo.2013.02.018\nMaguire, 2009, Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial, Lancet, 374, 1597, 10.1016\u002FS0140-6736(09)61836-5\nMainster, 1982, Scanning laser ophthalmoscopy: clinical applications, Ophthalmology, 89, 852, 10.1016\u002FS0161-6420(82)34714-4\nMaloca, 2019, Validation of automated artificial intelligence segmentation of optical coherence tomography images, PLoS One, 14, 10.1371\u002Fjournal.pone.0220063\nMariottoni, 2020, Artificial intelligence mapping of structure to function in glaucoma, Transl. Vis. Sci. Technol., 9, 10.1167\u002Ftvst.9.2.19\nMariottoni, 2021, An objective structural and functional reference standard in glaucoma, Sci. Rep., 11, 1, 10.1038\u002Fs41598-021-80993-3\nMarkowitz, 2013, Microperimetry and clinical practice: an evidence-based review, Can. J. Ophthalmol., 48, 350, 10.1016\u002Fj.jcjo.2012.03.004\nMarques, 2021, Optical coherence tomography angiography metrics monitor severity progression of diabetic retinopathy—3-Year longitudinal study, J. Clin. Med., 10, 2296, 10.3390\u002Fjcm10112296\nMarsiglia, 2013, Association between geographic atrophy progression and reticular pseudodrusen in eyes with dry age-related macular degeneration, Investig. Ophthalmol. Vis. Sci., 54, 7362, 10.1167\u002Fiovs.12-11073\nMassof, 1979, Rod sensitivity relative to cone sensitivity in retinitis pigmentosa, Investig. Ophthalmol. Vis. Sci., 18, 263\nMatsuura, 2018, Evaluating the usefulness of MP-3 microperimetry in glaucoma patients, Am. J. Ophthalmol., 187, 1, 10.1016\u002Fj.ajo.2017.12.002\nMcCoy, 2018, Understanding the use of composite endpoints in clinical trials, West. J. Emerg. Med., 19, 631, 10.5811\u002Fwestjem.2018.4.38383\nMcCulloch, 2015, ISCEV Standard for full-field clinical electroretinography (2015 update), Doc. Ophthalmol., 130, 1, 10.1007\u002Fs10633-014-9473-7\nMcGuigan, 2016, Automated light-and dark-adapted perimetry for evaluating retinitis pigmentosa: filling a need to accommodate multicenter clinical trials, Investig. Ophthalmol. Vis. Sci., 57, 3118, 10.1167\u002Fiovs.16-19302\nMcGwin, 2015, Binocular visual field impairment in glaucoma and at-fault motor vehicle collisions, J. Glaucoma, 24, 138, 10.1097\u002FIJG.0b013e3182a0761c\nMcKean-Cowdin, 2008, Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study, Ophthalmology, 115, 941, 10.1016\u002Fj.ophtha.2007.08.037\nMcLeod, 2019, Choosing primary endpoints for clinical trials of health care interventions, Contemp. Clin. Trials Commun., 16, 10.1016\u002Fj.conctc.2019.100486\nMedeiros, 2009, Prediction of functional loss in glaucoma from progressive optic disc damage, Arch. Ophthalmol., 127, 1250, 10.1001\u002Farchophthalmol.2009.276\nMedeiros, 2010, Who should be treated?, 1\nMedeiros, 2011, Combining structural and functional measurements to improve detection of glaucoma progression using Bayesian hierarchical models, Investig. Ophthalmol. Vis. Sci., 52, 5794, 10.1167\u002Fiovs.10-7111\nMedeiros, 2012, A combined index of structure and function for staging glaucomatous damage, Arch. Ophthalmol., 130, 1107, 10.1001\u002Farchophthalmol.2012.827\nMedeiros, 2012, Estimating the rate of retinal ganglion cell loss in glaucoma, Am. J. Ophthalmol., 154, 814, 10.1016\u002Fj.ajo.2012.04.022\nMedeiros, 2012, The structure and function relationship in glaucoma: implications for detection of progression and measurement of rates of change, Investig. Ophthalmol. Vis. Sci., 53, 6939, 10.1167\u002Fiovs.12-10345\nMedeiros, 2014, Evaluation of progressive neuroretinal rim loss as a surrogate end point for development of visual field loss in glaucoma, Ophthalmology, 121, 100, 10.1016\u002Fj.ophtha.2013.06.026\nMedeiros, 2015, Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients, Ophthalmology, 122, 293, 10.1016\u002Fj.ophtha.2014.08.014\nMeira-Freitas, 2013, Predicting progression in glaucoma suspects with longitudinal estimates of retinal ganglion cell counts, Investig. Ophthalmol. Vis. Sci., 54, 4174, 10.1167\u002Fiovs.12-11301\nVan Melkebeke, 2018, Optical coherence tomography angiography in glaucoma: a review, Ophthalmic Res., 60, 139, 10.1159\u002F000488495\nMessner, 2019, Light-induced changes of the subretinal space of the temporal retina observed via optical coherence tomography, Sci. Rep., 9, 1, 10.1038\u002Fs41598-019-50057-8\nMidena, 2011, Microperimetry in diabetic retinopathy, Saudi J. Ophthalmol., 25, 131, 10.1016\u002Fj.sjopt.2011.01.010\nMihailovic, 2020, Gait and balance as predictors and\u002For mediators of falls in glaucoma, Investig. Ophthalmol. Vis. Sci., 61\nMiki, 2014, Rates of retinal nerve fiber layer thinning in glaucoma suspect eyes, Ophthalmology, 121, 1350, 10.1016\u002Fj.ophtha.2014.01.017\nMitchell, 2011, The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema, Ophthalmology, 118, 615, 10.1016\u002Fj.ophtha.2011.01.031\nMollan, 2021, One eye or two: statistical considerations in ophthalmology with a focus on interventional clinical trials, J. Neuro Ophthalmol., 41, 10.1097\u002FWNO.0000000000001446\nMontesano, 2020, Structure–function analysis in macular drusen with mesopic and scotopic microperimetry, Transl. Vis. Sci. Technol., 9, 10.1167\u002Ftvst.9.13.43\nMontesano, 2020, Effect of fundus tracking on structure–function relationship in glaucoma, Br. J. Ophthalmol., 104, 1710\nMontesano, 2021, Determinants of test variability in scotopic microperimetry: effects of dark adaptation and test indices, Transl. Vis. Sci. Technol., 10, 10.1167\u002Ftvst.10.1.26\nMontesano, 2021, Improving the power of glaucoma neuroprotection trials using existing visual field data, Am. J. Ophthalmol., 229, 127, 10.1016\u002Fj.ajo.2021.04.008\nDe Moraes, 2022, Nicotinamide and pyruvate for neuroenhancement in open-angle glaucoma: a phase 2 randomized clinical trial, JAMA Ophthalmology, 140, 11, 10.1001\u002Fjamaophthalmol.2021.4576\nMorgan, 2016, Retinal venous pulsation: expanding our understanding and use of this enigmatic phenomenon, Prog. Retin. Eye Res., 55, 82, 10.1016\u002Fj.preteyeres.2016.06.003\nMoss, 1998, The 14-year incidence of visual loss in a diabetic population, Ophthalmology, 105, 998, 10.1016\u002FS0161-6420(98)96025-0\nMoult, 2016, Swept-source optical coherence tomography angiography reveals chorioscapillaris alterations in eyes with nascent geographic atrophy and drusen-associated geographic atrophy, Retina, 36, S2, 10.1097\u002FIAE.0000000000001287\nMursch‐Edlmayr, 2020, Artificial intelligence algorithms to diagnose glaucoma and detect glaucoma progression: translation to clinical practice, Transl. Vis. Sci. Technol., 9, 21, 10.1167\u002Ftvst.9.2.55\nMusch, 2014, Visual field improvement in the collaborative initial glaucoma treatment study, Am. J. Ophthalmol., 158, 96, 10.1016\u002Fj.ajo.2014.04.003\nNakanishi, 2017, Detecting glaucoma with a portable brain-computer interface for objective assessment of visual function loss, JAMA Ophthalmology, 135, 550, 10.1001\u002Fjamaophthalmol.2017.0738\nNassisi, 2018, Quantity of intraretinal hyperreflective foci in patients with intermediate age-related macular degeneration correlates with 1-year progression, Investig. Ophthalmol. Vis. Sci., 59, 3431, 10.1167\u002Fiovs.18-24143\nNassisi, 2019, OCT risk factors for development of late age-related macular degeneration in the fellow eyes of patients enrolled in the HARBOR study, Ophthalmology, 126, 1667, 10.1016\u002Fj.ophtha.2019.05.016\nNassisi, 2019, Choriocapillaris flow impairment predicts the development and enlargement of drusen, Graefe's Arch. Clin. Exper. Ophthalmol., 257, 2079, 10.1007\u002Fs00417-019-04403-1\nNassisi, 2021, Relationship between choriocapillaris flow and scotopic microperimetry in early and intermediate age-related macular degeneration, Am. J. Ophthalmol., 222, 302, 10.1016\u002Fj.ajo.2020.04.018\nNebbioso, 2014, Scotopic microperimetry in the early diagnosis of age-related macular degeneration: preliminary study, BioMed Res. Int., 2014, 10.1155\u002F2014\u002F671529\nNetwork, 2007, Relationship between optical coherence tomography–measured central retinal thickness and visual acuity in diabetic macular edema, Ophthalmology, 114, 525, 10.1016\u002Fj.ophtha.2006.06.052\nNicholson, 2015, Diagnostic accuracy of disorganization of the retinal inner layers in detecting macular capillary non‐perfusion in diabetic retinopathy, Clin. Exp. Ophthalmol., 43, 735, 10.1111\u002Fceo.12557\nNicholson, 2019, Retinal nonperfusion characteristics on ultra-widefield angiography in eyes with severe nonproliferative diabetic retinopathy and proliferative diabetic retinopathy, JAMA Ophthalmology, 137, 626, 10.1001\u002Fjamaophthalmol.2019.0440\nNishikawa, 2021, Macular microvasculature and associated retinal layer thickness in pediatric amblyopia: magnification-corrected analyses, Investig. Ophthalmol. Vis. Sci., 62\nNittala, 2012, Accuracy and reproducibility of automated drusen segmentation in eyes with non-neovascular age-related macular degeneration, Investig. Ophthalmol. Vis. Sci., 53, 8319, 10.1167\u002Fiovs.12-10582\nOchakovski, 2019, Effects of subretinal AAV8 gene therapy on microperimetry in CNGA3 achromatopsia patients, Investig. Ophthalmol. Vis. Sci., 60\nOng, 2020, A novel automated visual acuity test using a portable head-mounted display, Optom. Vis. Sci., 97, 591, 10.1097\u002FOPX.0000000000001551\nOnishi, 2019, Multi-level ischemia in disorganization of the retinal inner layers on projection-resolved optical coherence tomography angiography, Retina, 39, 1588, 10.1097\u002FIAE.0000000000002179\nOrder, 1977, Beneficial and detrimental effects of therapy on immunity in breast cancer, Int. J. Radiat. Oncol. Biol. Phys., 2, 377, 10.1016\u002F0360-3016(77)90101-8\nOrlando, 2020, Automated quantification of photoreceptor alteration in macular disease using optical coherence tomography and deep learning, Sci. Rep., 10, 1, 10.1038\u002Fs41598-020-62329-9\nOtani, 2010, Correlation between visual acuity and foveal microstructural changes in diabetic macular edema, Retina, 30, 774, 10.1097\u002FIAE.0b013e3181c2e0d6\nOuyang, 2013, Optical coherence tomography–based observation of the natural history of drusenoid lesion in eyes with dry age-related macular degeneration, Ophthalmology, 120, 2656, 10.1016\u002Fj.ophtha.2013.05.029\nPagot, 2017, Locomotion and visual search of objects with patients affected by retinitis pigmentosa in twilight conditions, Investig. Ophthalmol. Vis. Sci., 58\nPandiyan, 2020, The optoretinogram reveals the primary steps of phototransduction in the living human eye, Sci. Adv., 6, 10.1126\u002Fsciadv.abc1124\nPang, 2020, Validation of an automated‐ETDRS near and intermediate visual acuity measurement, Clin. Exp. Optom., 103, 663, 10.1111\u002Fcxo.13018\nPark, 2011, Toward a clinical protocol for assessing rod, cone, and melanopsin contributions to the human pupil response, Investig. Ophthalmol. Vis. Sci., 52, 6624, 10.1167\u002Fiovs.11-7586\nPark, 2020, Structural and functional abnormalities in early-stage diabetic retinopathy, Curr. Eye Res., 45, 975, 10.1080\u002F02713683.2019.1705983\nPatino, 2011, The impact of change in visual field on health-related quality of life: the Los Angeles Latino Eye Study, Ophthalmology, 118, 1310, 10.1016\u002Fj.ophtha.2010.12.018\nPaulsen, 2014, Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life, Am. J. Ophthalmol., 157, 799, 10.1016\u002Fj.ajo.2013.12.023\nPechauer, 2015, Optical coherence tomography angiography of peripapillary retinal blood flow response to hyperoxia, Investig. Ophthalmol. Vis. Sci., 56, 3287, 10.1167\u002Fiovs.15-16655\nPechauer, 2018, Assessing total retinal blood flow in diabetic retinopathy using multiplane en face Doppler optical coherence tomography, Br. J. Ophthalmol., 102, 126, 10.1136\u002Fbjophthalmol-2016-310042\nPellegrini, 2018, Optical coherence tomography angiography features of choroidal neovascularization associated with choroidal nevus, Retina, 38, 1338, 10.1097\u002FIAE.0000000000001730\nPircher, 2011, Polarization sensitive optical coherence tomography in the human eye, Prog. Retin. Eye Res., 30, 431, 10.1016\u002Fj.preteyeres.2011.06.003\nPondorfer, 2019, Association of vision-related quality of life with visual function in age-related macular degeneration, Sci. Rep., 9, 1, 10.1038\u002Fs41598-019-51769-7\nPotsaid, 2010, Ultrahigh speed 1050nm swept source\u002FFourier domain OCT retinal and anterior segment imaging at 100,000 to 400,000 axial scans per second, Opt Express, 18, 20029, 10.1364\u002FOE.18.020029\nPsaty, 1999, Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease, JAMA, 282, 786, 10.1001\u002Fjama.282.8.786\nQuerques, 2012, Choroidal changes associated with reticular pseudodrusen, Investig. Ophthalmol. Vis. Sci., 53, 1258, 10.1167\u002Fiovs.11-8907\nQuigley, 2012, Clinical trials for glaucoma neuroprotection are not impossible, Curr. Opin. Ophthalmol., 23, 144, 10.1097\u002FICU.0b013e32834ff490\nQuigley, 2019, Glaucoma neuroprotection trials are practical using visual field outcomes, Ophthalmology Glaucoma, 2, 69, 10.1016\u002Fj.ogla.2019.01.009\nRabin, 1995\nRabin, 2017, Measurement of dark adaptometry during ISCEV standard flash electroretinography, Doc. Ophthalmol., 135, 195, 10.1007\u002Fs10633-017-9614-x\nRabiolo, 2019, Quantification of visual field variability in glaucoma: implications for visual field prediction and modeling, Transl. Vis. Sci. Technol., 8, 10.1167\u002Ftvst.8.5.25\nRamulu, 2009, Glaucoma and disability: which tasks are affected, and at what stage of disease?, Curr. Opin. Ophthalmol., 20, 92, 10.1097\u002FICU.0b013e32832401a9\nRatnam, 2013, Relationship between foveal cone structure and clinical measures of visual function in patients with inherited retinal degenerations, Investig. Ophthalmol. Vis. Sci., 54, 5836, 10.1167\u002Fiovs.13-12557\nRavens-Sieberer, 2006, Generic health-related quality-of-life assessment in children and adolescents, Pharmacoeconomics, 24, 1199, 10.2165\u002F00019053-200624120-00005\nRaza, 2014, Improving glaucoma detection using spatially correspondent clusters of damage and by combining standard automated perimetry and optical coherence tomography, Investig. Ophthalmol. Vis. Sci., 55, 612, 10.1167\u002Fiovs.13-12351\nReddy, 2018, Efficacy of ranibizumab in eyes with diabetic macular edema and macular nonperfusion in RIDE and RISE, Ophthalmology, 125, 1568, 10.1016\u002Fj.ophtha.2018.04.002\nReiter, 2021, Analysis of fluid volume and its impact on visual acuity in the fluid study as quantified with deep learning, Retina, 41, 1318, 10.1097\u002FIAE.0000000000003023\nResnikoff, 2004, Global data on visual impairment in the year 2002, Bull. World Health Organ., 82, 844\nReumueller, 2021, Three-dimensional composition of the photoreceptor cone layers in healthy eyes using adaptive-optics optical coherence tomography (AO-OCT), PLoS One, 16, 10.1371\u002Fjournal.pone.0245293\nRichman, 2013, Contrast sensitivity basics and a critique of currently available tests, J. Cataract Refract. Surg., 39, 1100, 10.1016\u002Fj.jcrs.2013.05.001\nRogers, 2010, The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia, Ophthalmology, 117, 313, 10.1016\u002Fj.ophtha.2009.07.017\nRoh, 2019, Microperimetry in age-related macular degeneration: association with macular morphology assessed by optical coherence tomography, Br. J. Ophthalmol., 103, 1769\nRohrschneider, 2008, Use of fundus perimetry (microperimetry) to quantify macular sensitivity, Prog. Retin. Eye Res., 27, 536, 10.1016\u002Fj.preteyeres.2008.07.003\nRoman, 2007, Full-field stimulus testing (FST) to quantify visual perception in severely blind candidates for treatment trials, Physiol. Meas., 28, 10.1088\u002F0967-3334\u002F28\u002F8\u002FN02\nRoman, 2021, Full-field stimulus testing: role in the clinic and as an outcome measure in clinical trials of severe childhood retinal disease, Prog. Retin. Eye Res., 87\nRomo, 2019, Novel development of parafoveal capillary density deviation mapping using an age-group and eccentricity matched normative OCT angiography database, Transl. Vis. Sci. Technol., 8\nRoorda, 1999, The arrangement of the three cone classes in the living human eye, Nature, 397, 520, 10.1038\u002F17383\nRoorda, 2002, Adaptive optics scanning laser ophthalmoscopy, Opt Express, 10, 405, 10.1364\u002FOE.10.000405\nRoshandel, 2021, Multimodal retinal imaging and microperimetry reveal a novel phenotype and potential trial end points in CRB1-associated retinopathies, Transl. Vis. Sci. Technol., 10, 10.1167\u002Ftvst.10.2.38\nRossi, 2010, The relationship between visual resolution and cone spacing in the human fovea, Nat. Neurosci., 13, 156, 10.1038\u002Fnn.2465\nRossi, 2017, Imaging individual neurons in the retinal ganglion cell layer of the living eye, Proc. Natl. Acad. Sci. USA, 114, 586, 10.1073\u002Fpnas.1613445114\nVon Rückmann, 1995, Distribution of fundus autofluorescence with a scanning laser ophthalmoscope, Br. J. Ophthalmol., 79, 407, 10.1136\u002Fbjo.79.5.407\nRunkle, 2017, OCT angiography and ellipsoid zone mapping of macular telangiectasia type 2 from the AVATAR study, Investig. Ophthalmol. Vis. Sci., 58, 3683, 10.1167\u002Fiovs.16-20976\nRussell, 2012, Improved estimates of visual field progression using bayesian linear regression to integrate structural information in patients with ocular hypertension, Investig. Ophthalmol. Vis. Sci., 53, 2760, 10.1167\u002Fiovs.11-7976\nRussell, 2017, Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial, Lancet, 390, 849, 10.1016\u002FS0140-6736(17)31868-8\nRussell, 2020, Retinal nonperfusion in proliferative diabetic retinopathy before and after panretinal photocoagulation assessed by widefield OCT angiography, Am. J. Ophthalmol., 213, 177, 10.1016\u002Fj.ajo.2020.01.024\nRussell, 2020, Longitudinal angiographic evidence that intraretinal microvascular abnormalities can evolve into neovascularization, Ophthalmol. Ret., 4, 1146, 10.1016\u002Fj.oret.2020.06.010\nSabeti, 2021, Correlation of central versus peripheral macular structure-function with acuity in age-related macular degeneration, Transl. Vis. Sci. Technol., 10, 10.1167\u002Ftvst.10.2.10\nSadda, 2018, Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3, Ophthalmology, 125, 537, 10.1016\u002Fj.ophtha.2017.09.028\nSadda, 2020, Spectral-domain OCT analysis of risk factors for macular atrophy development in the HARBOR study for neovascular age-related macular degeneration, Ophthalmology, 127, 1360, 10.1016\u002Fj.ophtha.2020.03.031\nSahel, 2005, Saving cone cells in hereditary rod diseases: a possible role for rod-derived cone viability factor (RdCVF) therapy, Retina, 25, S38, 10.1097\u002F00006982-200512001-00015\nSahel, 2013, Gene therapy for blindness, Annu. Rev. Neurosci., 36, 467, 10.1146\u002Fannurev-neuro-062012-170304\nSallo, 2012, En face” OCT imaging of the IS\u002FOS junction line in type 2 idiopathic macular telangiectasia, Investig. Ophthalmol. Vis. Sci., 53, 6145, 10.1167\u002Fiovs.12-10580\nSallo, 2012, The IS\u002FOS junction layer in the natural history of type 2 idiopathic macular telangiectasia, Investig. Ophthalmol. Vis. Sci., 53, 7889, 10.1167\u002Fiovs.12-10765\nSayegh, 2015, Polarization-sensitive optical coherence tomography and conventional retinal imaging strategies in assessing foveal integrity in geographic atrophy, Investig. Ophthalmol. Vis. Sci., 56, 5246, 10.1167\u002Fiovs.14-15114\nSchaal, 2016, Anatomic clinical trial endpoints for nonexudative age-related macular degeneration, Ophthalmology, 123, 1060, 10.1016\u002Fj.ophtha.2016.01.034\nSchatzkin, 2002, The promise and peril of surrogate end points in cancer research, Nat. Rev. Cancer, 2, 19, 10.1038\u002Fnrc702\nSchiefer, 2009, Comparison of the new perimetric GATE strategy with conventional full-threshold and SITA standard strategies, Investig. Ophthalmol. Vis. Sci., 50, 488, 10.1167\u002Fiovs.08-2229\nSchlanitz, 2011, Performance of automated drusen detection by polarization-sensitive optical coherence tomography, Investig. Ophthalmol. Vis. Sci., 52, 4571, 10.1167\u002Fiovs.10-6846\nSchlegl, 2018, Fully automated detection and quantification of macular fluid in OCT using deep learning, Ophthalmology, 125, 549, 10.1016\u002Fj.ophtha.2017.10.031\nSchlegl, 2019, f-AnoGAN: fast unsupervised anomaly detection with generative adversarial networks, Med. Image Anal., 54, 30, 10.1016\u002Fj.media.2019.01.010\nSchmidt-Erfurth, 2018, Artificial intelligence in retina, Prog. Retin. Eye Res., 67, 1, 10.1016\u002Fj.preteyeres.2018.07.004\nSchmidt-Erfurth, 2018, Prediction of individual disease conversion in early AMD using artificial intelligence, Investig. Ophthalmol. Vis. Sci., 59, 3199, 10.1167\u002Fiovs.18-24106\nSchmidt-Erfurth, 2021, AI-based monitoring of retinal fluid in disease activity and under therapy, Prog. Retin. Eye Res.\nSchmitz-Valckenberg, 2006, Correlation between the area of increased autofluorescence surrounding geographic atrophy and disease progression in patients with AMD, Investig. Ophthalmol. Vis. Sci., 47, 2648, 10.1167\u002Fiovs.05-0892\nSchmitz-Valckenberg, 2016, Natural history of geographic atrophy progression secondary to age-related macular degeneration (Geographic Atrophy Progression Study), Ophthalmology, 123, 361, 10.1016\u002Fj.ophtha.2015.09.036\nSchönbach, 2017, Fixation location and stability using the MP-1 microperimeter in Stargardt disease: ProgStar Report No. 3, Ophthalmol. Ret., 1, 68, 10.1016\u002Fj.oret.2016.08.009\nSchönbach, 2017, Macular sensitivity measured with microperimetry in stargardt disease in the progression of atrophy secondary to stargardt disease (progstar) study: report no. 7, JAMA Ophthalmology, 135, 696, 10.1001\u002Fjamaophthalmol.2017.1162\nSchönbach, 2020, Faster sensitivity loss around dense scotomas than for overall macular sensitivity in Stargardt disease: ProgStar report no. 14, Am. J. Ophthalmol., 216, 219, 10.1016\u002Fj.ajo.2020.03.020\nSchönbach, 2020, Longitudinal microperimetric changes of macular sensitivity in Stargardt disease after 12 months: ProgStar Report No. 13, JAMA Ophthalmology, 138, 772, 10.1001\u002Fjamaophthalmol.2020.1735\nSchönbach, 2021, The progression of stargardt disease using volumetric hill of vision analyses over 24 Months: progstar report no. 15, Am. J. Ophthalmol., 230, 123, 10.1016\u002Fj.ajo.2021.04.015\nSchönbach, 2022, Longitudinal changes of fixation stability and location within 24 months in stargardt disease: progstar report no. 16, Am. J. Ophthalmol., 233, 78, 10.1016\u002Fj.ajo.2021.07.013\nSchulze-Bonsel, 2006, Visual acuities “hand motion” and “counting fingers” can be quantified with the freiburg visual acuity test, Investig. Ophthalmol. Vis. Sci., 47, 1236, 10.1167\u002Fiovs.05-0981\nSchuman, 2012, Detection and diagnosis of glaucoma: ocular imaging, Investig. Ophthalmol. Vis. Sci., 53, 2488, 10.1167\u002Fiovs.12-9483k\nSchuman, 1996, Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography, Ophthalmology, 103, 1889, 10.1016\u002FS0161-6420(96)30410-7\nSchütze, 2013, Lesion size detection in geographic atrophy by polarization-sensitive optical coherence tomography and correlation to conventional imaging techniques, Investig. Ophthalmol. Vis. Sci., 54, 739, 10.1167\u002Fiovs.11-7877\nScoles, 2014, In vivo imaging of human cone photoreceptor inner segments, Investig. Ophthalmol. Vis. Sci., 55, 4244, 10.1167\u002Fiovs.14-14542\nShin, 2021, Visual field inference from optical coherence tomography using deep learning algorithms: a comparison between devices, Transl. Vis. Sci. Technol., 10, 10.1167\u002Ftvst.10.7.4\nShoji, 2017, Progressive macula vessel density loss in primary open-angle glaucoma: a longitudinal study, Am. J. Ophthalmol., 182, 107, 10.1016\u002Fj.ajo.2017.07.011\nSim, 2014, Quantitative analysis of diabetic macular ischemia using optical coherence tomography, Investig. Ophthalmol. Vis. Sci., 55, 417, 10.1167\u002Fiovs.13-12677\nSophie, 2015, Predictors of functional and anatomic outcomes in patients with diabetic macular edema treated with ranibizumab, Ophthalmology, 122, 1395, 10.1016\u002Fj.ophtha.2015.02.036\nSpaeth, 2006, Evaluation of quality of life for patients with glaucoma, Am. J. Ophthalmol., 141, 3, 10.1016\u002Fj.ajo.2005.07.075\nSpaide, 2015, Optical coherence tomography angiography signs of vascular abnormalization with antiangiogenic therapy for choroidal neovascularization, Am. J. Ophthalmol., 160, 6, 10.1016\u002Fj.ajo.2015.04.012\nSpaide, 2015, Image artifacts in optical coherence angiography, Retina, 35, 2163, 10.1097\u002FIAE.0000000000000765\nSpaide, 2018, Optical coherence tomography angiography, Prog. Retin. Eye Res., 64, 1, 10.1016\u002Fj.preteyeres.2017.11.003\nSpaide, 2018, Subretinal drusenoid deposits AKA pseudodrusen, Surv. Ophthalmol., 63, 782, 10.1016\u002Fj.survophthal.2018.05.005\nSpaide, 2020, Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group, Ophthalmology, 127, 616, 10.1016\u002Fj.ophtha.2019.11.004\nSrinivas, 2017, Assessment of retinal blood flow in diabetic retinopathy using Doppler Fourier-domain optical coherence tomography, Retina, 37, 2001, 10.1097\u002FIAE.0000000000001479\nStanga, 2016, Swept-source optical coherence tomography angio™(Topcon Corp, Japan): technology review, OCT Angiogr. Ret. Macular Dis., 56, 13, 10.1159\u002F000442771\nStaurenghi, 2018, Impact of baseline diabetic retinopathy severity scale scores on visual outcomes in the VIVID-DME and VISTA-DME studies, Br. J. Ophthalmol., 102, 954, 10.1136\u002Fbjophthalmol-2017-310664\nStavrou, 2003, Letter contrast sensitivity changes in early diabetic retinopathy, Clin. Exp. Optom., 86, 152, 10.1111\u002Fj.1444-0938.2003.tb03097.x\nStefánsson, 2019, Retinal oximetry: metabolic imaging for diseases of the retina and brain, Prog. Retin. Eye Res., 70, 1, 10.1016\u002Fj.preteyeres.2019.04.001\nStingl, 2022, Spatial and temporal resolution of the photoreceptors rescue dynamics after treatment with voretigene neparvovec, Br. J. Ophthalmol., 106, 831, 10.1136\u002Fbjophthalmol-2020-318286\nStingl, 2018, Pupillographic campimetry: an objective method to measure the visual field, Biomed. Eng., 63, 729, 10.1515\u002Fbmt-2017-0029\nStingl, 2021, Clinical protocols for the evaluation of rod function, Ophthalmologica, 244, 396, 10.1159\u002F000510888\nStrauss, 2016, The natural history of the progression of atrophy secondary to stargardt disease (progstar) studies: design and baseline characteristics: progstar report no. 1, Ophthalmology, 123, 817, 10.1016\u002Fj.ophtha.2015.12.009\nStrauss, 2017, Progression of stargardt disease as determined by fundus autofluorescence in the retrospective progression of Stargardt disease study (progstar report no. 9), JAMA Ophthalmology, 135, 1232, 10.1001\u002Fjamaophthalmol.2017.4152\nStrauss, 2017, Incidence of atrophic lesions in stargardt disease in the progression of atrophy secondary to stargardt disease (progStar) study: report No. 5, JAMA Ophthalmology, 135, 687, 10.1001\u002Fjamaophthalmol.2017.1121\nStrauss, 2018, The progression of the stargardt disease type 4 (progstar-4) Study: design and baseline characteristics (progstar-4 report no. 1), Ophthalmic Res., 60, 185, 10.1159\u002F000491791\nStrauss, 2019, Scotopic microperimetric assessment of rod function in Stargardt disease (smart) study: design and baseline characteristics (report No. 1), Ophthalmic Res., 61, 36, 10.1159\u002F000488711\nStrauss, 2019, Progression of stargardt disease as determined by fundus autofluorescence over a 12-month period: progstar report No. 11, JAMA Ophthalmology, 137, 1134, 10.1001\u002Fjamaophthalmol.2019.2885\nSun, 2019, The diabetic retinopathy clinical research network (DRCR. net) and its contributions to the treatment of diabetic retinopathy, Ophthalmic Res., 62, 225, 10.1159\u002F000502779\nSun, 2010, Life satisfaction, positive youth development, and problem behaviour among Chinese adolescents in Hong Kong, Soc. Indicat. Res., 95, 455, 10.1007\u002Fs11205-009-9531-9\nSun, 2015, Neural retinal disorganization as a robust marker of visual acuity in current and resolved diabetic macular edema, Diabetes, 64, 2560, 10.2337\u002Fdb14-0782\nSun, 2019, OCT angiography metrics predict progression of diabetic retinopathy and development of diabetic macular edema: a prospective study, Ophthalmology, 126, 1675, 10.1016\u002Fj.ophtha.2019.06.016\nSung, 2011, Imaging of the retinal nerve fibre layer with spectral domain optical coherence tomography for glaucoma diagnosis, Br. J. Ophthalmol., 95, 909, 10.1136\u002Fbjo.2010.186924\nSunness, 2008, Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration, Ophthalmology, 115, 1480, 10.1016\u002Fj.ophtha.2008.03.009\nSvensson, 2013, Surrogate outcomes in clinical trials: a cautionary tale, JAMA Intern. Med., 173, 611, 10.1001\u002Fjamainternmed.2013.3037\nSwaminathan, 2021, Rapid initial OCT RNFL thinning is predictive of faster visual field loss during extended follow-up in glaucoma, Am. J. Ophthalmol., 229, 100, 10.1016\u002Fj.ajo.2021.03.019\nSwanson, 1993, In vivo retinal imaging by optical coherence tomography, Opt. Lett., 18, 1864, 10.1364\u002FOL.18.001864\nSzegedi, 2020, Repeatability and reproducibility of total retinal blood flow measurements using bi-directional Doppler OCT, Transl. Vis. Sci. Technol., 9, 10.1167\u002Ftvst.9.7.34\nTakahashi, 2019, Fundus autofluorescence and ellipsoid zone (EZ) line width can be an outcome measurement in RHO-associated autosomal dominant retinitis pigmentosa, Graefe's Arch. Clin. Exper. Ophthalmol., 257, 725, 10.1007\u002Fs00417-018-04234-6\nTalcott, 2011, Longitudinal study of cone photoreceptors during retinal degeneration and in response to ciliary neurotrophic factor treatment, Investig. Ophthalmol. Vis. Sci., 52, 2219, 10.1167\u002Fiovs.10-6479\nTan, 2018, Calcified nodules in retinal drusen are associated with disease progression in age-related macular degeneration, Sci. Transl. Med., 10, 10.1126\u002Fscitranslmed.aat4544\nTan, 2020, Quantitative microvascular analysis with wide-field optical coherence tomography angiography in eyes with diabetic retinopathy, JAMA Netw. Open, 3, 10.1001\u002Fjamanetworkopen.2019.19469\nTan, 2020, Approaches to quantify optical coherence tomography angiography metrics, Ann. Transl. Med., 8, 10.21037\u002Fatm-20-3246\nTan, 2022, Combining retinal and choroidal microvascular metrics improves discriminative power for diabetic retinopathy, Br. J. Ophthalmol.\nTan, 2021, Developing a normative database for retinal perfusion using optical coherence tomography angiography, Biomed. Opt. Express., 12, 4032, 10.1364\u002FBOE.423469\nTang, 2018, Baseline detrending for the photopic negative response, Transl. Vis. Sci. Technol., 7, 10.1167\u002Ftvst.7.5.9\nTatham, 2013, Estimated retinal ganglion cell counts in glaucomatous eyes with localized retinal nerve fiber layer defects, Am. J. Ophthalmol., 156, 578, 10.1016\u002Fj.ajo.2013.04.015\nTatham, 2013, The relationship between cup-to-disc ratio and estimated number of retinal ganglion cells, Investig. Ophthalmol. Vis. Sci., 54, 3205, 10.1167\u002Fiovs.12-11467\nTatham, 2014, Strategies for improving early detection of glaucoma: the combined structure–function index, Clin. Ophthalmol., 8, 611\nTepelus, 2020, Comparison and correlation of retinal sensitivity between microperimetry and standard automated perimetry in low-tension glaucoma, J. Glaucoma, 29, 975, 10.1097\u002FIJG.0000000000001599\nTerheyden, 2021, Use of composite end points in early and intermediate age-related macular degeneration clinical trials: state-of-the-art and future Directions, Ophthalmologica, 244, 387, 10.1159\u002F000513591\nThompson, 2015, Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the monaciano symposium, Investig. Ophthalmol. Vis. Sci., 56, 918, 10.1167\u002Fiovs.14-16049\nThompson, 2020, Advancing clinical trials for inherited retinal diseases: recommendations from the second monaciano symposium, Transl. Vis. Sci. Technol., 9, 10.1167\u002Ftvst.9.7.2\nThulliez, 2019, Correlations between choriocapillaris flow deficits around geographic atrophy and enlargement rates based on swept-source OCT imaging, Ophthalmol. Ret., 3, 478, 10.1016\u002Fj.oret.2019.01.024\nTimberlake, 1980, Automated clinical visual acuity testing, Am. J. Ophthalmol., 90, 369, 10.1016\u002FS0002-9394(14)74918-9\nTimberlake, 1982, Retinal localization of scotomata by scanning laser ophthalmoscopy, Investig. Ophthalmol. Vis. Sci., 22, 91\nTing, 2019, Deep learning in ophthalmology: the technical and clinical considerations, Prog. Retin. Eye Res., 72, 10.1016\u002Fj.preteyeres.2019.04.003\nVelaga, 2021, Post hoc analysis of ellipsoid zone changes beyond the central subfield in symptomatic vitreomacular adhesion patients from the OASIS trial, BMJ Open Ophthalmol., 6, 10.1136\u002Fbmjophth-2020-000648\nWaheed, 2016, Optical coherence tomography angiography of dry age-related macular degeneration, Dev. Ophthalmol., 56, 91, 10.1159\u002F000442784\nWan, 2018, Optical coherence tomography angiography compared with optical coherence tomography macular measurements for detection of glaucoma, JAMA Ophthalmology, 136, 866, 10.1001\u002Fjamaophthalmol.2018.1627\nWang, 2008, Retinal blood flow measurement by circumpapillary Fourier domain Doppler optical coherence tomography, J. Biomed. Opt., 13, 10.1117\u002F1.2998480\nWang, 2009, Retinal blood flow detection in diabetic patients by Doppler Fourier domain optical coherence tomography, Opt Express, 17, 4061, 10.1364\u002FOE.17.004061\nWang, 2011, Pilot study of optical coherence tomography measurement of retinal blood flow in retinal and optic nerve diseases, Investig. Ophthalmol. Vis. Sci., 52, 840, 10.1167\u002Fiovs.10-5985\nWeinreb, 2009, The glaucoma research community and FDA look to the future: a report from the NEI\u002FFDA CDER glaucoma clinical trial design and endpoints symposium, Investig. Ophthalmol. Vis. Sci., 50, 1497, 10.1167\u002Fiovs.08-2843\nWeinreb, 2011, Glaucoma research community and FDA look to the future, II: NEI\u002FFDA glaucoma clinical trial design and endpoints symposium: measures of structural change and visual function, Investig. Ophthalmol. Vis. Sci., 52, 7842, 10.1167\u002Fiovs.11-7895\nWeinreb, 2004, Primary open-angle glaucoma, Lancet, 363, 1711, 10.1016\u002FS0140-6736(04)16257-0\nWeinreb, 2014, The pathophysiology and treatment of glaucoma: a review, JAMA, 311, 1901, 10.1001\u002Fjama.2014.3192\nWeinreb, 2016, Primary open-angle glaucoma, Nat. Rev. Dis. Prim., 2\nWeinreb, 2018, Oral memantine for the treatment of glaucoma: design and results of 2 randomized, placebo-controlled, phase 3 studies, Ophthalmology, 125, 1874, 10.1016\u002Fj.ophtha.2018.06.017\nWeleber, 2005, Retinitis pigmentosa and allied disorders, ume 1, 395\nWeleber, 2015, VFMA: topographic analysis of sensitivity data from full-field static perimetry, Transl. Vis. Sci. Technol., 4, 10.1167\u002Ftvst.4.2.14\nWeleber, 2016, Results at 2 years after gene therapy for RPE65-deficient Leber congenital amaurosis and severe early-childhood–onset retinal dystrophy, Ophthalmology, 123, 1606, 10.1016\u002Fj.ophtha.2016.03.003\nWells, 2016, Association of baseline visual acuity and retinal thickness with 1-year efficacy of aflibercept, bevacizumab, and ranibizumab for diabetic macular edema, JAMA Ophthalmology, 134, 127, 10.1001\u002Fjamaophthalmol.2015.4599\nWerkmeister, 2015, Retinal oxygen extraction in humans, Sci. Rep., 5, 1, 10.1038\u002Fsrep15763\nWest, 2001, Prevention of blindness and priorities for the future, Bull. World Health Organ., 79, 244\nWickström, 2017, Biomarkers and surrogate endpoints in drug development: a european regulatory view, Investig. Ophthalmol. Vis. Sci., 58, BIO27, 10.1167\u002Fiovs.17-21778\nWild, 2017, Spatial entropy pursuit for fast and accurate perimetry testing, Investig. Ophthalmol. Vis. Sci., 58, 3414, 10.1167\u002Fiovs.16-21144\nWong, 2020, Focal structure–function relationships in primary open-angle glaucoma using OCT and OCT-A measurements, Investig. Ophthalmol. Vis. Sci., 61\nWong, 2021, Combining OCT and OCTA for focal structure–function modeling in early primary open-angle glaucoma, Investig. Ophthalmol. Vis. Sci., 62\nWood, 2021, Low luminance visual acuity as a clinical measure and clinical trial outcome measure: a scoping review, Ophthalmic Physiol. Opt., 41, 213, 10.1111\u002Fopo.12775\nWu, 2018, Impact of different visual field testing paradigms on sample size requirements for glaucoma clinical trials, Sci. Rep., 8, 1\nWu, 2018, Recent developments in visual field testing for glaucoma, Curr. Opin. Ophthalmol., 29, 141, 10.1097\u002FICU.0000000000000461\nWu, 2019, Sample size requirements of glaucoma clinical trials when using combined optical coherence tomography and visual field endpoints, Sci. Rep., 9, 1, 10.1038\u002Fs41598-019-55345-x\nWu, 2014, Optical coherence tomography–defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration, Ophthalmology, 121, 2415, 10.1016\u002Fj.ophtha.2014.06.034\nWu, 2016, Low luminance deficit and night vision symptoms in intermediate age-related macular degeneration, Br. J. Ophthalmol., 100, 395, 10.1136\u002Fbjophthalmol-2015-306621\nWu, 2016, Test–retest variability of fundus-tracked perimetry at the peripapillary region in open angle glaucoma, Investig. Ophthalmol. Vis. Sci., 57, 3619, 10.1167\u002Fiovs.15-19002\nWu, 2019, Improving the feasibility of glaucoma clinical trials using trend-based visual field progression end points, Ophthalmology Glaucoma, 2, 72, 10.1016\u002Fj.ogla.2019.01.004\nWu, 2021, Examining the added value of microperimetry and low luminance deficit for predicting progression in age-related macular degeneration, Br. J. Ophthalmol., 105, 711, 10.1136\u002Fbjophthalmol-2020-315935\nWu, 2021\nWykoff, 2018, Ranibizumab induces regression of diabetic retinopathy in most patients at high risk of progression to proliferative diabetic retinopathy, Ophthalmol. Ret., 2, 997, 10.1016\u002Fj.oret.2018.06.005\nWykoff, 2019, Intravitreal aflibercept for retinal nonperfusion in proliferative diabetic retinopathy: outcomes from the randomized recovery trial, Ophthalmol. Ret., 3, 1076, 10.1016\u002Fj.oret.2019.07.011\nYanoff, 1984, Pathology of human cystoid macular edema, Surv. Ophthalmol., 28, 505, 10.1016\u002F0039-6257(84)90233-9\nYarmohammadi, 2016, Optical coherence tomography angiography vessel density in healthy, glaucoma suspect, and glaucoma eyes, Investig. Ophthalmol. Vis. Sci., 57, OCT451, 10.1167\u002Fiovs.15-18944\nYe, 2021, Progression of macular vessel density in primary open-angle glaucoma: a longitudinal study, Am. J. Ophthalmol., 223, 259, 10.1016\u002Fj.ajo.2020.10.008\nYing, 2009, Description of the age-related eye disease study 9-step severity scale applied to participants in the complications of age-related macular degeneration prevention trial, Arch. Ophthalmol., 127, 1147, 10.1001\u002Farchophthalmol.2009.189\nYioti, 2012, Contrast sensitivity and color vision in eyes with retinitis pigmentosa and good visual acuity: correlations with SD-OCT findings, Pohthal. Surg Laser Imag. Ret., 43, S44\nYoung, 2012, Current electrophysiology in ophthalmology: a review, Curr. Opin. Ophthalmol., 23, 497, 10.1097\u002FICU.0b013e328359045e\nZayit-Soudry, 2015, Repeatability of cone spacing measures in eyes with inherited retinal degenerations, Investig. Ophthalmol. Vis. Sci., 56, 6179, 10.1167\u002Fiovs.15-17010\nZenouda, 2016, Effect of different lightning conditions on daily living activities of glaucoma patients, Acta Ophthalmol., 94, 10.1111\u002Fj.1755-3768.2016.0554\nZhang, 2013, A pilot trial of the iPad tablet computer as a portable device for visual acuity testing, J. Telemed. Telecare, 19, 55, 10.1177\u002F1357633X12474964\nZheng, 2022, Quantitative OCT angiography of the retinal microvasculature and choriocapillaris in highly myopic eyes with myopic macular degeneration, Br. J. Ophthalmol., 106, 681, 10.1136\u002Fbjophthalmol-2020-317632\nZheng, 2018, Measuring the contrast sensitivity function using the qCSF method with 10 Digits, Transl. Vis. Sci. Technol., 7, 10.1167\u002Ftvst.7.6.9\nZotter, 2012, Large-field high-speed polarization sensitive spectral domain OCT and its applications in ophthalmology, Biomed. Opt Express, 3, 2720, 10.1364\u002FBOE.3.002720",{"VOID":1580},"10.1016\u002Fj.preteyeres.2022.101160","2024-05-07T07:11:18.406+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1350946222001203",[1584,1654,1676,1689,1709,1724,1748],{"id":1585,"sortIndex":92,"researcher":24,"roles":1586,"affiliations":1587,"properties":1651,"displayName":1653,"givenName":24,"familyName":24},"2203d60f-902d-4dd5-9aa7-857dbbe092c7",[143],[1588,1596,1605,1614,1623,1632,1641],{"id":1589,"sortIndex":92,"affiliation":1590,"properties":24},"193c3a8d-c8ea-4ce2-b5bb-d69278cb8087",{"id":1589,"createTime":24,"updateTime":24,"relativeEntities":1591,"slug":24,"properties":1592,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1595,"statistic":24},[],{"title":1593},{"VI":1594},"Singapore Eye Research Institute, Singapore",[],{"id":1597,"sortIndex":870,"affiliation":1598,"properties":1604},"42a8444c-c54a-4c41-96a0-95edbe3123b2",{"id":1597,"createTime":24,"updateTime":24,"relativeEntities":1599,"slug":24,"properties":1600,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1603,"statistic":24},[],{"title":1601},{"VI":1602},"SERI-NTU Advanced Ocular Engineering (STANCE), Singapore",[],{},{"id":1606,"sortIndex":900,"affiliation":1607,"properties":1613},"9c538db1-9f13-41aa-a481-2e040b671c6c",{"id":1606,"createTime":24,"updateTime":24,"relativeEntities":1608,"slug":24,"properties":1609,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1612,"statistic":24},[],{"title":1610},{"VI":1611},"Academic Clinical Program, Duke-NUS Medical School, Singapore",[],{},{"id":1615,"sortIndex":914,"affiliation":1616,"properties":1622},"207c9c62-5fc4-4156-89b1-cb7bb7f15242",{"id":1615,"createTime":24,"updateTime":24,"relativeEntities":1617,"slug":24,"properties":1618,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1621,"statistic":24},[],{"title":1619},{"VI":1620},"School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University, Singapore",[],{},{"id":1624,"sortIndex":1110,"affiliation":1625,"properties":1631},"4d0070a4-4fea-4f94-a0b8-b8d7067a2701",{"id":1624,"createTime":24,"updateTime":24,"relativeEntities":1626,"slug":24,"properties":1627,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1630,"statistic":24},[],{"title":1628},{"VI":1629},"Department of Clinical Pharmacology, Medical University Vienna, Vienna, Austria",[],{},{"id":1633,"sortIndex":25,"affiliation":1634,"properties":1640},"70d1581a-894f-410d-8a2a-197a9f3eb96e",{"id":1633,"createTime":24,"updateTime":24,"relativeEntities":1635,"slug":24,"properties":1636,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1639,"statistic":24},[],{"title":1637},{"EN":1638},"Center for Medical Physics and Biomedical Engineering, Medical University Vienna, Vienna, Austria",[],{},{"id":1642,"sortIndex":1643,"affiliation":1644,"properties":1650},"2b54dc75-a876-4515-a9a5-237442f3b139",6,{"id":1642,"createTime":24,"updateTime":24,"relativeEntities":1645,"slug":24,"properties":1646,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1649,"statistic":24},[],{"title":1647},{"VI":1648},"Institute of Molecular and Clinical Ophthalmology, Basel, Switzerland",[],{},{"title":1652},{"VI":1653},"Leopold Schmetterer",{"id":1655,"sortIndex":870,"researcher":24,"roles":1656,"affiliations":1657,"properties":1673,"displayName":1675,"givenName":24,"familyName":24},"0a5f1147-d671-4c7e-b09a-f5d32bf8f87a",[143],[1658,1664],{"id":1642,"sortIndex":92,"affiliation":1659,"properties":24},{"id":1642,"createTime":24,"updateTime":24,"relativeEntities":1660,"slug":24,"properties":1661,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1663,"statistic":24},[],{"title":1662},{"VI":1648},[],{"id":1665,"sortIndex":870,"affiliation":1666,"properties":1672},"01c42248-d4b3-461d-b47d-271d98e9f717",{"id":1665,"createTime":24,"updateTime":24,"relativeEntities":1667,"slug":24,"properties":1668,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1671,"statistic":24},[],{"title":1669},{"VI":1670},"Department of Ophthalmology, University of Basel, Basel, Switzerland",[],{},{"title":1674},{"VI":1675},"Hendrik Scholl",{"id":1677,"sortIndex":900,"researcher":24,"roles":1678,"affiliations":1679,"properties":1686,"displayName":1688,"givenName":24,"familyName":24},"ce6be41c-2960-4762-8393-4865c5246633",[143],[1680],{"id":1624,"sortIndex":92,"affiliation":1681,"properties":24},{"id":1624,"createTime":24,"updateTime":24,"relativeEntities":1682,"slug":24,"properties":1683,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1685,"statistic":24},[],{"title":1684},{"VI":1629},[],{"title":1687},{"VI":1688},"Gerhard Garhöfer",{"id":1690,"sortIndex":914,"researcher":24,"roles":1691,"affiliations":1692,"properties":1706,"displayName":1708,"givenName":24,"familyName":24},"5c002758-2b50-409b-8116-ef358afe5908",[143],[1693,1699],{"id":1642,"sortIndex":92,"affiliation":1694,"properties":24},{"id":1642,"createTime":24,"updateTime":24,"relativeEntities":1695,"slug":24,"properties":1696,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1698,"statistic":24},[],{"title":1697},{"VI":1648},[],{"id":1665,"sortIndex":870,"affiliation":1700,"properties":1705},{"id":1665,"createTime":24,"updateTime":24,"relativeEntities":1701,"slug":24,"properties":1702,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1704,"statistic":24},[],{"title":1703},{"VI":1670},[],{},{"title":1707},{"VI":1708},"Lucas Janeschitz-Kriegl",{"id":1710,"sortIndex":1110,"researcher":24,"roles":1711,"affiliations":1712,"properties":1721,"displayName":1723,"givenName":24,"familyName":24},"a034c55d-e512-4d26-b007-18b060a5772f",[143],[1713],{"id":1714,"sortIndex":92,"affiliation":1715,"properties":24},"9cbe7564-ad60-4383-a078-9c55ba267af0",{"id":1714,"createTime":24,"updateTime":24,"relativeEntities":1716,"slug":24,"properties":1717,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1720,"statistic":24},[],{"title":1718},{"VI":1719},"Eye Clinic, Department of Biomedical and Clinical Sciences \"Luigi Sacco\", University of Milan, Italy",[],{"title":1722},{"VI":1723},"Federico Corvi",{"id":1725,"sortIndex":25,"researcher":24,"roles":1726,"affiliations":1727,"properties":1745,"displayName":1747,"givenName":24,"familyName":24},"4a3cb456-092a-4c25-b854-35911ad55b4d",[143],[1728,1736],{"id":1729,"sortIndex":92,"affiliation":1730,"properties":24},"9f30d8c0-76ca-4591-8bf3-7adbd390f94f",{"id":1729,"createTime":24,"updateTime":24,"relativeEntities":1731,"slug":24,"properties":1732,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1735,"statistic":24},[],{"title":1733},{"VI":1734},"Doheny Eye Institute, Los Angeles, CA, USA",[],{"id":1737,"sortIndex":870,"affiliation":1738,"properties":1744},"e8b3e343-4d08-4edd-bda0-505f888b1491",{"id":1737,"createTime":24,"updateTime":24,"relativeEntities":1739,"slug":24,"properties":1740,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1743,"statistic":24},[],{"title":1741},{"VI":1742},"Department of Ophthalmology, David Geffen School of Medicine at University of California, Los Angeles, CA, USA",[],{},{"title":1746},{"VI":1747},"SriniVas R. Sadda",{"id":1749,"sortIndex":1643,"researcher":24,"roles":1750,"affiliations":1751,"properties":1760,"displayName":1762,"givenName":24,"familyName":24},"c8412dd2-be66-425b-b7cd-b277f76d8411",[143],[1752],{"id":1753,"sortIndex":92,"affiliation":1754,"properties":24},"167f20a4-fd90-44a5-90b5-29d75f23bb68",{"id":1753,"createTime":24,"updateTime":24,"relativeEntities":1755,"slug":24,"properties":1756,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1759,"statistic":24},[],{"title":1757},{"VI":1758},"Vision, Imaging and Performance Laboratory, Department of Ophthalmology, Duke Eye Center, Duke University, Durham, NC, USA",[],{"title":1761},{"VI":1762},"Felipe A. Medeiros",{"url":1582,"publisher":1764,"properties":1811},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1765,"slug":10,"properties":1766,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":1771,"manageAffiliations":1780,"indexDatabases":1791,"url":90,"thumbnailPath":24,"statistic":1806,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":1767,"eissn":1768,"issn":1769,"title":1770},{"VOID":13},{"VOID":15},{"VOID":17},{"EN":19},[1772,1776],{"id":28,"createTime":24,"updateTime":24,"relativeEntities":1773,"label":1774,"description":1775,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":31},{},{"id":34,"createTime":24,"updateTime":24,"relativeEntities":1777,"label":1778,"description":1779,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":37},{},[1781,1786],{"id":41,"createTime":24,"updateTime":24,"relativeEntities":1782,"slug":24,"properties":1783,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1785,"statistic":24},[],{"title":1784},{"EN":45},[],{"id":48,"createTime":24,"updateTime":24,"relativeEntities":1787,"slug":24,"properties":1788,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1790,"statistic":24},[],{"title":1789},{"EN":52},[],[1792,1799],{"id":56,"indexDatabase":1793,"url":67,"indexYears":68,"academicFieldIds":1798,"indexDatabaseRanking":72},{"id":58,"createTime":24,"updateTime":24,"relativeEntities":1794,"label":1795,"description":1796,"key":64,"publicationTags":1797,"standard":24},[],{"EN":61,"VI":61},{"EN":61,"VI":63},[66],[70,71],{"id":74,"indexDatabase":1800,"url":87,"indexYears":24,"academicFieldIds":1805,"indexDatabaseRanking":24},{"id":76,"createTime":24,"updateTime":24,"relativeEntities":1801,"label":1802,"description":1803,"key":83,"publicationTags":1804,"standard":24},[],{"EN":79,"VI":79},{"EN":81,"VI":82},[85,86],[89],{"impactFactor":92,"impactFactorByYear":1807,"i10Index":92,"i10IndexLast5Year":92,"totalPublication":94,"totalPublicationByYear":1808,"totalCitation":92,"totalCitationByYear":1809,"totalCitationPerPublication":92,"totalCitationPerPublicationByYear":1810,"hindexLast5Year":92,"hindex":92},{},{"1994":96,"1995":97,"1996":98,"1997":99,"1998":100,"1999":101,"2000":102,"2001":103,"2002":104,"2003":102,"2004":100,"2005":103,"2006":105,"2007":106,"2008":98,"2009":106,"2010":97,"2011":105,"2012":104,"2013":107,"2014":105,"2015":108,"2016":108,"2017":109,"2018":110,"2019":111,"2020":112,"2021":113,"2022":114,"2023":111},{},{},{"pages":1812,"volume":1814},{"VOID":1813},"101160",{"VOID":1815},"97","2023-11-01",2023,"2026-01-15T06:37:01.999+00:00",[85,72],{"id":1821,"createTime":1822,"updateTime":1823,"relativeEntities":1824,"slug":1825,"properties":1826,"entityType":134,"verifyStatus":135,"verifyTime":1833,"verifyNote":137,"languages":24,"translateLanguages":24,"viewCount":92,"primaryUrl":1834,"fullTextUrl":24,"authors":1835,"publicationType":156,"publisherRelationship":1868,"citationCount":1921,"citationInfo":1922,"publishDate":1925,"publishYear":1923,"citationAnalyzeStatus":23,"lastCitationAnalyze":1823,"indexDatabases":1926,"openAccess":24,"references":24,"isForceReanalyzing":837},"e71d417b-76ab-403e-8054-ff7aa7ec9b80","2024-01-13T17:44:28.180+00:00","2025-07-18T02:16:36.604+00:00",[],"Clinical-in-vivo-confocal-microscopy-of-the-human-cornea-in-health-and-disease",{"title":1827,"gsPaper":1829,"doi":1831},{"EN":1828},"Clinical in vivo confocal microscopy of the human cornea in health and disease",{"VOID":1830},"[\"467482872815511669\"]",{"VOID":1832},"10.1016\u002Fj.preteyeres.2009.11.001","2024-05-01T13:41:32.533+00:00","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1350946209000706",[1836,1853],{"id":1837,"sortIndex":92,"researcher":24,"roles":1838,"affiliations":1839,"properties":1848,"displayName":1850,"givenName":24,"familyName":24},"4cfac891-039f-4c5c-9d35-7aed9f2cb6b1",[143],[1840],{"id":1841,"sortIndex":92,"affiliation":1842,"properties":24},"21a6cdc9-e14c-4046-b680-f477d5619c62",{"id":1841,"createTime":24,"updateTime":24,"relativeEntities":1843,"slug":24,"properties":1844,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1847,"statistic":24},[],{"title":1845},{"VI":1846},"Department of Ophthalmology, Faculty of Medical & Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand",[],{"title":1849,"gsAuthor":1851},{"VI":1850},"R.L. Niederer",{"VOID":1852},"[\"CxXskwwAAAAJ\"]",{"id":1854,"sortIndex":870,"researcher":24,"roles":1855,"affiliations":1856,"properties":1863,"displayName":1865,"givenName":24,"familyName":24},"cfd33170-e6d1-4941-bb65-a3395143c7d7",[143],[1857],{"id":1841,"sortIndex":92,"affiliation":1858,"properties":24},{"id":1841,"createTime":24,"updateTime":24,"relativeEntities":1859,"slug":24,"properties":1860,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1862,"statistic":24},[],{"title":1861},{"VI":1846},[],{"title":1864,"gsAuthor":1866},{"VI":1865},"C.N.J. McGhee",{"VOID":1867},"[\"aK5EoUwAAAAJ\"]",{"url":1834,"publisher":1869,"properties":1916},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1870,"slug":10,"properties":1871,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":1876,"manageAffiliations":1885,"indexDatabases":1896,"url":90,"thumbnailPath":24,"statistic":1911,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":1872,"eissn":1873,"issn":1874,"title":1875},{"VOID":13},{"VOID":15},{"VOID":17},{"EN":19},[1877,1881],{"id":28,"createTime":24,"updateTime":24,"relativeEntities":1878,"label":1879,"description":1880,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":31},{},{"id":34,"createTime":24,"updateTime":24,"relativeEntities":1882,"label":1883,"description":1884,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":37},{},[1886,1891],{"id":41,"createTime":24,"updateTime":24,"relativeEntities":1887,"slug":24,"properties":1888,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1890,"statistic":24},[],{"title":1889},{"EN":45},[],{"id":48,"createTime":24,"updateTime":24,"relativeEntities":1892,"slug":24,"properties":1893,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1895,"statistic":24},[],{"title":1894},{"EN":52},[],[1897,1904],{"id":56,"indexDatabase":1898,"url":67,"indexYears":68,"academicFieldIds":1903,"indexDatabaseRanking":72},{"id":58,"createTime":24,"updateTime":24,"relativeEntities":1899,"label":1900,"description":1901,"key":64,"publicationTags":1902,"standard":24},[],{"EN":61,"VI":61},{"EN":61,"VI":63},[66],[70,71],{"id":74,"indexDatabase":1905,"url":87,"indexYears":24,"academicFieldIds":1910,"indexDatabaseRanking":24},{"id":76,"createTime":24,"updateTime":24,"relativeEntities":1906,"label":1907,"description":1908,"key":83,"publicationTags":1909,"standard":24},[],{"EN":79,"VI":79},{"EN":81,"VI":82},[85,86],[89],{"impactFactor":92,"impactFactorByYear":1912,"i10Index":92,"i10IndexLast5Year":92,"totalPublication":94,"totalPublicationByYear":1913,"totalCitation":92,"totalCitationByYear":1914,"totalCitationPerPublication":92,"totalCitationPerPublicationByYear":1915,"hindexLast5Year":92,"hindex":92},{},{"1994":96,"1995":97,"1996":98,"1997":99,"1998":100,"1999":101,"2000":102,"2001":103,"2002":104,"2003":102,"2004":100,"2005":103,"2006":105,"2007":106,"2008":98,"2009":106,"2010":97,"2011":105,"2012":104,"2013":107,"2014":105,"2015":108,"2016":108,"2017":109,"2018":110,"2019":111,"2020":112,"2021":113,"2022":114,"2023":111},{},{},{"pages":1917,"volume":1919},{"VOID":1918},"30-58",{"VOID":1920},"29",277,{"total":1921,"publishYear":1923,"statisticByYear":1924},2010,{"2010":100,"2011":101,"2012":108,"2013":111,"2014":107,"2015":107,"2016":111,"2017":112,"2018":103,"2019":101,"2020":102,"2021":104,"2022":108,"2023":109,"2024":101,"2025":900},"2010-01-01",[85,72],{"id":1928,"createTime":1929,"updateTime":1930,"relativeEntities":1931,"slug":1932,"properties":1933,"entityType":134,"verifyStatus":135,"verifyTime":1930,"verifyNote":137,"languages":24,"translateLanguages":24,"viewCount":92,"primaryUrl":1940,"fullTextUrl":24,"authors":1941,"publicationType":156,"publisherRelationship":1960,"citationCount":24,"citationInfo":24,"publishDate":2013,"publishYear":2014,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":2015,"openAccess":24,"references":24,"isForceReanalyzing":837},"fcf18dc5-b4ec-4be3-b55d-e3e0bf6863de","2024-01-14T15:21:46.769+00:00","2025-02-27T01:40:25.475+00:00",[],"Endocannabinoids-in-the-retina-From-marijuana-to-neuroprotection",{"title":1934,"references":1936,"doi":1938},{"EN":1935},"Endocannabinoids in the retina: From marijuana to neuroprotection",{"VOID":1937},"Adams, 1975, Alcohol prolongs time course of glare recovery, Nature, 257, 481, 10.1038\u002F257481a0\nAdams, 1975, Alcohol and marijuana effects on static visual acuity, Am. J. Optom. Physiol. Opt., 52, 729, 10.1097\u002F00006324-197511000-00001\nAdams, 1978, Marijuana, alcohol, and combined drug effects on the time course of glare recovery, Psychopharmacology (Berl), 56, 81, 10.1007\u002FBF00571413\nAguado, 2007, The CB1 cannabinoid receptor mediates excitotoxicity-induced neural progenitor proliferation and neurogenesis, J. Biol. Chem., 282, 23892, 10.1074\u002Fjbc.M700678200\nAhmad, 2006, Stimulation of prostaglandin EP2 receptors prevents NMDA-induced excitotoxicity, J. Neurotrauma, 23, 1895, 10.1089\u002Fneu.2006.23.1895\nAkopian, 2000, Somatostatin modulates voltage-gated K+ and Ca2+ currents in rod and cone photoreceptors of the salamander retina, J. Neurosci., 20, 929, 10.1523\u002FJNEUROSCI.20-03-00929.2000\nBaker, 2006, In silico patent searching reveals a new cannabinoid receptor, Trends Pharmacol. Sci., 27, 1, 10.1016\u002Fj.tips.2005.11.003\nBalse, 2006, Glycine receptors in a population of adult mammalian cones, J. Physiol., 571, 391, 10.1113\u002Fjphysiol.2005.100891\nBarnes, 1991, Modulation of calcium-activated chloride current via pH-induced changes of calcium channel properties in cone photoreceptors, J. Neurosci., 11, 4015, 10.1523\u002FJNEUROSCI.11-12-04015.1991\nBarnett-Norris, 2005, Lipids, lipid rafts and caveolae: their importance for GPCR signaling and their centrality to the endocannabinoid system, Life Sci., 77, 1629, 10.1016\u002Fj.lfs.2005.05.040\nBegbie, 2004, Cannabinoid receptor, CB1, expression follows neuronal differentiation in the early chick embryo, J. Anat., 205, 213, 10.1111\u002Fj.0021-8782.2004.00325.x\nBegg, 2005, Evidence for novel cannabinoid receptors, Pharmacol. Ther., 106, 133, 10.1016\u002Fj.pharmthera.2004.11.005\nBeinfeld, 2001, Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to spatial memory defects produced by cannabinoids, Neurosci. Lett., 301, 69, 10.1016\u002FS0304-3940(01)01591-9\nBisogno, 1999, Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina, Arch. Biochem. Biophys., 370, 300, 10.1006\u002Fabbi.1999.1410\nBisogno, 2005, The endocannabinoid signalling system: biochemical aspects, Pharmacol. Biochem. Behav., 81, 224, 10.1016\u002Fj.pbb.2005.01.027\nBisogno, 2000, N-Acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo, Biochem. J., 351, 817, 10.1042\u002F0264-6021:3510817\nBiswas, 2004, Prostaglandin E2 receptor subtypes, EP1, EP2, EP3 and EP4 in human and mouse ocular tissues–a comparative immunohistochemical study, Prostaglandins Leukot. Essent. Fatty Acids, 71, 277, 10.1016\u002Fj.plefa.2004.03.021\nBojesen, 2003, Binding of anandamide to bovine serum albumin, J. Lipid Res., 46, 1790, 10.1194\u002Fjlr.M300170-JLR200\nBonhaus, 1998, Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses, J. Pharmacol. Exp. Ther., 287, 884\nBortolato, 2007, Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress, Biol. Psychiatry, 62, 1103, 10.1016\u002Fj.biopsych.2006.12.001\nBradshaw, 2005, The expanding field of cannabimimetic and related lipid mediators, Br. J. Pharmacol., 144, 459, 10.1038\u002Fsj.bjp.0706093\nBrandon, 1983, l-Glutamic acid: a neurotransmitter candidate for cone photoreceptors in human and rat retinas, Proc. Natl. Acad. Sci. U S A, 80, 5117, 10.1073\u002Fpnas.80.16.5117\nBreivogel, 2001, Evidence for a new G protein-coupled cannabinoid receptor in mouse brain, Mol. Pharmacol., 60, 155, 10.1124\u002Fmol.60.1.155\nBuckley, 1998, Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat, Neuroscience, 82, 1131, 10.1016\u002FS0306-4522(97)00348-5\nBurnstein, 2005, PPAR-γ: a nuclear receptor with affinity for cannabinoids, Life Sci., 77, 1674, 10.1016\u002Fj.lfs.2005.05.039\nCabral, 2008, CB2 receptors in the brain: role in central immune function, Br. J. Pharmacol., 153, 240, 10.1038\u002Fsj.bjp.0707584\nCalandra, 1999, Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor, Eur. J. Pharmacol., 374, 445, 10.1016\u002FS0014-2999(99)00349-0\nCarlin, 1972, Social facilitation of marijuana intoxication: impact of social set and pharmacological activity, J. Abnorm. Psychol., 80, 132, 10.1037\u002Fh0033317\nChaperon, 1999, Behavioral effects of cannabinoid agents in animals, Crit. Rev. Neurobiol., 13, 243, 10.1615\u002FCritRevNeurobiol.v13.i3.20\nChen, 2005, Finding of endocannabinoids in human eye tissues: implications for glaucoma, Biochem. Biophys. Res. Commun., 330, 1062, 10.1016\u002Fj.bbrc.2005.03.095\nChien, 2003, Effect of WIN 55212-2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys, Arch. Ophthalmol., 121, 87, 10.1001\u002Farchopht.121.1.87\nChin, 2001, Cyclooxygenase-2 gene expression and regulation in human retinal pigment epithelial cells, Invest. Ophthalmol. Vis. Sci., 42, 2338\nConsroe, 1997, The perceived effects of smoked cannabis on patients with multiple sclerosis, Eur. Neurol., 38, 44, 10.1159\u002F000112901\nCrandall, 2007, Neuroprotective and intraocular pressure-lowering effects of (−)Delta9-tetrahydrocannabinol in a rat model of glaucoma, Ophthalmic. Res., 39, 69, 10.1159\u002F000099240\nCravatt, 2001, Supersensitivity to anandamide and enhanced cannabinoid signaling in mice lacking fatty acid amide hydrolase, Proc. Natl. Acad. Sci. U S A, 98, 9371, 10.1073\u002Fpnas.161191698\nCravatt, 2004, Functional dissociation of the central and peripheral fatty acid amide signaling systems, Proc. Natl. Acad. Sci. U S A, 101, 10821, 10.1073\u002Fpnas.0401292101\nCristino, 2008, Immunohistochemical localization of anabolic and catabolic enzymes for anandamide and other putative endovanilloids in the hippocampus and cerebellar cortex of the mouse brain, Neuroscience, 151, 955, 10.1016\u002Fj.neuroscience.2007.11.047\nDacey, 1985, Wide-spreading terminal axons in the inner plexiform layer of the cat's retina: evidence for intrinsic axon collaterals of ganglion cells, J. Comp. Neurol., 242, 247, 10.1002\u002Fcne.902420207\nDainese, 2007, Modulation of the endocannabinoid system by lipid rafts, Curr. Med. Chem., 14, 2702, 10.2174\u002F092986707782023235\nDawson, 1977, Marijuana and vision – after ten years' use in Costa Rica, Invest. Ophthalmol. Vis. Sci., 16, 689\nDe Petrocellis, 2001, The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism, J. Biol. Chem., 276, 12856, 10.1074\u002Fjbc.M008555200\nDearry, 1986, Dopaminergic regulation of cone retinomotor movement in isolated teleost retinas: I. Induction of cone contraction is mediated by D2 receptors, J. Neurochem., 46, 1006, 10.1111\u002Fj.1471-4159.1986.tb00612.x\nDeutsch, 1993, Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist, Biochem. Pharmacol., 46, 791, 10.1016\u002F0006-2952(93)90486-G\nDeutsch, 1997, Methyl arachidonyl fluorophosphonate: a potent irreversibe inhibitor of anandamide amidase, Biochem. Pharmacol., 53, 255, 10.1016\u002FS0006-2952(96)00830-1\nDevane, 1988, Determination and characterization of a cannabinoid receptor in rat brain, Mol. Pharmacol., 34, 605\nDevane, 1992, Isolation and structure of a brain constituent that binds to the cannabinoid receptor, Science, 258, 1946, 10.1126\u002Fscience.1470919\nDiana, 2004, Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE), Br. J. Pharmacol., 142, 9, 10.1038\u002Fsj.bjp.0705726\nDiaz-Laviada, 2005, Signal transduction activated by cannabinoid receptors, Mini Rev. Med. Chem., 5, 619, 10.2174\u002F1389557054368808\nDi Marzo, 1994, Formation and inactivation of endogenous cannabinoid anandamide in central neurons, Nature, 6501, 686, 10.1038\u002F372686a0\nDinh, 2002, Brain monoglyceride lipase participating in endocannabinoid inactivation, Proc. Nat. Acad. Sci. U S A, 99, 10819, 10.1073\u002Fpnas.152334899\nEgertová, 2003, Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling, Neuroscience, 119, 481, 10.1016\u002FS0306-4522(03)00145-3\nEgertová, 2000, Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB1, J. Comp. Neurol., 422, 159, 10.1002\u002F(SICI)1096-9861(20000626)422:2\u003C159::AID-CNE1>3.0.CO;2-1\nEgertová, 1998, A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain, Proc. R. Soc. London B: Biol Sci., 265, 2081, 10.1098\u002Frspb.1998.0543\nEhinger, 1981, [3H]-d-aspartate accumulation in the retina of pigeon, guinea pig and rabbit, Exp. Eye Res., 33, 381, 10.1016\u002FS0014-4835(81)80090-5\nEl Remessy, 2003, Neuroprotective effect of delta(9)-tetrahydrocannabinol and cannabidiol in N-methyl-d-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite, Am. J. Pathol., 163, 1997, 10.1016\u002FS0002-9440(10)63558-4\nEmrich, 1991, Reduced binocular depth inversion as an indicator of cannabis-induced censorship impairment, Pharmacol. Biochem. Behav., 40, 689, 10.1016\u002F0091-3057(91)90383-D\nFan, 1999, Modulation of voltage-gated K+ currents (IK(v)) in retinal bipolar cells by ascorbate is mediated by dopamine D1 receptors, Vis. Neurosci., 16, 928, 10.1017\u002FS095252389916512X\nFan, 2003, Biphasic modulation of voltage-dependent currents of retinal cones by cannabinoid CB1 agonist, WIN 55212-2, Vis. Neurosci., 20, 177, 10.1017\u002FS095252380320208X\nFan, 2004, Inhibitory interaction of cannabinoid CB1 receptor and dopamine D2 receptor agonists on voltage-gated currents of goldfish cones, Vis. Neurosci., 21, 69, 10.1017\u002FS0952523804041070\nFan, 2005, Reciprocal inhibition of voltage-gated potassium currents (I K(V)) by activation of cannabinoid CB1 and dopamine D1 receptors in ON bipolar cells of goldfish retina, Vis. Neurosci., 22, 55, 10.1017\u002FS0952523805221089\nFan, 2007, Retrograde endocannabinoid inhibition of goldfish retinal cones in mediated by 2-arachidonoyl glycerol, Vis. Neurosci., 24, 257, 10.1017\u002FS095252380707006X\nFernández-Ruiz, 2004, Cannabinoids and gene expression during brain development, Neurotox. Res., 6, 389, 10.1007\u002FBF03033314\nFernández-Ruiz, 1999, Role of endocannabinoids in brain development, Life Sci., 65, 725, 10.1016\u002FS0024-3205(99)00295-7\nFlom, 1976, Alcohol and marijuana effects on ocular tracking, Am. J. Optom. Physiol. Opt., 53, 764, 10.1097\u002F00006324-197612000-00003\nFowler, 2007, The contribution of cyclooxgenase-2 to endocannabinoid metabolism and action, Br. J. Pharmacol., 152, 594, 10.1038\u002Fsj.bjp.0707379\nFowler, 2005, The endocannabinoid signaling system: pharmacological and therapeutic aspects, Pharmacol. Biochem. Behav., 81, 248, 10.1016\u002Fj.pbb.2005.01.023\nFride, 2008, Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development, J. Neuroendocrinol., 20, 75, 10.1111\u002Fj.1365-2826.2008.01670.x\nFried, 1995, The Ottawa Prenatal Prospective Study (OPPS): methodological issues and findings – it's easy to throw the baby out with the bath, Life Sci., 56, 2159, 10.1016\u002F0024-3205(95)00203-I\nFukudome, 2004, Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1M3-mediated indirect suppression through endocannabinoid signaling, Eur. J. Neurosci., 19, 2682, 10.1111\u002Fj.0953-816X.2004.03384.x\nFunakoshi, 2005, Differential development of TRPV1-expressing sensory nerves in peripheral organs, Cell Tissue Res., 1\nGaliegue, 1995, Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations, Eur. J. Biochem., 232, 54, 10.1111\u002Fj.1432-1033.1995.tb20780.x\nGallego, 1965, Mammalian retina: associational nerve cells in ganglion cell layer, Science, 150, 1313, 10.1126\u002Fscience.150.3701.1313\nGalve-Roperh, 2006, Endocannabinoids: a new family of lipid mediators involved in the regulation of neural cell development, Curr. Pharm. Des., 12, 2319, 10.2174\u002F138161206777585139\nGaoni, 1964, Isolation, structure and partial synthesis of an active constituent of hashish, J. Am. Chem. Soc., 86, 1646, 10.1021\u002Fja01062a046\nGawienowski, 1982, Effect of delta 9-tetrahydrocannabinol on monoamine oxidase activity in bovine eye tissues, in vitro, Invest. Ophthalmol. Vis. Sci., 22, 482\nGilbert, 2007, Delta9-tetrahydrocannabinol protects hippocampal neurons from excitotoxicity, Brain Res., 1128, 61, 10.1016\u002Fj.brainres.2006.03.011\nGlaser, 2005, Endocannabinoids in the intact retina: 3H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide, Vis. Neurosci., 22, 693, 10.1017\u002FS0952523805226020\nGlaser, 2005, Anadamide transport: a critical review, Life Sci., 77, 1584, 10.1016\u002Fj.lfs.2005.05.007\nGlass, 1997, Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor, J. Neurosci., 17, 5327, 10.1523\u002FJNEUROSCI.17-14-05327.1997\nGoparaju, 1999, Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors, Biochem. Pharmacol., 57, 417, 10.1016\u002FS0006-2952(98)00314-1\nGoparaju, 1998, Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand, FEBS Lett., 422, 69, 10.1016\u002FS0014-5793(97)01603-7\nGrant, 1996, On bipolar cell responses in the teleost retina are generated by two distinct mechanisms, J. Neurophysiol., 76, 3842, 10.1152\u002Fjn.1996.76.6.3842\nGreen, 1979, The ocular effects of cannabinoids, Curr. Top. Eye Res., 1, 175\nGulyas, 2004, Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala, Eur. J. Neurosci., 20, 441, 10.1111\u002Fj.1460-9568.2004.03428.x\nHarsanyi, 1993, Modulation of cone to horizontal cell transmission by calcium and pH in the fish retina, Vis. Neurosci., 10, 81, 10.1017\u002FS0952523800003242\nHartwick, 2004, Adenosine A1-receptor modulation of glutamate-induced calcium influx in rat retinal ganglion cells, Invest. Ophthalmol. Vis. Sci., 45, 3740, 10.1167\u002Fiovs.04-0214\nHeidelberger, 1994, Dopamine enhances Ca2+ responses in synaptic terminals of retinal bipolar neurons, Neuroreport, 5, 729, 10.1097\u002F00001756-199402000-00018\nHerkenham, 1991, Characterization and localization of cannabinoid receptors in rat brain: A quantitative in vitro autoradiographic study, J. Neurosci., 11, 563, 10.1523\u002FJNEUROSCI.11-02-00563.1991\nHermann, 2006, 2-Arachidonoylglycerol (2-AG) membrane transport: history and outlook, AAPS J., 8, E409, 10.1208\u002Faapsj080247\nHewett, 2000, Cyclooxygenase-2 contributes to N-methy-d-aspartate-mediated neuronal cell death in primary cortical cell culture, J. Pharmacol. Exp. Ther., 293, 417\nHill, 2007, Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons, J. Neurophysiol., 97, 2580, 10.1152\u002Fjn.00603.2006\nHillard, 2003, Cellular accumulation of anandamide: consensus and controversy, Br. J. Pharmacol., 140, 802, 10.1038\u002Fsj.bjp.0705468\nHohmann, 2006, Endocannabinoid mechanisms of pain modulation, AAPS J., 8, E693, 10.1208\u002Faapsj080479\nHollister, 1971, Marihuana in man: three years later, Science, 172, 21, 10.1126\u002Fscience.172.3978.21\nHowlett, 2004, Cannabinoid physiology and pharmacology: 30 years of progress, Neuropharmacology, 47, 345, 10.1016\u002Fj.neuropharm.2004.07.030\nHwang, 2000, Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances, Proc. Natl. Acad. Sci. U S A, 97, 6155, 10.1073\u002Fpnas.97.11.6155\nIribane, 2008, Cannabinoid receptors in conjunctival epithelium: identification and functional properties, Invest. Ophthalmol. Vis. Sci., June 19\nIversen, 2003, Cannabis and the brain, Brain, 126, 1252, 10.1093\u002Fbrain\u002Fawg143\nIversen, 2000\nJärvinen, 2002, Cannabinoids in the treatment of glaucoma, Pharmacol. Ther., 95, 203, 10.1016\u002FS0163-7258(02)00259-0\nJayamanne, 2006, Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models, Br. J. Pharmacol., 147, 281, 10.1038\u002Fsj.bjp.0706510\nJu, 2003, Increased activity of cyclooxygenase-2 signals early neurodegenerative events in the rat retina following transient ischemia, Exp. Eye Res., 77, 137, 10.1016\u002FS0014-4835(03)00128-3\nJung, 1999, Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel, J. Neurosci., 19, 529, 10.1523\u002FJNEUROSCI.19-02-00529.1999\nJung, 2002, Agonist recognition sites in the cytosolic tails of vanilloid receptor 1, J. Biochem. (Tokyo), 46, 44448\nKamermans, 2001, Hemichannel-mediated inhibition in the outer retina, Science, 292, 1178, 10.1126\u002Fscience.1060101\nKaplan-Messas, 2003, Ocular hypotensive effects of cholinergic and adrenergic drugs may be influenced by prostaglandins E2 in the human and rabbit eye, Eur. J. Ophthalmol., 13, 18, 10.1177\u002F112067210301300103\nKárai, 2004, Vanilloid receptor 1 regulates multiple calcium compartments and contributes to Ca2+-induced Ca2+-release in sensory neurons, J. Biol. Chem., 279, 16377, 10.1074\u002Fjbc.M310891200\nKaranian, 2005, Dual modulation of endocannabinoid transport and fatty acid amide hydrolase protects against excitotoxicity, J. Neurosci., 25, 7813, 10.1523\u002FJNEUROSCI.2347-05.2005\nKatona, 1999, Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons, J. Neurosci., 19, 4544, 10.1523\u002FJNEUROSCI.19-11-04544.1999\nKatona, 2006, Molecular composition of the endocannabinoid system at glutamatergic synapses, J. Neurosci., 26, 5628, 10.1523\u002FJNEUROSCI.0309-06.2006\nKaufmann, 1996, COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex, Proc. Natl. Acad. Sci. U S A, 93, 2317, 10.1073\u002Fpnas.93.6.2317\nKim, 2004, Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus, Nat. Neurosci., 7, 697, 10.1038\u002Fnn1262\nKiplinger, 1971, Dose-response analysis of the effects of tetrahydrocannabinol in man, Clin. Pharmacol. Ther., 12, 650, 10.1002\u002Fcpt1971124650\nKlooster, 2001, Localization of the AMPA subunit GluR2 in the outer plexiform layer of goldfish retina, J. Comp. Neurol., 441, 155, 10.1002\u002Fcne.1404\nKogan, 2007, Cannabinoids in health and disease, Dialogues Clin. Neurosci., 9, 413, 10.31887\u002FDCNS.2007.9.4\u002Fnkogan\nKourennyi, 2004, Reciprocal modulation of calcium dynamics at rod and cone photoreceptor synapses by nitric oxide, J. Neurophysiol., 92, 477, 10.1152\u002Fjn.00606.2003\nKozak, 2000, Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2, J. Biol. Chem., 275, 33744, 10.1074\u002Fjbc.M007088200\nKreitzer, 2001, Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells, Neuron, 29, 717, 10.1016\u002FS0896-6273(01)00246-X\nKurreny, 1994, Modulation of ion channels in rod photoreceptors by nitric oxide, Neuron, 13, 315, 10.1016\u002F0896-6273(94)90349-2\nLadanyi, 1986, In-vivo labeling of (3H)d-aspartate uptake sites in monkey retina, Cell Tissue Res., 243, 59, 10.1007\u002FBF00221852\nde Lago, 2007, Cannabinoids and neuroprotection in motor-related disorders, CNS Neurol. Disord. Drug Targets, 6, 377, 10.2174\u002F187152707783399210\nLambert, 2005, The endocannabinoid system: drug targets, lead compunds, and potential therapeutic applications, J. Med. Chem., 48, 5059, 10.1021\u002Fjm058183t\nLalonde, 2006, Cannabinoid receptor-mediated inhibition of calcium signalling in rat retinal ganglion cells, Mol. Vis., 12, 1160\nLauckner, 2005, The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq\u002F11 G proteins, Proc. Natl. Acad. Sci. U S A, 102, 19149, 10.1073\u002Fpnas.0509588102\nLaVail, 1974, C57BL\u002F6J mice with inherited retinal degeneration, Arch. Ophthalmol., 91, 394, 10.1001\u002Farchopht.1974.03900060406015\nLedent, 1999, Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice, Science, 283, 401, 10.1126\u002Fscience.283.5400.401\nLeonelli, 2005, Developmental expression of cannabinoid receptors in the chick retinotectal system, Brain Res. Dev. Brain Res., 156, 176, 10.1016\u002Fj.devbrainres.2005.02.009\nLeweke, 1999, Effects of synthetic 9-tetrahydrocannbinoi on binocular depth inversion in man, Psychopharmacology (Berl), 142, 230, 10.1007\u002Fs002130050884\nLiang, 2004, Upregulation of orphan nuclear receptor Nur77 following PGF(2alpha), bimatoprost, and butaprost treatments. Essential role of a protein kinase C pathway involved in EP(2) receptor activated Nur77 gene transcription, Br. J. Pharmacol., 142, 737, 10.1038\u002Fsj.bjp.0705829\nLiang, 2003, Comparison of prostaglandin F2alpha, bimatoprost (prostamide), and butaprost (EP2 agonist) on Cyr61 and connective tissue growth factor gene expression, J. Biol. Chem., 278, 27267, 10.1074\u002Fjbc.M301009200\nLichtman, 2004, Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia, Pain, 109, 319, 10.1016\u002Fj.pain.2004.01.022\nLiu, 2005, Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia, Ann. Neurol., 57, 748, 10.1002\u002Fana.20461\nLiu, 2008, Multiple pathways involved in the biosynthesis of anadamide, Neuropharmacology, 54, 1, 10.1016\u002Fj.neuropharm.2007.05.020\nLiu, 2003, Versatile regulation of cytosolic Ca2+ by vanilloid receptor I in rat dorsal root ganglion neurons, J. Cell Biol., 278, 5462\nLograno, 2004, Cannabinoid agonists induce contractile responses through Gi\u002Fo-dependent activation of phospholipase C in the bovine ciliary muscle, Eur. J. Pharmacol., 494, 55, 10.1016\u002Fj.ejphar.2004.04.039\nLu, 2000, Expression of CB2 cannabinoid receptor mRNA in adult rat retina, Vis. Neurosci., 17, 91, 10.1017\u002FS0952523800171093\nMackie, 2006, Cannabinoid receptors as therapeutic targets, Annu. Rev. Pharmacol. Toxicol., 46, 101, 10.1146\u002Fannurev.pharmtox.46.120604.141254\nMaejima, 2001, Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors, Neuron, 31, 463, 10.1016\u002FS0896-6273(01)00375-0\nMaejima, 2005, Synaptically driven endocannabinoid release requires Ca2+-assisted metabotropic glutamate receptor subtype 1 to phospholipase Cbeta4 signaling cascade in the cerebellum, J. Neurosci., 25, 6826, 10.1523\u002FJNEUROSCI.0945-05.2005\nMaihofner, 2001, Expression of cyclooxygenase-1 and -2 in normal and glaucomatous human eyes, Invest. Ophthalmol. Vis. Sci., 42, 2616\nMailleux, 1992, Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry, Neuroscience, 48, 655, 10.1016\u002F0306-4522(92)90409-U\nManeuf, 1997, Paradoxical action of the cannabinoid WIN 55,212-2 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices, Br. J. Pharmacol., 120, 1397, 10.1038\u002Fsj.bjp.0701101\nMarc, 1981, Uptake of aspartic and glutamic acid by photoreceptors in goldfish retina, Proc. Natl. Acad. Sci. U S A, 78, 7185, 10.1073\u002Fpnas.78.11.7185\nMarc, 1995, Pattern recognition of amino acid signatures in retinal neurons, J. Neurosci., 15, 5106, 10.1523\u002FJNEUROSCI.15-07-05106.1995\nMarsicano, 1999, Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain, Eur. J. Neurosci., 11, 4213, 10.1046\u002Fj.1460-9568.1999.00847.x\nMarsicano, 2002, Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1, J. Neurochem., 80, 448, 10.1046\u002Fj.0022-3042.2001.00716.x\nMartínez-Orgado, 2007, The seek of neuroprotection: introducing cannabinoids, Rec. Patents CNS Drug Discov, 2, 131, 10.2174\u002F157488907780832724\nMatias, 2006, Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration, Prostaglandins Leukot. Essent. Fatty Acids, 75, 413, 10.1016\u002Fj.plefa.2006.08.002\nMatsuda, 1990, Structure of a cannabinoid receptor and functional expression of the cloned cDNA, Nature, 346, 561, 10.1038\u002F346561a0\nMatsuda, 1997, Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues, Exp. Eye Res., 64, 707, 10.1006\u002Fexer.1996.0265\n2005, Visual Neurosci., 22, 553, 10.1017\u002FS0952523805225026\nMcAllister, 2002, CB1 and CB2 receptor-mediated signalling: a focus on endocannabinoids, Prostaglandins Leukot. Essent. Fatty Acids, 66, 161, 10.1054\u002Fplef.2001.0344\nMcCullough, 2004, Neuroprotective function of the PGE2 EP2 receptor in cerebral ischemia, J. Neurosci., 24, 257, 10.1523\u002FJNEUROSCI.4485-03.2004\nMcIntosh, 2007, Agonist-dependent cannabinoid signalling in human trabecular meshwork cells, Br. J. Pharmacol., 152, 1111, 10.1038\u002Fsj.bjp.0707495\nMcIntosh, 1998, CB1 cannabinoid receptor: cellular regulation and distribution in N18TG2 neuroblastoma cells, Mol. Brain Res., 53, 163, 10.1016\u002FS0169-328X(97)00294-5\nMcKinney, 2005, Structure and function of fatty acid amide hydrolase, Annu. Rev. Biochem., 74, 411, 10.1146\u002Fannurev.biochem.74.082803.133450\nMechoulam, 2002, Discovery of endocannabinoids and some random thoughts on their possible roles in neuroprotection and aggression, Prostaglandins Leukot. Essent. Fatty Acids, 66, 93, 10.1054\u002Fplef.2001.0340\nMechoulam, 1995, Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors, Biochem. Pharmacol., 50, 83, 10.1016\u002F0006-2952(95)00109-D\nMechoulam, 1967, The absolute configuration of D1-tetrahydrocannabinol, the major active constituent of hashish, Tetrahedron Lett., 1109, 10.1016\u002FS0040-4039(00)90646-4\nMechoulam, 2007, Endocannabinoids and traumatic brain injury, Mol. Neurobiol., 36, 68, 10.1007\u002Fs12035-007-8008-6\nMicale, 2007, Endocannabinoids and neurodegenerative diseases, Pharmacol. Res., 56, 382, 10.1016\u002Fj.phrs.2007.09.008\nMillns, 2006, Effects of inhibition of fatty acid amide hydrolase vs. the anandamide membrane transporter on TRPV1-mediated calcium responses in adult DRG neurons; the role of CB1 receptors, Eur. J. Neurosci., 24, 3489, 10.1111\u002Fj.1460-9568.2006.05236.x\nMora-Ferrer, 1999, Dopamine D1-receptor immunolocalization in goldfish retina, J. Comp. Neurol., 411, 704, 10.1002\u002F(SICI)1096-9861(19990906)411:4\u003C705::AID-CNE14>3.0.CO;2-Y\nMunro, 1993, Molecular characterization of a peripheral receptor for cannabinoids, Nature, 365, 61, 10.1038\u002F365061a0\nNagayama, 1999, Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures, J. Neurosci., 19, 2987, 10.1523\u002FJNEUROSCI.19-08-02987.1999\nNakamichi, 2003, Effects of intraocular injection of a low concentration of zinc on the rat retina, Neuropharmacology, 45, 637, 10.1016\u002FS0028-3908(03)00206-5\nNavarrete, 2008, Endocannabinoids mediate neuron-astrocyte communication, Neuron, 57, 883, 10.1016\u002Fj.neuron.2008.01.029\nNeal, 2001, Activation of nicotinic receptors on GABAergic amacrine cells in the rabbit retina indirectly stimulates dopamine release, Vis. Neurosci., 18, 55, 10.1017\u002FS0952523801181058\nNjie, Y.F., Qiao, Z., Xiao, Z., Wang, W., Song, Z.H., 2008. N-arachidonylethanolamide-induce increase in aqueous humor outflow facility. Invest. Ophthalmol. Vis. Sci. June 6 [Epub ahead of print].\nNogawa, 1997, Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage, J. Neurosci., 17, 2746, 10.1523\u002FJNEUROSCI.17-08-02746.1997\nNoyes, 1975, The analgesic properties of delta-9-tetrahydrocannabinol and codeine, Clin. Pharmacol. Ther., 18, 84, 10.1002\u002Fcpt197518184\nNucci, 2007, Involvement of the endocannabinoid system in retinal damage after high intracellular pressure-induced ischemia in rats, Invest. Ophthalmol. Vis. Sci., 48, 2997, 10.1167\u002Fiovs.06-1355\nOhno-Shosaku, 2005, Calcium signaling and synaptic modulation: regulation of endocannabinoid-mediated synaptic modulation by calcium, Cell Calcium, 38, 369, 10.1016\u002Fj.ceca.2005.06.014\nOhno-Shosaku, 2001, Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals, Neuron, 29, 729, 10.1016\u002FS0896-6273(01)00247-1\nOhno-Shosaku, 2002, Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses, J. Neurosci., 22, 3864, 10.1523\u002FJNEUROSCI.22-10-03864.2002\nOku, 2004, Adenosine protects cultured retinal neurons against NMDA-induced cell death through A1 receptors, Curr. Eye Res., 29, 449, 10.1080\u002F02713680490522443\nOlah, 2001, Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1, J. Biol. Chem., 276, 11021, 10.1074\u002Fjbc.M008392200\n2006\nOpere, 2006, Inhibition of potassium- and ischemia-evoked [3H] d-aspartate release from isolated bovine retina by cannabinoids, Curr. Eye Res., 31, 645, 10.1080\u002F02713680600762747\nOsborne, 2004, Retinal ischemia: mechanisms of damage and potential therapeutic strategies, Prog. Retin. Eye Res., 23, 91, 10.1016\u002Fj.preteyeres.2003.12.001\nPatrick, 1995, Auditory and visual P300 event related potentials are not altered in medically and psychiatrically normal chronic marihuana users, Life Sci., 56, 2135, 10.1016\u002F0024-3205(95)00199-G\nPazos, 2005, Functional neuroanatomy of the endocannabinoid system, Pharmacol. Biochem. Behav., 81, 239, 10.1016\u002Fj.pbb.2005.01.030\nPertwee, 2005, The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids, AAPS J., 7, E625, 10.1208\u002Faapsj070364\nPertwee, 2006, Cannabinoid pharmacology: the first 66 years, Br. J. Pharmacol., 147, S163, 10.1038\u002Fsj.bjp.0706406\nPertwee, 2002, Cannabinoid receptors and their ligands, Prostaglandins Leukot. Essent. Fatty Acids, 66, 101, 10.1054\u002Fplef.2001.0341\nPettit, 1998, Immunohistochemical localization of the neural cannabinoid receptor in rat brain, J. Neurosci. Res., 51, 391, 10.1002\u002F(SICI)1097-4547(19980201)51:3\u003C391::AID-JNR12>3.0.CO;2-A\nPicaud, 1998, GABAA and GABAC receptors in adult porcine cones: evidence from a photoreceptor-glia co-culture model, J. Physiol., 513, 33, 10.1111\u002Fj.1469-7793.1998.033by.x\nPiomelli, 2003, The molecular logic of endocannabinoid signalling, Nat. Rev. Neurosci., 4, 873, 10.1038\u002Fnrn1247\nPorcella, 1998, Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana, Mol. Brain Res., 58, 240, 10.1016\u002FS0169-328X(98)00105-3\nPorcella, 2000, The human eye expresses high levels of CB1 cannabinoid receptor mRNA and protein, Eur. J. Neurosci., 12, 1123, 10.1046\u002Fj.1460-9568.2000.01027.x\nPorcella, 2001, The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies, Eur. J. Neurosci., 13, 409, 10.1046\u002Fj.0953-816X.2000.01401.x\nQuigley, 1999, Neuronal death in glaucoma, Prog. Retin. Eye Res., 18, 39, 10.1016\u002FS1350-9462(98)00014-7\nRamos, 2005, Effects on development, Handb. Exp. Pharmacol., 168, 643, 10.1007\u002F3-540-26573-2_22\nReese, 1991, Cannabis seems to improve night vision of fisherman, Chem. Eng. News, 69, 44, 10.1021\u002Fcen-v069n031.p044\nRosch, 2005, Prostaglandin E(2) induces cyclooxygenase-2 expression in human non-pigmented ciliary epithelial cells through activation of p38 and p42\u002F44 mitogen-activated pritein kinases, Biochem. Biophys. Res. Commun., 338, 1171, 10.1016\u002Fj.bbrc.2005.10.051\nRosch, 2006, R(+)-Methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human non-pigmented ciliary epithelial cells, J. Pharmacol. Exp. Ther., 316, 1219, 10.1124\u002Fjpet.105.092858\nRoss, 2003, Anandamide and vanilloid TRPV1 receptors, Br. J. Pharmacol., 140, 790, 10.1038\u002Fsj.bjp.0705467\nRusso, 2004, Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?, Neuroendocrinol. Lett., 25, 31\nRusso, 2004, Cannabis improves night vision: a case study of dark adaptometry and scotopic sensitivity in kif smokers of the Rif mountains of northern Morocco, J. Ethnopharmacol., 93, 99, 10.1016\u002Fj.jep.2004.03.029\nSaario, 2004, Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes, Biochem. Pharmacol., 67, 1381, 10.1016\u002Fj.bcp.2003.12.003\nSagar, 1988, Somatostatin-like immunoreactive material in associational ganglion cells of human retina, Neuroscience, 27, 507, 10.1016\u002F0306-4522(88)90284-9\nSang, 2007, COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity, J. Neurochem., 102, 1966, 10.1111\u002Fj.1471-4159.2007.04668.x\nSang, 2005, Postsynaptically synthesized prostaglandin E2 (PGE2) modulates hippocampal synaptic transmission via a presynaptic PGE2 EP2 receptor, J. Neurosci., 25, 9858, 10.1523\u002FJNEUROSCI.2392-05.2005\nSarker, 2003, Anandamide induces cell death independently of cannabinoid receptors or vanilloid receptor 1: possible involvement of lipid rafts, Cell. Mol. Life Sci., 60, 1200, 10.1007\u002Fs00018-003-3055-2\nSavinainen, 2004, Detection of cannabinoid CB1, adenosine A1, muscarinic acetylcholine, and GABA(B) receptor-dependent G protein activity in transducin-deactivated membranes and autoradiography sections of rat retina, Cell Mol. Neurobiol., 24, 243, 10.1023\u002FB:CEMN.0000018619.18631.53\nSchlicker, 1996, Cannabinoid receptor-mediated inhibition of dopamine release in the retina, Naunyn Schmiedebergs Arch. Pharmacol., 354, 791, 10.1007\u002FBF00166907\nSchlotzer-Schrehardt, 2002, Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues, Invest. Ophthalmol. Vis. Sci., 43, 1475\nSemple, 2003, Reduced binocular depth inversion in regular cannabis users, Pharmacol. Biochem. Behav., 75, 789, 10.1016\u002FS0091-3057(03)00140-0\nSharif, 2004, Molecular pharmacology of the DP\u002FEP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes, J. Ocul. Pharmacol. Ther., 20, 489, 10.1089\u002Fjop.2004.20.489\nShivachar, 2007, Cannabinoids inhibit sodium-dependent, high affinity excitatory amino acid transport in cultured rat cortical astrocytes, Biochem. Pharmacol., 73, 2004, 10.1016\u002Fj.bcp.2007.03.018\nSkosnik, 2006, The effect of cannabis use and gender on the visual steady state evoked potential, Clin. Neurophysiol., 117, 144, 10.1016\u002Fj.clinph.2005.09.024\nSlanina, 2005, Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus, Neuropharmacology, 49, 653, 10.1016\u002Fj.neuropharm.2005.04.019\nSommer, 2006, Neuroprotective cannabinoid receptor antagonist SR141716A prevents downregulation of excitotoxic NMDA receptors in the ischemic penumbra, Acta Neuropathol., 112, 277, 10.1007\u002Fs00401-006-0110-8\nSong, 2000, Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2, J. Pharmacol. Exp. Ther., 292, 136\nStamer, 2001, Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues, Eur. J. Pharmacol., 431, 277, 10.1016\u002FS0014-2999(01)01438-8\nStella, 1997, A second endogenous cannabinoid that modulates long-term potentiation, Nature, 388, 773, 10.1038\u002F42015\nStella, 2003, Endogenous adenosine reduces glutamatergic output from rods through activation of A(2)-like adenosine receptors, J. Neurophysiol., 90, 165, 10.1152\u002Fjn.00671.2002\nStella, 2002, A(2) adenosine receptors inhibit calcium influx through L-type calcium channels in rod photoreceptors of the salamander retina, J. Neurophysiol., 87, 351, 10.1152\u002Fjn.00010.2001\nStraiker, 2006, Cannabinoids, electrophysiology, and retrograde messengers: challenges for the next 5 years, AAPS J., 8, E272, 10.1007\u002FBF02854897\nStraiker, 2003, Cannabinoid receptor activation differentially modulates ion channels in photoreceptors of the tiger salamander, J. Neurophysiol., 89, 2647, 10.1152\u002Fjn.00268.2002\nStraiker, 1999, Localization of cannabinoid CB1 receptors in the human anterior eye and retina, Invest. Ophthalmol. Vis. Sci., 40, 2442\nStruik, 2006, Cannabinoid agonist WIN 55212-2 speeds up the cone light offset response in goldfish, Vis. Neurosci., 23, 285, 10.1017\u002FS0952523806232127\nStumpff, 2005, Stimulation of cannabinoid (CB1) and prostanoid (EP2) receptors opens BKCa channels and relaxes ocular trabecular meshwork, Exp. Eye Res., 80, 697, 10.1016\u002Fj.exer.2004.12.003\nSugiura, 1995, 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain, Biochem. Biophys. Res. Commun., 215, 89, 10.1006\u002Fbbrc.1995.2437\nSulcova, 1998, Biphasic effects of anandamide, Pharmacol. Biochem. Behav., 59, 347, 10.1016\u002FS0091-3057(97)00422-X\nSun, 2004, Biosynthesis of anandamide and N-palmitoylethanolamne by sequential actions of phospolipase A2 and phospholipase D, Biochem. J., 380, 749, 10.1042\u002Fbj20040031\nSawzdargo, 1999, Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain, Brain Res. Mol. Brain Res., 64, 193, 10.1016\u002FS0169-328X(98)00277-0\nSzabo, 1998, Inhibition of gabaergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum, Neuroscience, 85, 395, 10.1016\u002FS0306-4522(97)00597-6\nSzabo, 2006, Depolarization-induced retrograde synaptic inhibition in the cerebellar cortex is mediated by 2-arachidonoylglycerol, J. Physiol., 577, 262, 10.1113\u002Fjphysiol.2006.119362\nSzallasi, 1993, Vanilloid receptors in the urinary bladder: regional distribution, localization on sensory nerves, and species-related differences, Naunyn Schmiedebergs Arch. Pharmacol., 347, 624, 10.1007\u002FBF00166945\nTachibana, 1984, g-Aminobutyric acid acts at axon terminals of turtle photoreceptors: difference in sensitivity among cell types, Proc. Natl. Acad. Sci. U S A, 81, 7961, 10.1073\u002Fpnas.81.24.7961\nTakadera, 2006, Prostaglandin E2 deteriorates N-methyl-d-aspartate receptor-mediated cytotoxicity possible by activating EP2 receptors in cultured cortical neurons, Life Sci., 78, 1878, 10.1016\u002Fj.lfs.2005.08.026\nTakadera, 2002, Prostaglandin E(2) induces caspase-dependent apoptosis in rat cortical cells, Neurosci. Lett., 317, 61, 10.1016\u002FS0304-3940(01)02449-1\nThomas, 1997, Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system, J. Neurosci. Res., 50, 1047, 10.1002\u002F(SICI)1097-4547(19971215)50:6\u003C1047::AID-JNR16>3.0.CO;2-1\nTomida, 2004, Cannabinoids and glaucoma, Br. J. Ophthalmol., 88, 708, 10.1136\u002Fbjo.2003.032250\nToth, 2005, Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain, Brain Res. Mol. Brain Res., 135, 162, 10.1016\u002Fj.molbrainres.2004.12.003\nTsou, 1998, Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system, Neuroscience, 83, 393, 10.1016\u002FS0306-4522(97)00436-3\nTsou, 1998, Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry, Neurosci. Lett., 254, 1, 10.1016\u002FS0304-3940(98)00700-9\nTwitchell, 1997, Cannabinoids inhibit N- and P\u002FQ-type calcium channels in cultured rat hippocampal neurons, J. Neurophysiol., 78, 43, 10.1152\u002Fjn.1997.78.1.43\nValenti, 2005, The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake, J. Neurochem., 95, 662, 10.1111\u002Fj.1471-4159.2005.03406.x\nValenti, 2004, Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain, Cell. Mol. Life Sci., 61, 945, 10.1007\u002Fs00018-003-3453-5\nVan der Stelt, 2004, Endovanilloids, Eur. J. Biochem., 271, 1827, 10.1111\u002Fj.1432-1033.2004.04081.x\nVan der Stelt, 2005, Cannabinoid receptors and their role in neuroprotection, Neuromolecular Med., 7, 37, 10.1385\u002FNMM:7:1-2:037\nVarvel, 2006, Fatty acid amide hydrolase (−\u002F−) mice exhibit an increased sensitivity to the disruptive effects of anandamide or oleamide in a working memory water maze task, J. Pharmacol. Exp. Ther., 317, 251, 10.1124\u002Fjpet.105.095059\nVeldhuis, 2003, Neuroprotection by the endogenous cannabinoid anandamide and arvanil against in vivo excitotoxicity in the rat: role of vanilloid receptors and lipoxygenases, J. Neurosci., 23, 4127, 10.1523\u002FJNEUROSCI.23-10-04127.2003\nVellani, 2000, Modulation of the synaptic Ca2+ current in salamander photoreceptors by polyunsaturated fatty acids and retinoids, J. Physiol. (London), 529, 333, 10.1111\u002Fj.1469-7793.2000.00333.x\nWagner, 1993, Microanatomy of the dopaminergic system in the rainbow trout retina, Vision Res., 33, 1345, 10.1016\u002F0042-6989(93)90042-U\nWarrier, 2007, Endocannabinoid signaling regulates spontaneous transmitter release from embryonic retinal amacrine cells, Vis. Neurosci., 24, 25, 10.1017\u002FS0952523807230160\nWatanabe, 2005, Immunohistochemical localization of vanilloid receptor subtype 1 (TRPV1) in the guinea pig respiratory system, Pulm. Pharmacol. Ther., 18, 187, 10.1016\u002Fj.pupt.2004.12.002\nWeber, 2001, Modulation of dopamine release in the guinea-pig retina by G(i)- but not by G(s)- or G(q)-protein-coupled receptors, Fundam. Clin. Pharmacol., 15, 393, 10.1046\u002Fj.1472-8206.2001.00056.x\nWeil, 1968, Clinical and psychological effects of marihuana in man, Science, 162, 1234, 10.1126\u002Fscience.162.3859.1234\nWest, 1991, Cannabis and night vision, Nature, 351, 703, 10.1038\u002F351703b0\nWestlake, 1994, Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains, Neuroscience, 63, 637, 10.1016\u002F0306-4522(94)90511-8\nWilson, 2001, Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses, Nature, 410, 588, 10.1038\u002F35069076\nWise, 2007, Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors, Eur. J. Pharmacol., 557, 44, 10.1016\u002Fj.ejphar.2006.11.002\nWong, 2004, Retinal bipolar cell input mechanisms in giant danio: II. Patch-clamp analysis of ON bipolar cells, J. Neurophysiol., 93, 94, 10.1152\u002Fjn.00270.2004\n2004, Vision Res., 44, 3233, 10.1016\u002Fj.visres.2004.09.012\nYazulla, 1995, Differential effects of dopamine depletion on the distribution of 3H-SCH23390 and 3H-spiperone binding sites in the goldfish retina, Vision Res., 35, 2509, 10.1016\u002F0042-6989(95)00010-0\nYazulla, 1997, Light adaptation affects synaptic vesicle density but not the distribution of GABAA receptors in goldfish photoreceptor terminals, Microsc. Res. Tech., 36, 43, 10.1002\u002F(SICI)1097-0029(19970101)36:1\u003C43::AID-JEMT4>3.0.CO;2-#\nYazulla, 2004, Vanilloid receptor like 1 (VRL1) immunoreactivity in mammalian retina: colocalization with somatostatin and purinergic P2X1 receptors, J. Comp. Neurol., 474, 407, 10.1002\u002Fcne.20144\nYazulla, 2001, Neurochemical anatomy of the zebrafish retina as determined by immunocytochemistry, J. Neurocytol., 30, 551, 10.1023\u002FA:1016512617484\nYazulla, 1999, Immunocytochemical localization of cannabinoid CB1 receptor and fatty acid amide hydrolase in rat retina, J. Comp. Neurol., 415, 80, 10.1002\u002F(SICI)1096-9861(19991206)415:1\u003C80::AID-CNE6>3.0.CO;2-H\nYazulla, 2000, Cannabinoid receptors on goldfish retinal bipolar cells: electron-microscope immunocytochemistry and whole-cell recordings, Vis. Neurosci., 17, 391, 10.1017\u002FS0952523800173079\nYazulla, 1989, Immunocytochemical localization of GABAA receptors in goldfish and chicken retinas, J. Comp. Neurol., 280, 15, 10.1002\u002Fcne.902800103\nYu, 1997, Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2, J. Biol. Chem., 272, 21181, 10.1074\u002Fjbc.272.34.21181\nZhang, 2008, Endocannabinoid 2-AG protects neurons by limiting COX-2 elevation, J. Biol. Chem., 282, 22601, 10.1074\u002Fjbc.M800524200\nZheng, 2007, Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes, Invest. Ophthalmol. Vis. Sci., 48, 361, 10.1167\u002Fiovs.06-0510\nZhu, 2005, Heterogeneous expression and regulation of PGE2 receptors in the hippocampus, J. Neurosci. Res., 81, 817, 10.1002\u002Fjnr.20597\nZimmer, 1999, Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice, Proc. Natl. Acad. Sci. U S A, 96, 5780, 10.1073\u002Fpnas.96.10.5780\nZimov, 2007, Vanilloid receptor 1 (TRPV1\u002FVR1) co-localizes with fatty acid amide hydrolase (FAAH) in retinal amacrine cells, Vis. Neurosci., 24, 581, 10.1017\u002FS095252380707054X\nZygmunt, 1999, Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide, Nature, 400, 452, 10.1038\u002F22761",{"VOID":1939},"10.1016\u002Fj.preteyeres.2008.07.002","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1350946208000487",[1942],{"id":1943,"sortIndex":92,"researcher":24,"roles":1944,"affiliations":1945,"properties":1957,"displayName":1959,"givenName":24,"familyName":24},"be0f3c72-381f-47c0-bf8c-972e6dc95b9d",[143],[1946],{"id":1947,"sortIndex":92,"affiliation":1948,"properties":1954},"f77cccba-8e41-4f76-bae9-2a347e604aa3",{"id":1947,"createTime":24,"updateTime":24,"relativeEntities":1949,"slug":24,"properties":1950,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1953,"statistic":24},[],{"title":1951},{"VI":1952},"Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, NY 11794-5230, USA",[],{"title":1955},{"VI":1956},"Department of Neurobiology and Behavior, Stony Brook University, Stony Brook, NY 11794-5230, United States",{"title":1958},{"VI":1959},"Stephen Yazulla",{"url":1940,"publisher":1961,"properties":2008},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":1962,"slug":10,"properties":1963,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":1968,"manageAffiliations":1977,"indexDatabases":1988,"url":90,"thumbnailPath":24,"statistic":2003,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":1964,"eissn":1965,"issn":1966,"title":1967},{"VOID":13},{"VOID":15},{"VOID":17},{"EN":19},[1969,1973],{"id":28,"createTime":24,"updateTime":24,"relativeEntities":1970,"label":1971,"description":1972,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":31},{},{"id":34,"createTime":24,"updateTime":24,"relativeEntities":1974,"label":1975,"description":1976,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":37},{},[1978,1983],{"id":41,"createTime":24,"updateTime":24,"relativeEntities":1979,"slug":24,"properties":1980,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1982,"statistic":24},[],{"title":1981},{"EN":45},[],{"id":48,"createTime":24,"updateTime":24,"relativeEntities":1984,"slug":24,"properties":1985,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":1987,"statistic":24},[],{"title":1986},{"EN":52},[],[1989,1996],{"id":56,"indexDatabase":1990,"url":67,"indexYears":68,"academicFieldIds":1995,"indexDatabaseRanking":72},{"id":58,"createTime":24,"updateTime":24,"relativeEntities":1991,"label":1992,"description":1993,"key":64,"publicationTags":1994,"standard":24},[],{"EN":61,"VI":61},{"EN":61,"VI":63},[66],[70,71],{"id":74,"indexDatabase":1997,"url":87,"indexYears":24,"academicFieldIds":2002,"indexDatabaseRanking":24},{"id":76,"createTime":24,"updateTime":24,"relativeEntities":1998,"label":1999,"description":2000,"key":83,"publicationTags":2001,"standard":24},[],{"EN":79,"VI":79},{"EN":81,"VI":82},[85,86],[89],{"impactFactor":92,"impactFactorByYear":2004,"i10Index":92,"i10IndexLast5Year":92,"totalPublication":94,"totalPublicationByYear":2005,"totalCitation":92,"totalCitationByYear":2006,"totalCitationPerPublication":92,"totalCitationPerPublicationByYear":2007,"hindexLast5Year":92,"hindex":92},{},{"1994":96,"1995":97,"1996":98,"1997":99,"1998":100,"1999":101,"2000":102,"2001":103,"2002":104,"2003":102,"2004":100,"2005":103,"2006":105,"2007":106,"2008":98,"2009":106,"2010":97,"2011":105,"2012":104,"2013":107,"2014":105,"2015":108,"2016":108,"2017":109,"2018":110,"2019":111,"2020":112,"2021":113,"2022":114,"2023":111},{},{},{"pages":2009,"volume":2011},{"VOID":2010},"501-526",{"VOID":2012},"27","2008-09-01",2008,[85,72],{"id":2017,"createTime":2018,"updateTime":2019,"relativeEntities":2020,"slug":2021,"properties":2022,"entityType":134,"verifyStatus":135,"verifyTime":2019,"verifyNote":137,"languages":24,"translateLanguages":24,"viewCount":92,"primaryUrl":2029,"fullTextUrl":24,"authors":2030,"publicationType":156,"publisherRelationship":2072,"citationCount":24,"citationInfo":24,"publishDate":2125,"publishYear":2126,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":2127,"openAccess":24,"references":24,"isForceReanalyzing":837},"ca4fe518-f3a7-4b0a-b534-cb0eef1fafa7","2024-01-20T14:37:48.187+00:00","2025-02-26T20:03:01.501+00:00",[],"The-regulation-of-trabecular-meshwork-and-ciliary-muscle-contractility",{"title":2023,"references":2025,"doi":2027},{"EN":2024},"The regulation of trabecular meshwork and ciliary muscle contractility",{"VOID":2026},"Allen, 1994, The biochemical basis of the regulation of smooth muscle contraction, Trends in Pharmacol. Sci. (TIPS), 19, 362\nAndrea, 1992, Protein kinase C of smooth muscle, Hypert., 20, 585, 10.1161\u002F01.HYP.20.5.585\nBàràny, 1962, The mode of action of pilocarpine on outflow resistance in the eye of a primate, Invest. Ophthalmol., 1, 712\nBehar-Cohen, 1996, Decreased intraocular pressure induced by nitric oxide donors is correlated to nitrite production in the rabbit eye, Invest. Ophthalmol. Vis. Sci., 37, 1711\nBerridge, 1993, Inositole trisphophate and calcium signaling, Nature, 361, 315, 10.1038\u002F361315a0\nBolton, 1999, Excitation-contraction coupling in gastrointestinal and other smooth muscles, Annu. Rev. Physiol., 61, 85, 10.1146\u002Fannurev.physiol.61.1.85\nChrzanowska-Wodnicka, 1996, Rho-stimulated contractility drives the formation of stress fibers and focal adhesions, J. Cell. Biol., 133, 1403, 10.1083\u002Fjcb.133.6.1403\nCoroneo, 1991, Electrical and morphological evidence for heterogeneous populations of cultured bovine trabecular meshwork cells, Exp. Eye. Res., 52, 375, 10.1016\u002F0014-4835(91)90032-A\nde Kater, 1992, Localization of smooth muscle and nonmuscle actin isoforms in the human aqueous outflow pathway, Invest. Ophthalmol. Vis. Sci., 33, 424\nDi Salvo, 1993, Tyrosine kinase inhibitors suppress agonist-induced contraction in smooth muscle, Biochem. Biophys. Res. Commun., 190, 968, 10.1006\u002Fbbrc.1993.1144\nEpstein, 1999, Acto-myosin drug effects and aqueous outflow function, Invest. Ophthalmol. Vis. Sci., 40, 74\nErickson-Lamy, 1988, Outflow facility studies in the perfused bovine aqueous outflow pathways, Curr. Eye. Res., 7, 799, 10.3109\u002F02713688809033211\nFlammer, 1999, Vascular dysregulation: a principal risk factor for glaucomatous damage?, J. Glaucoma, 8, 212, 10.1097\u002F00061198-199906000-00012\nFlügel, 1990, Über strukturelle Unterschiede im Aufbau des Ziliarmuskels des Primatenauges, Fortschr. Ophthalmol., 87, 384\nFlügel, 1991, Different cell populations in bovine trabecular meshwork: an ultrastructural and immunocytochemical study, Exp. Eye Res., 52, 681, 10.1016\u002F0014-4835(91)90020-F\nGabelt, 1997, Anterior segment physiology after bumetanide inhibition of Na-K-Cl cotransport, Invest. Ophthalmol. Vis. Sci., 38, 1700\nGil, 1997, Muscarinic receptor subtypes in human iris-ciliary body measured by immunoprecipitation, Invest. Ophthalmol. Vis. Sci., 38, 1434\nGilabert, 1997, Facility changes mediated by cAMP in the bovine anterior segment in vitro, Vision. Res., 37, 9, 10.1016\u002FS0042-6989(96)00106-X\nGong, 1996, Morphology of the aqueous outflow pathway, Microsc. Res. Tech., 33, 336, 10.1002\u002F(SICI)1097-0029(19960301)33:4\u003C336::AID-JEMT4>3.0.CO;2-N\nGrierson, 1996, Glaucoma and nitric oxide, Lancet, 347, 1781, 10.1016\u002FS0140-6736(96)91613-X\nHerbert, 1990, Chelerythrine is a potent and specific inhibitor of protein kinase C, Biochem. Biophys. Res. Commun., 172, 993, 10.1016\u002F0006-291X(90)91544-3\nHollenberg, 1994, The acute actions of growth factors in smooth muscle systems, Science, 54, 223\nIto, 1986, Membrane and contractile properties of the dog ciliary muscle, Br. J. Pharmacol., 88, 629, 10.1111\u002Fj.1476-5381.1986.tb10244.x\nKaczorowski, 1996, High-conductance calcium-activated potassium channels; structure, pharmacology, and function, J. Bioenerg. Biomembr., 28, 255, 10.1007\u002FBF02110699\nKaiser, 1995, Endothelin-1 plasma levels in normal-tension glaucoma: abnormal response to postural changes, Graefes Arch. Clin. Exp. Ophthalmol., 233, 484, 10.1007\u002FBF00183429\nKaufman, 1984, Aqueous humor outflow, Curr. Top. Eye Res., 4, 97\nKohmoto, 1994, Effects of endothelin-1 on [CCa2+]i and pHi in trabecular meshwork cells, Curr. Eye Res., 13, 197, 10.3109\u002F02713689408995777\nKrauss, 1997, Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle, Exp. Eye Res., 64, 447, 10.1006\u002Fexer.1996.0224\nLepple-Wienhues, 1991, Differential smooth muscle-like contractile properties of trabecular meshwork and ciliary muscle, Exp. Eye Res., 53, 33, 10.1016\u002F0014-4835(91)90141-Z\nLepple-Wienhues, 1991, Endothelin-evoked contractions in bovine ciliary muscle and trabecular meshwork: interaction with calcium, nifedipine and nickel, Curr. Eye Res., 10, 983, 10.3109\u002F02713689109020335\nLepple-Wienhues, 1992, Endothelin-like immunoreactivity in the aqueous humour and in conditioned medium from cultured ciliary epithelial cells, Curr. Eye Res., 11, 1041, 10.3109\u002F02713689209015075\nLepple-Wienhues, 1992, Effects of endothelin and calcium channel blockers on membrane voltage and intracellular calcium in cultured bovine trabecular meshwork cells, Germ. J. Ophthalmol., 1, 159\nLepple-Wienhues, 1994, Electrophysiological properties of cultured human trabecular meshwork cells, Exp. Eye Res., 59, 305, 10.1006\u002Fexer.1994.1112\nLevitzki, 1995, Tyrosine kinase inhibition: An approach to drug development, Science, 267, 1782, 10.1126\u002Fscience.7892601\nLiu, 1991, Endogenous hormonal changes and circadian elevation of intraocular pressure, Invest. Ophthalmol. Vis. Sci., 32, 496\nLivneh, 1997, Linking protein kinase C to cell-cycle control, Europ. J. Biochem., 248, 1, 10.1111\u002Fj.1432-1033.1997.t01-4-00001.x\nLlobet, 1999, Bradykinin decreases outflow facility in perfused anterior segments and induces shape changes in passaged BTM cells in vitro, Invest. Ophthalmol. Vis. Sci., 40, 113\nLograno, 1986, Receptor-responses in fresh human ciliary muscle, Br. J. Pharmacol., 87, 379, 10.1111\u002Fj.1476-5381.1986.tb10827.x\nLütjen-Drecoll, 1989, Morphology of aqueous outflow pathways in normal and glaucomatous eyes, 89\nLütjen-Drecoll, 1999, Functional morphology of the trabecular meshwork in primate eyes, Progr. Ret. Eye Res., 18, 91, 10.1016\u002FS1350-9462(98)00011-1\nMergler, 1998, Altered regulation of L-type channels by protein kinase C and protein tyrosine kinases as a pathophysiological effect in retinal degeneration, FASEB J., 12, 1125, 10.1096\u002Ffasebj.12.12.1125\nMuramatsu, 1988, Distinctive actions of epidermal growth factor-urogastrone in isolated smooth muscle preparations from guinea pig stomach: Differential inhibition by indomethacin, J. Pharmacol. Exp. Ther., 245, 625\nNathanson, 1995, Alterations of ocular nitric oxide synthase in human glaucoma, Invest. Ophthalmol. Vis. Sci., 36, 1774\nNelson, 1995, Physiological roles and properties of potassium channels in arterial smooth muscle, Am. J. Physiol., 268, C799, 10.1152\u002Fajpcell.1995.268.4.C799\nNoske, 1997, Endothelin-like immunoreactivity in aqueous humor of patients with primary open glaucoma and cataract patients, Graefes Arch. Clin. Exp. Ophthalmol., 235, 10.1007\u002FBF00947082\nPawlowski, 1992, Mechanisms of intrinsic tone in ferret vascular smooth muscle, J. Pysiol., 448, 121, 10.1113\u002Fjphysiol.1992.sp019032\nPawson, 1995, Protein tyrosine kinases. Getting down to specifics, Nature, 373, 477, 10.1038\u002F373477a0\nPeterson, 1999, Latrunculin-A increases outflow facility in the monkey, Invest. Ophthalmol. Vis. Sci., 40, 931\nQuigley, 1999, Neuronal death in glaucoma, Prog. Retin. Eye Res., 18, 39, 10.1016\u002FS1350-9462(98)00014-7\nRich, 1999, Effects of melatonin on ionic currents in cultured ocular tissues, Am. J. Physiol., 276, C923, 10.1152\u002Fajpcell.1999.276.4.C923\nRingvold, 1978, Actin filaments in trabecular endothelial cells in eyes of the vervet monkey, Acta Ophthalmol., 56, 217, 10.1111\u002Fj.1755-3768.1978.tb01347.x\nRohen, 1964, Das Auge und seine Hilfsorgane, 189, 10.1007\u002F978-3-642-48157-4_5\nRohen, 1982, Biology of the trabecular meshwork, 141\nRuzycky, 1989, Involvement of the protein kinase C system in calcium-force relationships in ferret aorta, Brit. J. Ophthalmol., 97, 391\nShade, 1996, Effects of muscarinic agents on cultured human trabecular meshwork cells, Exp. Eye Res., 62, 201, 10.1006\u002Fexer.1996.0025\nSomlyo, 1994, Signal transduction and regulation of smooth muscle, Nature, 372, 231, 10.1038\u002F372231a0\nStahl, 1991, Measurements of intracellular calcium and contractility in human ciliary muscle, Pflügers Arch., 418, 531, 10.1007\u002FBF00370567\nStanden, 1998, K+ channel modulation in arterial smooth muscle, Acta. Physiol. Scand., 164, 549, 10.1046\u002Fj.1365-201X.1998.00433.x\nSteinhausen, 1999, Trabecular meshwork cells express L-type calcium channels, Pflügers Arch., 437, R79\nStrauss, 1997, Regulation of L-type calcium channels by protein tyrosine kinase and protein kinase C in cultured rat and human retinal pigment epithelial cells, FASEB J., 11, 859, 10.1096\u002Ffasebj.11.11.9285484\nStumpff, 1997, Characterization of maxi-K-channels in bovine trabecular meshwork and their activation by cyclic guanosine monophosphate, Invest. Ophthalmol. Vis. Sci., 38, 1883\nStumpff, 1999, Stimulation of maxi-K channels in trabecular meshwork by tyrosine kinase inhibitors, Invest. Ophthalmol. Vis. Sci., 40, 1404\nStumpff, 1999, Flufenamic acid stimulates maxi-K channels in trabecular meshwork cells, Pflügers Arch., 437, R79\nTamm, 1992, Contractile cells in the human scleral spur, Exp. Eye Res., 54, 531, 10.1016\u002F0014-4835(92)90132-C\nTamm, 1995, Innervation of myofibroblast-like scleral spur cells in human monkey eyes, Invest. Ophthalmol. Vis. Sci., 36, 1633\nThieme, 1999, The effects of protein kinase C (PKC) on trabecular meshwork and ciliary muscle contractility, Invest. Ophthalmol. Vis. Sci., 40\nThieme, 1999, The effects of the carbonic anhydrase inhibitors methazolamide, diclofenamide and dorzolamide on trabecular meshwork and ciliary muscle contractility, Exp. Eye Res., 68\nTian, 1999, H-7 increases trabecular facility and facility after ciliary muscle disinsertion in monkeys, Invest. Ophthalmol. Vis. Sci., 40, 239\nTian, 1998, Effects of H-7 on the iris and ciliary muscle in monkeys, Arch. Ophthalmol., 116, 1070, 10.1001\u002Farchopht.116.8.1070\nTripathi, 1974, Comparative physiology and anatomy of the aqueous outflow pathway, 5, 163\nTripathi, 1980, Contractile protein alteration in trabecular endothelium in primary open-angle glaucoma, Exp. Eye Res., 31, 721, 10.1016\u002FS0014-4835(80)80056-X\nWagner, 1996, Membrane voltage and whole-cell currents in cultured pericytes of control rats and rats with retinal dystrophy, Curr. Eye Res., 15, 1045, 10.3109\u002F02713689609017654\nWang, 1998, Rho A regulates sustained smooth muscle contraction through cytoskeletal reorganization of HSP27, Am. J. Physiol., 275, G1414\nWelge-Lüssen, 1998, Classification of human scleral spur cells in monolayer culture, Eur. J. Cell Biol., 75, 78, 10.1016\u002FS0171-9335(98)80050-2\nWiederholt, 1994, Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide, Invest. Ophthalmol. Vis. Sci., 35, 2515\nWiederholt, 1995, Regulation of outflow rate and resistance in the perfused anterior segment of the bovine eye, Exp. Eye Res., 61, 223, 10.1016\u002FS0014-4835(05)80042-9\nWiederholt, 1996, Contractile response of the isolated trabecular meshwork and ciliary muscle to cholinergic and adrenergic agents, Ger. J. Ophthalmol., 5, 146\nWiederholt, 1997, Effect of diuretics, channel modulators and signal interceptors on contractility of the trabecular meshwork, Ophthalmologica, 211, 153, 10.1159\u002F000310783\nWiederholt, 1998, Direct involvement of trabecular meshwork in regulation of aqueous humor outflow, Curr. Opin. Ophthalmol., 9, 46, 10.1097\u002F00055735-199804000-00009\nWiederholt, 1998, The trabecular meshwork and aqueous humor reabsorption, 45, 163\nWiederholt, 1998, Role of protein tyrosine kinase on regulation of trabecular meshwork and ciliary muscle contractility, Invest. Ophthalmol. Vis. Sci., 39, 1012\nWoldemussie, 1993, Characterization of muscarinic receptors in cultured human iris sphincter and ciliary smooth muscle cells, Exp. Eye Res., 56, 385, 10.1006\u002Fexer.1993.1052\nYamaguchi, 1990, Contraction of porcine ocular ciliary muscle by epidermal growth factor-urogastrone, Europ. J. Pharmacol., 191, 245, 10.1016\u002F0014-2999(90)94156-R",{"VOID":2028},"10.1016\u002Fs1350-9462(99)00015-4","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1350946299000154",[2031,2046,2059],{"id":2032,"sortIndex":92,"researcher":24,"roles":2033,"affiliations":2034,"properties":2043,"displayName":2045,"givenName":24,"familyName":24},"b66a34cd-13be-4b34-8bb2-56244db63271",[143],[2035],{"id":2036,"sortIndex":92,"affiliation":2037,"properties":24},"49c7ce36-4dac-4018-bba0-7d9fb1db0506",{"id":2036,"createTime":24,"updateTime":24,"relativeEntities":2038,"slug":24,"properties":2039,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2042,"statistic":24},[],{"title":2040},{"VI":2041},"Institut für Klinische Physiologie, Universitätsklinikum Benjamin Franklin, Freie Universität Berlin, 12200 Berlin, Germany",[],{"title":2044},{"VI":2045},"Michael Wiederholt",{"id":2047,"sortIndex":870,"researcher":24,"roles":2048,"affiliations":2049,"properties":2056,"displayName":2058,"givenName":24,"familyName":24},"03131377-a965-42de-a106-f99105ed802f",[143],[2050],{"id":2036,"sortIndex":92,"affiliation":2051,"properties":24},{"id":2036,"createTime":24,"updateTime":24,"relativeEntities":2052,"slug":24,"properties":2053,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2055,"statistic":24},[],{"title":2054},{"VI":2041},[],{"title":2057},{"VI":2058},"Hagen Thieme",{"id":2060,"sortIndex":900,"researcher":24,"roles":2061,"affiliations":2062,"properties":2069,"displayName":2071,"givenName":24,"familyName":24},"cefa3c9b-6a28-49c8-8666-6113c2a249d6",[143],[2063],{"id":2036,"sortIndex":92,"affiliation":2064,"properties":24},{"id":2036,"createTime":24,"updateTime":24,"relativeEntities":2065,"slug":24,"properties":2066,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2068,"statistic":24},[],{"title":2067},{"VI":2041},[],{"title":2070},{"VI":2071},"Friederike Stumpff",{"url":2029,"publisher":2073,"properties":2120},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2074,"slug":10,"properties":2075,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":2080,"manageAffiliations":2089,"indexDatabases":2100,"url":90,"thumbnailPath":24,"statistic":2115,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":2076,"eissn":2077,"issn":2078,"title":2079},{"VOID":13},{"VOID":15},{"VOID":17},{"EN":19},[2081,2085],{"id":28,"createTime":24,"updateTime":24,"relativeEntities":2082,"label":2083,"description":2084,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":31},{},{"id":34,"createTime":24,"updateTime":24,"relativeEntities":2086,"label":2087,"description":2088,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":37},{},[2090,2095],{"id":41,"createTime":24,"updateTime":24,"relativeEntities":2091,"slug":24,"properties":2092,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2094,"statistic":24},[],{"title":2093},{"EN":45},[],{"id":48,"createTime":24,"updateTime":24,"relativeEntities":2096,"slug":24,"properties":2097,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2099,"statistic":24},[],{"title":2098},{"EN":52},[],[2101,2108],{"id":56,"indexDatabase":2102,"url":67,"indexYears":68,"academicFieldIds":2107,"indexDatabaseRanking":72},{"id":58,"createTime":24,"updateTime":24,"relativeEntities":2103,"label":2104,"description":2105,"key":64,"publicationTags":2106,"standard":24},[],{"EN":61,"VI":61},{"EN":61,"VI":63},[66],[70,71],{"id":74,"indexDatabase":2109,"url":87,"indexYears":24,"academicFieldIds":2114,"indexDatabaseRanking":24},{"id":76,"createTime":24,"updateTime":24,"relativeEntities":2110,"label":2111,"description":2112,"key":83,"publicationTags":2113,"standard":24},[],{"EN":79,"VI":79},{"EN":81,"VI":82},[85,86],[89],{"impactFactor":92,"impactFactorByYear":2116,"i10Index":92,"i10IndexLast5Year":92,"totalPublication":94,"totalPublicationByYear":2117,"totalCitation":92,"totalCitationByYear":2118,"totalCitationPerPublication":92,"totalCitationPerPublicationByYear":2119,"hindexLast5Year":92,"hindex":92},{},{"1994":96,"1995":97,"1996":98,"1997":99,"1998":100,"1999":101,"2000":102,"2001":103,"2002":104,"2003":102,"2004":100,"2005":103,"2006":105,"2007":106,"2008":98,"2009":106,"2010":97,"2011":105,"2012":104,"2013":107,"2014":105,"2015":108,"2016":108,"2017":109,"2018":110,"2019":111,"2020":112,"2021":113,"2022":114,"2023":111},{},{},{"pages":2121,"volume":2123},{"VOID":2122},"271-295",{"VOID":2124},"19","2000-05-01",2000,[85,72],{"id":2129,"createTime":2130,"updateTime":2131,"relativeEntities":2132,"slug":2133,"properties":2134,"entityType":134,"verifyStatus":23,"verifyTime":2131,"verifyNote":2139,"languages":24,"translateLanguages":24,"viewCount":92,"primaryUrl":2140,"fullTextUrl":24,"authors":2141,"publicationType":156,"publisherRelationship":2142,"citationCount":24,"citationInfo":24,"publishDate":2197,"publishYear":2198,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":2199,"openAccess":24,"references":24,"isForceReanalyzing":837},"9fb21acf-0fba-4124-b51b-4498ba35510d","2024-01-10T23:05:42.194+00:00","2025-02-26T17:39:54.856+00:00",[],"Critical-pathogenic-events-underlying-progression-of-neurodegeneration-in-glaucoma",{"title":2135,"doi":2137},{"EN":2136},"Critical pathogenic events underlying progression of neurodegeneration in glaucoma",{"VOID":2138},"10.1016\u002Fj.preteyeres.2012.07.001","Author title is blank","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1350946212000535",[],{"url":2140,"publisher":2143,"properties":2190},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2144,"slug":10,"properties":2145,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":2150,"manageAffiliations":2159,"indexDatabases":2170,"url":90,"thumbnailPath":24,"statistic":2185,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":2146,"eissn":2147,"issn":2148,"title":2149},{"VOID":13},{"VOID":15},{"VOID":17},{"EN":19},[2151,2155],{"id":28,"createTime":24,"updateTime":24,"relativeEntities":2152,"label":2153,"description":2154,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":31},{},{"id":34,"createTime":24,"updateTime":24,"relativeEntities":2156,"label":2157,"description":2158,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":37},{},[2160,2165],{"id":41,"createTime":24,"updateTime":24,"relativeEntities":2161,"slug":24,"properties":2162,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2164,"statistic":24},[],{"title":2163},{"EN":45},[],{"id":48,"createTime":24,"updateTime":24,"relativeEntities":2166,"slug":24,"properties":2167,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2169,"statistic":24},[],{"title":2168},{"EN":52},[],[2171,2178],{"id":56,"indexDatabase":2172,"url":67,"indexYears":68,"academicFieldIds":2177,"indexDatabaseRanking":72},{"id":58,"createTime":24,"updateTime":24,"relativeEntities":2173,"label":2174,"description":2175,"key":64,"publicationTags":2176,"standard":24},[],{"EN":61,"VI":61},{"EN":61,"VI":63},[66],[70,71],{"id":74,"indexDatabase":2179,"url":87,"indexYears":24,"academicFieldIds":2184,"indexDatabaseRanking":24},{"id":76,"createTime":24,"updateTime":24,"relativeEntities":2180,"label":2181,"description":2182,"key":83,"publicationTags":2183,"standard":24},[],{"EN":79,"VI":79},{"EN":81,"VI":82},[85,86],[89],{"impactFactor":92,"impactFactorByYear":2186,"i10Index":92,"i10IndexLast5Year":92,"totalPublication":94,"totalPublicationByYear":2187,"totalCitation":92,"totalCitationByYear":2188,"totalCitationPerPublication":92,"totalCitationPerPublicationByYear":2189,"hindexLast5Year":92,"hindex":92},{},{"1994":96,"1995":97,"1996":98,"1997":99,"1998":100,"1999":101,"2000":102,"2001":103,"2002":104,"2003":102,"2004":100,"2005":103,"2006":105,"2007":106,"2008":98,"2009":106,"2010":97,"2011":105,"2012":104,"2013":107,"2014":105,"2015":108,"2016":108,"2017":109,"2018":110,"2019":111,"2020":112,"2021":113,"2022":114,"2023":111},{},{},{"issue":2191,"pages":2193,"volume":2195},{"VOID":2192},"6",{"VOID":2194},"702-719",{"VOID":2196},"31","2012-11-01",2012,[85,72],{"id":2201,"createTime":2202,"updateTime":2203,"relativeEntities":2204,"slug":2205,"properties":2206,"entityType":134,"verifyStatus":135,"verifyTime":2203,"verifyNote":137,"languages":24,"translateLanguages":24,"viewCount":92,"primaryUrl":2213,"fullTextUrl":24,"authors":2214,"publicationType":156,"publisherRelationship":2356,"citationCount":24,"citationInfo":24,"publishDate":2409,"publishYear":211,"citationAnalyzeStatus":23,"lastCitationAnalyze":24,"indexDatabases":2410,"openAccess":24,"references":24,"isForceReanalyzing":837},"0ff7c834-8060-4327-b4bf-52857faa3d70","2024-02-07T00:52:53.002+00:00","2025-02-26T04:26:57.220+00:00",[],"Functional-and-morphological-characteristics-of-the-retinal-and-choroidal-vasculature",{"title":2207,"references":2209,"doi":2211},{"EN":2208},"Functional and morphological characteristics of the retinal and choroidal vasculature",{"VOID":2210},"Afzal, 2007, Retinal and choroidal microangiopathies: therapeutic opportunities, Microvasc. Res., 74, 131, 10.1016\u002Fj.mvr.2007.04.011\nAird, 1997\nAird, 2003, Endothelial cell heterogeneity, Crit. Care Med., 31, S221, 10.1097\u002F01.CCM.0000057847.32590.C1\nAird, 2005, Spatial and temporal dynamics of the endothelium, J. Thromb. Haemost., 3, 1392, 10.1111\u002Fj.1538-7836.2005.01328.x\nAird, 2007\nAird, 2007, Phenotypic heterogeneity of the endothelium: II. Representative vascular beds, Circ. Res., 100, 174, 10.1161\u002F01.RES.0000255690.03436.ae\nAird, 2012, Endothelial cell heterogeneity, Cold Spring Harb. Perspect. Med., 2, 1, 10.1101\u002Fcshperspect.a006429\nAk, 2001, The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus, J. Diabetes. Complicat., 15, 150, 10.1016\u002FS1056-8727(01)00137-4\nAl-Mehdi, 2012, Perinuclear mitochondrial clustering creates an oxidant-rich nuclear domain required for hypoxia-induced transcription, Sci. Signal, 5, ra47, 10.1126\u002Fscisignal.2002712\nAlder, 1993, Oxygen reactivity of the feline isolated ophthalmociliary artery, Investig. Ophthalmol. Vis. Sci., 34, 1\nAlder, 1996, Asymmetrical response of the intraluminal and extraluminal surfaces of the porcine retinal artery to exogenous adenosine, Exp. Eye Res., 63, 557, 10.1006\u002Fexer.1996.0146\nAlfaro, 2006\nAlm, 1987, Ocular circulation, 183\nAlm, 1992, Ocular circulation, 199\nAmes, 1992, Energy metabolism of rabbit retina as related to function: high cost of Na+ transport, J. Neurosci., 12, 840, 10.1523\u002FJNEUROSCI.12-03-00840.1992\nAnderson, 1965, The effects of hyperbaric oxygenation on retinal arterial occlusion, Arch. Ophthalmol., 73, 315, 10.1001\u002Farchopht.1965.00970030317004\nAnderson, 1969, Ultrastructure of human and monkey lamina cribrosa and optic nerve head, Arch. Ophthalmol., 82, 800, 10.1001\u002Farchopht.1969.00990020792015\nAndo, 2009, Vascular mechanobiology: endothelial cell responses to fluid shear stress, Circ. J., 73, 1983, 10.1253\u002Fcircj.CJ-09-0583\nAndo, 2011, Effects of shear stress and stretch on endothelial function, Antioxid. Redox Signal, 15, 1389, 10.1089\u002Fars.2010.3361\nAndries, 1993, Endocardial endothelium in the rat: cell shape and organization of the cytoskeleton, Cell. Tissue Res., 273, 107, 10.1007\u002FBF00304617\nArora, 2012, The choroid is thicker in angle closure than in open angle and control eyes, Investig. Ophthalmol. Vis. Sci., 53, 7813, 10.1167\u002Fiovs.12-10483\nArslan, 2010, Steady and disturbed flow effects on human umbilical vein endothelial cells (HUVECs) in vascular system: an experimental study, Acta Bioeng. Biomech., 12, 3\nAviv, 2001, Age dependent aneuploidy and telomere length of the human vascular endothelium, Atherosclerosis, 159, 281, 10.1016\u002FS0021-9150(01)00506-8\nBalaratnasingam, 2009, Histomorphometric measurements in human and dog optic nerve and an estimation of optic nerve pressure gradients in human, Exp. Eye Res., 89, 618, 10.1016\u002Fj.exer.2009.06.002\nBaron, 1994, Hemodynamic actions of insulin, Am. J. Physiol., 30, E187\nBarth, 1992, Ultrastructural quantitation of mitochondria and myofilaments in cardiac muscle from 10 different animal species including man, J. Mol. Cell Cardiol., 24, 669, 10.1016\u002F0022-2828(92)93381-S\nBertram, 2008, Flow-induced oscillation of collapsed tubes and airway structures, Respir. Physiol. Neurobiol., 163, 256, 10.1016\u002Fj.resp.2008.04.011\nBertram, 2009, Fluid flow in distensible vessels, Clin. Exp. Pharmacol. Physiol., 36, 206, 10.1111\u002Fj.1440-1681.2008.05047.x\nBharadwaj, 2013, Role of the retinal vascular endothelial cell in ocular disease, Prog. Retin Eye Res., 32, 102, 10.1016\u002Fj.preteyeres.2012.08.004\nBhuyan, 1991, Desferal-Mn(III) in the therapy of diquat-induced cataract in rabbit, Arch. Biochem. Biophys., 288, 525, 10.1016\u002F0003-9861(91)90230-G\nBond, 2011, Morphological evidence for a change in the pattern of aortic wall shear stress with age, Arterioscler. Thromb. Vasc. Biol., 31, 543, 10.1161\u002FATVBAHA.110.219683\nBrandes, 2005, Endothelial aging, Cardiovasc. Res., 66, 286, 10.1016\u002Fj.cardiores.2004.12.027\nBrockhurst, 1980, Vortex vein decompression for nanophthalmic uveal effusion, Arch. Ophthalmol., 98, 1987, 10.1001\u002Farchopht.1980.01020040839008\nBrummel-Ziedins, 2005, Thrombin generation profiles in deep venous thrombosis, J. Thromb. Haemost., 3, 2497, 10.1111\u002Fj.1538-7836.2005.01584.x\nBrylla, 2003, Differences between retinal and choroidal microvascular endothelial cells (MVECs) under normal and hypoxic conditions, Exp. Eye Res., 77, 527, 10.1016\u002FS0014-4835(03)00219-7\nBurnstock, 2008, Dual control of vascular tone and remodelling by ATP released from nerves and endothelial cells, Pharmacol. Rep., 60, 12\nBurnstock, 2009, Purinergic regulation of vascular tone and remodelling, Auton. Autacoid Pharmacol., 29, 63, 10.1111\u002Fj.1474-8673.2009.00435.x\nBurrig, 1991, The endothelium of advanced arteriosclerotic plaques in humans, Arterioscler. Thromb., 11, 1678, 10.1161\u002F01.ATV.11.6.1678\nCalifano, 2010, Exogenous and endogenous force regulation of endothelial cell behavior, J. Biomech., 43, 79, 10.1016\u002Fj.jbiomech.2009.09.012\nCarmeliet, 2003, Blood vessels and nerves: common signals, pathways and diseases, Nat. Rev.\u002FGenet., 4, 710, 10.1038\u002Fnrg1158\nCartwright, 2009, Fluid dynamics in developmental biology: moving fluids that shape ontogeny, HFSP J., 3, 77, 10.2976\u002F1.3043738\nCavallaro, 2000, Phenotypic alterations in senescent large-vessel and microvascular endothelial cells, Mol. Cell Biol. Res. Commun., 4, 117, 10.1006\u002Fmcbr.2000.0263\nChakrabarti, 2000, Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy, Diabetes Metab. Res. Rev., 16, 393, 10.1002\u002F1520-7560(0000)9999:9999\u003C::AID-DMRR157>3.0.CO;2-G\nChan, 2012, Quantitative morphometry of perifoveal capillary networks in the human retina, Investig. Ophthalmol. Vis. Sci., 53, 5502, 10.1167\u002Fiovs.12-10265\nChan, 2013, Quantitative changes in perifoveal capillary networks in patients with vascular comorbidities, Investig. Ophthalmol. Vis. Sci., 54, 5175, 10.1167\u002Fiovs.13-11945\nChang, 2005, Comparison of early passage, senescent and hTERT immortalized endothelial cells, Exp. Cell Res., 309, 121, 10.1016\u002Fj.yexcr.2005.05.002\nCharnock-Jones, 1994, Vascular endothelial growth factor receptor localization and activation in human trophoblast and choriocarcinoma cells, Biol. Reprod., 51, 524, 10.1095\u002Fbiolreprod51.3.524\nCheung, 2008, Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis, Investig. Ophthalmol. Vis. Sci., 49, 4297, 10.1167\u002Fiovs.08-1826\nChi, 2003, Endothelial cell diversity revealed by global expression profiling, Proc. Natl. Acad. Sci. U. S. A., 100, 10623, 10.1073\u002Fpnas.1434429100\nChiu, 1998, Effects of disturbed flow on endothelial cells, J. Biomed. Eng., 120, 2, 10.1115\u002F1.2834303\nChiu, 2009, Vascular endothelial responses to altered shear stress: pathologic implications for atherosclerosis, Ann. Med., 41, 19, 10.1080\u002F07853890802186921\nChiu, 2011, Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives, Physiol. Rev., 91, 327, 10.1152\u002Fphysrev.00047.2009\nChristoffersen, 1999, Pathophysiology and hemodynamics of branch retinal vein occlusion, Ophthalmology, 106, 2054, 10.1016\u002FS0161-6420(99)90483-9\nCines, 1998, Endothelial cells in physiology and in the pathophysiology of vascular disorders, Blood, 91, 3527\nConnolly, 1989, Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis, J. Clin. Investig., 84, 1470, 10.1172\u002FJCI114322\nConrad, 1969, Pressure–flow relationships in collapsible tubes, IEEE Trans. Biomed. Eng., 16, 284, 10.1109\u002FTBME.1969.4502660\nCoyle, 1993, Oxidative stress, glutamate, and neurodegenerative disorders, Science, 262, 689, 10.1126\u002Fscience.7901908\nDahl, 2010, Mechanobiology and the microcirculation: cellular, nuclear and fluid mechanics, Microcirculation, 17, 179, 10.1111\u002Fj.1549-8719.2009.00016.x\nDallinger, 1998, Age dependence of choroidal blood flow, J. Am. Geriatr. Soc., 46, 484, 10.1111\u002Fj.1532-5415.1998.tb02471.x\nDallinger, 2000, Endothelin-1 contributes to hyperoxia-induced vasoconstriction in the human retina, Investig. Ophthalmol. Vis. Sci., 41, 864\nDavies, 1993, Endothelium as a signal transduction interface for flow forces: cell surface dynamics, Thromb. Haemost., 70, 124, 10.1055\u002Fs-0038-1646172\nDavies, 1995, Flow-mediated endothelial mechanotransduction, Physiol. Rev., 75, 519, 10.1152\u002Fphysrev.1995.75.3.519\nDavies, 1997, Overview: temporal and spatial relationships in shear stress-mediated endothelial signalling, J. Vasc. Res., 34, 208, 10.1159\u002F000159224\nDavies, 2009, Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology, Nat. Clin. Pract. Cardiovasc. Med., 6, 16, 10.1038\u002Fncpcardio1397\nDeguchi, 2005, Flow-induced hardening of endothelial nucleus as an intracellular stress-bearing organelle, J. Biomech., 38, 1751, 10.1016\u002Fj.jbiomech.2005.06.003\nDewey, 1981, The dynamic response of vascular endothelial cells to fluid shear stress, J. Biomech. Eng., 103, 177, 10.1115\u002F1.3138276\nDi, 2010, Cardiovascular risk factors and outcome in patients with retinal vein occlusion, J. Thromb. Thrombolysis, 30, 16, 10.1007\u002Fs11239-009-0388-1\nDuling, 1997\nDurand, 2013, Diversity in mechanisms of endothelium-dependent vasodilation in health and disease, Microcirculation, 20, 239, 10.1111\u002Fmicc.12040\nEhrlich, 2008, Age-related macular degeneration and the aging eye, Clin. Interv. Aging, 3, 473, 10.2147\u002FCIA.S2777\nEhrlich, 2009, Age-related ocular vascular changes, Graefes Arch. Clin. Exp. Ophthalmol., 247, 583, 10.1007\u002Fs00417-008-1018-x\nEhrlich, 2010, Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process, Acta Ophthalmol., 88, 279, 10.1111\u002Fj.1755-3768.2008.01501.x\nEl Remessy, 2003, Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor, Am. J. Pathol., 162, 1995, 10.1016\u002FS0002-9440(10)64332-5\nErdogmus, 2008, Anatomic characteristics of the ophthalmic and posterior ciliary arteries, J. Neuro Ophthalmol., 28, 320, 10.1097\u002FWNO.0b013e318183c4bb\nErnest, 1968, Pathophysiology of the distal portion of the optic nerve I. Tissue pressure relationships, Am. J. Ophthalmol., 66, 373, 10.1016\u002F0002-9394(68)91520-1\nErusalimsky, 2006, Endothelial cell senescence, Handb. Exp. Pharmacol., 213, 10.1007\u002F3-540-36028-X_7\nFarkas, 2001, Cerebral microvascular pathology in aging and Alzheimer's disease, Prog. Neurobiol., 64, 75, 10.1016\u002FS0301-0082(00)00068-X\nFeist, 1992, Branch retinal vein occlusion and quadratic variation in arteriovenous crossings, Am. J. Ophthalmol., 113, 664, 10.1016\u002FS0002-9394(14)74791-9\nFeletou, 2006, Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture), Am. J. Physiol. Heart Circ. Physiol., 291, H985, 10.1152\u002Fajpheart.00292.2006\nFerrara, 1989, Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells, Biochem. Biophys. Res. Commun., 161, 851, 10.1016\u002F0006-291X(89)92678-8\nFlaherty, 1972, Endothelial nuclear patterns in the canine arterial tree with particular reference to hemodynamic events, Circ. Res., 30, 23, 10.1161\u002F01.RES.30.1.23\nFrangieh, 1982, Histopathologic study of nine branch retinal vein occlusions, Arch. Ophthalmol., 100, 1132, 10.1001\u002Farchopht.1982.01030040110020\nFunk, 1997, Blood supply of the retina, Ophthalmic Res., 29, 320, 10.1159\u002F000268030\nGalley, 2004, Physiology of the endothelium, Br. J. Anaesth., 93, 105, 10.1093\u002Fbja\u002Faeh163\nGeier, 1995, Ocular microangiopathy syndrome in patients with AIDS is associated with increased plasma levels of the vasoconstrictor endothelin-1, Klin. Monatsblatter Fur Augenheilkd., 207, 353, 10.1055\u002Fs-2008-1035389\nGidday, 1993, Adenosine-mediated autoregulation of retinal arteriolar tone in the piglet, Investig. Ophthalmol. Vis. Sci., 34, 2713\nGidday, 1993, Microcirculatory responses to adenosine in the newborn pig retina, Pediatr. Res., 33, 620, 10.1203\u002F00006450-199306000-00018\nGorman, 1986, Endothelial cell uptake of adenosine in canine skeletal muscle, Am. J. Physiol., 250, H482\nGrammas, 2003, Retinal endothelial cells are more susceptible to oxidative stress and increased permeability than brain-derived endothelial cells, Microvasc. Res., 65, 18, 10.1016\u002FS0026-2862(02)00016-X\nGranstam, 1992, Ocular effects of endothelin-1 in cats, Curr. Eye Res., 11, 325, 10.3109\u002F02713689209001786\nGranstam, 1993, Vascular effects of Endothelin-1 in the cat; modification by indomethacin and L-NAME, Acta Physiol. Scand., 148, 165, 10.1111\u002Fj.1748-1716.1993.tb09546.x\nGreen, 1981, Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases, Trans. Am. Ophthalmol. Soc., 79, 371\nGrisanti, 2008, The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration, Prog. Retin Eye Res., 27, 372, 10.1016\u002Fj.preteyeres.2008.05.002\nGrunwald, 1993, Effect of aging on retinal macular microcirculation: a blue field simulation study, Investig. Ophthalmol. Vis. Sci., 34, 3609\nGuyton, 2006\nHaefliger, 2001, Endothelium-dependent vasoactive modulation in the ophthalmic circulation, Prog. Retin Eye Res., 20, 209, 10.1016\u002FS1350-9462(00)00020-3\nHamid, 2008, Branch retinal vein occlusion, J. Ayub Med. Coll. Abbottabad, 20, 128\nHarris, 1999, Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration, Prog. Retin Eye Res., 18, 669, 10.1016\u002FS1350-9462(98)00037-8\nHayflick, 1961, The serial cultivation of human diploid cell strains, Exp. Cell Res., 25, 585, 10.1016\u002F0014-4827(61)90192-6\nHayreh, 1975, Segmental nature of the choroidal vasculature, Br. J. Ophthalmol., 59, 631, 10.1136\u002Fbjo.59.11.631\nHayreh, 1983, Acute occlusive disorders of the choroidal vasculature, Int. Ophthalmol., 6, 139, 10.1007\u002FBF00127642\nHayreh, 1994, Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics, Am. J. Ophthalmol., 117, 429, 10.1016\u002FS0002-9394(14)70001-7\nHayreh, 2005, Prevalent misconceptions about acute retinal vascular occlusive disorders, Prog. Retin Eye Res., 24, 493, 10.1016\u002Fj.preteyeres.2004.12.001\nHellewell, 1983, Metabolism of circulating adenosine by the porcine isolated perfused lung, Circ. Res., 53, 1, 10.1161\u002F01.RES.53.1.1\nHinnen, 2007, Vascular disrupting agents in clinical development, Br. J. Cancer, 96, 1159, 10.1038\u002Fsj.bjc.6603694\nHirase, 2012, Endothelial dysfunction as a cellular mechanism for vascular failure, Am. J. Physiol. Heart Circ. Physiol., 302, H499, 10.1152\u002Fajpheart.00325.2011\nHirata, 2006, The choroidal circulation assessed by laser-targeted angiography, Prog. Retin Eye Res., 25, 129, 10.1016\u002Fj.preteyeres.2005.08.001\nHogan, 1971\nHossmann, 1994, Viability thresholds and the penumbra of focal ischemia, Ann. Neurol., 36, 557, 10.1002\u002Fana.410360404\nHoste, 1990, Effects of beta-antagonists on contraction of bovine retinal microarteries in vitro, Investig. Ophthalmol. Vis. Sci., 31, 1231\nHu, 2011, Imaging features of varix of the vortex vein ampulla: a small case series, Clin. Exp. Ophthalmol., 2, 1\nHuang, 2012, Modulation of smooth muscle cell phenotype: the other side of the story, Circ. Res., 111, 659, 10.1161\u002FCIRCRESAHA.112.277368\nHuttner, 1983, Vascular endothelium in hypertension, 473\nIannaccone, 1998, Plasma endothelin-1 concentrations in patients with retinal vein occlusions, Br. J. Ophthalmol., 82, 498, 10.1136\u002Fbjo.82.5.498\nInoguchi, 2007, The effect of gradually graded shear stress on the morphological integrity of a huvec-seeded compliant small-diameter vascular graft, Biomaterials, 28, 486, 10.1016\u002Fj.biomaterials.2006.09.020\nJain, 2012, Therapeutic stratagems for vascular degenerative disorders of the posterior eye, Drug Discov. Today, 17, 748, 10.1016\u002Fj.drudis.2012.03.006\nJefferies, 1993, An anatomical study of retinal arteriovenous crossings and their role in the pathogenesis of retinal branch vein occlusions, Aust. N. Z. J. Ophthalmol., 21, 213, 10.1111\u002Fj.1442-9071.1993.tb00959.x\nJohnson, 1982, Senescence of aortic endothelial cells in vitro: influence of culture conditions and preliminary characterization of the senescent phenotype, Mech. Ageing Dev., 18, 1, 10.1016\u002F0047-6374(82)90025-2\nKaiser, 1995, Endothelin-1 plasma levels in normal-tension glaucoma: abnormal response to postural changes, Graefes Arch. Clin. Exp. Ophthalmol., 233, 484, 10.1007\u002FBF00183429\nKang, 2011, Morphometric characteristics of central retinal artery and vein endothelium in the normal human optic nerve head, Investig. Ophthalmol. Vis. Sci., 52, 1359, 10.1167\u002Fiovs.10-6366\nKang, 2013, Alterations to vascular endothelium in the optic nerve head in patients with vascular comorbidities, Exp. Eye Res., 111, 50, 10.1016\u002Fj.exer.2013.03.005\n2003\nKaul, 1992, Asymmetry of vascular responses of perfused rabbit carotid artery to intraluminal and abluminal vasoactive stimuli, J. Physiol., 458, 223, 10.1113\u002Fjphysiol.1992.sp019414\nKawamura, 2008, Rod and cone photoreceptors: molecular basis of the difference in their physiology, Comp. Biochem. Physiol. A Mol. Integr. Physiol., 150, 369, 10.1016\u002Fj.cbpa.2008.04.600\nKeunen, 2011, Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma, Proc. Natl. Acad. Sci. U. S. A., 108, 3749, 10.1073\u002Fpnas.1014480108\nKiel, 2000, Endothelin modulation of choroidal blood flow in the rabbit, Exp. Eye Res., 71, 543, 10.1006\u002Fexer.2000.0911\nKim, 1992, Corneal endothelial cytoskeletal changes in F-actin with aging, diabetes, and after cytochalasin exposure, Am. J. Ophthalmol., 114, 329, 10.1016\u002FS0002-9394(14)71800-8\nKlein, 1992, Diabetes, hyperglycemia, and age-related maculopathy: the Beaver Dam eye study, Ophthalmology, 99, 1527, 10.1016\u002FS0161-6420(92)31770-1\nKlein, 2000, The epidemiolgy of retinal vein occlusion: the Beaver Dam Eye Study, Trans. Am. Ophthalmol. Soc., 98, 133\nKliche, 2001, VEGF receptor signaling and endothelial function, IUBMB Life, 52, 61, 10.1080\u002F15216540252774784\nKluge, 2013, Mitochondria and endothelial function, Circ. Res., 112, 1171, 10.1161\u002FCIRCRESAHA.111.300233\nKnowlton, 1912, The influence of variations in temperature and blood-pressure on the performance of the isolated mammalian heart, J. Physiol., 44, 206, 10.1113\u002Fjphysiol.1912.sp001511\nKobayashi, 1999, Quantitative comparison of Zeiss-Humphrey model 840 and Rion UX-02 systems of ultrasound biomicroscopy, Graefes Arch. Clin. Exp. Ophthalmol., 237, 381, 10.1007\u002Fs004170050248\nKolka, 2013, The endothelium in diabetes: its role in insulin access and diabetic complications, Rev. Endocr. Metab. Disord., 14, 13, 10.1007\u002Fs11154-012-9233-5\nKroll, 1989, Transendothelial transport and metabolism of adenosine and inosine in the intact rat aorta, Circ. Res., 64, 1147, 10.1161\u002F01.RES.64.6.1147\nKu, 1993, Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries, Am. J. Physiol., 265, H586\nKumar, 1998, The distribution of angioarchitectural changes within the vicinity of the arteriovenous crossing in branch retinal vein occlusion, Ophthalmology, 105, 424, 10.1016\u002FS0161-6420(98)93022-6\nKur, 2012, Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease, Prog. Retin Eye Res., 31, 377, 10.1016\u002Fj.preteyeres.2012.04.004\nLaties, 1966, A comparative study of the autonomic innervation of the eye in monkey, cat, and rabbit, Anat. Rec., 156, 383, 10.1002\u002Far.1091560403\nLaties, 1967, Central retinal artery innervation, Arch. Ophthalmol., 77, 405, 10.1001\u002Farchopht.1967.00980020407021\nLehoux, 2003, Cellular mechanics and gene expression in blood vessels, J. Biomech., 36, 631, 10.1016\u002FS0021-9290(02)00441-4\nLew, 1992, Access of blood-borne vasoconstrictors to the arteriolar smooth muscle, J. Vasc. Res., 29, 341, 10.1159\u002F000158949\nLinsenmeier, 1992, Oxygen distribution and consumption in the cat retina during normoxia and hypoxemia, J. Gen. Physiol., 99, 177, 10.1085\u002Fjgp.99.2.177\nLip, 2000, Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment, Investig. Ophthalmol. Vis. Sci., 41, 2115\nLiu, 2013, Mechanosensitive properties in the endothelium and their roles in the regulation of endothelial function, J. Cardiovasc. Pharmacol., 61, 461, 10.1097\u002FFJC.0b013e31828c0933\nLiu, 1990, Ischemia and reperfusion increase 125I-labeled endothelin-1 binding in rat cardiac membranes, Am. J. Physiol., 258, H829\nLiu, 2008, Endothelial cytoskeletal elements are critical for flow-mediated dilation in human coronary arterioles, Med. Biol. Eng. Comput., 46, 469, 10.1007\u002Fs11517-008-0331-1\nManiotis, 1997, Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure, Proc. Natl. Acad. Sci. U. S. A., 94, 849, 10.1073\u002Fpnas.94.3.849\nMarcelo, 2013, Regulation of endothelial cell differentiation and specification, Circ. Res., 112, 1272, 10.1161\u002FCIRCRESAHA.113.300506\nMarcucci, 2010, Retinal vein occlusions: a review for the internist, Intern. Emerg. Med., 6, 307, 10.1007\u002Fs11739-010-0478-2\nMasaki, 1992, Physiology and pharmacology of endothelins, Med. Res. Rev., 12, 391, 10.1002\u002Fmed.2610120405\nMather, 2013, The vascular endothelium in diabetes–a therapeutic target?, Rev. Endocr. Metab. Disord., 14, 87, 10.1007\u002Fs11154-013-9237-9\nMatsuki, 1993, Comparison of conduit vessel and resistance vessel Reactivity: influence of intimal permeability, Am. J. Physiol., 33, H1251\nMay, 2005, Non-vascular smooth muscle cells in the human choroid: distribution, development and further characterization, J. Anat., 207, 381\nMcAllister, 2009, Management of submacular haemorrhage in age related macular degeneration with intravitreal tenecteplase, Br. J. Ophthalmol., 94, 260, 10.1136\u002Fbjo.2009.158170\nMcAllister, 2012, Central retinal vein occlusion: a review, Clin. Exp. Ophthalmol., 40, 48, 10.1111\u002Fj.1442-9071.2011.02713.x\nMcCue, 2004, Shear-induced reorganization of endothelial cell cytoskeleton and adhesion complexes, Trends Cardiovasc. Med., 14, 143, 10.1016\u002Fj.tcm.2004.02.003\nMeissner, 2007, The hemodynamics and diagnosis of venous disease, J. Vasc. Surg., 46, 4S, 10.1016\u002Fj.jvs.2007.09.043\nMendis, 2010, Correlation of histologic and clinical images to determine the diagnostic value of fluorescein angiography for studying retinal capillary detail, Investig. Ophthalmol. Vis. Sci., 51, 5864, 10.1167\u002Fiovs.10-5333\nMeyer, 1995, Effects of calcium channel blockers on the response to endothelin-1, bradykinin and sodium nitroprusside in porcine ciliary arteries, Exp. Eye Res., 60, 505, 10.1016\u002FS0014-4835(05)80065-X\nMolema, 2012, Vascular heterogeneity in the kidney, Semin. Nephrol., 32, 145, 10.1016\u002Fj.semnephrol.2012.02.001\nMonos, 1995, Local control of veins: biomechanical, metabolic, and humoral aspects, Physiol. Rev., 75, 611, 10.1152\u002Fphysrev.1995.75.3.611\nMorgan, 1995, The influence of cerebrospinal fluid pressure upon the lamina cribrosa tissue pressure gradient – correspondence, Investig. Ophthalmol. Vis. Sci., 36, 2163\nMorgan, 1995, The influence of cerebrospinal fluid pressure on the lamina cribrosa tissue pressure gradient, Investig. Ophthalmol. Vis. Sci., 36, 1163\nMorgan, 1998, The correlation between cerebrospinal fluid pressure and retrolaminar tissue pressure, Investig. Ophthalmol. Vis. Sci., 39, 1419\nMori, 2009, Hyperglycemia accelerates impairment of vasodilator responses to acetylcholine of retinal blood vessels in rats, J. Pharmacol. Sci., 110, 160, 10.1254\u002Fjphs.08320FP\nNees, 1985, The coronary endothelium: a highly active metabolic barrier for adenosine, Basic Res. Cardiol., 80, 515, 10.1007\u002FBF01907915\nNgai, 1993, Effects of adenosine and its analogues on isolated intracerebral arterioles – extraluminal and intraluminal application, Circ. Res., 73, 448, 10.1161\u002F01.RES.73.3.448\nNickla, 2010, The multifunctional choroid, Prog. Retin Eye Res., 29, 144, 10.1016\u002Fj.preteyeres.2009.12.002\nNielsen, 1989, Adrenergic responses in isolated bovine retinal resistance arteries, Int. Ophthalmol., 13, 103, 10.1007\u002FBF02028648\nNikonov, 2008, Mouse cones require an arrestin for normal inactivation of phototransduction, Neuron, 59, 462, 10.1016\u002Fj.neuron.2008.06.011\nNoma, 2006, Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion, Graefes Arch. Clin. Exp. Ophthalmol., 244, 309, 10.1007\u002Fs00417-004-1087-4\nNoma, 2009, Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion, Ophthalmology, 116, 87, 10.1016\u002Fj.ophtha.2008.09.034\nNoria, 2004, Assembly and reorientation of stress fibers drives morphological changes to endothelial cells exposed to shear stress, Am. J. Pathol., 164, 1211, 10.1016\u002FS0002-9440(10)63209-9\nOgawa, 1993, Role of the endothelium on extraluminal and intraluminal vasoactive mechanisms in the perfused rabbit basilar artery, Neurol. Res., 15, 154, 10.1080\u002F01616412.1993.11740128\nOldendorf, 1977, The large apparent work capability of the blood-brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat, Ann. Neurol., 1, 409, 10.1002\u002Fana.410010502\nOnat, 2011, Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis, Curr. Diabetes. Rep., 11, 193, 10.1007\u002Fs11892-011-0182-2\nOrth, 1978, Retinal branch vein occlusion, Surv. Ophthalmol., 22, 357, 10.1016\u002F0039-6257(78)90132-7\nPaneni, 2013, Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I, Eur. Heart J., 34, 2436, 10.1093\u002Feurheartj\u002Feht149\nPapadaki, 1999, Fluid shear stress as a regulator of gene expression in vascular cells: possible correlations with diabetic abnormalities, Diabetes Res. Clin. Pract., 45, 89, 10.1016\u002FS0168-8227(99)00036-4\nPapadopoulou, 2009, Intravitreal ranibizumab may induce retinal arteriolar vasoconstriction in patients with neovascular age-related macular degeneration, Ophthalmology, 116, 1755, 10.1016\u002Fj.ophtha.2009.03.017\nPark, 2011, Mitochondrial network determines intracellular ROS dynamics and sensitivity to oxidative stress through switching inter-mitochondrial messengers, PLoS One, 6, e23211, 10.1371\u002Fjournal.pone.0023211\nPark, 1997, Evaluation of parafoveal blood flow in branch retinal vein occlusion (BRVO) patients using heidelberg retina flowmeter (HRT), Investig. Ophthalmol. Vis. Sci., 38, S774\nParodi, 2009, Branch retinal vein occlusion: classification and treatment, Ophthalmologica, 223, 298, 10.1159\u002F000213640\nPatterson, 2001, Update on pulmonary edema: the role and regulation of endothelial barrier function, Endothelium, 8, 75, 10.3109\u002F10623320109165319\nPenn, 2008, Vascular endothelial growth factor in eye disease, Prog. Retin Eye Res., 27, 331, 10.1016\u002Fj.preteyeres.2008.05.001\nPolak, 2001, Effect of endothelin and BQ123 on ocular blood flow parameters in healthy subjects, Investig. Ophthalmol. Vis. Sci., 42, 2949\nPollack, 1989, The fellow eye in retinal vein occlusive disease, Ophthalmology, 96, 842, 10.1016\u002FS0161-6420(89)32801-6\nPospelova, 2013, An integrated approach for monitoring cell senescence, Methods Mol. Biol., 965, 383, 10.1007\u002F978-1-62703-239-1_26\nPotter, 1984, The clinical significance of the vortex veins, J. Am. Optom. Assoc., 55, 822\nPournaras, 2008, Regulation of retinal blood flow in health and disease, Prog. Retin Eye Res., 27, 284, 10.1016\u002Fj.preteyeres.2008.02.002\nPrasain, 2009, The actin cytoskeleton in endothelial cell phenotypes, Microvasc. Res., 77, 53, 10.1016\u002Fj.mvr.2008.09.012\nPries, 1995, Structure and hemodynamics of microvascular networks: heterogeneity and correlations, Am. J. Physiol., 269, H1713\nPries, 2006, Normal endothelium, Handb. Exp. Pharmacol., 1, 10.1007\u002F3-540-32967-6_1\nPries, 2008, The vascular endothelium: structural, functional and pathophysiological aspects, Biomed. Pharmacother., 62, 503, 10.1016\u002Fj.biopha.2008.07.032\nPries, 2009, Origins of heterogeneity in tissue perfusion and metabolism, Cardiovasc. Res., 81, 328, 10.1093\u002Fcvr\u002Fcvn318\nProvis, 1998, Ontogeny of the primate fovea: a central issue in retinal development, Prog. Neurobiol., 54, 549, 10.1016\u002FS0301-0082(97)00079-8\nPuro, 2012, Retinovascular physiology and pathophysiology: new experimental approach\u002Fnew insights, Prog. Retin Eye Res., 31, 258, 10.1016\u002Fj.preteyeres.2012.01.001\nQuyyumi, 2003, Prognostic value of endothelial function, Am. J. Cardiol., 91, 19H, 10.1016\u002FS0002-9149(03)00430-2\nRead, 2007, Actin structure in the outflow tract of normal and glaucomatous eyes, Exp. Eye Res., 84, 214, 10.1016\u002Fj.exer.2005.10.035\nRegan, 2012, Dynamical systems approach to endothelial heterogeneity, Circ. Res., 111, 110, 10.1161\u002FCIRCRESAHA.111.261701\nRehak, 2008, Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities, Curr. Eye Res., 33, 111, 10.1080\u002F02713680701851902\nRehak, 2010, Retinal vein thrombosis: pathogenesis and management, J. Thromb. Haemost., 8, 1886, 10.1111\u002Fj.1538-7836.2010.03909.x\nReinhart-King, 2008, Physiologic stress-mediated signaling in the endothelium, Methods Enzymol., 443, 25, 10.1016\u002FS0076-6879(08)02002-8\nResch, 2009, Endothelial dysfunction in glaucoma, Acta Ophthalmol., 87, 4, 10.1111\u002Fj.1755-3768.2007.01167.x\nResnick, 2003, Fluid shear stress and the vascular endothelium: for better and for worse, Prog. Biophys. Mol. Biol., 81, 177, 10.1016\u002FS0079-6107(02)00052-4\nRiva, 1986, Regulation of local oxygen tension and blood flow in the inner retina during hyperoxia, J. Appl. Physiol., 61, 592, 10.1152\u002Fjappl.1986.61.2.592\nRogers, 2010, The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia, Ophthalmology, 117, 313, 10.1016\u002Fj.ophtha.2009.07.017\nRosar, 2001, Fluid flow in collapsible elastic tubes: a three dimensional numerical model, N. Y. J. Math., 7, 281\nRudolphi, 1992, Adenosine and brain ischemia, Cerebrovasc. Brain Metab. Rev., 4, 346\nRyan, 2012\nSato, 2005, Biorheological views of endothelial cell responses to mechanical stimuli, Biorheology, 42, 421\nSciotti, 1997, Changes in extracellular adenosine during chemical or electrical brain stimulation, Brain Res., 613, 16, 10.1016\u002F0006-8993(93)90448-V\nSeitz, 1964\nSenger, 1983, Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid, Science, 219, 983, 10.1126\u002Fscience.6823562\nSimionescu, 1977, Methods for ultrastructural studies of the microcirculation, Bibl. Anat., 332\nSimionescu, 1984, Ultrastructure of the microvascular wall: functional correlations, 41\nSimmons, 2012, Heterogeneity of endothelial cell phenotype within and amongst conduit vessels of the swine vasculature, Exp. Physiol., 97, 1074, 10.1113\u002Fexpphysiol.2011.064006\nSmith, 1985\nSnodderly, 1990, Retinal vasculature of the fovea of the squirrel monkey, Saimiri sciureus: three-dimensional architecture, visual screening, and relationships to the neuronal layers, J. Comp. Neurol., 297, 145, 10.1002\u002Fcne.902970111\nSnodderly, 1992, Neural-vascular relationships in central retina of macaque monkeys (Macaca fascicularis), J. Neurosci., 12, 1169, 10.1523\u002FJNEUROSCI.12-04-01169.1992\nStefansson, 2006, Ocular oxygenation and the treatment of diabetic retinopathy, Surv. Ophthalmol., 51, 364, 10.1016\u002Fj.survophthal.2006.04.005\nSteinle, 2003, Nerve growth factor regulates human choroidal, but not retinal, endothelial cell migration and proliferation, Auton. Neurosci., 108, 57, 10.1016\u002FS1566-0702(03)00151-6\nStitt, 1995, Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients, Br. J. Ophthalmol., 79, 362, 10.1136\u002Fbjo.79.4.362\nStraubhaar, 2000, Choroidal laser Doppler flowmetry in healthy subjects, Arch. Ophthalmol., 118, 211, 10.1001\u002Farchopht.118.2.211\nSu, 1995, Altered vasoactivity in the early diabetic eye: measured in the isolated perfused rat eye, Exp. Eye Res., 61, 699, 10.1016\u002FS0014-4835(05)80021-1\nSu, 1996, Direct vasodilatory effect of insulin on isolated retinal arterioles, Investig. Ophthalmol. Vis. Sci., 37, 2634\nSu, 2000, Continued progression of retinopathy despite spontaneous recovery to normoglycemia in a long-term study of streptozotocin-induced diabetes in rats, Graefes Arch. Clin. Exp. Ophthalmol., 238, 163, 10.1007\u002Fs004170050028\nSu, 2012, An experimental study of VEGF induced changes in vasoactivity in pig retinal arterioles and the influence of an anti-VEGF agent, BMC Ophthalmol., 12, 10, 10.1186\u002F1471-2415-12-10\nSugiyama, 1996, The effects of intravitreally injected endothelin-1 on the iris- ciliary body microvasculature in rabbits, Curr. Eye Res., 15, 633, 10.3109\u002F02713689609008903\nTan, 2012, Quantitative confocal imaging of the retinal microvasculature in the human retina, Investig. Ophthalmol. Vis. Sci., 53, 5728, 10.1167\u002Fiovs.12-10017\nTan, 2013, Regional heterogeneity of endothelial cells in the porcine vortex vein system, Microvasc. Res., 89, 70, 10.1016\u002Fj.mvr.2013.06.004\nTanaka, 2007, Age-dependent telomere-shortening is repressed by phosphorylated alpha-tocopherol together with cellular longevity and intracellular oxidative-stress reduction in human brain microvascular endotheliocytes, J. Cell. Biochem., 102, 689, 10.1002\u002Fjcb.21322\nTaylor, 1993, Morphometric assessment of the central retinal artery and vein in the optic nerve head, Can. J. Ophthalmol., 28, 320\nThorin, 2009, Vascular endothelial ageing, heartbeat after heartbeat, Cardiovasc. Res., 84, 24, 10.1093\u002Fcvr\u002Fcvp236\nThorin, 2011, Vascular disease risk in patients with hypertriglyceridemia: endothelial progenitor cells, oxidative stress, accelerated senescence, and impaired vascular repair, Can. J. Cardiol., 27, 538, 10.1016\u002Fj.cjca.2011.03.014\nThurston, 2000, Determinants of endothelial cell phenotype in venules, Microcirculation, 7, 67, 10.1111\u002Fj.1549-8719.2000.tb00743.x\nTopper, 1999, Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype, Mol. Med. Today, 5, 40, 10.1016\u002FS1357-4310(98)01372-0\nTriggle, 2012, The endothelium: influencing vascular smooth muscle in many ways, Can. J. Physiol. Pharmacol., 90, 713, 10.1139\u002Fy2012-073\nTsai, 2003, Oxygen gradients in the microcirculation, Physiol. Rev., 83, 933, 10.1152\u002Fphysrev.00034.2002\nTuma, 2008\nTurello, 2010, Retinal vein occlusion: evaluation of “classic” and “emerging” risk factors and treatment, J. Thromb. Thrombolysis, 29, 459, 10.1007\u002Fs11239-009-0384-5\nUyama, 2000, Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology, Ophthalmology, 107, 441, 10.1016\u002FS0161-6420(99)00141-4\nVadapalli, 2000, Estimating oxygen transport resistance of the microvascular wall, Am. J. Physiol. Heart Circ. Physiol., 279, H657, 10.1152\u002Fajpheart.2000.279.2.H657\nVaghefi, 1978, Correlation of clinicopathologic findings in a patient. Congenital night blindness, branch retinal vein occlusion, cilioretinal artery, drusen of the optic nerve head, and intraretinal pigmented lesion, Arch. Ophthalmol., 96, 2097, 10.1001\u002Farchopht.1978.03910060477019\nvan Heuven, 1977, Pathogenesis of central retinal vein occlusion, Bibl. Anat., 1\nvan Nieuw Amerongen, 2008, Thrombin-induced endothelial barrier disruption in intact microvessels: role of RhoA\u002FRho kinase-myosin phosphatase axis, Am. J. Physiol. Cell Physiol., 294, C1234, 10.1152\u002Fajpcell.00551.2007\nVanhoutte, 2009, Endothelial dysfunction and vascular disease, Acta Physiol. (Oxf), 196, 193, 10.1111\u002Fj.1748-1716.2009.01964.x\nVinores, 1999, Cellular mechanisms of blood-retinal barrier dysfunction in macular edema, Doc. Ophthalmol., 97, 217, 10.1023\u002FA:1002136712070\nVoleti, 2013, Age-related eye disease, Maturitas, 75, 29, 10.1016\u002Fj.maturitas.2013.01.018\nVouret-Craviari, 1998, Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function, Mol. Biol. Cell., 9, 2639, 10.1091\u002Fmbc.9.9.2639\nWeinberg, 1990, Anatomy of arteriovenous crossings in branch retinal vein occlusion, Am. J. Ophthalmol., 109, 298, 10.1016\u002FS0002-9394(14)74554-4\nWeis, 2005, Pathophysiological consequences of VEGF-induced vascular permeability, Nature, 437, 497, 10.1038\u002Fnature03987\nWhite, 1983, Factors influencing the expression of stress fibers in vascular endothelial cells in situ, J. Cell. Biol., 97, 416, 10.1083\u002Fjcb.97.2.416\nWilliamson, 1997, Central retinal vein occlusion: what's the story?, Br. J. Ophthalmol., 81, 698, 10.1136\u002Fbjo.81.8.698\nWolf, 1991, Retinal capillary blood flow measurement with a scanning laser ophthalmoscope. Preliminary results, Ophthalmology, 98, 1000, 10.1016\u002FS0161-6420(91)32192-4\nWolinsky, 1980, A proposal linking clearance of circulating lipoproteins to tissue metabolic activity as a basis for understanding atherogenesis, Circ. Res., 47, 301, 10.1161\u002F01.RES.47.3.301\nYong, 2006, Trends in registered blindness and its causes over 19 Years in Western Australia, Ophthalmic Epidemiol., 13, 35, 10.1080\u002F09286580500473779\nYoshida, 1996, Morphological and cytoskeletal changes in endothelial cells of vein grafts under arterial hemodynamic conditions in vivo, J. Electron Microsc. (Tokyo), 45, 428, 10.1093\u002Foxfordjournals.jmicro.a023461\nYost, 1988, Age-related and site-specific adaptation of the arterial endothelial cytoskeleton during atherogenesis, Am. J. Pathol., 130, 595\nYu, 1990, The response of rat vitreal oxygen tension to stepwise increases in inspired percentage oxygen, Investig. Ophthalmol. Vis. Sci., 31, 2493\nYu, 1992, Relaxation effects of diltiazem, verapamil, and tolazoline on isolated cat ophthalmociliary artery, Exp. Eye Res., 55, 757, 10.1016\u002F0014-4835(92)90180-Z\nYu, 1992, Agonist response of human isolated posterior ciliary artery, Investig. Ophthalmol. Vis. Sci., 33, 48\nYu, 1994, Intraretinal oxygen distribution in rats as a function of systemic blood pressure, Am. J. Physiol., 36, H2498\nYu, 1999, Intraretinal oxygen distribution in the rat with graded systemic hyperoxia and hypercapnia, Investig. Ophthalmol. Vis. Sci., 40, 2082\nYu, 2001, Oxygen distribution and consumption within the retina in vascularised and avascular retinas and in animal models of retinal disease, Prog. Retin Eye Res., 20, 175, 10.1016\u002FS1350-9462(00)00027-6\nYu, 2001, Comparison of the vasoactive effects of the docosaoid unoprostone and selected prostanoids on isolated perfused retinal arterioles, Investig. Ophthalmol. Vis. Sci., 42, 1499\nYu, 2002, Outer retinal anoxia during dark adaptation is not a general property of mammalian retinas, Comp. Biochem. Physiol., 132, 47, 10.1016\u002FS1095-6433(01)00528-1\nYu, 2005, Intraretinal oxygen distribution in the monkey retina and the response to systemic hyperoxia, Investig. Ophthalmol. Vis. Sci., 46, 4728, 10.1167\u002Fiovs.05-0694\nYu, 1994, Vasoactivity of intraluminal and extraluminal agonists in perfused retinal arteries, Investig. Ophthalmol. Vis. Sci., 35, 4087\nYu, 1998, Effect of betaxolol, timolol and nimodipine on human and pig retinal arterioles, Exp. Eye Res., 67, 73, 10.1006\u002Fexer.1998.0495\nYu, 1999, Systemic and ocular vascular roles of the antiglaucoma agents beta-adrenergic antagonists and Ca2+ entry blockers, Surv. Ophthalmol., 43, S214, 10.1016\u002FS0039-6257(99)00042-9\nYu, 2003, Isolated preparations of ocular vasculature and their applications in ophthalmic research, Prog. Retin Eye Res., 22, 135, 10.1016\u002FS1350-9462(02)00044-7\nYu, 2007, Intraretinal oxygen distribution and consumption during retinal artery occlusion and graded hyperoxic ventilation in the rat, Investig. Ophthalmol. Vis. Sci., 48, 2290, 10.1167\u002Fiovs.06-1197\nYu, 2012, Author response: morphometric characteristics of central retinal artery and vein in the optic nerve head of patients with diabetes, Investig. Ophthalmol. Vis. Sci., 53, 1637, 10.1167\u002Fiovs.12-9703\nYu, 1996, Effect of different flow rates on retinal endothelial microfilaments, Aust. N. Z. J. Ophthalmol., 24, 67, 10.1111\u002Fj.1442-9071.1996.tb01000.x\nYu, 1997, Heterogeneous endothelial cell structure along the porcine retinal microvasculature, Exp. Eye Res., 65, 379, 10.1006\u002Fexer.1997.0340\nYu, 1998, Intracellular structures of retinal vascular endothelium in normal and early diabetic rats, Aust. N. Z. J. Ophthalmol., 26, S53, 10.1111\u002Fj.1442-9071.1998.tb01372.x\nYu, 2000\nYu, 2000, Acetylcholine-induced relaxation in rat ocular vasculature, J. Ocul. Pharmacol. Ther., 16, 447, 10.1089\u002Fjop.2000.16.447\nYu, 2001, Tetrahydrobiopterin reverses the impairment of acetylcholine-induced vasodilatation in diabetic ocular microvasculature, J. Ocul. Pharmacol. Ther., 17, 123, 10.1089\u002F10807680151125438\nYu, 2005, Endothelial F-actin cytoskeleton in the retinal vasculature of normal and diabetic rats, Curr. Eye Res., 30, 279, 10.1080\u002F02713680590923230\nYu, 2010, The structural relationship between the microvasculature, neurons, and glia in the human retina, Investig. Ophthalmol. Vis. Sci., 51, 447, 10.1167\u002Fiovs.09-3978\nYu, 2010, Microstructure and network organization of the microvasculature in the human macula, Investig. Ophthalmol. Vis. Sci., 51, 6735, 10.1167\u002Fiovs.10-5415\nYu, 2012, Age-related changes in venous endothelial phenotype at human retinal artery-vein crossing points, Investig. Ophthalmol. Vis. Sci., 53, 1108, 10.1167\u002Fiovs.11-8865\nYu, 2013, Phenotypic heterogeneity in the endothelium of the human vortex vein system, Exp. Eye Res., 115C, 144, 10.1016\u002Fj.exer.2013.07.006\nZhao, 1993, Arteriovenous crossing patterns in branch retinal vein occlusion. The eye disease case-control study group, Ophthalmology, 100, 423, 10.1016\u002FS0161-6420(93)31633-7",{"VOID":2212},"10.1016\u002Fj.preteyeres.2014.02.001","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1350946214000135",[2215,2248,2275,2302,2329],{"id":2216,"sortIndex":92,"researcher":24,"roles":2217,"affiliations":2218,"properties":2245,"displayName":2247,"givenName":24,"familyName":24},"6e6efc38-3527-4612-807d-8da76f45f3fe",[143],[2219,2227,2236],{"id":2220,"sortIndex":92,"affiliation":2221,"properties":24},"2464be55-8b60-4050-9593-bc3a74477238",{"id":2220,"createTime":24,"updateTime":24,"relativeEntities":2222,"slug":24,"properties":2223,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2226,"statistic":24},[],{"title":2224},{"VI":2225},"Centre for Ophthalmology and Visual Science, The University of Western Australia, Perth, Australia",[],{"id":2228,"sortIndex":870,"affiliation":2229,"properties":2235},"2a08440b-9b72-4392-826d-626cc4590a50",{"id":2228,"createTime":24,"updateTime":24,"relativeEntities":2230,"slug":24,"properties":2231,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2234,"statistic":24},[],{"title":2232},{"VI":2233},"Australian Research Council Centre of Excellence in Vision Science, The University of Western Australia, Perth, Australia",[],{},{"id":2237,"sortIndex":900,"affiliation":2238,"properties":2244},"70b3f218-7102-46fc-b316-0366ff9920f7",{"id":2237,"createTime":24,"updateTime":24,"relativeEntities":2239,"slug":24,"properties":2240,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2243,"statistic":24},[],{"title":2241},{"VI":2242},"Lions Eye Institute, The University of Western Australia, Perth, Australia",[],{},{"title":2246},{"VI":2247},"Dao-Yi Yu",{"id":2249,"sortIndex":870,"researcher":24,"roles":2250,"affiliations":2251,"properties":2272,"displayName":2274,"givenName":24,"familyName":24},"28e5807a-e39b-4181-8072-f6514c1d233b",[143],[2252,2258,2265],{"id":2220,"sortIndex":92,"affiliation":2253,"properties":24},{"id":2220,"createTime":24,"updateTime":24,"relativeEntities":2254,"slug":24,"properties":2255,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2257,"statistic":24},[],{"title":2256},{"VI":2225},[],{"id":2228,"sortIndex":870,"affiliation":2259,"properties":2264},{"id":2228,"createTime":24,"updateTime":24,"relativeEntities":2260,"slug":24,"properties":2261,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2263,"statistic":24},[],{"title":2262},{"VI":2233},[],{},{"id":2237,"sortIndex":900,"affiliation":2266,"properties":2271},{"id":2237,"createTime":24,"updateTime":24,"relativeEntities":2267,"slug":24,"properties":2268,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2270,"statistic":24},[],{"title":2269},{"VI":2242},[],{},{"title":2273},{"VI":2274},"Paula K. Yu",{"id":2276,"sortIndex":900,"researcher":24,"roles":2277,"affiliations":2278,"properties":2299,"displayName":2301,"givenName":24,"familyName":24},"11fe952e-8e49-42b4-9bec-b3a276852bed",[143],[2279,2285,2292],{"id":2220,"sortIndex":92,"affiliation":2280,"properties":24},{"id":2220,"createTime":24,"updateTime":24,"relativeEntities":2281,"slug":24,"properties":2282,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2284,"statistic":24},[],{"title":2283},{"VI":2225},[],{"id":2228,"sortIndex":870,"affiliation":2286,"properties":2291},{"id":2228,"createTime":24,"updateTime":24,"relativeEntities":2287,"slug":24,"properties":2288,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2290,"statistic":24},[],{"title":2289},{"VI":2233},[],{},{"id":2237,"sortIndex":900,"affiliation":2293,"properties":2298},{"id":2237,"createTime":24,"updateTime":24,"relativeEntities":2294,"slug":24,"properties":2295,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2297,"statistic":24},[],{"title":2296},{"VI":2242},[],{},{"title":2300},{"VI":2301},"Stephen J. Cringle",{"id":2303,"sortIndex":914,"researcher":24,"roles":2304,"affiliations":2305,"properties":2326,"displayName":2328,"givenName":24,"familyName":24},"202a0614-ce28-4bd6-bbbb-5fa788e1f1c3",[143],[2306,2312,2319],{"id":2220,"sortIndex":92,"affiliation":2307,"properties":24},{"id":2220,"createTime":24,"updateTime":24,"relativeEntities":2308,"slug":24,"properties":2309,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2311,"statistic":24},[],{"title":2310},{"VI":2225},[],{"id":2228,"sortIndex":870,"affiliation":2313,"properties":2318},{"id":2228,"createTime":24,"updateTime":24,"relativeEntities":2314,"slug":24,"properties":2315,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2317,"statistic":24},[],{"title":2316},{"VI":2233},[],{},{"id":2237,"sortIndex":900,"affiliation":2320,"properties":2325},{"id":2237,"createTime":24,"updateTime":24,"relativeEntities":2321,"slug":24,"properties":2322,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2324,"statistic":24},[],{"title":2323},{"VI":2242},[],{},{"title":2327},{"VI":2328},"Min H. Kang",{"id":2330,"sortIndex":1110,"researcher":24,"roles":2331,"affiliations":2332,"properties":2353,"displayName":2355,"givenName":24,"familyName":24},"51695bd1-89ae-4388-924e-070e826289c5",[143],[2333,2339,2346],{"id":2220,"sortIndex":92,"affiliation":2334,"properties":24},{"id":2220,"createTime":24,"updateTime":24,"relativeEntities":2335,"slug":24,"properties":2336,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2338,"statistic":24},[],{"title":2337},{"VI":2225},[],{"id":2228,"sortIndex":870,"affiliation":2340,"properties":2345},{"id":2228,"createTime":24,"updateTime":24,"relativeEntities":2341,"slug":24,"properties":2342,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2344,"statistic":24},[],{"title":2343},{"VI":2233},[],{},{"id":2237,"sortIndex":900,"affiliation":2347,"properties":2352},{"id":2237,"createTime":24,"updateTime":24,"relativeEntities":2348,"slug":24,"properties":2349,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2351,"statistic":24},[],{"title":2350},{"VI":2242},[],{},{"title":2354},{"VI":2355},"Er-Ning Su",{"url":2213,"publisher":2357,"properties":2404},{"id":6,"createTime":7,"updateTime":8,"relativeEntities":2358,"slug":10,"properties":2359,"entityType":22,"verifyStatus":23,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":25,"subjectFields":2364,"manageAffiliations":2373,"indexDatabases":2384,"url":90,"thumbnailPath":24,"statistic":2399,"gsStatistic":24,"type":24,"analyzePriority":24},[],{"country":2360,"eissn":2361,"issn":2362,"title":2363},{"VOID":13},{"VOID":15},{"VOID":17},{"EN":19},[2365,2369],{"id":28,"createTime":24,"updateTime":24,"relativeEntities":2366,"label":2367,"description":2368,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":31},{},{"id":34,"createTime":24,"updateTime":24,"relativeEntities":2370,"label":2371,"description":2372,"parentId":24,"standard":24,"scholarHubFieldId":24},[],{"EN":37},{},[2374,2379],{"id":41,"createTime":24,"updateTime":24,"relativeEntities":2375,"slug":24,"properties":2376,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2378,"statistic":24},[],{"title":2377},{"EN":45},[],{"id":48,"createTime":24,"updateTime":24,"relativeEntities":2380,"slug":24,"properties":2381,"entityType":24,"verifyStatus":24,"verifyTime":24,"verifyNote":24,"languages":24,"translateLanguages":24,"viewCount":24,"url":24,"parentIds":2383,"statistic":24},[],{"title":2382},{"EN":52},[],[2385,2392],{"id":56,"indexDatabase":2386,"url":67,"indexYears":68,"academicFieldIds":2391,"indexDatabaseRanking":72},{"id":58,"createTime":24,"updateTime":24,"relativeEntities":2387,"label":2388,"description":2389,"key":64,"publicationTags":2390,"standard":24},[],{"EN":61,"VI":61},{"EN":61,"VI":63},[66],[70,71],{"id":74,"indexDatabase":2393,"url":87,"indexYears":24,"academicFieldIds":2398,"indexDatabaseRanking":24},{"id":76,"createTime":24,"updateTime":24,"relativeEntities":2394,"label":2395,"description":2396,"key":83,"publicationTags":2397,"standard":24},[],{"EN":79,"VI":79},{"EN":81,"VI":82},[85,86],[89],{"impactFactor":92,"impactFactorByYear":2400,"i10Index":92,"i10IndexLast5Year":92,"totalPublication":94,"totalPublicationByYear":2401,"totalCitation":92,"totalCitationByYear":2402,"totalCitationPerPublication":92,"totalCitationPerPublicationByYear":2403,"hindexLast5Year":92,"hindex":92},{},{"1994":96,"1995":97,"1996":98,"1997":99,"1998":100,"1999":101,"2000":102,"2001":103,"2002":104,"2003":102,"2004":100,"2005":103,"2006":105,"2007":106,"2008":98,"2009":106,"2010":97,"2011":105,"2012":104,"2013":107,"2014":105,"2015":108,"2016":108,"2017":109,"2018":110,"2019":111,"2020":112,"2021":113,"2022":114,"2023":111},{},{},{"pages":2405,"volume":2407},{"VOID":2406},"53-93",{"VOID":2408},"40","2014-05-01",[85,72]]